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INTRODUCTION 
The research of this thesis has been focused on the biomedical engineering aspects of new 
techniques of echocardiography. In close collaboration with the engineers of the Experimental 
Echocardiography Department of the Thoraxcentre, Erasmus University, Rotterdam, new methods 
to measure coronary blood flow and arterial wall elasticity with intravascular ultrasound (IVUS) 
have been developed. We have also investigated the clinical application of these measurements and 
have tried to improve traditional techniques based on intracoronary Doppler wires. In another field, 
we have developed a method to determine the radiation dose delivered in the wall of coronary 
arteries treated with brachytherapy. in collaboration with the Emory University, Atlanta, GA. This 
method utilizes 3-dimensional IVUS reconstruction combined with radiotherapy treatment plan-
ning. Finally, the tools developed for the recording of the signals of intracoronary Doppler wires have 
been adapted, during a stay at the Cleveland Clinic Foundation, OK for the study of left ventri-
cular mechanics and the compliance of the large arteries. This has been achieved by simultaneous 
acquisition of non-invasive pressure (with tonometry) and flow (with transthoracic Doppler 
echocardiography) signals. The fruits of an old and close collaboration with the Institute 
Biomedical Technology of the Ghent University can also be found in different chapters. This work 
is subdivided in five major parts, and a detailed introductory chapter precedes each one. 
What is biomedical engineering? 
Following the report of a panel of experts of the NIH (National Institutes of Health), biomedical 
engineering is rooted in physics. mathematics. chemistry, biology and life sciences. It is the appli-
cation of a systematic, quantitative and integrative way of thinking about and approaching solutions 
to problems that are important to biology, medical research and population studies. The NIH defi-
nition is the following: "Bioengineering integrates physical, chemical or mathematical sciences and 
engineering principles for the study of biology, medicine, behavior or health. It advances funda-
mental concepts, creates knowledge from the molecular to the organ systems levels, and develops 
innovative biologics. material. processes. implants, devices, and informatics approaches for the 
prevention, diagnosis, and treatment of disease, for patient rehabilitation, and for improving 
health." 
Biomedical engineering is the fastest growing specialty at engineering schools today. In the United 
States alone, there are 10,000 companies specializing in medical devices, diagnostic products and 
health information systems, creating opportunities for many of these new engineers. Efforts span 
from using engineering principles to help decipher the intricacies of cell signaling. to developing 
new imaging technologies. Bioengineering-related research projects require a multidisciplinary 
team of engineers, computer scientists, mathematicians, physicists, physicians and biologists to 
work on biological problems. As an illustration, table 1 summarizes the ever-expanding number of 
different societies where "bioengineers" can be found, and their related peer-review journals. 
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Tobie 1: Bioengineering Md biomedical societies Md joumols (focusing on ultro.sound) 
Acoustical Society of America 
American As...;ociation for the Advancement of Science 
American Medical Informatics Association 
American Society of Mechanical Engineers 
Association for the Advancement 
of Medical Instrumentation 
Biomedical Engineering Society 
Biophysical Society 
Controlled Release Society 
European Federation of Societic...; 
For Ultrasound in Medicine and Biology 
International Federation for 
Medical and Biological Engineering 
International Society for Optical Engineering 
Institute of Electrical and Electronics Engineers 
Journal of the Acoustical Society of America 
Science 
Journal of the American Medical Informatics Association 
Journal of Biomechanical Engineering Annual Reviews 
Biomedical Instrumentation and Technology 
Annals of Biomedical Engineering 
Biomedical Engineering Society Bulletin 
Biophy.sical Journal 
Journal of Controlled Release 
European Journal of Ultra."ound 
IFBME news and clinical engineering update 
Medical and Biological Engineering and Computing 
Journal of Biomedical Optics 
IEEE EMBS Book Series 
IEEE Engineering in Medicine and Biology Magazine 
IEEE Transactions on Biomedical Engineering 
IEEE Transactions on Medical Imaging 
IEEE Transactions on Neural Systems and Rehabilitation 
IEEE Transactions on Ultru...;onics, Ferroelectrics and Frequency 
Control 
Nationa1 Science Foundation NSF Engineering Senior Design Projects to Aid the Disabled 
Society for Biomaterials Journal of Biomedical Materials Research 
World Federation for Ultr~ound in Medicine and Biology Ultrasound in Medicine nod Biology 
Others Annual Reviews in Biomedical Engineering 
Biomatcrials 
Clinical Biomechanics 
Dental Materials 
Journal of Biomechanics 
Medical Engineering .:md Physics 
Ultrasonics 
Ultrasonic Imaging 
The most important areas of biomedical engineering are thought to be computational science. 
imaging and tissue engineering: 
14 
Genome: the genome project, the increasing demand of gene sequencing and the functional 
genomics application, studying how genes are turned on and off and how proteins interact. 
require the most powerful computers available to present, manipulate, visualize, understand 
or exchange these data. Other bioengineering developments that require similar extensive 
number-crunching performances include artificial sight, life-support in hostile environments 
such as space flights, and nanotechnologies; 
Imaging: visualization needs range from three-dimensional x-ray crystallography to 
functional imaging of organs. with the integration of the fourth dimension: movement over 
time. The visualization of the results of any bio-engineering project requires graphical 
representations of the data too numerous to be only reported in tables and listings; 
Tissue engineering: in conventional biology, molecular regulation of ceil behavior has been 
studied. However, now, with tissue engineering. research is focused on ways to modify these 
molecular regulations with polymeric materials. Possible applications range from gene 
therapy (embedding gene sequences in microcapsules designed to enter specific cells) to 
artificial organs. 
Numerous other research topics in bioengineering are given in table 2. Most of them require ex-
tensive signal processing for BEG, ECG, biorythms, MRI, X-rays acquisition, presentation and 
interpretation. 
Table 2: Bioengineering topics 
Biomedical Engineering 
Rehabilitation Engineering 
Medical Imaging 
Signal processing 
Modeling 
Bioelectronics 
Devices 
Electromagnetic fields 
Optics 
LJ.~ers and electro-optics 
Intelligence systems 
DNA sequencing 
Brain--computer interfaces 
Functional neuromuscular stimulation 
EMG and EEG studies 
Posture and gait 
Wheelchairs and seating 
Sensory substitution 
Ultrasound imaging 
X-ray 
Magnetic resomnce imaging 
Optical imaging 
Computed tomography 
Single photon emission computed tomogmphy 
Electron microscopy 
Image processing (segmentation. compression,,,) 
Image guided surgery 
There was little activity in biomedical engineering before World War II and little communication 
or interaction existed between the engineer and the life scientist. However, there were exceptions 
and the studies of Aristotle (384-322 BC) or Leonardo da Vinci ( 1452-1519) on the movements of 
animals and of the human body can be seen as the foundations of biomechanics, one of the major 
field of bioengineering and rehabilitation medicine today. It is very difficult to define when bio-
engineering really begun. Galileo Galilei (1564-1642) was first a student of medicine before 
becoming a famous physicist and could be considered as one of the first bioengineers: he disco-
vered the constancy of the period of the pendulum. and used the pendulum to measure the pulse 
rate of people, expressing the results quantitatively in terms of the length of a pendulum synchro-
nous to the heart. William Harvey (1578-1658), probably a disciple of Galileo. was influenced by 
his theories in biomechanics and his principles of measurements. By measuring the capacity of the 
heart, he estimated that the heart beats were pumping more than 200 liters of blood in one hour, and 
he could only conclude that the circulation was a necessary condition for the function of the heart. 
However, bioengineering really took off only in the 1950's with a strong influence of electrical 
engineers in the medical and life-support fields. Medical instrumentation and medical electronics 
were the major areas of research, but also applications in biological modeling, blood-flow dyna-
mics, prosthetics. biomechanics,. biological heat transfer and biomaterials increased steadily. Early 
developments started from specific desire such as the need for surgeons to bypass the heart or the 
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need to take over the function offailing kidneys, The early contacts established between physicians 
or physiologists and engineers were personal. The communication between them was immediately 
recognized as a problem. Most of these engineers had just had a minimal exposure to life science 
and biology during their curriculum. It is only much later, when recognizing a need to assist in 
overcoming the communication barrier as well as to prepare engineers for the future, that engi-
neering schools developed curricula in biomedical engineering. The other way to be directly 
involved in biomedical engineering is reflected by this thesis: a clinician, during and after his me-
dical school and clinical fellowship, tries to understand how the biological systems are working, as 
wel1 as the devices used to measure these activities. By keeping a close collaboration and dialogue 
with engineers, new tools can be developed that will remain focused on clinically relevant pro-
blems. Finally, a MD arguing some expertise in bioengineering is perhaps only someone who can 
help clinical and engineering experts, living in completely different worlds, to communicate. 
Outline of the thesis: 
The first part of this thesis focuses on measurements of the coronary blood flow and pressure using 
conventional 0.014" wires and is introduced in chapter 1 by a review of different developments in 
this field. In chapter 2, we investigate the determinants of the coronary flow and resistance reserve 
in a population of patients where histologic studies of the microvascular bed were possible. 
Capillary density was measured from surgical specimens of patients with hypertrophic cardio-
myopathy and cardiac biopsies in transplant recipients served as the control group. In chapter 3, 
we present the development of an acquisition system for the combined recording of raw Doppler 
signals together with physiological signals such as an ECG or pressure recordings. This system, 
which improves the archiving and post-processing of intracoronary Doppler measurements. facili-
tates the evaluation of parameters combining pressure and flow measurements. In chapter 4, we 
compare the cost-effectiveness of a strategy of balloon angioplasty guided by Doppler flow velo-
city and angiography wlth a strategy of primary stenting. The patients randomized to provisional 
angioplasty were further sub-randomized, after optimization, to either additional stenting or termi-
nation of the procedure to further investigate what could be optimal. Optimal results, initially based 
on a previous study, were defined as a coronary flow reserve >2.5 and a diameter stenosis S: 35%. 
In chapter 5, we test in vitro whether the fractional flow reserve (FFR), a physiological index based 
on coronary pressure measurements recently introduced for the assessment of coronary stenoses 
and interventions, can discriminate between suboptimally and optimally deployed stents. We per-
formed quantitative angiography as well as IVUS in order to determine which imaging technique 
best correlated to the FFR results. 
Chapter 6 explains the principles of a new methodology developed in our laboratory and intro-
duces the second part of this thesis, describing the simultaneous combined assessment of morpho-
logical and physiological parameters with one IVUS catheter. Flow velocity is estimated from the 
decorrelation of successive radiofrequency (RF) traces. Validations of these measurements, based 
on a rotating scanner, that were performed in a carotid pig model are presented in chapter 7. In 
chapter 7b preliminary clinical data are further illustrated by a case report. In chapter 8, the dis-
turbances in the 3-D velocity profile induced by the catheter in the coronary lumen are evaluated 
by applying computational fluid dynamics. The latest developments and in vitro calibration of the 
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IVUS flow method using an array catheter are reported in chapter 9. In this chapter we analyse the 
influence of factors such as the catheter ring-down (the artefact related to its vibration after elec-
trical excitation), the catheter eccentricity, noise. 
Part three of this thesis deals with a new method developed for measuring the local elastic proper-
ties of coronary arteries using intravascular ultrasound. In chapter 10 the principles of coronary 
elastography are introduced. We give an overview of the innovative developments and applications 
of this rapidly growing field. including the potential to detect vulnerable plaques. The feasibility to 
pe1form these measurements during percutaneous interventions is reported in chapter 11. A sim-
plified method of elastography, called palpography, potentially more robust in a clinical setting. and 
faster to process, is introduced in chapter 12. 
The fourth part of this dissertation is related to the use of radioactive sources in interventional car-
diology (coronary brachytherapy) to decrease the restenosis process. In chapter 13, we stress the 
importance of IVUS imaging in coronary brachytherapy. We illustrate the different applications of 
IVUS in assessing vascular remodeling, in helping the prescription of an optimal dose and in 
assessing the vessel wall dosimetry. In chapter 14. we emphasize our contribution in this field. 
with the development of 3-dimensional dosimetry and the evaluation of dose volume histograms. 
We have investigated, by computer simulation, the different existing modalities in brachytherapy 
(centered- or non-centered b-and g-sources) and the influence of their respective use on the homo-
geneity of the dose distribution across the arterial wall. We demonstrate that 3-d dosimetry is a 
valuable tool to understand IVUS (chapter 15) and quantitative coronary angiography (chapter 
16) outcomes of patients treated with brachytherapy. 
The last part of this thesis summarizes non-coronary applications based on transthoracic echocar-
diography. The principles of this important imaging modality in cardiology are given in chapter 17. 
The tools developed for the recordings of invasive Doppler and pressure signals have been applied 
to non-invasive transthoracic Doppler echocardiography. In chapter 18, we develop a combined 
acquisition of of non-invasive pressure and flow data for the assessment of the compliance of the 
large arteries using the pulse pressure method, which had been previously only investigated in ani-
mals using invasive recordings. Considering the limitations of carotid tonometry, we have investi-
gated the changes of the arterial pressure contour wave between the carotid and radial sites in order 
to preferentially use this site. The transfer function that we could characterize is reported in chap-
ter 19. Finally. in chapter 20, we demonstrate an original evaluation of ventricular contractility 
based on the determination of left ventricular peak power during supine exercise. In the studied 
population, the derived contractile reserve index correlated well with the simultaneously measured 
peak oxygen consumption (V02). 
17 
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PART I 
Intracoronary Doppler and Pressure Measurements 
19 
20 
Chapter 1 
Intracoronary Doppler and pressure monitoring. 
SG Carlier, C DiMario, M J Kern, PW Serruys. 
E Topol (ed), Textbook of lnterventional Cardiology (3rd ed), 1998; p 748-781. 
21 
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CHAPTER 
40 
Stephane G. Cartier / Carlo DiMario / Morton j Kern 
Patrick W. Serruys 
Intracoronary Doppler and 
Pressure Monitoring 
Andre::J.$ Grii.nt7Jg performed the first percutaneous tr.tnslumi· 
n:ll coro=.ry :mgiopl:tSty (PTCA) in 1977 using 4-French dilation 
catheters with a double lumen, :tllowing on one side balloon 
inflation and on the other side pressure recordings. He de· 
scribed trans-stenotic pressure gradient measurements as a 
guide to the progress of the dilation.' At th:lt time, pressure 
gradient measurements were routinely performed and used to 
monitor the intervention and tO :tSSCSS the final results: a rcsid· 
ual trnns-stenotic gradient less than 20 mm Hg v.':!.S considered 
optimal.~ However, with technical developments such ::1.$ the 
flexible-tipped guidev.·ire introduced in the lumen previously 
used to measure pressure :md the low-profile b:tlloons, pressure 
recordings were more difficult tO perform. Moreover, the rda· 
tions among the measured pressure gradient, the diameter ste· 
nosis, and the le:;ion length were imprecisely known, and they 
depended on the presence of the catheter itself in the stenosis.·' 
Finally, pressure gradient had a limited prognostic value and 
distal pn.--ssure recordings were abandoned because the pres-
sure channel 'W:lS eliminated to improve the crossing profile of 
the b:illoons :md because of the advent of quantitative coronary 
angiography (QCA). 
In parallel, attempts were made to mount pie.t.oe!ectric crys-
tal at the tip of catheters•· ~ to cha.r:~.ctcrize coronary blood flow, 
but the panial obstruction of the coronary ostium by those 
relatiYe!y large catheters limited their dinical use. With the 
development of pa.r:Lmeters to :tSsess the functional significance 
of a stenosis from its geometry with QCA/• many intcrvcntional 
cardiologists considered that the available anatOmic information 
wa.s sufficient :tnd that these attempts to perform physiologic 
pressure and flow recordings were only for research purposes. 
The limitations of QCA for the physiologic assessment of 
intermediate coronary lesions in unsdected patients with exten· 
sive coronary atherosclerosis have now been recognizcd"· 11; the 
haziness of the borders of the vessel after PTCA also limits the 
use of QCA tO assess the acute results of an intervention. 
On the other hand, technical improvements have allowed the 
development of miniaturized pressure and Doppler trn.nsduce("S, 
mounted on 0.014-in. guidewires, which alleviate the initial 
fluid dynamics problems. The clinical importance of the coro-
nary flow r<..-servc (CFR) distal to a stenosis, derived from Dopp-
ler recording, or the myocardial fractional flow reserve 
(FFRmyo). derived from pressure recordings, are explained in 
this chapter. 
Recently. the association of a CFR greater than 2.5 and a 
diameter stenosis less than 35% h:tS been demonstr.ttcd as a 
prognostic factor for the recurrence of ~ymptoms and the restc-
nosis r.tte in patient..; underj.:oinp; PTCA.'' The safety of not 
performing an angioplasty for intermediate stenosb without 
a functional significant severity asses....;ed hy flow or pressure: 
748 
mea::."Uremems has also been demonstrated. '0 • '' 1bis new inter· 
est in pressure and flow recordings illustrates one more =m-
ple of the swing back of the pendulum, a commonly seen 
process in interventional cardiology. 
INTRACORONARY DOPPLER PROBES 
Principles of Doppler Velocimetry 
An observer moving toward a sound source hears a tone with 
higher frequency than at rest; an observer moving away from 
the source hears a tone of lower frequency. This change in 
frequency is called the Dopplr.:r effect after 01ristian Johann 
Doppler (1803 to 1853), an Austrian physicist who was the 
first tO describe this phenomenon. This principle is applied in 
practice by mounting a piezoelectric crystal that emits and 
receive:; high-frequency sounds on the tip of an intrav:J.Scular 
catheter. The blood flow velocity alters the return frequency. 
causing the Doppler shift. Electronic circuits performing spec· 
tra.l analysis of the received signal allow continuous determina-
tion of the Doppler shift and of blood flow velocity, b:tSed on 
the following Doppler equation: 
where V "" velocity of blood flow, F" "" tr.tnsmitting (trn.ns-
ducer) frequency, F, "" returning frequency, C "" const:mt: 
speed of sound in blood, and<!> = angle of incidence. 
Ma:Umum velocity can be recorded, provided the transducer 
beam is nearly parallel to blood flow and <!> is zero so that the 
cosine (<\>) is 1. With cominuous-\vave Doppler, the signal rc· 
Deets all the flow velocities encountt:red by the exploring ultr.:t· 
sound beam. In contrn.st, a pulsed.wave Doppler permits deter-
mination of both magnitude and direction of the flow changes 
at a predetermined distance from the transducer. lntracoronary 
Doppler has several adva.nt:J.ges for the assessment of the coro-
nary circulation. Doppler flowmeters directly measure the red 
blood cell velocity so that flow markers are not required. 
allowing a continuous assessment of flow. Since the C'.ttheter 
can be selectively insened in cpicardial vessels, regional mea-
suremen~ are possible. There is a direct relation between vdoc· 
ity and volumetric flow. where blood flow = vessel cross-sec-
tional an:a X m<::l.n flow velocity. The differenc<."S or chan~-:es 
in Doppler coronary flow velocities. tbus. can be u:;cd to repre-
sent changes in absolute coronary Dow, provided the eros....;. 
sectional aro remains constant. lntr.tcoronary Doppler, how-
ever, also ha..; several limit:J.tions. l11e method is extremely 
~space dependent~ and may be afft:cted hy the stenosis gcomc-
23 
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try as well as by the intracoronary velocity profile.• The angle 
existing between the piezoelectric crystal and the main stream 
of the blood is critical. for the estimation of flow velocity. ' 2 In 
addition, the sampling volume Cl.I1 be rnther limited and does 
not necessarily represent the mean velocity of the blood 
stream.'~ Finally, the catheter itself changes the velocity profile 
in the arterial lumen, and this velocity profile is not constant 
during the pul~tile-flow condition of a cardiac cycle. 
Doppler Probes Mounted on Angiographic 
Catheters 
The first attempts to record Doppler tracings at the ostium 
of the native coronary vessels were performed with a 2Q..MHz 
piezoelectric crystal mounted at the tip of a standard 8-French 
Sones catheter'j and later on a Judkins c:~thctcr.~ 
With these systems, however, no selective measurements 
were made in the vessel(s) of interest, and a contamination of 
the coronary flow due to aortic components was present. The 
presence of the relatively large catheter in the coronary ostium 
was partly limiting the coronary blood flow, especially during 
hyperc."ffiia. 
Intracoronary Doppler Catheters 
At the University of IOW':l, special suction-mounted epicardi::tl 
Doppkr probes were designed for intraopt..-rative and experi-
mental use, 14 and an evaluation of relative flow changes was 
performed.'s Changes in coronary blood flow velocity measured 
with this intravascular ultrasonic flowmeter correlated well with 
flow measurcmc.-nt performed with microsphcrcs and electro-
magnetic flowmeters.'~- "' 
\'Vith this ~ystem, a selective intracoronarv measurement of 
flow velocities became possible during cardi~c catheterization. 
Further technical development allowed an easier a.nd safer intc-
gntion of Doppler measurements in the cs.thcterization labora-
tory during coronary interventions, owing to the availability of 
an internal lumen for a movable guidewire in the second-genera-
tion catheters. 
Subsclectivc Doppler recordings using a circular end-
mounted crystal on a flexible 3-French catheter amenable to 
guidcwire insertion were later described by Sibley and :t."5oci-
ates.17 In this :.ystem, the angle between the ultrasonic beam 
and the centerline of the intravascular flow profile was mini-
mized. 
The flow :.tream interference due to the presence of the 
catheter in the blood stream is of concern if velocities close to 
the transducc.-r have to be measured. Tadaoka and colleagues"' 
reported that in an in vitro model, a blunt or M-shaped velocity 
profile, depressed at the centerline, is present several millime-
ters distal to the catheter tip, resulting in underestimation of 
flow velocity aW':ly from the transducer. A distance of at least 
10 catheter diameters was required to have a complete restora-
tion of the flow-velocity profile. 
A prototype series of coronary balloon catheters with an end-
mounted 20-MHz Doppler crystal has been ev:aluated in our 
laboratory. ' 9 The system allowed the recording of high-quality 
Doppler tracings distal to the stenosis before, during, and after 
balloon inflation. The ma..ximal hyperemic velocity after balloon 
inflation was found to be a useful guide for the assessment of 
the result of angioplasty. 
Doppler Guidewire Probes 
Although side- and end-mounted Doppler catheters have 
been used extensively in research cardiac catheterization la.bora-
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tories, mainly for assessing relative changes of coronary veloci-
ties, several limitations have prevented their widespread clinical 
application. 
1. Ca.theters with a 1-mm diameter are unlikely to be :m 
obstacle to flow in proximal coronary arteries with a 3- to 4-
mm diameter. However, across or distal to a stenotic segment, 
the obstruction due tO the catheter may induce marked reduc-
tion or disappearance of the :mterognde flow. 
2. The catheters had to be inserted before and after coronary 
interventions, resulting in repeated and complex exchange pro-
cedures and in the inability to monitor coronary blood flow 
velocities during the most critical phases of the procedure. 
3. Their small sample volume required an optimal position 
inside the vessel to record a high-quality signal, including the 
highest blood velocities. Their ma...-ximal recording velocity was 
110 em/sec, limiting the measurements across a stenosis. More-
over, only zero-crossing (ZC) detectors were available with 
these Doppler probes. 
The Doppler guidewirc is a 0.014-in.-<l.iameter, 175-cm-long, 
flexible, and steerablc guidc.-wire with handling characteristics 
similar to traditional angioplasty guidewires. The latest "wide-
beam~ model has a 12-MHz pic-~,;oelectric ultrasound transducer 
intc.'gt:lted onto the tip. It has a minimal cross-sectional area of 
0.1 -mm~. which is 12% of the cross-sectional area of a 1-mm 
catheter. The cross-sectional area of the Doppler guidewire 
causes a 9% area reduction of a circular lumen of 1.2-mm 
diameter, whereas a 1-mm diameter catheter induces a 70% 
obstruction. The wire creates less dh'tllrbance of the flow pro-
file distal to its tip when placed within a ves.'iCI and can be 
passed into smaller coronary arteries without creating signifi-
cant stenoses. The flexibility and steerabllity of the Doppler 
guidewire are designed for crossing intracoronary arterial ob-
structions and maintaining a stable, prolonged placement in the 
distal ponion of the cororury artery during coronary angio-
pla.sty procedures. When a Doppler-tipped guidcwire is substi-
tuted for a standard angioplasty guidewirc, phasic coronary 
flow-velocity measurements .are c.-asily incorporated into an an-
gioplasty procedure without adding unnecessary technical m.a-
neuvcrs. In the b.test model, the forv.rard&ected uitra..<;Ound 
beam <liverges at 35 degrees from the Doppler transducer, so 
that the Doppler sample volume is approximately 0.65-mm 
thick X 3.1-mm diameter when maintained 5.2 mm bevond the 
tr:l.n."<!ucer, distal to the area. of flow-velocity profile distortion 
induced by the Doppler guidcwirc. 'H 'This broad ultrasound 
beam provides a relativcly large area. of insonifi.cation, sampling 
a large portion of the flow-velocity profile (Fig. 40-1). An adjust-
able pulse-repetition frequency of 16 to 94kHz, pulse dur.ttion 
of 0.83 ~J,>sec, and sampling delay of 0.5 fJ-SCC provides satisfac-
tory parameters for spectral signal analysis. The signal transmit-
ted from the piezoelectric transducer is processed from the 
quadrature Doppler audio signal by a real-time spectral analy-.ler 
using on-line fust Fourier transformation (FF'I), providing a 
scrolling gray scale spectral display. The frequency response of 
this ~)'Stem calculates approxinutely 90 spectra per second. 
The spectral analysis of the signal and the Doppler audio signals 
are videorecorded for later review. Simultaneous elcctrocardlo-
gr.un and blood pressure arc displayed with the spectral veloc-
ity. We have recently demonstrated the feasibility of recording 
the quadrature signals with :m independent PC-ba..'ied .analogi<: 
to digital acquisition system for archiving and postprocessing 
of such Doppler spectra.::o 
The Doppler flo\V\Virc (FloWrre, Cardiometries, Inc., Moun-
tain View, CA) has been validated during intravascular me::tSure-
ment of coronary arterial flow velocity by Doucette and co-
workers. 21 The Doppler flow-velocity signal was recorded in 
model tubes with pulsatile blood flow in straight tubes, with 
intema.l diameters varying from 0.79 to 4.76 mm. The peak 
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FIGURE -iO-L Diasram ~howing the large sample volume of a Doppler 
guide\vire ameroJ;rnddy inserted into the kft anterior d~cnding coro-
nary artery. The ultr.L.-.ound beam opens at 15 degrees from the Doppler 
crystal to obtain a larger Dopplcr ...ample volume. (From Ofili EO, 
Labovitz AJ. Kern Mj: Coronary flow vclocit)' dyn;unic~ in norm:l.l and 
di.."«.-a~d :mctics. AmJ Clrtliol li:3D-9D. 1993.) 
spectr.ll flow velocity W:lS lin<.':lrl.y related to absolute flow 
velocity measured by on-line electromagnetic flowmeters. 
Quantiutive volumetric flow W:lS calculated from vessel cross-
sectional area and mean flow velocity. The average peak velocity 
was less accurate in larger tubes (> 7.5 mm), :tnd a slightly 
reduced correlation with absolute flow W:lS observed in some 
tortuous model SL-g:ments. In four C:lnine circumflex coronary 
arteries. the electromagnetic flow probe and the Doppler guide-
wire :tlso demo0$trated high correlations in both the proximal 
:tnd disul segmentS. Using QCA to determine art<:ri:tl diameter, 
absolute volume flo~ were closely correlated. Measurements 
were not significantly affected by incr<.-a.sing heart rates to 150 
beats/min in the C:lnine model. These data indicated that the 
Doppler guidewire accurately measures phasic flow-velocity 
patterns and linearly tracks ch:lllges in flow rates in small, 
prcdorrtinantly straight coronary arteries. 
The in \"h'O studies established sever.ll important featun .. "'S 
applicable to patient use.u The Doppler guid<:wire could be 
easily steered in the proximal and dlst:tl branches of the coro-
nary artcri:tl tree. The phasic velocity recordings had a high 
sig:n:tl-to-noise ratio and were satisfactory for prolonged moni· 
taring periods, with a good separation of forward and reverse 
flows. I..o-.v-frequency wall motion artifu.ctS were occasionally 
encountered :llld could be minimized by repositioning of the 
guidev.in:. 
Comparison studies were performed using an 8-French Jud· 
kins Doppler CJ.theter.~-' There was no significant difference 
between the Doppler guid<:wire :llld Doppler C:ltheter mean 
velocities and coronary vasodilator rx:serve. 
The safety of the instrumentation of normal and mildly dis-
ca.-.;eU coronary arteries v.ith the Doppler guidcwire during 
diav,nostic coronary angiogrnphy was a.~essed in 120 patients. 
i\o complic-.ttions n::lated to the use of the guidewire were 
observed immediately after the procedure and at 6-month fol-
low-up.~· 
Analysis of the Doppler Signal: Advant:lgcs of 
the Spectral Analysis 
Simple, straightfor.vard Doppler velocity regist..rations can be 
obtained with a ZC detector. The intervn.l between each pair of 
adjacent ZCs of the same polarity is measured :md the Doppler 
frequency shift is calculated. TI1is method \V:lS implemented on 
most of the first generntion of Doppler Cl.theters. Although 
inexpensive, simple, a.nd convenient, this teclmique is less accu-
rnte than spcctr.J.l. signal analysis in ar<.":lS of disrnrbed flow and is 
unable to detect the peak velocities.'> TI1e different frequencies 
corresponding to the velocities of the scatters are best <.-xam· 
ined by a full-power spectrum provided by FFT, which also has 
the advantage of distinguishing !an1inar from disturbed turbu-
lent flow patterns, and which can detect the ma."\;im:tl Doppler 
shift. 
Comparison of ZC detectors and FFT has been performed in 
vitro and in :lllimal models. 1 ~· ~'·-"' ZC detectors underestimated 
consistently the true velocity m<.-a.sured with FFT but seemed 
.sufficiently reliable for the evaluation of relative tlow ch:lllgcs. 
Comparison in patients has been reported by Di Mario and 
coworkers."'' The mean velocity measured with a ZC detector 
(Millar ~1VD 20) was compared with the FFT-derived time· 
averaged maximal and me:lll velocities in the s.1me period in 
19 patients. TI1cre were large differences between the paired 
measurementS, suggesting tl1at the two techniqUt:S of an:tlysis 
are not interchangeable. Furthermore, only the spectral analysis 
allowed the detection of frequency aliasing Juring recordings 
within a stenosis. I;trge dif!CrenCL'S between flow-velocity mea· 
surements obtained with ZC and FFT were also observed by 
Pick and :lSSOciates.·"' 
CORONARY BLOOD FLOW-VELOCITY 
PATTER. "'S 
Pulsatile Characteristics of Coronary Flow 
The pulsatility of coronary arterial flow was described by 
SC:lramucci in the late s<.-vcntecnth century.·" In cont~t with 
the flow characteristics of most arterial districts, arteri:tl coro-
nary blood now has a distinctive and unique phasic p:mcrn. 
Blood Jlow is higher in diastole and lower in systole. L:t~e 
differences, however, :u-e present between the flow pattern in 
the left (LCA) and in the right coronary artery (RG\) (Fig. 
40-2). An opposite flow pattern is present in the coronary 
v<.-ins, which arc characterized by a predominant ::.ystolic com-
ponent, by now variations during the cardiac cycle ~ynchronous 
with the right atrial pressure w-.tves, and by la~e phasic changes 
due to respiration. These opposite !low changes during the 
c:u-di:lc cycle can be explained only by :J.SSuming the presence 
of a blood reservoir between the arterial and venous sides 
of the coronary circulation (intr.tmyocardial capacitance). The 
classic experimentS of Sabiston and Gregg confirmed that the 
~ystolic reduction of arterial coronary flow results from the 
contr:action of the heart, with a squeezing of the capillary 
network.·'~ More recently, an incr<.-ased systolic stiffness of the 
cardi:lc myocytes has been considered a possible alternative. 
The different patterns of flow during the cardiac cycle in the 
LCA.s and the RCAs is in part attributable to the ~-ater systolic 
compressive force of the left ventricle or to the higher stiffness 
of the left ventricular myocytt:s during the contr-.tctilc phase. 
Both theoriL-s can then explain the presence of a r<.-verx~l of 
flow <.luring systole in some patients with SL-vcre aortic valve 
stenosis or obstructive hypertrophic cardiomyopathy."·~· 
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FIGL"RE ·10-2. Flow-velocity me-.. tsuremcnt.-. obtained in the left main 
cororury artery (L'\fC) and the proxim:::tl ~egment.-. of the left anterior 
descending (IAD), left circumflex (LC.,\,'), :md ri);ht coro~ry artery 
(RCA) of a p:ttient without epicardial coronary steno~es. Note the 
prt:v.llent diastoUc component and the similar )Y.Ittern and ma..-...imal 
velocity ob:<erved in the LAD and LCX arteries. 
Normal Blood Flow Velocity and Flow Pattern 
Knowledge of normal flow-velocity r-.mgc and of sigrul char-
acteristics in normal proximal and dist:t.l coronary :trtcries is :m 
c~scntial prerequisite for the ev::Jwtion of the flow-velocity 
ch:tnges in patient,..; with coronary lesions. To define the normal 
r-.tn,~;e of coronary flow velocity, the time-averaged blood flow 
velocity w:c; measured in 81 proxinul coronary :trteries v.rithout 
hemodyn:unic:illy ~ignific:mt coronary stenosis.;' A Doppler 
guidewire was advanced into a str.tight, smooth and regular 
proximal segment of the studied :trtery. An on-line me:J.Surement 
of time-averaged peak blood flow velocity and mean diastolic-to-
~·ptolic velocity ratio is autooutie:tlly av.illable in the previously 
described Doppler g:uidewire ~)'$tern. The videoreeorded Dop-
pler spectra were also tr.lced using a digiti:dng t:tblet. The 
~-ystolic and di:tstolic components were defined b:t...;ed on the 
simultaneously recorded electroe:trdiogr:un (QRS complex), aor-
tic pressure (dicrotic notch), and flow clungcs (Fig. 4.0-3). A 
repe:lted independent analysis of 10 Doppler tracings from the 
same ob:::.en·er or from a second observer showed less than 5% 
interobserver and intr.lobserv<.-'1' vari::Lbility for all the :tn:Lly..:ed 
p:tr:tmeters. The time-averaged peal;: velocity wa:; 23 :!: 11 em/ 
sec (mean ::':: SD of all the :trt<.-'rial s<.-gments). A b.q;e range of 
velocity (9 to 61 cmjsec) w::tS obs<.-rved . .\1a.."illnl.l blood flow 
velocity was 42 ± 17 cm;sec (range, 14 to 82 em/sec). 
The differences in flow velocity and pattern between proxl· 
mal and distal segments have also been investigated in 55 
angiog:raphically normal, proximal, and distal cororury :trteries-" 
:tnd arc summ:t.rized in Table 40-1. Proxinul and dist:t.l velocities 
in each :trtery were not different at b:t..;cline or hyperemia. All 
three coronary arteries showed a di:c;tolic-predon:rirunt pattern 
in both proximal and disui :trterial segments. This pattern was 
less m:trked in the RCA, which had a ~ignificantly lower peak 
di~tolic-to-:;ystolic flow-velocity ratio comp:tred v.rith the left 
anterior dc....;cending (LAD) coronary artery. The LAD had higher 
hyperemic di:tstolic velocities. CFR (hyperemic-to-b~al flow-
velocity ratio) wa.,-; similar in all three arteries. Thus, proximal 
and dist:t.l normal native coronary :trtcries luve similar rel:J.tive 
flow-velocity p:trameters and V:tSOdilator re._..;erve, v.rith a di:t-
stolic-predomil:unt p:tttem. The dilstolic-to-sy~;tolic flow-veloc-
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ity ratio greater than 1.5 is maint:lined in both the proximal and 
dist:t.l segments in patients v.rithout hemodynamie:tlly signifiC:lllt 
coro=ry stenosis and v.rith normal left vemrides. The minor 
reduction in flow vclodty observed when advancing the Dop-
pler probe from pro:dmal to dist:t.l is somewhat surprising when 
the b.q_.:e reduction of the corresponding cro~ection:tl area 
:tnd, consequently, coronary flow is considered. The mainte-
nance of flow velocity across the k:ngth of the epicu:dial artery 
is the result of the gradwlly diminishing vessel :l!'e:t :c; volumet-
ric flow is distributed to side branches ::tlong the pro.ximal-to-
di..;uJ vessel course. An:ttomically, the division of the coronary 
arteries is extremely irregul:tr, with the presence of small 
transmural arteries directly branching from the major epic:trdial 
arteries and of a noll."oymmetric divbion of the mother vessel 
into nurnetous smaller d:tughter br.mche~. Strahler ordering and 
f:rnct.:l.l models have been proposed to describe the hcterogent.'-
Coronaryf-----4 
cycle 
FIGURE ·i0-3. Top pand, Flow-velocity recordin~ in a proximal left 
anterior descendin~; cororury artery. :-Tote the prominent diastolic com-
ponent. The dl.'l._'itOUc-to-~~tolic flow-velocity r.<tlon (DSVR) :mtomati· 
c:illy calculated on-line :J.Dd displ:tyed in the top fi~ Js based on the 
l"'.ttio between mean ~tol:ic and ~~tolic Dow velocity. Bottom pand, 
The comp:ui.:<on between dlastolic and '>)'Stolic component ean be 
b:t._'<ed on the pe:lk velocity in dl:u;tole and ~ystole (PVd and PY~) or, 
more correctly, on the flow intcgr:ll.~ (Dvi/Svi). ECG, clectroca.rdiogram: 
Ao, aorta; 1/3 FF. one third flow fraction. (From Ofili EO, Llbovitz A], 
Kern MJ; Coronary flow velocity dyoo.mics in norm.1.1 and dL«:tsed 
artcrles. Am J Cardiol l7:3D-9D. 1993.) 
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TABLE 40-1. BASELINE AND HYPEREML\. VELOCITY PARAMETERS IN INDIVIDGAL CORO:"'ARY ARTERIES 
BASEliNE HYPERE.'IIA< 
LAD LCX RCA LAD LCX RCA 
Pro.\·imal 
Peak D Vel 49::!: 20 ·iO::!: 15 37 ± 12 104 ::!: 28t 79::!: 20 72::!: 13 
Mean Vel 31 ::!: 15 25 ::!: 8 26::!: 7 66::!: 1St 50 ::!: 14 48::!: 13 
D Vellnt 18 ± n• 13 ± 5 11 ::!: 4 37 ::!: 55t 27 ::!: 12 22 ± 9 
l/3 FF (%) 45::!: 4• 44 ::': 5 40 :!: 5 44 ::!: 5 43 ± 6 41:!: .j 
DIS 2.0:!: 0.5" 1.8 ::': 0.7 1.5 ::': 0.5 2.0 ± 0.5 1.9::!: 0.6 1.9 :!: 0.8 
Distal 
Pt":lk DVd 35 ::': 16 35 :!: 8 28 ::!: 8 70:!: 17 71 ± 22 67 :!: 16 
)I.Jc:an Vel 23 ::!: 11 21 + 6 21 ::!: 9 45 :': 12 45 :': 12 42 :': 9 
D Vel lnt 13 :': 9 10::!: 3 8 :': 5 9::!:6 11 :': 8 9:!: 2 
1/3 FF (%) 46::!: 2 45 ± 9 39::!: 6 45 :': 3 42 ::!: 7 40::!: 9 
D/S 2A ± o.8· 2.1 ::!: 0.8 lA::!: 0.3 2.2 ::!: 1.0 1.9 :': 0.8 1.6 :': 0.3 
"L\D V<:l":'>u.~ RCA(>"< .05). 
tL\D vel":'>u.~ LCX and RCA (>" < .05). 
i:Ail thr<:<: coron~ry arterit!l< h~d ~it:nificamly higher ab;.olute velocity parametcn. during hyperemia (P < .001). 
Note: Ano\-a:; SCheff<: F tot only tot U.'>l!d for eompari-.on. 
D, d!a.,tollc: D!S. pe;lk dia.,tollchp"tolic velocity: D Vel lnt, dla.,tollc llow-velocity lmegr-..1.1 (U): Vel, velocity (cm/"-'c); 1/3 FF. one third !low fraction: lAD. left anterior 
de.cendlng coron:u"}" ano:ry; LOC. left drcumflcx coronary artery; RCA. riJ.:ht coronary :lrtcry. 
From O!ili EO. L:tbovit;: I'J, Kern MJ: Coron~ry !low-velocity dynamic~ ln normal and dl"-':t.'>l!d artcrio. Am) C:!rdiol 17:30-90. 1993. 
ity of the vessel distribution, analogous to other phy~;iologic 
structures such as the :Urways of the lung. J.<• 
When only the incre:tSe of the toul arterial cross-section::tl 
a.rea between mother and daughter vessels in large epic:trdial 
arteries is considered, :t progressive moder:J.te increase is otr 
served, in accordwce with the principles of limited/adaptive 
va...<;eul:tr she:tr stress, of minimum va..."Cul:tr volume :tt bifurca-
tions, and of minimum viscous energy loss. After three-dimen-
sional reconstruction of the arterial tree, Seiler and colleagues-" 
e:tlcul:tted a ratio between the area of the mother vessel and 
the m(.-:tn of the :lfe:tS of the daughter vessels of 1.647, similar 
to the r:J.tio predicted based on the previously mentioned princi-
ples (1.588). 
Consequently, the cross-sectional :tre:t increases by a factor 
of 1.214 per bifurcation so that the large increase in cross-
section:t.l are:t between the coronary entr:tnce arteries and the 
capillary bed c:m be explained only by the larger number of 
consecutive bifurcations. These consider:~.tions explain why 
only :t moder:~.te decrease, inver:;ely proportional to the moder-
:tte increa.se in tot:t.l cros..vsectional arC:t, occurs from proximal 
to distal in the coronary arterial tree. Aow velocity, theretOrc, 
is rclativdy uniform in the epicardial arteries of the same pa-
tient, and a r:~.pid decrease indicates redistribution of flow in 
the lower-resist:mce branches proximal to a flow-limiting coro-
nary stenosis. 
Vascular Resistance in Proximal and Distal 
Coronary Segments 
The differenti:tl ch=cterization of blood flow velocity and 
vascular resistance between proximal and disul normal epicar-
dial human arteries has been e::amined by Ofili and cowork-
ers."" Using mean and peak velocity and cross-sectional area of 
the proximal and distal segments, coronary volumetric blood 
flow and vascul:tr r(.'Sist:mces were computed .. \1e:tn velocity 
and CFR were similar for :til three native arteries and were 
preserved from proximal to dist:t.l coronary segments. Volumet· 
ric flow decreased from proximal to distal segments. The dem-
onstration of :tn inverse and curvilinear polynomial relationship 
between volumetric Jlow :tnU vascular resist:t.nce agrees with 
the theoretical and animal models of coronary physiologic char-
:tcteristics and suggests a nadir of coronary V"".J.scular re:.i:.tan-ce 
below which coronary flow can no longer decrease. For the 
three coronary arteries, the distal coronary flow velocity reserve 
:tnU coronarv volumetric flow were similar at 55 ::!: 45, 51 ::!: 
25, and 64 ·± 35 mL/m.in for the IAD, circumflex, and RCAs 
respectively. CFR for the same ves...;els was 2.5, 2.6, .. and 2.4, 
respectively. Although the flow-volume gradient (ratio of proxi-
mal to dist:tl flow) was 2.9, 2.5. and 3.1 for the IAD, circumflex, 
and RCAs, respectively, the decrement in disul volumetric tlow 
was o::.xpected for the br:tnching myocardium receiving the ap-
propriate myocardial blood supply. The vascular resistance was 
signific:mtly grL-a.ter in the distal th:tn in the proximal coronary 
segments for e:tch ves..o;el: on average, 2.7 = 1.8 versus 0.8 ± 
OA. Volumetric Dow, as expected, diminishes from proximal to 
distal regions primarily because of the gradual reduction in 
vessel cross-sectional area with increasing tot:t.l arterial perfu-
sion :tre:t through br:tnching vessel systems. The nonline:tr in-
verse relation between absolute coronary blood flow and coro-
nary va..."<:ul:tr resistance in proximal and disul segments has 
been previously identified by coronary physiologists in models, 
suggesting that at low levels of coronary vascular resistance, 
further decrL"':tSCS do not necessarily result in increases in coro-
nary blood flow. 
Flow Velocity in Saphenous Veins and 
Mammary Arteries Used as Coronary Conduits 
The saphenous vein grafts have a predominantly diastolic 
flow, similar to the flow in native coronary arteries.~'' In the 
proximal saphenous veins used as aortocoronary bypass, how-
ever, large high-peaked ~)'Stolic waves may be present, probably 
reflecting the high distensibility of these long, thin-walled vascu-
lar conduits, with a higher vascul:t.r capacitance than the shorter 
and smaller native coronary arteries. In the proximal segment 
of in situ internal thor:~.cic (m:unmary) arteries anastomosed to 
coronary arteries, the pha..-.;ic blood flow velocity resembles th:tt 
of the subclavian artery;'''·""' with a predominant systolic peak 
velocity (diastolic-to-~)'Stolic mean velocity r:J.tio == 0.6 ± 0.2). 
The velocity pattern char;ges in the disul internal mammary 
artery near the coronary anastomosis with a predominant dia-
stolic !low showing diastolic velocities simib.r to those recorded 
in native coronary arteries.·'''· " A peculiar characteristic of sa-
phenous veins used a..-.; scqucnti:tl conUuit:. is the suUden dccrc:t..o;c 
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in velocity observed clli.Lal to a coron:ll)' amstomosis, in con-
tt:lSt with the progt'b>sive velocity decrease observed from prox-
im:tl to dist:ll in native coron:ll)' :J.rteries. The low flow velocity 
consequent to the inability to adjust the caliber according to 
flow demand may explain why saphenous vein gr.tfts arc more 
prone to accelerated athero~erosis than arc native coro=ry 
arteries or. mammary arteries u.-;ed a.s coro=ry bypa.ss. The low 
flow velocity a.nd shear rate may f.lcilitatc thrombosis and 
gte::Lter interactions betwc1..-n blood dements a.nd intimal sur-
f.tce. 
Variations in Normal Coronary Vasodilatory 
Reserve 
Variations in CFR, defined as the ratio of ma:xim:tl coronary 
flow in hyperemia to baseline flow, in multiple :trterics in large 
numbers of patients in the cardi:tc catheterization labomtory 
have led to controversy regarding normal values. 'Ibis issue is 
especially pertinent for asses..~ing the significance of coron:ll)' 
stenosis in patients with angiographically near-normal coron:ll)' 
:u-reries and early atherosdcrotic disease who may have con-
comiunt imp:tirment of the microcirculation. To a.ssess the 
spectrum of CFR respon.">es found in adult patients undergoing 
cardiac C".ttheteriz:ation, CFR was measured in 410 coron.-u-y 
anerics in 214 patients comprising three groups: atypical chest 
pain ~)'lldrome (n = 85) :tnd angiographic~y normal coronary 
arteries; coronary :u-rery di~..;c and angiographicaUy norma! 
ves..o;els (n = 21): and angiographically normal tr.utsplant recipi-
ents (n = 108)Y 
Int:racoron:ll)' flow velocity W".JS measured with an 0.018-
in. Doppler flowwire. ~a.-..::imal hyperemia v.ra..-.; stimulated with 
intracoro=ry ad1..-nosinc (12 to 18 IJ.g bolus) and CFR W".JS 
computed as hyperemia + basal average peak (mean) velocity 
(Fig. 40-4). BcClusc bolus adenosine docs not incret..>.;e vessel 
cFOs..~ectional area;"' coronary flow-velocity re-,;crve :lS the ratio 
of ma."<inul hyper1..-mic mean flow velocity to basal mean flow 
velocity ~ u.-;ed as a surrogate for CFR. 
CFR (fable 40-2), on average, in normal patients with chest 
pain :>)'Odromes ~ approximately 2.9 ± 0.6, and similar in 
the angiographically normal artery in patients with coronary 
artery disease (2.5 ± 0.95); both values W<:re higher than the 
poststcnotic diseased-vessel CFR (1.8 ± 0.6). T.ranspl:mt arterie.s 
had the highest CFR (3.1 ± 0.9). Among different normal 
arteries, there ~ no difference in CFR for circum11cx, RCA, or 
LCAs. Region:U differences w~_.-re not present, suggesting that 
relative CFR should be 1.0 ± 0.2. These data should be consid· 
ered for studies involving ~scssmcnt of coronary microcircula· 
tion in patient.-.; in the cardiac catheteri7.ation laboratory. :Micro-
circulatory abnormalities may be differentiated from abnormal 
CFR due to stenosis using relative coron:ll)' va.:;odi.latory re-
~ervc."'·' 
Erbcl and :l.._"SOCiates"'' have reported CFR values in angio-
grnphically norma! coroJUrY arteries in which intravascular uJ. 
tmsound (IVUS) was performed to furth1..-r cla.ssify patients with 
~..--arly atherosck-rosis. Of 44 patients, 16 (group 1) had a normal 
flGt:RE ·:iO-<"i. Spectral coron;uy flow velocity signals u~d in the c:ilcul:J.tlon of coronary v-.tsodibtory reserve. 
The di~play :;o-cen b split into top and bonom, which b then subdivided into left and right paneh. lop S<·ctlon, 
Continuou:<·plu..~ic flow velocity during hyperemln. The velocity ~e is 0 to 120 crn/~c. Electrocardlogr.u:n and 
arterial p~urc are the top two tracings. S and 0 indicate ~y:;tolic and dl:tstolic perio<b. The he:trt rate and ~ystolic 
:tnd di;L.-.;tolic pressures are ~hown a:, the number>. in the gt"".IY box at the upper left corner of the flow panel. 
Bottom flft ami right panels, Coronary flow velocity at ba~>eline :tnd at peak hYJ)Cl"Clllb i..~ shown In the lower 
panel of the l<plit ~creen. The =e velocity scale i..~ u._"\ed in the upper panel. APY, average peak velocity; DSVR. 
diastolic-to-~ystolic velodty ratio; M.PV, ma:Wnal peak velocity; PVl, peak velocity integral: CFR, coronary flow 
reserve. Coronary vasodllatory res(:rve b calculated from ba.'-til average peak velocity (BAPV) of l·i <:m/~C :md 
peak average pe:tk. velocity (PAPV) of 53 cm/~c to produce a coron.-uy v.~._-.odllatory re:;erve ratio of 3.9 (~hown in 
the lower far left light gray panel). 
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TABLE 40-2. CORONARY FLOW RESERVE IN ANGIOGRAPHICALLY NOit.'\1AL ARTERIES 
GROUP NO., 
DESCRIP110N 
l. Korm:tl 
2, NljAB 
3. T~~pb.nt recipients 
• P < 0.05 V». other f:!'OUp>. 
tP < 0.05 "'· LAD, RCA. 
t.P < 0.05 ""·men. 
:.'\O.OF 
ARTERIES 
STI.JDIES LAD 
150 2.68 
20/20 2.76/1.78" 
280 3.04• 
ARTERY SEX 
RCA CFX M= Women 
2.81 2.39~· 2.69 2.5l:j: 
2.42/1.85• 2.42/1.85. 2.44/1.79• 2.53/1.8J•<j: 
3.29" 3.06· 3.09• 3.09' 
U.O, left :tnterlor de-cendlng artery; RCA. right coron:u')' artery; CFX, drcumJlex coron:try an"ry. 
From K<:rn MJ, A,r;ulrre FY, e:tch RG, et al; V:trl:ttlon_~ In normal coron:try V'.!.'>Odilutory re.'exve by artery, >eX. 'turu.~ po;,t tran.~pbntution, and r=:.ote coron:uy di~ca..-.e 
(ub-.tr:lct), Circulation 90:!·15-l, 199•1. 
coronary morphology by IVUS :md a CFR greater than 3.0 
(mean = 5.3 ± 1.8), :md 7 (~up 2) had a normal rvcs 
appc:tr.lllce but a reduced CFR (2.1 :<: 0.4). Pl:tque formation 
wa:; found in a tot:ll of 21 patients. Mean plaque :;;izes were 
3.6 ± 1.6 mm' for the patients with a CFR greater d1:m 3 
(group 3), :tnd 5.0 ::::: 2.3 mm' in d10se having a reduced CFR 
(group 4). TI1e author:; concluded that only 36% of the patients 
with normal angiogram:; were true normal, that 48% exhibited 
an e:ll'!y :;rage of coronary athero:;;clcro:;;i:;;, and that the patients 
in group 2 might be con::>idt.-red as :;;yndrome X. Th~e data 
were in agreement with earlier reports of abnormal CFR in 
patients with angina but normal coronary angiogrnphy:"'"''' 
Relative Coronary Flow Reserve 
Abwlute CFR i:;; the :;;ummation of the conduit :tnd microcir-
culatory respon::>e. CFR i:;; simibr among the three major ve:;;se\ 
territories, :md the ratio of CFR in :mv rwo territorie:;; i:;; 1.0 :': 
0.2:'~ Relative CFR (CFRTARGET/CF~CE) in patients wid1 
coronary artery dbea.se :;;hould e.xdude the differences attribut-
able to microv:L:;cul:ll' disease :md different hemodynamic state:; 
for ~erial studic::>. Baumg:art :md collcagu~'0 compared FFRMYO, 
derived from intracoronary pres::>ure mt.·asurements (sec follow-
ing pa.r:tgraph) to relative flow reserve (computed a....; CFRTARGET/ 
Pre PTCA Prox LAD 
CF'R.ItEFERE.-.:cc). TI1e correlation coefficient for FFRMYo ver:;;us 
absolute CFR was r = 0.045 compared with the correlation for 
relative flow re::>erve (r "" 0.95) for steno:;es severity rnnging 
between 50% and 95% diameter narrowed. 
Similarly, Uren :md coworkers5 ' demon::>trated the difference 
between FFRm·o :md absolute CFR in 11 ::>tenosb in three 
experimental canine models. The ::>teno:;e:;; were created with a 
cuff ocdudcr and the percent :ll'<..-a :;;teno:;;is was evalmtcd with 
QCA. FFR'>fYO correlated better than absolute CFR for ::>teno:;;i:;; 
severity in bod1 abwlute (minimum luminal di=eter [.MLD]) 
:md relative (pcrcent diameter) values. 
Th~e preliminary data indicated that relative flow re::>ef'\.·e 
had :m excellent correlation \vith FFRMYo :md that ab:;;olute 
flow re::>erve had a poor correlation bccau:;;c .of tile unexpected 
:md unpredict:tble abnorm:ilities of microcirculation. The reb· 
tive CFR ~eem::> to be more appropriate for lesion ::>pecificity 
than ab:;;olute CFR, and its application will likely facilitate im· 
proved dccbion making u:;;ing coronary Doppler measurements. 
Figure 40-5A and B demonstrate tl1e use of rel:ttive tlow rc· 
:;;erve. 
Calculation of Volume Flow from Flow-Velocity 
Measurements 
1\vo cruci:tl. step:; are required to accurately calculate ab:;o. 
lute (volume) flow from flow-velocity m<.":l.Surem<."llts: the calcu-
FIGL"RE ·i0-5. A. Demon.~tration of the value of relative coronary tlow reserve 1n :t patient undergoing percutune-
ou.' trans!umitul coronMy anglop~ty (PTCA). An 82·}'e:tr-Qld woman had S<."Vere clrcum.Uex coronary :J.rtery 
steno~l~ and progressive angina pecrorb despite medlcal thernpy. Coronary flow velocity was masured !n the 
proximal left anterior deM:endlng (Prox lAD), the dbtal drcumJlex (Dbtal CD..), and the obtuse marginal branch 
beyond the :;;teno~L«. The coronary tlow re:;erve in the proxim:tl !AD was 1.5, 1n the dbtal normal circumtlex \va..' 
1.2, and ln the distal circumfl= 1n the normal segment \v:t.'< 1.7. Relative coron::uy J-Jow reserve prcangioplasty was 
1.2/1.7 "' 0.70. B, After ;mgiopl:L.'<ty, coronary flow reserve was 1.8 in the normal rcterence !AD, 1.6 in the t:l.tget 
obtu.-.e marginal br.mch, and 1.7 in the adjacent reference 7.one. Relative coronary flow reserve incrca..~cd to 0.9. 
TilL'< patient had co=!stlng microva..-;cul:tr db=.,e. See Figure 40-4 legend for additional abbreviations. 
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J:ttion of the mean blood flow velocity in a given vascubr cross-
section, and the accurate rnc-.J.Sun:ment of the cros..,..sectional 
area at the site of the m<.-asurement. 
Assessment of Mean Blood Flow Velocity 
TI1e measurement of the mean blood flow velocity requires 
an adequ:1te Doppler sampling of the peak flow region within 
a vessel, with the ultrasound beam optimally aligned par.t!Iel 
\Vith the ccnt<.-rline of flow, and with the entire flow profile or at 
least a significant proportion that includes the m:t.-ximal velocity 
insonificd. The physical presence of the Doppler probe should 
not modify the velocity profile at the. site of the Doppler sample 
volume :md a spectrnl analysis of the Doppler frequency should 
give the different velocities in the s:tmplc volume, induding the 
maximal velocity. 
Although theoretically possible," s<.-vernl technical shortcom-
ings limit the pr.tctic.:!.l usefulness of the measurement of mcm 
blood flow velocity from the velocity spectrum. A different 
approach is based on the use of the ma..xi.mal blood flow velocity 
that is. less sensitive to the presence of noi..<;<; and is more easily 
included in the s:unple volume based on the earlier-described 
characteristics of the Doppler flowwire . .'V!ean blood flow veloc-
ity c-.tn be estimated from the ma..xim:ll blood flow velocity 
:t...;suming Poiscuille's flow using the equation d<.-scribing the 
velocity of a laminar flow field: 
VMAX = l;P(4 f.l-L X r", (I) 
in which VMA..'\ is the ma..-..imal velocity of the flow, f;.p is the 
pressure gn.dient in the va .. <;<;ubr .segment of length I., f.l- is 
blood flow v:iscosit)~ r is the r.tdius, and L is the length in 
millimeters of the considered segment. Under the :tSsumed 
conditions and if mean velocity times cros..vscctional area (A) 
equal~ blood flow (Q), from the Poiseuille equation it follows 
that: 
VMEA;'-1 = Q!A "" (LlPm"/8 !J.L)/A, (2) 
with A = -rrr", Equation 2 c.:m be simplified to: 
{3) 
An important limitation to the applicability of this formula i..<. 
that the veiocit)' profile is assumed to be parabolic and fully 
developed. The distance L necessary to allow the full develop-
ment of a parabolic flow profile is defined by the equation'·': 
L = (0.03 RE)d, (4) 
~·here RE is the R<.;'nolds number and d is the di.:lm<.'tcr of the 
conduit. Consequently, the vclocit)' measurem<..ont should be 
taken at a distance of four to sL-.. times the vessel diameter to 
allow a complete development of the velocity profile at the 
R<.J'nolds numbers present in normal epicardial coronary arter-
ies (150 to 200). The same issues must be considered when 
sampling velocity dh>"ta.! to major bifurcations of the vessel or 
stenotic segments. The non-newtonian charactcrh1:ics of blood 
and the pulsatility of the flow induce a blunted velocity profile 
so that the mean blood flow velocity may be underestim:J.tcd 
by VMA.'(/2.'"'-"'' Validation studies have shown a high correlation 
both in vitro and in vivo between volumetric flow m<.-asured 
with an electromagnetic flowmeter"' or with a transit-time ultra-
sound flowmeter'~ and flow derived from Doppler measure-
ments obtained with the Doppler guid<.-wire probe, using for 
the calculation of the blood flow: 
cross-sectional area X aver.tge pe:t.k velocit)' X 0.5 
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Conver:<.dy, other in vitro and in vivo data using a 3-French 
Doppler system or Doppler wire also d<..""'lllonstrnted good corre-
lation between the flow c-.tlcu!ated as cro.s..-;...seetional ~ X 
aver--tge peak velocity and the measured flow.~''·..,._,., Since in 
m-ost of the recordings in human coronary arteries the :t.."".."'ump-
tion of a parabolic vel-ocity profile b rarely encountered. no 
definitive v:~.lue can be defined. However, in most clinical ~itua­
tion~ it is the r-ttio of the hyperemic flow over the b:t..«linc 
flow that is clinically relev:~.nt. 'W'hen a constant vdocit)' profile 
at the sampling site is assumed, there is then a .simplification of 
the variable related to the velocity profile for the calculation of 
th-e coronary flow reserve. 
Assessme11t of tbe Cross*Sectional Area at tbe 
Sile of tbe Doppler Sample Volume 
A high-quality angiogr-.tm, suitable for measurements of the 
cross-section at the site of the Doppler sample volume, on be 
performed almost :<.imu!taneou.sly with the acquisition of the 
Doppler recording with the Doppler flowwire. 1-!oweYer. more 
accurate measurement::> arc obtained when the probe b posi-
tioned in an arterial segment of uniform caliber .so that a mean 
cross-sectional area over a short arterial segment immediately 
distal to the Doppler probe can be obtained. 
An alternative method is the combination of :intr.tcoronary 
Doppkr and bidimensional IVC'S imaging. A continuous re-
cording of high-qu:tlit)• echogrnphic cross-sections, suitable for 
automated QCA, can be achieved with the modern ultra..""'Ound 
imaging catheters. Linker''' and Eichhorn"' and their colk:agues 
described this approach using sequentially a 3-Frcnch Doppler 
catheter and then an IVUS catheter. TI1e introduction of the 
Doppler guidewire allowed then .simultaneous asses~ment!>. The 
slightly different position of the Doppler sample volume and 
of the cchographic cross-section and the potential electrical 
interference arc minor limitations of this approach. Since the 
first data reported by Sudhlr and coworkers in dogs.'""~ this 
method has been used mainly in .studies of the coronary endo-
thelial function: simultaneous changes in luminal size .:md in 
coronary blood !lo\v velocitks during the pharmacologic proYo-
cation with acetylcholine can be monitored.''!·'" Coronary blood 
flow and CFR using this method have been recently reported 
by C1.racciolo and coworkers''' in a population of 36 a.ngio-
grnphically norm.1.l orthotopic lleart transp!.:tnt recipient!>. In 
this study, it was demonstrated tll:u the cpic:lrdial intimal thick-
ening docs not diminish conduit and resistance vessel r<.-sponse 
during endothelial-independent vasodilator administr:~.ti-on of 
adenosine or nitroglycerin. 
ASSESSME!'.'T OF STENOSIS. SEVERITY 
Poststcnotic Coronary Blood Flow-Velocity 
Patterns 
Severe coronary stenoses arc characteriZed by three major 
alterations in the intr.tcoronaf)' flow-velocity pattern. These 
changes arc discussed in the fo!lowing sections. 
Diastolic-to-5ystolk Velocity Ratio 
Previous investig:~.tors documented a reduction in the dia-
stolic-to-sy~tolic coronary flow ratio distal to experiment:ll. st<.-
noses in animal models."'·'~'"'"' Intraoperative Studies con1irmed 
a reduction in diastolic flow velocity and unchanged ~-:--stolic 
flow velocity during graft occlusion. :z-;.~.t~ Abnormal arteries show 
:t reduction of diastolic flow velocity with relatively presen·ed 
t.--ystolic flow velocity. The .systolic-predominant pattern wa.s 
.seen in more than 50% of abnormal arteries and in none of the 
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normal an:eries.''1• cu There is :1 normali:r.:ttion of the diastolic-to-
systolic velocity ratio after :mgiopL'lSty."-7; 
Proximal~to-Distal Flow~ Velocity Ratio 
The distal flow-velocity p:tr:uneters in normal compared with 
abnonn:l.J arteries showed a db'tinct pattern of abnormality, 
with significantly lo\ver mean velocity, peak diastolic velocity, 
and peak ::.:·stolic velocity in the abnormal arteries compared 
with the normal arteries. 
Tmpaired Coronary Blood Flow Reserve 
A blunted hyperemic r<..>sponse of the distal abnormal arteries 
comp:tred \Yith normal is also characteristic of hemo<.lyn:tm.i-
etlly significant lesions. Since the original work of Gould an<.! 
colleagues:"' the assessment of CFR has been viewed as a 
method to establbh the severity of a stenosis located in one of 
the major epicardial YC%els. It is assumed that the reduction in 
hyperemic flow thrm1gh the stenotic lesion \vould be an indiCt-
tor of stenosis :;everity. This assumption is derived from the 
complex ht:modynamic principles regulating the coronary cir· 
culation. At re:;t, flow is independent from the driving pre:;:;ure 
on~r a wide range (60 to ISO mm Hg) of physiologic pn:s:;ure:;, 
a pht:nomenon classically d<..'Scribt:d as autoregu!:ttion of the 
coronar:_.· circul:ttion. During maximal va:;odilation, flow be-
comes linearly rdateU to the driving pressure,.,.., The presence 
of :1 tlow-limiting steno:;b in a major epicardial vessel r.:enerates 
:1 pressure drop :tcro:;s the stenotic lesion th:tt is the result of 
viscou:; and turbulent r<..-sistances, so th:tt the driving pre::;:;ure 
distal to the stenosis decrc:tsr:s exponentially in response to the 
tlow increase."' 
The CFR concept i:; :tppealing to the clinician beetuse it 
constitutes a functional surrog.1.te to the an:ttomic de:;cription 
of the lesions located in the epicardial ves:;d:;. Many investiga-
tors han: shown in :tnimal experiments that a decre:t."C in 
flo\v reserve m:ty discriminatingly detect lesions of incrC~Sing 
se,·erity.- Although the concept may bt: CL.~ily and accurately 
applied in an optimal physiologic :;ituation in human:;,~H. ''' it 
should be n:cognized that CFR is influenced by several fuctors 
independent from the hydrodynamic ch:tracteristics of the ste-
notic lesion. Since tlow re:;erve is by definition a ratio, simil::tr 
values may be obtained at different levels of resting and hyper-
emic flow. Ch:tnges in ba...;a! resting flow without ch:tnges in 
hypt:rt:mic llow would considerably affect the ratio. Further-
more, any factors affecting the hyperemic pressure-flow rela-
tionship would likewise modify the flow reserve and thereby 
change the assessment of tht: .severity of tht: coron:try le:;ion 
under study. The hyperemic pressure-tlow rdation:;hip is influ-
enced by factors such as heart rate, prelo:td, myocardial hyper-
trophy, contractility, or dbea.-.;e of the microvasculature."·'"' This 
has bt:en demon:;trated in open-chest dogs~' and in difft:rent 
:;tudies in patients . ...:-~' 
Eff<..--cts of the Ph:J.rm:tcologic Agents Used 
to Induce Maximal Hyperemia 
An increase: in coronary blood flow can be observed either 
during reactive hyperemia induct:d by tran:;lumin:tl occlusion 
or by phann:tcologica!ly induced hyperemia. Widely used vaso-
dilator agent:; are dipyridamole, nitroglycerin, papaverine, and 
adenosine. The hyperosmol:tr ionic and low-o:;mo!ar nonionic 
contrast media cannot be u:;ed, becau:;e they do not produce 
ma;xim:tl v:t.sodilation."'' Nitr-.tt<..'S have a predominant effect on 
brt;e conductance \'esscls, so that tht: flow change:; due to 
peripheral vasodilation arc partially masked by the large simulta-
neous increase in cross-sectional area in the proximal arterial 
segments. Continuous infusion of an adequate dose of dipyrida-
mole results in maximal coronary vasodilation, but it has the 
disadv:mt:tge of a long duration of action, which nukes the 
repeated a..--sessment of the coronary hyperemic response of the 
coronary vascular bed or the asse::;sment of different coronary 
vascular bed response during the :;arne procedure impossible. 
Bookstein and Higgins'"' have :;hown in dogs that the hyper-
emic response after an intracoronary bolus injection of adeno-
sine triphosphate or papaverine i:; of the :;:une m:tgnitude as 
that occurring after :1 15-:;econd ocdu:;ion of the coronary 
artery. The do:;e range of intracoronary papaverine needed to 
produce ma.."illnal coronary vasodibtion has been r:st:tblishc<.l in 
humans by Wilson and 'Wh.ite."7 Selective intracoronary infusion 
of papaverine produced a ma..·•dmal hyperemic respon:;e in most 
coronary :u-teries (30%) after 8 mg and in all coronary :trterie:; 
:liter 12 mg. P:tp:tverine in thb dose range (8 to 12 mg) pro-
duced a «.'Sponse equal to that of an intravenous infu:;ion of 
dipyridamole in a dose of 0.56 to 0.84 mgfk:g of body weight. 
The coronary va....;odibtion after intravenous or intracoronary 
adenosine is of a comparable m:tgnitude to that observed after 
papaverine. The time from intracoronary injection of adenosine 
to peak hyperemia, as well as the total dur-.ltion of the hyper-
emic r<..-sponse, is about four times shorter than that of papaver· 
ine."" Furthermore, adenosine does not prolong the QT interv-.11 
and avoid:; the potentially dangerous ventricular arrhythmias 
observed after pap:tverine."'' Wilson and :t."i....;ociates'"' reported 
th:tt an intr:tcoron:try bolu:; or infu:;ion of :tdeno:;ine increases 
coronary velocity to level:; :;imilar to those recorded :tfter p:tpav-
erine without significant ::.)'Stemic effects or ::.-ymptoms. Adeno-
:;ine can also be administered intravenouslv. Kern and col-
leagues have shown that :1 continuous intrav~nous inJusion of 
140 1-1-£ ·kg·' · min·• induces maximal coron:try vasodilation in 
mo:;t patient:;.'" Development of mild hypotension, bradycardia, 
or first- or second-degree atrioventricular block or ::.)·mptoms 
(flushing, chr:st discomfort, he:tdache, dyspn<..':l) rarely requires 
discontinuation of the infusion.''~ In view of t11e extremely high 
s:lfety profile of :tdeno:;ine, thi:; agent b the pharmacologic 
:;timulus of l::hoice. 
Effect of the Ph.::t.rmacologic Agent Used to 
Induce Hyperemia on Stenosis Geometry 
The ideal vasodilator :;hould dilate t:xclusively the r<..-sistance 
ve:;seb without affecting the geometry of the flow-limiting ste-
nosis in the epicardial coronary artery. Gould and Kelley found 
important changes in stenosis r.:eometry caused by papaverine-
induced hyperemia in dogs.''' Zijlstra and coworkers'" have 
reported an incn:a."C in the cross-sectional area of the steno:;i:;, 
Since change in v<.-ssel caliber caused by the coronary vasodila-
tor (dipyridamole~ papaverine, or adenosine) may alter the pres--
sure-flow relationship, administration of nitrat<..-s before the mea-
surement of CFR is strongly advocated to negate tht: t:picardi:t! 
va._..;odilator action of the drugs used for the induction of maxi-
rrial hyperemia. 
Differences in Proximal and Distal 
CotOO!I.l")' Flow R<:SC.t"VC 
Because of the influence of low re:;btance and pr<..'Stenotic 
branches, differences in proximal and poststenotic flow velocity 
have been observed and attributed to the br:mching circula-
tion.~·'"· w. Donohue and associatt:s have reported in 101 pa-
tients :;imult:meou:; mea:;urement:; of pres:;ure gradient and of 
proximal and distal CFR.Y' In the di.seased vesseLs, the proxi-
mally measured CFR was not :;t:ttbtica.lly different for any tran:;-
lesional gradient. The dbt:tl CFR wa:; :;ignificantly lower in 
arr:erie:; with a gradient greater than 20 mm Hg (1.4 ± 0.6 vs. 
2.1 :!.: 0.7). The poststenotic flow re::>en:e is thus a better 
descriptor of the $everity of a coronary :;teno:;i:;, the proxim:tl 
flow reserve being inlluenced by the br-.1nching and preMenotic 
diversion of flow to regions with lower resistance. 
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Effect of Heart Rate., Arterial Pres-.-.ure, 
and Ventricular Preload 
The coron."'l)' flow-velocity re..<.erve is c.-•sti.m.1-ted by the ratio 
of pL-;lk·to-r~sting flow velocity. One of the potential problem_"' 
of this measurement is that the flow-vclocitv ntio can be :tf-
fected by a change in resting flow velocity· cau...;ed either by 
factors increasing myoc-.trdial oxygen consumption (e.g .. thyro-
toxicosis) or by factors producing a resting high-flow state (e.g .. 
anemia). CFR mL-a. .. -urements are highly reproducible in the 
absence of condition."' known to affect resting or hyperemic 
coronary blood flow, but increa..;es in heart r:tte or preload 
reduced CFR because rl..-sting coronary blood flow velocity in-
Cf{_"':l.-<;ed. In contrast, changes in mean arterial pre~ure do not 
alter CFR because of similar increase in resting and hyperemic 
blood flow."~-*' De Bruvne and colleaguL-s~' have reccntlv ana-
ly-/.ed the short-term reProducibility of CFR measurcmen~. CFR 
\"\.'$ measured twice at 3-mlnute intervals and under :J.trial pac-
ing and nitroprusside and then dobutamine administration. The 
coefficient of variation of CFR was 10.5% between the two 
baseline measurements. CFR did not change during infusion of 
nitroprusside but decrL-ased during atrial pacing and dobutam-
ine infusion. 
Interpretation of CFR mc-J..Suremcnts should thus account for 
the variable hemodynamic conditioru; at which the flow-vclocitv 
mea...,urements are obtained. · 
Technical Facton; Influencing the 
Accuracy of Doppler-Based Corotury 
Flow Reserve 
There is a possible induction of flow obstruction due to the 
large guiding cathetL--r engaged in the coronary ostium: in an 
ostium of 3 mm in di.'UUL"ter, the tip of an 8-Frcnch guiding 
catheter occupies 77% of the luminal area.''" With a blood 
collection method, it W3S demonstrated that the maximal flow 
through the :;ide holes of such a catheter does not exceed SO 
mL/min, It is thus advocated that when impedance of the flow 
could occur, after selective injection of the vasodilator. the 
c:tthL"ter should be immediately pulled out from the ostium 
without moving the Doppler probe. A careful monitoring of 
the pre~sure waveform recorded through the guiding catheter 
can facilitate the detection of damping of vdodty (Fig. 40-6). 
Use of diagno~1:i.c coronary catheters (5 or 6 French) is an e-J..Sier 
:J.ltemative possibility to prevent flow obstruction. 
Side holes permit continued blood flow. but there is :m 
unpredictable amount of adenosine being lost in the aort:l 
during intracoronary bolus injection that inllucnces the mea-
surement of CFR.'~' A larger dose (up to 36 )Jog) should be used 
to assess CFR when guiding catheters with side holes are used. 
Finally, when the signal-to-noise r-.ttio of the recdved Doppler 
signal is low, the automatic contour detection implemented in 
this ~~'tern fails to recognize the true ma.."'timal velocity profile. 
This c:m occur in up to 16% of the cases. '00 Manual retracing 
with an off-line ::.y:,;tcm for the calculation of the avL-rage peak 
velocity and the CFR is necessary. We have demonstrated re-
cently that digitiEA1.tion of the raw Doppler signal associated 
with automatic off-line processing allows a better evaluation of 
ma:dmal flow. 10 ' 
Long-term Variability of Corona.ry Flow 
Reserve 
Di Mario and coworkers""' analy/.ed long-tenn changes in 
baseline and hyperemic imracoronary flow velocity and CFR 
in angiogt:J.phically normal arteries. Ba...;eline and hyperemic 
velocities were :;imilar between baseline :t.<;..'<essment md after 6 
months. but the agreement between succes:>ive ml..-asurement:; 
was rather poor. The long-term reproducibility wa:; improved 
when flow velocity was normalized for the cross-section.1-l an..-a 
at the site of measurements. To improve the reproducibility of 
the measurement.-., the u._-;c of intracoronary nitrate:> is recom-
mended to reduce the velocity changes related to changes of 
the cross-sectional area at the site of the Doppler sample vol-
ume. 
Application of the Continuity Equation in 
Coronary Stenosis 
The continuity equation states that in a tube without 
branches, the velocity-arL-a product at my point h equal to the 
velocity-area product at any other point in the tube. The conti-
I BASELINE ~NOSINE I 
FIGURE 40-6. In the upper p:ut of the illustration...,, note the ~imultaneous recordln~ of the pre~utc in the 
ascending aort:1 (tip manometry) and of the proxim:tl coronary p~ure (fluid-filled S-French guidin~ catheter at 
the ostium of the left coronary artery). At baseline the two tr.ldngs arc superimpo.;ed, indic:~ting that the 
voluruinou~ guiding catheter doe~ not Impede the flow in the main. .. tem of the left coron:u:y ;II'tery. The intr.tcoro-
nary adrninL~trntion of 181!-g of <~denosine induce:; the development of a pre~~-ure gradient between the aort.'l and 
left main coronary ;II'tery, generated by the pre~nce of the ~din~ catheter. Note the ventricul:ui.;-.atlon of the 
proxim:tl coronary pre;;surc and. in the lower p:ut of the illu.stl.".ttion, the simultaneous chan~es in flow velocity 
recorded u~l.n~ a Doppler guidewire positioned in the proxi.nul left anterior dc:;cending artery. (From Scrruys pw, 
Di M<lrio C, Meneveau r-;, et :tl: Intracoron:try pre~~urc and flow velocity from scnsor-tlp guide'Wircs: A new 
m(.'thodological comprehensive approach for the :t.'<..o,;e;;sment of coronar.· hemodvnamics before and after coronarv 
intervention.~. Am] Cardiol li:<ilD-530. 1993.) ' · · 
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nuiry equation is a principle largely applied for the calculation 
of cardiac valve areas in echoca.rdiogrnphy. '"~ Miniaturi:-.ation of 
the Doppler probes h:ls allowed the application of this principle 
for the assessment of the severity of coronary artery stenoses. 
In \itro studies in hydrnulic models of coronary stenoses have 
shown an excellent correlation between this method and true 
cross-sectional area of stenosb. '"" Similar results were obtained 
in :mimal experiments.::- and in humans for the assessment of 
moder:tte (<50% diameter) coronary stenoses, using 3-French 
intr:tcoronary Doppler cathett.'CS that cannot. howt.•ver. be used 
in :s-evere coronary stenoses."" 
The feasibility of measuring maximal jet vdocity within a 
stenosis with the Doppler guidewire was tested in 52 consecu· 
rive patients, in a total of 61 arteries. prior to coronary angio-
pl~ty. "" Based on the continuity equation, percentage cross--
sectional area stenosis '>V:l.S calculated as: 
%CSA St = (1 - APV Rcf/,\PV St) X 100, 
where St == stenosis. Ref = reference segment. CSA == crOS$-
:s.ectional area, ami APV = aver:tgc peak velocity. 
.-\.0 incr<.."':lSC in flow velocity :u..!v:tncing the guidewire into the 
stenosis was observed in 17 arteries. Only in 10 cases (16%), 
howe'>·er, was the quality of the Doppler recording sufficient to 
allo\v the measurement of the time-avernged peak velocity. In 
these cases, the time-aver:tged peak velocity incr<..":l.St:d from 15 
= 5 em/sec to 110 :± 34 em/sec from the reference normal 
~--.mcnt to the stenosis. A marked decrease was observed in 
the :mgiogr:tphically measured cross--sectional areas (7.75 ::!:: 
2.55 mm~ vs. 1.05 ± 0.61 mm~ JOr the reference and steno~is 
areas. respectively). Consequo::ntly. compar:tble volumetric tlow 
'>':l.luL-s were calculated in the stenosis and in the reference 
segment from the corresponding How-velocity and cross-sec· 
tiona! area measurements. 111e percentage reduction of cross.-
secrional ar<.."'::l calculated from the QCA measurements and from 
the Doppler flow-velocity measurements were signi.fiClfltly cor-
related. But the application of the continuity equation for the 
:l..'-'<Ssmcnt of stenosis severity has significant pr:tctica.l and 
theoretical limitations. 111e first problem is the choice of the 
reference "normal~ segment. Epicardial and IVUS have con-
fumed the pathology findings showing that diffuse or foc:tl 
intimal thickening is present in angiogr:tphically normal arterial 
segments.""'· '"~ If the: tlow·velocity measurement is obtained in 
a segment already narrO\ved by the atherosclerotic '>v:tll en-
croachment, the percentage cross--sectional area stenosis c:tlcu-
!ated from the velocity mt:asurements will unden.:stimate the 
~tc:nosis severity. In the presence of s<..-vere stenoses. the flow 
is preferentially diverted to the pn:stcnotic br.wches so that 
di::-ta.l Dow is reduced, resulting in a high proximal-to-distal flow-
velocity r:ttio. The rdi.:rencc: Jlow vdocity in a segment distal 
to the stenosis shoukl thus be: used. Another important limita-
tion is related to the mc::tsurc:ment of the: flow velocity in the 
stenosis. where the velocity profile is modified (in the pro::sence 
of abntpt changes of ~u!ar diameter stenosis, a \ra.o.;cular 
segmc:nt four to six times longer than the vascular diameter is 
n.·quired to reconstitute a fully developed par:tbolic profile).'-' 
Therefore, for short stenoses, the use of the maximal velocity 
may underestimate the percentage cross-sectional are.1 stenosis. 
But the most important practical limitation to the applicability 
of the continuity equ:ttion for severe coronary ksions is the 
possibility of obtaining Doppler recordin~s suitable for qu:tntiti· 
7.ation only in a minority of the study popul:.ttion. The :tppro-
priate orientation of the Doppler sample volume in the narrow 
tapering segment immediately proximal to the lesion is difficult, 
re-::-ulting in inability to capture the sm:lll stenotic jc.:t. Extensive 
manipulation or tip reshaping of the Doppler guidewire may 
yield a higher acquisition r.1te of jet velocity signals in the 
stenosis but is a..-.sociated with a potc.:nti:tl risk of wall dissection 
betOre access to the dist:tl vessel h:ts been secured. 
1'ranslesional Pressure-The Fractional 
Coronary Flow Reserve 
After the initi:tl description by Andreas Grtint7Jg of the use 
of the translcsional pressure gradient for the assessment of 
the ~l.lccc:ss of an angioplasty,' pressure me:t!>l.lrcments were 
progressively abandoned. 
From translesional pressure measurements made with a guide-
wire transducer during ma.."im:tl hyperemia, a new concept for 
the determination of coron:try blood flow, the FFR.\IYO has 
c:mergcd. "*' '\Vhen blood flows from the proximal to the: distal 
p:trt of the normal epicardi:tl coronary artery, virtually no en· 
ergy is lost and, therefore, the pressure remains constant 
throughout the conduit. In the case of epicardi:tl coronary 
narrowing. potential energy is transformed in kinetic energy 
and in heat when blood tr:tverses the lesion. The result:lllt 
pres~l.lre drop reflects the total loss of energy. To maintain 
resting myoClrdial perfu~ion at a constant level, a decrease in 
myocardi:tl resistance will compensate for any resi:;tance of tlow 
due to the epicardial narrowing. Arteriolar resistance decreases 
to m:timain the tlow. The decrease in myoca.rdi:tl resistance 
reserve is proportional to the resistance that can be computed 
from the pressure gr.1dient-tlow rdmion and, ho::nce, the pres--
sure at constant maximal flow can represent an index of the 
physiologic consequences of a given coronary narrowing on 
the myocardium. 
111e ma..'Xim:tl myocardi:tl blood tlow in the presence of a 
::.tenosis is reduced relative to expected norm:tl tlow in the 
absence of a stenosis :tnd can be <..-xpressed as a frnction of its 
norm:tl expected value, if there was no lesion. 11lis value, called 
FFR.,tYo, can be derived from pr<."'Ssure data :tlonc: separately for 
the myocardium, the epicardi:tl coronary artery, and the collat· 
er:ll supply, based on sever..tl assumptions regarding tr:tnsle-
~ional pressure measured during ma.."'imal hyperemia.""' ""' TI1e 
proposed equations have been derived from a theoretical model 
of the coronary circulation and have been v:didated experi-
mentally in instrumented dogs, and later in humans, by the 
comparison with myocardial flow measured by positron emis--
sion tomography (PET).''" During ma.:ximal hyperc:mia (with 
papaverine or adenosine), coronary resistance is at the lowest 
level and rem:tins constant, so that tlow is directly related to 
the measured pressure gmdient. The total myocardial blood 
flow (QJ in an area de-served by a coronary artery with a 
stenosis is the sum of the Jlow through the stenosis (Q.,) and 
the collateral flow (Q<). The FFR.\\YO is defined as the ratio of 
the m<..-asurc:d flow (QJ over the maximal flow that should be 
pr<..-sent without any ~tcnosis CQ")"*'· "': 
FFR.\1YO =- 0/0" =: (Po - Pv)/R 
-- (PA Pv)/R 
with P,\ =: mean arterial pressure; Pv = mean venous pres.~ure; 
PD = mean pressure distal to the stenosis, and R ::: the resis--
tance of the myocardial v:tscu!ar hed. Jkcause this rt:Sistance is 
assumed constant, 
FFR.\\YO = (Pn - Pv) = l 
(PA - PV 
~p 
------(PA- Pv) 
Pn 
p, 
with Pv assumed low and constant. FFR.\1Yo can thus he esti-
mated ::t..'> the ratio between the: mean distal coronary blood 
pressure (using ultr-.1thin pressure tr.tnsducers) OVL"f the mean 
aortic blood pre-sure (measured by the guiding catheter). For 
a normal vessel, FFR~wo is unc:quivocally equal to lOO'X •. Since 
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each myocardial territory serves as its <Jwn control, it is a lesion-
specific ind<.·x independent of the microcirculation, heart r.th:, 
blood pressure, and other hemodynamic variables, and it c-.tn 
be applied in multivcssd disease. 
Fr.tctional collatcr:ll flow n . -scn•c (FFRcou.) and fmctional coro-
nary flow reserve (FFRcoR) arc calcul:tted with similar equa-
tions: 
FFRCoR == 1 - h.P/(PA - P\>;•) 
FFRcou. = FFR.\JYO - FFRcoR 
with Pw = the coronary wedge pressure measured dist:dly 
when the PTCA balloon is inflated in the artery. 
Thank._..; to the development of miniaturized pressure tr:tns-
duc<:rs, the mean tr.tns-stenotic pressure gr.tdient h.P c-.tn be 
mc-.tsured without a signific:mt overestimation of the tntc pres-
sme gr.tdient.' '-' Investigated pressure wires were 0.0 15-in. fluid 
filled''-' or high-fidelity 0.018-in. tip pre.s..~ure tr.msduccrs based 
on optic fibers (Pressure Guide, RadiMedical Systems, Uppsal:t, 
Sweden).'"'·'" 
Tecbnlcal Limitations to Pressure Guidewires 
The R:tdi and Premo pre:i.sure guide::. and the Tracker catheter 
produce excellent phasic signals. TI1e Premo \Virc (fluid-tilled 
pressure monitoring guidewire) produces damped pressure 
tracings owing to its small inner lumen. However, all three 
system::. reliably rdlect mean pressures. TI1e e\':.tluation of pres-
sure gradients is valuable only if a reliable pressure tr:tcing can 
be obtained. 1l1e reliability of pressure gmdients is questioned 
when one is dealing with small vessels (<2.5-mm diameter), 
acute artery b<:nds, or multiple lesions in a vessel. An artifactual 
pressure drop due to obstmction of the tip of the pressure 
catheter is highly unlikely when the catheter is aligned in a 
normal and relatively str:tiglu se~ment of a coronary artery. In 
contr:LSt with angioplasty catheters, the pressme measurements 
made with guidewires and Tracker c-.ttheters are not generally 
affected by tortuosity of :t proximal artery segm<.--nt. 
Clinical Significauce of Pressure Gradh'1ltS 
The risk of abrupt closure and re!->tenosi.s incre:tses with high 
rcsidu:tl pressure gradients after angioplasty.·'· '"' A persistent 
postprocedure pressure gr:tdient, especially if the angiogr.:tphic 
result is suboptim."LI, is an indication for further balloon infla-
tions (either prolonged inflations or up-si7ing of the balloon) or 
stent. A pressure gradient of less than 15 mm Hg has been 
con..-;idcred a successful postangiopl~cy result. II<• Ho\vever, in-
vestigations have identified limitations in using the resting pres-
sure gradient alone to assess the potential for ischemia due to 
a given stenosis. 117• "" 
In its initial clinical \':.llidation, FFlh1YO h:ts been compared 
with the relath·e flow reserve (RFR) measured by '~0-Jabded 
\vater and PET and to QCA.'"' Isolated proximal discrete steno-
sis of the L\0 coronary artery were investigated. FFR.wto and 
RFR were realized 24 hours ap:trt. They were measured during 
nu.ximal vasodilation under adenosine (140 p.g · kg-• ·min-' 
intravenous). RFR was defined as the ratio of the ma.ximal 
achk-vable absolute flow in the anterior region to the ma.xim:tl 
achievable absolute flow in the lateral region. PET RFR and 
FFRMYO were highly correl:tted, while the correlation between 
indices derived from QCA and RFR was markedly weaker. 
To define the threshold of FFR\lYO b<:low which inducible 
ischemia is present Pijls"" and DeBruyne''~ and their associates 
conducted independent, but JXtrallel and complementary, inves-
tigations. Pijls and coworkers studied 60 patients accepted for 
a single-vessel PTCA who had a positive ex:erci'<e te~1: in the 
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preceding 24 hours. FFR\1Yo was measured before and 15 min-
utes after PTCA and the cxercbe test \V:J.S repeated after 1 
w-eek. If the second exercise test had reverted to normal after 
PTCA, FFR.\lVO v-.tlues were a.s..'iOciated with inducible ischemia. 
All, except two, FFR\JYO mc-J.Surements p-eater than 0.74 were 
not a...;sociated with ischemi:l, and all FFR\lYO o.-4 or less were 
related to inducible iSchemia. In normal coronarr arteri<:s. 
FFRMYo was 0.98:!:: 0.03. DeBruyne and coworkers'''' studied 
FFRMYO in 60 patient:; with one bolated lesion in one major 
coronary artery who had a maximal exercise test 6 houn; before 
catheterization. ST segment depression wa:; compared to 
FFR,\lYo, h.P."'A:x, :md h.Ptu:.::.T. Intersection of sensiti\ity and speci-
ficity curves were at 87')-{,, 83%, and 75%, respectively, for 
FF&\1YO =:= 0.66, ~PMA.'X =:= 31 mm Hg, and ~PRE..q =:= 12 mm 
Hg. !';o abnormal test was present for FFR.\1YO grt':lttr th:tn 0.72. 
FFR\tYO has also been compared to the result...; of dobutamine 
echocardiogr.tphy in 75 pati<:nts with normal left n•ntricular 
function and single-vessel coronary artery disca....;e''"': the degree 
of dobutamine-induccd dys-synergy correlated sif!nifiCtntly \Vith 
th<.' QCA data, but the correlation \V:l~ markedly !x'tter \Vith 
FFRMYO. All but one patient \Vith an FFR\lYO gr<.-:tter than 0.75 
had a norm:tl stress test resttlt. 
Amon1; the most important reports of FFR\lYO is that of 
Pijls and colleagues,'~' who compared FFR,\1YO \'.'ith the unique 
ischemic standard of common nonim':.lsive testing modalities in 
45 patknts with moderate coronary stenoses and chest pain 
syndromes. 'When the FFRMYO was lower than 0.75 (21 pa-
tients), r<.'\'ersible myocardial ischemia \vaS demonstrated un· 
equivocally on at k-ast one noninvasive test (bicycle exercbe 
testing, thallium scintifr.tphy, stress echocardiog.raphy with do-
butlmine), and all these positive test results were reYerted after 
PTCA or coronary art<.'!)-' bypass grafting (CABG). In 21 of 24 
patients with an FFR.-..lYO greater than 0.75. all the test were 
negative, with no demonstration of ischemia, and no revascu· 
lari7A1.tion procedure W!IS performed. None were required after 
14 months of follow-up. The sensiti-..·ity of FFR-..tYo in the identi· 
ticttion of reversible ischemia was 88%, the specificity was 
100%, the positive predictive \'alue was 100%. the n<.-gative 
predicted value was 88%, and the accuracy was 93'::;. 
DeBruyne and a...;sociates~~ demon~'trated also in humans that 
FFRMYO is independent of hemodynamic condition:;: changes in 
he::trt rate by pacing, in contractility by dobut:uninc infusion. 
and in blood pressure by nitroprusside infusion did not alter 
FFR,tvo. TI1e coefficient of\':.triability bet\·\'Cen t\\'0 consecutiYe 
measurements ·was 4.2%, lower th.1n 17.7% for the CFR mea-
sured with a Doppler wire. 
Fractional and Coronary Flow Reserves a11d 
Myocardial Peifusion Imaging 
To assess the relationship among radionuclide perfusion im· 
aging, po::.tstenotic coronary flow velocity, and translesional 
pressure gradients using flov.,.welocity guidewires and 2.7· 
French fluid-filled tracking Cttheters, Tron and colleagues inves-
tigated 6S arteries in 59 patients. at ba..-.eline and during maxi-
mal hyperemia (intracoronary [ic] adenosine). m FFR,-..tYO of 0.7 
or less had positive and negative predictive \':!lues for perfusion 
imaging defects of71% and 57%, respectively. PostStenotic flO\\' 
reserve (>2.0 units) had a positive and nega.tin: predictiYe 
valu<.-s of 83% and 74%, respectively. 
The pressure measuring catheter used in this study \v:IS larger 
than a pressure guide-wire and likely induced a ~,;y~'tematic in-
cr<.>-;:tSe in hyperemic pressure gradients. CFR had a higher posi-
tive and negative predictive value th.1.n FFRMYO for the perfu...;ion 
im:lg:ing results. It should not be surprising that myocardial 
perfusion reSponses arc not translated into directly measured 
tr:mslesional pressure gradient since dist.1.l myoClrdial bed resL"' 
tance may be variable or impaired and not accoumed for in the 
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primary assumptions of this methodology. The use of transle-
sional gradients has important value for determining lesion 
signifiCUlee, especi:illy when distal myocardial flow reserve is 
impaired. 
Simultaneous Measurement of Flow Velocity 
and Trans-Stenotic Pressure Gradient 
Assessment of Coronary Stenosis Using Sensor-
Tip Pressure and Doppler Wires 
Trans..stenotic blood flow velocity and pressure gradient a.re 
the parnmeters used to define the hemodynamics of a steno-
sis.' H Combined use of St::nsor-tip pressure and Doppler guide-
wires has been evaluated in 21 patients.'"-' Flow-velocity and 
poststenotic pressure recordings were obtained dist:tl to the 
stenosis, both in baseline conditions and after intracoron:u-y 
bolus injection of papaverine. 
Tile nu.ximal hyperemic tr.ms-stenotic gradient showed a sig-
nific;nt inverse correlation with the sinmltaneously measured 
hyperemic coronary tlow. P..ttients with nonsignilic:lllt stenoses 
were identified by the pre:;ence of hyperemic trans-stenotic 
gradients kss than 20 mm Hg :c>sociated with a maximal coro-
nary tlow greater than 150 mljmin or a CFR kss than 2. At the 
other extreme, the presence of large tf'.tns-stenotic gradients 
during hyperemia associated with a low ma.ximal hyperemic 
tlow identified the most severe stenoses. 
The simultant'ous measurement of the trans-stenotic pressure 
gradient and flow velocity h:ts s<.-ver-.tl practictl advantages. The 
pos.'>ible misinterpretation of a low-flow increase during ma..xi· 
mal vas<XIilation is avoided because the simultaneous presence 
of a high-pressure gradient discriminates a low-flow increa...-...e 
due to a hemodyn:unic:tl.ly severt' stenosis from a reduction of 
the maximal trnns-stenotic flow increase due to impairment of 
the <listal va:;odilatory mechanisms or to competition of flow 
through a well--devdopcd collater-.tl circulation. Conversely. 
wht'n a low-ma.xim:ll flow is present owing to facto["!; not depen-
dent on the stenosis rcistance, the measurement of a low trans-
stenotic pressure gr::tdient can be misleading and the presence 
of a ~ig,niticant stenosis onnot be ruled out. 
flzstalltaneous Hyperemic Coronary Pressure~ 
Gradient/Flow-Velocity Relation 
The tr.tns-stenotic pn:ssurc-p-.tdknt/flow-vdocity relation has 
been ".IJl:l.l}'"/.t'd from digitized pressure and flow velocity during 
mid-diastole in 15 patients.',-' 
A cl<::!.r Doppler envelope allowing a reliable automatic detec· 
tion of the hyperemic dia.-;tolic peak velocity during four con-
secutive beats was obtained in 12 of l 5 cases (80%). A linear 
relation betWet'n trans-stenotic ~;r-.tdient and flow velocity was 
observed in 5 of 12 patients (42%) (Fig. 40-7). In the remaining 
7 patknrs, a quadntic equation had the best fitting for the data 
obtained. In all but one case :1n intercept dose to 0 (within 
:±: I 0 mm Hg) was observed. Steeper increases of the trans-
stenotic pressure gr::tdient at a given tlow increase were mc::a-
sun."t.i in the arteries with the most severe reduction in luminal 
cross-sectional area. 
Although the maximal flow and, consequently, the ma.ximal 
tr-.tns-stenotic gradient is determined also by f::tctors indepen-
dent from the stenosis resistance, the pressure-gradient/flow-
velocity relation is intimately correlated with the stenosis hemo-
dynamks. Two approaches are available to assess the slope of 
tile pressure-gradient/flow-velocity relation. The fif"!;t is based 
on the masurcment of the changes of the me.tn tt:lll$-Stenotic 
pr<."!>.'>Ure and flow velocity from ha.'iCJinc conditions to maximal 
hyperemia."'' A technically more complex approach is based 
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FIGURE 40-7. lnsunw.neotlS hyperemic diastolic pres~ure-gradient/ 
flow.vdocity rc:Jation for 12 stenoM:s of increasing hemo<.lyn:tmic ::.<:Ver-
ity (from right to left and from bottom to top). Y!LCSA, minimum 
luminal cro:,..Y.;t:ction:t.l :uea. 
NO. CATII. :-<'0. MLCSA (mm') EQUATI0:-1 
92707 0.21 y= 21 + 3.72.1: 
2 92999 0.33 y~ -6 + 5.76.1: 
3 921858 1.16 y = 2 + 2.01x + 0.0275.\""' 
., 921132 OA9 y~ 25 + 0.79x 
5 920922 0.82 y~ 2 + 0.11.1: + 0.073-'1...,! 
6 922047 0.83 y~ 1.6 + 0.50..1: + 0.00;$5.'1."' 
7 930201 1.72 y~ -4 + 0.28.'\." + 0.009.\""' 
8 920908 0.83 Y"" 
_, + 0.76.1: 
9 921502 0.36 y = 9 + 0.0055.\""' 
10 921504 1.19 Y" -0.1 + 0.0074x' 
11 9214,-18 4.61 Y"" -1 + 0.23-'1.' 
12 921330 2.09 y~ 5 + 0.0011.\""' 
on the a_7;_<;essment of the instantaneous pressme-gradient/tlow-
velocity relation during the progressive tlow decrease in mid to 
late diastole. The advantage of an assessment based on instanta-
neous inst<.":l.d of m<."3.11 gradient/flow changes during the cardiae 
cycle is that the phases of acceleration/deceleration of How, 
influenced by factors unrelated to stenosis resistance, can be 
eliminated from the analysis. The pressure·gr-.tdient/tlow-veloc-
ity relation can also be studied during a prolonged cardiac arre~t 
induced with a high-dose intr-.tcoronary bolus of adenosine 
during papaverine-induced maximal hyperemia (Fig. 40-8). In 
principle, howevt'r, the pre:;sure-gr-.tdient/flow-vdocity relation 
is independent from the hemodynamic conditions of a.-;sess--
ment, including the ma...,.imal level of tlow and pressure g.r.tdi-
ent, and could give sufficient information to char-.tctt'riZe stt'no-
sis s<.-verity also in resting conditions. 
Mancini and coworkers'~' have v-.tlidated in dogs tht' slope of 
the instantaneous pr<.-ssurc-flow relation as an inde.'X of coronary 
stenosis. This relation was compared with a microsphere..Je-
rived inde.x of myocardial conductance. The instantaneous hy-
per<."1Tiic flow ve~-us pressure inde.'X demonstrated no depen· 
dence on heart rate, left ventricular end--diastolic pressure, 
mean aortic pres..'>ure, or inotropic changes."'· '·"''· ,_..,. Tht' de-
crease in flow-pressure slope with the presence of stenoses of 
increasing severity correlated well with the transmural and the 
subendocardial microsphere-dcrived measurements. 
The feasibility and the reproducibility of the assessment of 
the slope of the instantaneous diastolic relation between coro--
nary !low velocity and aortic pressure during ma.'Ximal hyper-
emia (lHDVPS) have bet'n investig:tted in 95 patients.'""' It is 
postulated that the changes in coronary blood vdocities re· 
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corded by the Doppler wire are directly, and only, related to 
changes in flow (assuming a constant velocity profile and a 
constant coronary diameter), to derive Mancini's inde..x from 
velocity-pressure relation. ln the arteries with Jess than 30% 
di:unett..-r stenosis, blood flow velocity was me~<ll'Cd in a regular 
;.tr.:tight pro:odmal-middle segment of the artery where an opti-
mal Doppler signal could be obtained. The Doppler signal \\l':lS 
acquired distal to the stenosis using a Doppler guidew.ire. The 
proximal corOnary pressure was measured through the guiding 
catheter. Iin(."al" regression analysis was used to assess the slope 
of the digitized pressure-velocity relation (em· sec~'· mm 
Hg-') in foUl' consecutive beats during ma..ximal coronary v:t..~o­
dilation. A de:u- Doppler envelope allowing a reliable autom."LtiC 
detection of the hyperemic diastolic peak velocity during four 
consecutive beats was obtained in 79 (83%) of 95 patients. A 
CFR greater than 2 and an IHDVPS greater than I were present 
in 5 (21%) and 3 (12%), patients with greater than 30"/u diam(.-ter 
stenosis. ln the normal group, a CFR and an lliDVPS equal to 
or Jess than th<::se levels were observed in ·'i (1%) and 8 (14%) 
arteries, respectively. Using these :trbitr.lrily dciined cutoff val-
ues, CFR and lliDVPS correctly id<::ntified 79"/o and 88% of the 
arteries with greater than 30"/o diameter stenosis and excluded 
the presence of a stenosis in 93% and 86% of the 55 control 
arteries (NS). On average, the beat-to-beat variability of the 
pressure-velocity slope was 15±8%. 
A possible limitation of IHDVPS is the dependence of the 
hyperemic pressUl'e-velocity slope from the cross-sectional are-.t, 
as expected for an index reflecting coronary conductance. The 
inability to normalize coronary flow for the perfused myocardial 
mass limits the comparability of measlll'ement...;; performed in 
vessels of different dimensions. However, coronary flow veloc-
ity shows only a mod(.-rate decrease from large epicardial arter-
ies to the more di;.lal branches, suggesting that a comparison 
remains po~ible in normal-sized proximal/middle epicardial :u--
terie..;;. The malysis of the pressure-velocity relation of long 
diastolic pauses sugge;.1:ed th:lt the linearity of the pressUl'e/ 
flow-velocitV relation observed during normal ;.inus be-.1ts can-
not be exmpolated over a la-rger rnnge of pressures and flow 
velocity, probably because of a significant reduction of arterial 
cross-section at low dh1:ending pre~Ul'es. This technique, there-
fore, c:tnnot be used for an accurate estimation of the %(."To-
flow pre~;.-ure. 
De Bruyne and colleagues"' have compared the f(.-asibility and 
v-.uiability of IHDVPS, CFR, and FFR.ww. Both CFR and FFRMYo 
could be calculated in all cases, but IHDVPS could only be 
calculated in 82 (19%) of the 104 inve;.'tigated patients. CFR was 
sensitive to hemodynamic changes (atrial pacing, dobutamine 
infusion). Conversely, ll·IDVPS and FFR.m:o were not influenced. 
Coefficients of variation between two consecutive mea.·•ure-
ments were 4.2% for FFRMYo, significantly lower than 17.7% 
and 24.7%, for CFR :tnd lliDVPS, n.-spectively. 
Quantitative Coronary Angiography, 
Translesional Pressure, and Flow Velocity 
The imperfect nature of angiography in assessing the func-
tional significance of coronary stenoses, mostly attributable to 
large interob~rver and intt:lobserver variability, h~ be(.""ll well 
docum<::nted. QCA \\l':lS developed to overcome the limitations 
of visual interpretation, and its accuracy and reproducibility 
have been demonstr.lted.'"' On the basis of stenosis geometry 
and fundamen'tal fluid dynamic equations, QCA methods have 
been able to provide mathematically derived translesional pres-
sure gradients and coronary blood flow. QCA-derived hemody-
namic data also provide an e;.1:imate of flow reserve attributed 
to the coronary lesion (stt."llOtic flow reserve).':«> Tr:mslcsional 
prcs;.ure gradient.-; arc generated from fluid-dyn:unic formula._.;; 
validated in n-perimen'tal models.'' These parameters were cor-
related only with functional indexes of coronary stenoses in 
selected patients with limited coronary atherosclerosis,7"· ' 1' but 
not wht..-n n'tensive atherosckrosis was present.7·" 
Comparison of QCA with pres;.'UI'C gradient.~ and coronary 
flow measUl'ements with a Doppler wire has been performed 
in several studies. Donohue and coworkers"' have measured 
CFR, transle;.ional gradient at re;.1: with a 2.2-French infusion 
catheter, and QCA (Philips DCI or ImageComm [Statview Sys-
tem, Sunnyvale, CA) ;.ystems) in 33 patients.'" There was a 
we-ak correlation between an.giographic lesion .s<.-verity and cor-
responding gradients, and in the -10% to 60% angiographically 
intermediate range, there was no correlation between lesion 
diameter narrowing and gndient. 
Angiographically :;cvere (concentric, >SO%) l~ions generally 
had significant (>30 mm Hg) gndient.-". However, the Umita-
tions of mgiogr-..tphy are well kno\VTI for both operator and 
tt::chnlcal .fucto-rs, making lesion interpretation difficult and, at 
times, impossible. 'When studies of stenosis severity are re-
viev:ed, often a single ·worst-ca..~e· vkw will be reported. An 
eccentric k--sion with one view of SO% :tnd one view of 40')\.. 
may not be associated with a tnns[esional gradient. Conversely. 
a moderate concentric lesion can frequently be a._.;;..;;ociatcd \vith 
a significant gndient. 
More recently, Tron and associates measured tt:ln.slesional 
hemodvnamic.s in the same artt..-ries in which QCA pressure and 
flow w~re measured (Philips DCI-ACA)Y~ Stenotic flow reserve 
and baseline :tnd ma.."Xim.1.l tr.mslesional preSSW'e gradients were 
calculated from the worst QCA projection. Tr.msk-sional pres-
sure gradients were measured with a 2.7-French fluid-filled 
tracking catheter. Intracoronary Doppler flow velocities at rest 
and during m.1..ximal hyperemia (ic adenosine) were m~ured 
with a Doppler wire in 28 arterks from 25 patients. The rc:>ults 
of this study indic-.1ted that QCA did not correlate wi'th mea-
sured gradients at baseline or at ma..ximal hypen."lllia. No correla-
tion was found between QCA-predicted stenotic flow reserve 
FJGL"'RE ·i0-8. Prolont::ed d.t:L.~toUc pause induced by the intracoronary injection of 3 m~ of :tdeno~ine durin~ 
ma_.'<lrn;ll hypc:remia. induced by papaverine. A progres~ive decre:t:<e of flow velocity :md aortic pres._'\ure b observt::d 
during the 6 se<:oncb of cardiac :J.I'l'CSt. In the first beat~. induced by ventricular pacin~. note the pre..;;.~un: of :t 
l:lrgc ~~toUc flow component indicating relil.l.mg of the capacitance of the t::picardlal coronary artery. The dotted 
tr'..tcing :tt the top of the Doppler envelope indicates tbt:: in~-unt:tncou~ pe-.lk velocity (automatically detectt::d on-
line and used for the analysis of tht:: pres..~ur<::/velocity relation). 
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:md measured CFR. For intermediately severe :mgiographic ste-
noses. no correlation C.'\:isted among measured pressure grndi· 
ent. CFR. lesion diameter. or cross-sectional area. This study 
suggests that because of inherent limitations of :mgiogrnphy, 
state of the distal bed. and assumptions of the physiologic 
state for fluid dyn::tmic equ::ttions. QCA-dcrived parnmeters of 
tr::mslesion:ll physiology p::trticularly relev::tnt for intervention:U 
decisions do not corrcbte with directly measured tr.tns!esional 
pressure :md flow. But ::t limitation in this study could be the 
use of a 2.7·French device to measure dist::tl coronary pressure, 
\Vhich could overestim::tte the true pressure gradient. 
In ::t more recent study, QCA has been compared with FFRMYO 
determined with ::t 0.015·in. lluid·tilled pressure monitoring 
guidt."\Yire (Premo wire).'-'-' Qu:mtit::ttive assessment of stenosis 
geometry \v::tS performed on·line using the ACA ::.ystcm. Before 
angioplasty, QCA \vaS obt::tincd in 105 patients, ::tnd ::tfter the 
procedure, pressure mo:.-asuremcnts and QCA were performed 
::tgain in 52 p::tticnts. With pooled preangioplasty :tnd postangio-
plasty results, ::t curvilinear relation was found between diame· 
ter stenosis :md myoc::trdi:llllow reserve, and bt.'t'.Veen MLD :md 
myocardial tlow resen·e, in agreement with pf<.''.riously pub-
lbhed dau.'-.,_, A linear equation was also found bemreen ::tngio-
grn.phic stenosis flow resen'e ::tnd FFRVIYO. This study demon· 
str:ned that in :m unselectcd cohort scheduled for PTCA, :l11 
OYerall correlation exists between QCA me::tsurements an-d 
FFR\IYO. There was a rather l::tr~:e dispo:.-r::.ion of the data; no:.-vc-r-
theless. the di:tgno~tic accuracy of ::tn MLD ofless th::tn 1.5 mm 
::tnd ::t di::tmeter stenosis greater th::tn 50% in detecting ksions 
::ts::.ociated with an FFR\JYO of less th::tn 0. 72 were 92% and 89%, 
n:spectiYely. 
Perfusion Im.o.ging and Poststcnotic Coronary 
Blood Flow 
Clinical decisions for coronary interventions are often b::tscd 
on the results of out-of-laboratory physiologic testing such as 
stress thallium perfusion myocardi::tl im::tging. Bcc::tusc the physi· 
ologic assessment of angiographic::tlly intermediate stenoses re-
mains problem::ttic, functional measurements of poststcnotic 
intracoronary flow velocity reserve m::ty be useful in clinical 
decision m::tking. Ho\vcvcr, the correlation between poststeno-
tic CFR and hyperemic myoc::trdi::tl perfusion scintif,r:tphic irn· 
aging ,,.as l::tcking. :0.1illcr ::tnd colle::tguesM studied 33 patients to 
correlate ::."tress myoc::trdial perfusion imaging using technetium 
99m sestamibi with poststenotic coronary llow reserve in p-a· 
tients with angiographically intermediate stenoses. A Kappa 
statistic mo:.-asuring the strength of correlation among the veloc-
ity. im::tging, ::tnd QCA variable:; was computed. QCA stenosis 
seYcriry (~ 50% di::tmeter stenosis) and poststenotic coronary 
tlo\v ,-elocity reserve of 2.0 or less were corrcl::tted in 20 of 27 
p::ttients. Perfusion imaging abnorm::tlitics and coronary anglo-
graphic stenosis severity were correlated in 28 of 33 patients. 
The strongt:st corn:lation w;u; notcU lx;tween hypcremi<; post· 
stenotic flow velocity reserve ::tnd sest::tmibi perfusion imaging 
in 24 of 27 p::ttients. :'\'c::trly ::tl! p::ttients with abnonn::tl distal 
hyperemic flow velocity values h::td corro:.-sponding: reversible 
myocardial perfusion tomographic imaging defects. The high 
correlation bctWeen t\VO different physiologic techniques to 
assess myocardial perfusion in the poststcnotic region suggests 
that clinical decisions c:m be made in the b.boratory in a fa.....;hion 
similar to out-of-l::tborntory testing. The physiologic assessment 
of coronary stenoses, t.:speci::tlly those of angiographically inter· 
mediate severity, may be improvt.:d by the use of posbtenotic 
tlow vdocity mo:.-asurements when perfusion imaging has not -or 
CJ.nnot bt: performed. 
A similar correspondence between poststenotic CFR and 
my<x.""ardial perfusi()n imag_ing has been described by joye and 
coworkers,'"' who compared single-photon emission-computed 
tomographic (SPECT) th::tl!ium im::tging to CFR in 30 patients 
with intermedi::tte coronary stenoses. The poststenotic tlow 
reserve and SPECf thallium studies were compared with 
blinded interpretation of tht.: results. A CFR of 2.0 or less \v::ts 
considered abnormal. The sensitivity, specificity, :tnd overnll 
predictive ::tccuracy of Doppler-derived CFR with stress SPEer 
thallium 201 results were 94%. 95'%, :md 9-1%, respectively. 
More recently, Miller :md associ::ttes1·" h::tve correlated regional 
myoc::trdi::tl blood flow (R.L\IIBF) derived from ["O]H.,O PET \vith 
directly measured poststenotic intrncoronary Doppkr flow ve-
locity under bas::tl conditions and dipyridamole-induced hyper-
emi::t in II p::ttients. There was a highly significant correlation 
bet\veen Doppler-<.krived CFR and PET-dt:rived myocardi::tl per-
fusion reserve (MPR). TIH::re w::ts ::t trend tO\v::trd a correlation 
bet\veen Doppler-derived CFR and Y!LD, but no correlation 
w::ts found bet\veen PET--derived perfusion reserve ::tnd MLD or 
diameter stenosis. This demonstrates that the corrd::ttion of two 
physiologic endpoints of coronary blood .flow more accurately 
retlects the functional severity of coron::try stenoses than docs 
::tngiography alone. These physiologic techniques provide objec-
tive evidence of lesion significance, which is useful to support 
the decision for coronary revascul::triz:ttion inten-·entions. 
To address the rd::ttionship between ::trtery stenosis and dist::tl 
coron:try blood flow, 35 p::ttients with single-vessel coron::try 
artery disease undenvent ! "O]H~O PET a._..,-::;es._..;ment of coron;:~ry 
blood How at rest :tnd during hyperemia (intravenous a<knosine 
140 J..l.-g ·kg-'· min-• or dipyridamole 0.56 mg/kg).'-"' Twenty-
one p::ttients were studied :tS ::tge match-control subjects. The 
results indicated th::tt bas::tl myocardial blood tlow (1.14 ::!: 0.42 
mL · min-• · g-') was simil::tr bct\veen p::ttiems 1.13 ::!: 0.26 mL 
min-' · g-') ::tnd controls. However, during hypercmi:1. myocar-
dial blood flow was lower in patients (2.10 vs. 3.37 
mL·min-•·g-•. Basal Jlow remained unch:tnged regardless of 
stenosis severity for diameter stenosis i,mg_!ng from 17% to 
87%. Flow during hyperemia w:t....- inversely corrcl::tted with the 
degree of stenosis severity ::tnd directly corrcl::ttcd with MLD. 
CFR declined with diameter n:trrowing g.rc::ttcr than "io•:;, and 
::tpproachcd unity ::tt stenosis severity of SO% or greater. 111esc 
d:tt::t :tre important rel:ttive to assessment of coron:~ry blood 
flow in p::tticnL" tmdergoing coron::try interventions that usc 
angiog_ra.phic endpoints. Physiologic considerations using intra· 
coron:1ry Doppler techniques em idt:ntify residu:1l luminal nar· 
rowing of 40% or greater not appreci::tted by angiography. w 
INTRACORO:-.IARY DOPPLER IN THE 
ASSESSMENT OF CORONARY 
!YfERVENTIONS 
Since the advent of coronary angioplasty, the assc~~mcnt of 
the acute results of interventions h::ts been a source of debate 
::tnd di.scussion. In recent yl-ars, major efforts were made to 
::tccuratdy measure the luminal ::trca of the stenotic ksion before 
::tnd :liter coronary ::tng_iopl:t...;ty using QCA with computer·b:t.-..cd 
automatic edge detection.'"'"'·'"'·'"' However. !Or the evaluation 
of the angioplasty result~. this technique has inht:rent limita· 
tions. The disnlption of the intern::tl \vall of the vessel tOJlo,ving 
the barotrauma of ::tngiopl:!.sty cannot be e::tsily delineated by 
contour detection of the shado\Vgr:J.m obtained with coronary 
ang_lof.r:tphy.•·•" TI1ese limitations have prompted investigators 
to use alternative methods bascod on the functional aSSe!>.-.;mcnt 
of angiopbsty results. 1''· ''' The ::tvail::tbility of the Doppler angio· 
plasty guidewire and pressure wires allows continuous monitor· 
ing of bl<xx.l tlow during a routine angiopl:t.'>ty and assessment 
of the results of this intervention. 
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Balloon Coron:1ry Angioplasty 
One of the t".trliest C:.!'Xperiences in IY.tlloon PTCA was a study 
of 3S patients performed in our labootory.7 ' The angiopJa.o;t)· 
guidewin: w:~.s successfully used to cross the stenosis in 32 
(89%) of 36 arteries. A flow-velocity recording was obtained 
distal to the stenosis, both in ba.:;eline conditions and during 
hyperemia (ic bolus injection of papavcrim:: 8 mg for the RCA 
:md 12.5 mg for the LCA and R~ph<..-nous vein bypass graft). 
!nt!"J.COronary nit!".ttes were used before the injection of papav-
erine to induce a maximal coron:;u:v vasodilation and avoid 
chan~es in cross-sectional area betwec'n ba_<;eline and postpapav-
erinc a.s_<;c:-.."ment. The Doppler J;ttidewire v.~.ls left in place distal 
to the lesion durin~ the dil:ttion procedure. The Doppler si~nal 
was continuously acquired during IY.llloon inflation and :J.fter 
deflation to monitor the d<..·vdopment of coll:tt<::!".tl flow, the 
restor.ttion of flow after b:tlloon dcll:ttion, the phase of postoc· 
elusive reactive hyperemia and, incidcnt:tl!y, the development 
of flow-limiting complications. Monitoring coronary blood flow 
during intr-.lcoronary interventions has potential adV".lntag,es as 
an early indicator of acute closure, thrombus formation, or 
vasospasm. TI1ese events currently arc detected only by re-
peated angiography. The quality of angiogr-.lphy and the clinical 
effects of increased !"Jdiogr-.tphic contntst mcdi".t administration 
arc obvious but unavoid.1.blc limitations. During balloon infb.-
tion a complete disappear.lncc of flow was observed in 26 
arteries (81%). In t11c remaining Si..'L cases (19%), tile flow veloc-
ity progressively incrt".t.sed during infl'J.tion, with a negative 
flow-velocity signal in five patk-nts indica.ting recruitment of 
collater-.l! coronary flow. The restor.ltion of anterograde flow 
could be immediately d<..-tccted during the deflation of the bal-
loon, before the disappearance of the dcctrocardiogr.tphic 
changes or of the symptoms. In three ca..-.;cs (9%) a sudden 
decrea.."<: in blood flow velocity was the first w:~.ming signal that 
a flow-limiting \V:lll dissection develop<.'<~ after angioplasty. 
Cyclic Flow Variations as a Predictor of 
Intracoronary Thrombus Formation After 
Ang:ioplasty 
ln animal models witlt :m :trtificially created coron:try stenosis 
and imracoronary thrombus, cyclic coronary blood flow varia-
tions can be abolished with antiplatclet or antithrombotic 
agents.''""'" Similar cyclic flow variations have been reported 
to occur in patients during coronary angiopl:tSt)'. '"'' Cyclic flow 
\':triations in :m artery with the potential for intraluminal throm-
bus formation appear to be a marker of continued prothrom-
botic activity that, despite adequate anticoagulation, may result 
in f:tilure of the procedure. 
Tix· endothelial damage associated with severe coron:tf)' ste-
nosis usually result.." in a cyclic pattern of flow reductions and 
restor-J.tions related to recurrent episodes of platelet aggregation 
and subsequent dislodgement of thrombus.'•"·''" 'When platelets 
aggregate, vasoconstrictor substances, including serotonin and 
thrombo:<ane A, are known to change ves.-.;cl caliber, promote 
rheologic disturbances, and induce further platelet aggregation 
and thrombus formation."''·'.,_. In patients, cyclic flow variations 
measured in the distal coronary artery bed may be the result of 
mechanica.l vasoconstrictor and pbtclet aggrega.tory effects. 
The detection of intracoronary thrombus may be obscured 
by angiogr:aphic difficulties related to the mechanical disruption 
of the coronary intimal surface. Monitoring coronary blood flow 
velocity in patients at risk for intracoronary t11rombt1S may 
provide an early indication of uns.1.tisfactory dilation or of the 
need for increased heparin or thrombolytic therapy prior to the 
potentially serious management problems of abrupt artery clo-
sure. 
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The abrupt cha.ng<..-s in flow velocity observed during the 
development of coronary spasm or of .s<.-v<::re flow-limiting dis-
section a.nd the pcrsb1:ent flow decre:t!;e in the presence of a 
significant elastic recoil "-• can be distinguished from the cyclic 
flow variations due to the formation of thrombi.'.,.. 
A recent prospective investigation including the first 102 
patients of the Doppler Endpoints Balloon Angioplasty Trial 
Europe (DEBATE) study (described in the folJowing pa.ragr:aph) 
has recently highlighted the rebtion between the presence of 
cyclic flow variation after angioplasty and immediate complica-
tions. •~~ In 94 patients (92%), a stable and reliable Doppler 
signal could be recorded for 15 minutes after the procedure. 
Cyclic flow variation defined as a gradual decline in flow over 
sevcr".tl minut<.-~ followed by sudden restoiJ.tion to higher Vliuc~ 
was observed in 4 patients. In 3 patients, immCdiate complica-
tion occum:d: 2 intr-.tcoronarv tllrombosis a.nd I acute closure. 
None of the 90 patients without cyclic flow V".triation ha.d an 
:tcute closure during their hospital stay. TI1is demonstrates that 
coronary cyclic flow after angiograpllically successful elective 
PTCA is rare (4.3%) but hig,hly sensitive for the prediction of 
abrupt occlusion, in agreement with the observation of Kern 
and associates,'"' w110 found a higher prevalence of such 
events, but in a more heterogenous population, including acute 
myocardial infarction, atherectomy, urgent stenting, and desob-
struction procedures. 
Assessment of Results 
In our preliminary study," for the 29 coronary arteries with· 
out acute complication, baseline average peak velocity in-
crea..-.;ed significantly from 16 :±; 9 em/SeC before PTCA to T 
:t- 14 em/sec after PTCA. A more than twofold increa..<;e was 
observed for the averar::e peak velocity recorded at the m:a.xi.mal 
effect of papaverine (27 ± 17 em/sec before PTCA and 60 ::.':: 
28 em/sec after PTCA). The cross-sectional area at the site of 
the Doppler recording showed ::t non..;;ignificant change befor<:: 
and after coronary angioplasty, suggesting that tile velocity 
changes reflected a true Oow increase after PTCA in baseline 
and hyperemic conditions. CFR. as a ratio of the hyperemic-to-
ba.:;dine flow-vdocitv measun:ments, showed a moderate but 
signific-.tnt increase 'after PTCA (from 1.75 ± 0.55 to 2.39 
± 0.75). 
Se£a.l and colleagues''! have also reported their results after 
balloon angioplasty in 38 patients. Twelve patients without 
significant coronary artery disease served as a control r::roup. 
Following angioplasty, the time-averaged peak vclocit)' in the 
distal vessel increased from 19 :::!:: 12 to 35 ± 16 em/sec (P < 
0.01), whereas in the proximal vessel velocity incn!:t.."<:d tO a 
lesser extent (34 ± 18 em/sec before angioplasty versus 41 :!:: 
14 cmjsec after angioplasty; P "" 0.04). CFR did not increa..<.e 
significantly after angioplasty, whether measured in either the 
diStal or proximal coronaf)· artery. Simibr finding.<; h:ave been 
reported by Ofili and coworkers'' before and after angioplasty 
in 32 patients. After angioplasry, improvement in the di:c>tolic-
to-systolic velocity ratio and increases in the total vclocit)' inte-
grn.l and in the peak diastolic velocity during hyperemia in the 
distal region were noted. 
In the peripheral circulation, a ca.tegorical cutoff criterion 
based on Doppler measurements (ma.."(imal velocity after nitro-
glycerin distal to the stenosis ;::::48 cmjsec) predicted 32 of 3-l 
cases with a successful procedure based on angiography, IVL"S. 
and clinical results.'~' 
11K-se data suggested that measurement of distal velocity 
variables after coronaf)' balloon angiopl::tsty provides important 
information concerning the immediate physiologic outcome of 
the procedure. However, acute changes in resting blood flow 
together with changes in the anatomy of the stenotic lesion and 
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concomit:tnt persistent modifications of the hyperemic pres-
sure-velocity rel:ltionship should be considered when CFR is 
used for the assessment of the functional results.M· 70• '""· 1"" The 
aforementioned considerations are schematically illustrated in 
Figure 40-9. 
Heller and colleagues have reported original data. regarding 
the RCA: rest average peak velocity, measured with a Doppler 
wire, did not decrease distal to the stenoses (23.3 ::!::: 9.4 em/ 
sec proximal vs. 20.2 ::!::: 11.1 em/sec distal), proximal-to-distal 
velocity ratio was 1.4 ± 0.9 before angioplasty and did not 
signiticantly decrease after angioplasty, and diastolic-predomi-
nant flow after angioplasty was not observed in the proximal or 
distal RCA, but was present in the posterolateral and posterior 
descending coronary arteries.""' 
Clinical Outcome of Deferring Angioplasty 
Based on Nonnal Translesional 
Hemodynanu·cs 
The clinical significance of intermediate coronary stenoses on 
angiography frequently requires adjunctive noninvasive stre~ 
testing. Direct transksional flow measurements now av.tilable 
correlate well with myocardial perfusion im.1.ging studies and 
may assist in clinical decision making. A prospective study was 
pertOrmed to detem1ine the feasibility, safety, and outcome of 
deferring angioplasty in patients with such lesions.'" Tr:msle-
sional pressure and flow velocity data were obtained with a 2.7-
French infusion catheter and a Doppler wire in 88 patients !Or 
100 lesions (26 single-vessel :md 74 mtlltivessel lesions). The 
mean diameter stenosis by QCA was 54 ± 7% (range 40% to 
7-i%). Pn:determined normal values of tr:mslesional flow veloc· 
ity (proximal-to-dist:l.! average pe-.tk velocity r.ttio) of less than 
1.7 or a pres.:;ure gr.tdient less than 25 mm Hg, or both, were 
required to defer :tngioplasty. P'.nient follow-up ranged from 6 
to 30 months (mean 9 ± 5 months). The ttall51csional hemody-
namics of the deferred angioplasty group were similar to those 
of a normal reference group. By study design, tr.lllSlesional 
pn:ssure gradient in the deferred group \V:J.S I 0 ± 9 mm H_g 
compared with 45 ::!::: 22 mm Hg in the angioplasty group. At 
follow-up 4, 6, 0, :tnd 2 patients in the deferred angiop!asty 
group required subsequent :tngiop!asty, required bypass surgery, 
had a myoca.rdial infarction, or died, respectively. One death 
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FIGURE 40-9. Pressure/J]ow rdation~hip in restin~,: nnd hypc:remk 
condition~. The curved line indicates the now incre:t~e in the proence 
of a Jlow-limitin~_.: "teno~i~. Two confoundin~_.: factors may preclude the 
a.• .. :;e~smem of the improvement (3) of coronary now re:.erve following 
a pcrcut:tneous tr.tnsluminal coron:try :m~opla.~ty (PTCA) procedure: 
an incren.-;e in retin~ blood !low {I) and/or :tcutc or chronic ch:m~:e~ 
in the prc.-..-.urc-/low relationship during hyperemi:t (2). (From Scrruys 
PW. Di Mario C, Meneve:tu N. et a[; !ntr.Jcomn:try prcsurc and How 
velodty from sen~r-tip guidewin.:s: A n<.-w mcthodolo~cal compreh<.-n-
sive approach for the ... ,.,._":>,mcnt of coronary hemodynamics b<:forc 
and :tfter coron:try interventions. Am J Cardiol 17:41D-53D, 19")3.) 
was related to angiop!asty of a nontarg<.-t lesion, :tnd one death 
was the r<.>sult of ventricular fibrillation in :r. patient with severe 
multivessel disease 12 months :r.fter lesion assessment. In the 
IO patients later requiring coronary revascularization, only sb: 
procedures were performed on previously assessed t:ltgL-t arter-
ies that had a normal flow. Of the sLx procedures, four had 
conversion from normal to abnormal flow pattern. No patient 
had :r. complication of transksional flow or p~sure measure-
ments. The investigators concluded that the safety, feasibility, 
and clinical output of deferring angioplasty of coronary stenoses 
associated with normal tr:mslesional hemodynamic va.riabks 
were satisfactory. This a.<;Sessment ha._<; since been further va.Ji-
dated in other Ct.!nters. "''"'"~ 
Similar results have been reported using FFRvtYo"": in 100 
consecutive patients in whom angioplasty .. vas deferred because 
measured FFR\1YO \V:J.S 0.75 or g.n:ater, the MLD was 1.68 ± 
0,44 mm and the percentage diameter stenosis was 46.8 ± 
9.4%. During a follow-up of IS ± 3 months, 2 patients died 
from noncardiac causes and 89 remained free of any events. In 
the 9 patients with coronary events, 2 had an infarction, 4 had 
unstable angina follo\ved by PTCA, 2 had elective PTCA, and I 
had elective CABG (but the last 3 were because of disea.-.;c 
progression in other vessels). A prospective. randomizt.!d trial 
(DEFER) evaluating the safety of this approach is ongoing. 
Given the practice of performing angioplasty without ische-
mic testing or when ischemic testing is inconclusive, transle-
sional hemodynamic data can identify patients in whom it is 
safe to forego coronary intervention. Coupled with the correla-
tion of poststenotic tlow reserve with scintigraphic stress im-
:tging, !<:!;ion a.-;sc..-ssment in the cardiac catheteri7.ation Labora-
tory can now become a cost-etiective method to a.-;sess pmients 
before intervention. 
Prognostic Value of Intracoronary Flow 
Velocity and Diameter Stenosis in Assessing 
the Outcome of Coronary Balloon Angioplasty 
Until recently, no appropriately sized and prospectively con-
ducted study had assessed the value of flow-velocity indiCL'S 
in predicting immediate complications and the recurrence of 
stenosis and symptoms after PTCA. The aim of tl1e DEBATE 
study was to identify Doppler flow-velocity indices predictive 
of the short· and long-term clinical outcome after angioplasty. 
The hypothesis was that a normali:;.ation of flow-velocity pat-
terns and rheology within the dilat<::d segment would have a 
6.vorablc impact on th<:: restenosis process. 111e study popula-
tion consisted of 297 p:ttients undergoing balloon angioplasty 
of a single major native coronary artery.'' Flow-velocity measure-
ments were realized with the Doppler wire in a proximal nor-
mal vessel segment, and distal to the lesion, in baseline condi-
tions, and after intr-J.coronary administration of adenosine (12 
IJ.g in the RCA and IS IL,t:: in the LCA). Proxima11y and distally, 
a distance from the stenosis greater than five times the vessd 
diameter was maintained to avoid prestenotic acceleration of 
flow or poststenotic turbulent flow. Recommendations were 
given to disengage (whenever possible) the guiding cath<::ter 
from the ostium at the time of hyperemia to avoid impedance 
of the ma.xima! flow. At the end, flow-velocity recordings were 
obtained in the same position as betOre dilation. Assessm<::nt of 
the angioplasty procedure was based only on angiographic crite-
ria (diameter stenosis <SO%), using at least two cite angio~J.ms 
in orthogonal projections. At I month of follow-up, the patient's 
anginal status was determined using the Canadian Cardiova.-;cu-
lar Society Angina Classification and. wh<::never possible, a 
symptom-limit<::d bicycle stress test was also performed. At 6 
months, anginal status was re-evaluated and a control QCA 
(using the same projection) was made. All the QCA mea.-.;ure-
ments were perform<::d off-line with the C ..AAS II sy~tcm (Pie 
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Medical, The ~ethcrlands) by an indqx:ndent core Iabor.ttory, 
which was blinded to the clinical and the Doppler information. 
&cau.se of bail-out :;tenting or protocol violation, matched 
recordings of prcprocedure :md postprocedure CFR were avail· 
able in 225 patients leaving the hospital without any major 
adverse cardiac event. A complete set of recording:; preproce-
dun: and postprocedurc of the CFR, the ratio of average dia-
stolic-to-aver.tge ::.)'stolic velocities and the proximal-tcx.listal 
velocity flow r.ttio were av.tilable in tot:ll in 187 patients. A 
summary of angiogr.tphic and !low measurements is il!ustr.tted 
in Figure 40-10. Diameter steno:;is decr<."::.Sed from 62 mm ± 
9% to 37 ± S'X,, Distal CFR significantly incrx.--ased from 1.60 ± 
0.62 before PTCA to 2.74 mm ± 0.94 after d1e procedure. No 
difference wa..-; pn:sent between the RCAs and the LCAs. Distal 
basdinc diastolic-to-~)'Sto!ic velocity r.ttio increased from 1.71 
± 0.65 to 2.06 mm ± 0.92 postprocedure. Pre-PTCA diastolic-
to-systolic velocity ratio W".l$ significantly lower in the RCA 
compared to the LCA (1.44 ± 0.35 vs. 1.82 ± 0.71), and the 
diastolic-to-systolic velocity ratio remained unchanged in the 
RCA after the procedure, confirming the observa.tion of Heller 
and associates."" 
After 4 weeks, 82% of patients were free of ::.ymptoms and 
i.schemic events, wherL"";"J.S IS'Xi experienced either typical chL-st 
pain or had an electrocardiographic positive exerci::;e test. At 6 
month:;, 224 patients (99.6% of the eligible population) were 
monitored for the occurrence of any adverse major cardiac 
event: no death or myocardial infarction occurred and 166 
patients had no target lesion re~cularization (TLR). At the 
same time, 204 patients (91% of the eligible population) undL-r-
went clinical ev.tluation and a bicycle test and 123 were free of 
angina and/or ischemia. Control angiography was done in 202 
patients: 130 had no restenosis. 
P:ttients with or without ~)'mptoms and/or i.schemia 1 month 
after PTCA had similar angiographic measurements after PTCA. 
HowL-ver, among tllem, dist:ll po:;tangiopl:tSty CFR W".tS signifi· 
candy lower (2.38 ± 0. i4) compared with the ~ymptomatic 
patients (2.82 ± 0.95). The dbstolic-to-sy:;tolic velocity and 
proximal-to-distal r.~.tios were similar and thus had no prognostic 
~lues. After 6 months''fo!low-up, :mg,iographic measurements 
were not different bet\veen patients with or without TLR, 
whereas dbc:tl CFR ~ significantly higher (2.80 ± 0.95) in 
patients without TI.R compared witl1 those with TLR (2.50 ± 
0./7). Po:;tprocedur.~.l diameter stenosis wa .. ; significantly higher 
in patients with angiographic re~1:enosis at 6 months (41 ± 8%) 
compared witl1 patients free from restenosis (35 ± 8"/o). Re· 
ceiver oper.J.ting cha.r.tcteristic curves an:.t.!ysis showed that post· 
procedural CFR appears tO h:!.ve a mod~< prognostic value in 
predicting the incidence of ::.)'mptOm':i and/or ischemia at 4 
weeks. Prognostic V.tlue for symptoms and/or ischemia and for 
TLR at 6 months W".J$ weaker, with an optimal prognostic cut-
APV 
(cm/s) 
!50 
off ofapproximatclyCFR "' 2.5. Di:.tmeter :>te.nosis h:!.d a rea..o:.on-
able prognostic value in predicting angiogr.tphic resteno:;i:; and 
symptoms and/or ischemia recurrence at 6 months, with an 
optimal cut-off value of 35%. Multivariate logistic regrc:;sion 
demon:;trated that CFR and diameter stenosis had significant 
independent prognostic v.llue, which permitted categorization 
of the population into subgroups·. tbo:;e with or without a CFR 
of 2.5 or less and those with or without a diameter :;ceno:;i:; of 
35% or less. The subset with the best outcome ~ the one 
char.tctcrizcd by a CFR of greater than 2.5 and a diameter 
stenosis of 35% or kss (n = 44), Compared with the three 
other pooled groups (n "" 158), early recurrence of ischemia 
W".l$ present in 10% versus 19"/u (? "" 0.15) of the patients. late 
recurrence in 23% versus 47% (P = 0.005), TLR in 16% n:rsu.s 
34% (P = 0.02), and restcnosi:c; rate in 16% versus ,;j 1% 
(P "" 0.002). 
TI1i:; :;tudy demonstrnted that flow-velocity parameters re· 
corded at the time of the procedure arc the most important 
prognostic indicators of C"".J.rly clinical recurrence, whereas diam-
eter st<..-nosis is a better predictive marker of angiogr.tphic reste· 
nosi:;. TI1e combination of a CFR of grt.."";"J.tct" th:tn 2.5 and a 
diameter stenosis of 35% or kss is a predictor of 6 months' 
recurrence of ::-)'mptoms and TIR. A patient with a diameter 
st<..-nosis of less than 35% will have a 26% incidence of (.·vents 
at 6 months, a patient with a CFR of greater than 2.5 will haYe 
a 24% incidence of events, but a patient with a diameter steno-
sis of 35% or less and a CFR of greater than 2.5 will haYe the 
best long-term result, with an event rnte of 16%, comparable to 
results so far obt:llncd with :;tents."'' In this trial, 20% to 25% 
o{ the population did not need further therapy to achi<..-..·e a 
clinical outcome similar to tho~ obscn·ed after stenting. The 
cost effectiveness of a thcr.tpeutic policy in which no :;tent is 
implanted when the criteria of CFR greater than 2 .. 5 :md diame-
ter stL-nosis of 35% or less are present after conventional balloon 
:mgioplasry is being investigated in a ne\v ongoing trial: DE-
BATE II. 
The DESTIN! study is also a trial of provision:.t.l steming in 
which CFR and rx.-sidual diameter stenosis after PTCA are u~d 
for clinical decision making.""' The initial results haYe shO\Yn 
that 50% of the 305 lesions treated with Doppler and QC.A-
guided balloon angioplasty received a stent because the func-
tional or angiogr.tphic endpoints were not met. In both the 
patient.-> receiving a stcnt and the patients remaining in the 
PTCA group, the incidence of inhospital adverse events was 
lower than 4%. 
Nonballoon Coronary Interventions 
Stem Implantation 
Angiography has dear limitations in the asses:;ment of the 
hemodynamic severity of a dissection after balloon angiopla.sry. 
APV 
!50 
100 lcFii"l 
MLD(rum) 1.79±0.34 
DS(%) 37±8 
MLCA(mrul) 341±141 ~ 
CFR 
69±27 2.7±0.9 50'~~ 
B 0 I BIIS Hyper 
!9±9 v146± 17 
BIIS J. Hyper 
FIGURE 40-10. Sumnury of the acute :mgiogrnphic and velocity measurements obt:tined pre-PTCA (A) and po:;t· 
PTCA (S) procedure in the DEBATE study in 225 patients: minimum (B) luminal diameter (MLD). diameter Stenosi:, 
(DS) and minimum luminal cros..-..sectional area (MLCA) by densitometry, and avemgc peak velocit)" (APV) in 
baseline condition (Ba.~) and during hyperemia (Hyper), proxinul!y and distally to the le;ion. Mill increased from 
1.06 ± 0.27 to 1.7 ± 0.34 mm, with a decrease in DS from 62 ± 9".4 to 37 ± 8%. Dbtal coronary flow reserve 
(CFR) increased from 1.6 ± 0.6 to 2.i ::':: 0.9. PTCA. percutaneom; translumina! coronary angiop!:lsty. 
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.. 
FIGURE ·10-1 I. A, Aow·vdodtr recording> Jmmedi.1tdy distal and wi!hin a stented conmary segment. i>:otc th.u 
tht maximal n~lodty and velocity pattem are unchanged proximal to the stent (uppa left panel) and within the 
stent (upper right pauel). In the lower kft tune!, an arrow Indicates the position of the Doppler sample volume 
pro:-.imal to the sknt and two lints indlc.lte the ,<.;~.mple volume within the stcnt. In the tluorostopic Image In the 
lower right panel, arrows Indicate the poorly radiopaque stent. B, Hnw·velocity n::con!ings distal (H) and \\ithin 
(C,D) :~. coronary 5tenosis after coron.lT}· balloon angiopilSI): In the right upper pand (A) the position of the 
wlodty recordings distJI to the stenosis is Indicated with :m arrow and, more proximally, the tip of the Doppler 
guldewin· Is positioned in the ~egment tr<~Jted with balloon dilation. i>:ute the markt'd Increase in flow velocity 
from the dist~l rdncnce segment (H) tn the dibted stenosis (c,;n), with an almost continuous flow and a negative 
velocity component probably !ndic.1ting a retrogratk filling of the anglographic:Jlly \is!hle dissection . 
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Intr-..tcoron:.try Doppler c..tn detect the presence of an impaired 
flow dbtal to the dissection n:·quiring tre-..ttment with coronary 
stenting. 1 ''~ Stent implantation i.s the only coronary intervention 
inducing a complete normali;r..ation of the arterial cross-section:~! 
area in most cases. This providL"S a unique opportunity to verify 
whether a complete flow normali7..ation occurs :titer the arterial 
geometry normalization following stL-nting. 
Coronary artery lumen enlargement with stenting, improving 
coronary blood flow, ha...; reduced the historically high resteno-
sis rate of balloon angiop!a::.l)'.""" "" Reduced ~tenosis is re-
lated to blocking clastic recoil, a.s well as improved blood 
rheology. ,~u. ''' Coronary blood flow reserve after balloon angio-
plasty has been persistently abll<lrm::tl in more than 50% of 
patients, attributed to microcirculatory abnormality and/or inad-
equate epicardial lumen L-xpansion not id<..'nti.iied by successful 
;mgiogF..tphy. "~· "'' 
A pos_-;iblc method of assessing the adequacy of the arterial 
conduit obtained after stem implantation is the measurement 
of flo\v velocity immediately dist:ll, within, and proximal to the 
stent. The presence of an unchanged vdocity and velocity 
pattern directly demonstntcs, based, on the continuity equa-
tion, the normaliz:ttion of flow dynamics (Fig. 40-11). 
5<.-veral authors have reported a statistically significant in-
crease in the CFR distal to a ~1:enosis (dCFR) measured after 
stent implantation, compared with the dCFR measured after the 
angioplasty, but in rather small S<.-ries of patients.,~,.,~-· A recent 
analysis'" of the first 27 patients who required a ~tent impl:mta-
tion for a nonoptimal angiographic result after PTCA in the 
DEBATE study h:l..'i demonstnted similar results: after PTCA, 
MLD increased from 1.05 ± 0.23 mm to 1.77 :!:: 0.31 mm, and 
after stent implantation, it increased to 2.57 :!:: 0.35 mm. At 
the same time, dCFR significantly increased from 1.38 :!:: 0.4 
before the procedure to 1.82 :!:: 0.43 after PTCA, and to 2.57 :!:: 
0.56 after stenting. A similar improvement in the fluid dyn:tmic 
properties of stented epicardial ves .. •;ds has been measured \Vith 
pressure wires by the a:;sessment of the FFR.MYo. 1"' 
Role of Coronary Lumen Enlargl..-joment in 
Improving Coronary Blood Flow After Balloou 
Augioplasty a11d Stenti11g 
A combined 1:\fl:S and Doppler flow imaging study to demon-
stnte the role of the conduit lumen on coronary blood flow 
after b:t!Joon angiopla::.l)' and coronary stenting was p<..'rformed 
in 42 patients. '·'7 Data were collected before and after angio-
p!asty and again after stem placement. A subset of 17 patients 
underv.rent IVUS e:umination of the target and reference S<.-g-
ments after <.-ach intervention. Tile angiogr.tphic percent diame-
ter stenosis decreased from 84 :!:: 13% to 37 ± 18'Yo after 
angioplasty and to S :!:: 8"/o :titer stenting. CFR was minimally 
changed from 1.70 :!:: 0.79 at baseline to 1.89 :!:: 0.56 after 
angioplasty and increased to 2.49 :!: 0.6S after stent placement, 
a •.ralue simib.r to that of the reference vessel of 2.61 :!:: 0.46 
(Fig. 40-12). Comparing stenting and postangioplasty results, 
IVUS cross-sectional area was 8.39:!:: 2.09 versus 5.10:!:: 2.03 
nun' (P < 0.01). Increasing CFR was correlated with incn..-asing 
lumen cross-section:ll area as determined by rvr.;S and angiogra-
phy (Fig. 40-13) and QCA percent area stenosis. The relative 
CFR (CfRTARGET/CFRREFERENcE) was 0.65 ± 0.03 before angio-
plasty, significantly increasing to 0.72 ± 0.21 after angioplasty 
and normalizing to 1.03 ± 0.3 after stenting (normal relative 
CFR .should be 1.0 ± 0.2). 
For the entire subset of patients, the TVUS imaging data 
demonstr:lted tlu.t total vessel cross-sectional :1[(.-':l was similar 
for the reference segments before and after angioplasty and 
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FIGURE 40-12. A. Individual p;otient data for coron~ry no,-.; rc-,erve 
(CVR) measurements before (diamond~) and :tfter (square:.) percuune-
ou:. tr:msluminal coronary an~iop!asty (l'TCA) and again :~fter ,tent 
placement (tri:mglc.:l>). B. CVR in the reference scgnK'rlt (circle) ver~us 
tile ,tent segment (triangles). (From Kern MJ, DuPouy P, Drury JH. ct 
a!: Role of coronary artery lumen enlargement in improving coronary 
blood flow after bailoon an(tioplasty :m<.l stenting: A combined intr.I\':L,.. 
cular ultr..L'>{}Und Doppler now and imaging study. J Am Coil Cardiol 
:?:9:1520~1527, 1997. Reprinted with permis.~ion from tlte c\.merican 
Colkgc ofCtr<.liology.) 
stcnting (16 :;t 3 mm'), but then: was an 80 ± 59% increase 
in lumen area from 5.1 to 8.39 mm2 after stenting. 
Although angiography Ius been used to guide the endpoint 
decision of coron:.tf)' angioplasty, the relationship of CFR to 
residual conduit lumen cross-sectional narro\ving suggests than 
an endpoint decision based solely on anatomy may be incom-
plete in some cases. Stenting app<..-ars tO normalize absolute 
CFR in most patients. For those with CFR of lc~ than 2.0, 
stenting normalized relative CFR in 95% of patients. 
11K'SC data indicated th~tt incre:L."'-t:S in CFR were a.."'-.<;QCiated 
with incrL·a.•;es in coronarv lumen cross-sectional arL':l in most 
p:tticnts. The data further ;uggest that impaired CFR after angio-
pla.-;ty is more often related to the degree of residual narrowing 
dun the occurrence of microvascular flow impairment. These 
data also support a physiologically complemented appro:tch 
to balloon angiopl:t.sty that may improve procedunl outcome 
decisions for provisional stenting. 
Directional Coronary Athercctomy 
TI1c dinical application of intracoronary Doppler for the 
assessment of directional atherecromy was limited in the early 
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FJGt.:RE 40-13. A. Relation~hip between percent diameter ~teno~i~ 
and coronary flow re:;erve (CVR). B. Minimum luminal diameter (MLD) 
and CVR !Or the prestcm patient.'> (circles). the post·PTO\ result•.; 
(squ:J.rcs). :md the poststem results (diamonds). PTC\, percuuneous 
tr".msluminal coronary angiopl.a.'>ty. (From Kem M). DuPouy P, Drory )H. 
et al: Role of coronary artery lumen enlargement in improving coronary 
blood !low after balloon :mgiop!asty and stcming: A combined intrnv-.t.v 
cular ultnsound Doppler flow and ima~ing study. ) Am Col! C:ir<Jiol 
29:1520-1527, 1997. Reprinted with permi~~ion from the Americ:m 
College of Cardiology.) 
days bec:~.u::;e of a pnctical limiettion related to the incompati-
bilit)' of the 0.018-in. Doppler guidcwirc with the lumen of the 
d<:\iCes used, which is now solved with the 0.014-in. modeL 
NeYcrthelcss, obse[""V:ltions have confirmed the potential use-
fulness of intr.lcoronary Doppler,'" but massive rele= of local 
v:tso::tctive factors due to extensive wall damage could h::tmper 
an :~.cute restor.ltion of ::t norm::tl coron::try flow reserve. 
Rotational Coronary Athercctomy 
Routional atherectomy b being performed with increasing 
frequency in distinct subsets of patients with lesion clmr::tcteris-
tics unfa,·or.:tble for either conventional b::tlloon :mgioplasty Ol" 
din:ction::tl ::ttherectomy. Although S:ttisfactory :mgiographic lu-
min::tl enl::trgement e::tn be accomplished with roettion::tl abl::ttion 
alone, documentltion of the physiologic influence of this tech-
nique :md the benefici::tl dfect of adjunctive angiopbsty wen:: 
l::tcking. Khoury and associates' 7" and, more recently, Bowers 
and collC:lgues, '"'"' have investig::tted this issue, Khoury and as::;o. 
elates studied 14 arteries treated by percutaneous tr::tnslumin:ll 
corOn:ll')' roettional athercctomy (PTCRA) followed by angio-
pl::tSty in 13 p::ttients. :VXLD mc:u.-ured by quantitative angiogr::t-
phy increased after PTCRA from 0.7 ± 0.4 mm to 1.9 ± 
0.4 mm, ::tnd a further signific::tnt increase W::tS obt:lined after 
::tdjunctive b::tlloon ::tngiopla.sty (2.4 ± 0.5 mm). Dist::tl to the 
stenosis, coronary blood flow at b:lSeline, measured with a 
Doppler wire, v.r:tS 47 ± 23 m[jmin ::tnd 57 ::!::: 38 mlJmin 
during hyperemia (ic ::tdcnosine). After PTCRA, coronary blood 
flow increased to 104 ::!::: 59 m[jmin at baseline :md tO 132 ± 
73 mlJmin during hyperemia. Adjunctive angiopl:JSty did not 
signifie::tntly increase baseline and hyperemic flow compared 
with PTCRA (84 ± 40 mUmin md 143 ::!::: 81 mLJmin, respec-
tively), Poststenotic flow reserve, not significantly increased 
after PTCRA ::tlone (1.1 ::!::: 0.2 versus 1.3 ::!:::· 0.3), signifie::tntly 
increased after ::tdjunctive b::tlloon ::tngioplasty (1.6 ± 0.3). Simi-
lar mc:u.llrements were found by Bowers and coworkers'"~? in a 
series of 22 p::ttients. They reported a significant incre= in 
MLD from 0.8 ± 0.1 to 1.5 ± 0.2 after Roetbl::ttor ::ttl1erectomy, 
and a further increase to 2.0 ± 0.1 mm after adjunctive balloon 
angiopl::tsty. There W::tS ::t nonsignific:mt increase in baseline and 
hyperemic dist::tl average pe::tk velocities. There W::tS a significant 
increase, versus baseline, in cfu.-ul. average peak velocity tO 39.5 
± 3.7 em/sec (53.4 em/sec during hyperemia) after ::tdjunctive 
PTCA. There W::tS no ~""t:ltistically significant increase in the CFR 
after Rota.bl::ttor or after b::tlloon angiopl:t:o."ty. 
The mechanism of roettion::tl atherectomy relies on pl::tque 
pulverization and embolization of microp::trticks, usu::tlly small 
enough to pass through the e~piU::try circul::ttion, that ::tre re-
moved by the reticuloendothelial. system."'" These two studks 
demonstrnte that after roution::tl atherectomy and ::tdjunctive 
balloon angioplasty, ::tlthough a lumin::tl enl:.trgcment is obtained 
and coron::try blood flow is improved, with ::t restoration of the 
diastolic predominant p::tttern in the LCA, there is a persistent 
imp::tirment of CFR. Further studies arc required to understand 
the possible underlying e::tUSI...-s: residu::tl stenosis of the epicar· 
di::tl conduit ::trteries, seconda.ry impairment of the microcircul::t-
tion, or trnnsient secondary increase in basal flow velocity. 
Laser-Assisted Angioplasty 
E..'<:plosivc g::tS bubble form::ttion represents a mechanism of 
tissue ablation during laser ::tpplic::ttion, C."{pl::tining the persis-
tent high incidence of l::tser-induced dissections.•~• The u.se of 
intr.tcoronary Doppler in combination with a laser catheter 
has shown acoustic disruption of the Doppler signal that w::ts 
temporarily limited to the period of active laser firing, thus 
confirming that gas formation is a normal oper.1tive mechanism 
of tissue ablation in vivo during Excimer l::t..-.;er angioplasty, ca.r-
rying a potential risk of w:tll dissection.'~' 
After multiple passages of laser probes, the obta.incd luminal 
enlargement is insufficient in most e::tscs to restore ::t normal 
flow velocity both in coronary and peripher-.t1 arteries. After 
completion of the procedure with balloon angioplasty, a nor-
mali7.ation of the indicc reflecting flow dynamics :tcross the 
stenosis was observed.7~ Similar results have been confirmed in 
periphernl ::tnd coronary arteries by Isner and colleagues. •~-' 
INTRACORONARY DOPPLER AS A 
RESEARCH TOOL FOR TilE STUDY OF 
CORONARY CIRCULATION 
Doppler Coronary Flow Velocity and Acute 
Myocardial Infarction 
Physiology of Acute Myocardia/Infarction 
Coronary blood flow CUI be accurately measured using intr-J.-
coron::try Doppler blood flow velocit)' and comp::tred with semi-
quantita.tive but clinically predictive Thrombolysis in Myoordi::tl 
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Infarction (TIM!) angiographic flow, an establish<:<.! standard of 
repcrfusion therapies. To address the relationship of Tl.\11 flow· 
to-flow velocity, coronary flow velocity was measured lx."fore 
and after primary or rescue angioplasty using a Doppler wire 
in 41 patients with acute myocardial infarction.',.. TIM! anglo. 
graphic flow grade was assessed by two independent observers 
:mel also quantitated by frames.ro-opacification method from 
cincfilm. Before angioplasty, 34 patients had TIM! grade 0 or 1, 
5 patients had TIM! grade 2, and 3 patients had TIM! grnde 3 
flow in the infarcted artery. Fo!lowing angioplasty, diameter 
stenosis improved from 95 ± 7% to 22 ± 10%. One patient 
had TIM! grade 1, 5 patients had TIM! grade 2, and 35 patients 
had TIM! grade 3 flow. Poststenotic flow velocity increased 
from 6.6 ± 6.1 em/sec to 20.0 ± 11.1 em/sec following 
angjopbsty. Before :mgioplasty there were no statisticll differ· 
cnccs betwel->n poststenotic flow velocity values among inf..trct 
vessels with TIM! gr.tde 0, 1, or 2; hOWl-'"Ver, TIM! grade 3 had 
higher flow velocity (9.4 ± 5 em/sec vs. 16 :.'.: SA em/sec). 
Postangioplasty flow velocity correlated with angiogrnphic 
frame count. However, for TIM! grade 3, there was a large 
overlap with low TIMI :S2 flow velocity (<20 em/sec), despite 
framcs--to-opacifiCltion below 60 (Fig. 40-14). 
These results indicate that semiquantitative TI.\1! perfusion 
grades are distinguished by differences in coronary flow veloc-
ity, with TIMI grade S2 consistently associated with low flow 
values. On avernge, TIM! gr-..1de 3 flow velocity is higher than 
TIMI grades :S2 flow, but there is a substantial overlap with 
low flow values of TIM! S2 flow. Quantitative assessment of 
flow velocity after reperfusion could potentially establish im-
portant physiologic correl:ttions among clinical outcomes after 
various repcrfusion therapies. 
Impaired CorOllary Flow Reserve After 
Myocardial Infarction: Residual Steuosis, 
Microcirculatory Stuuning, or Botb? 
CFR in target ref:ions after myocardial infarction is frequently 
impaired. Whether the abnormal CFR is related to residual 
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FIGURE 40-14. Comp:trison of dist.11 aver:~.ge peak velocity (.1\PV) with 
cine f=es--to-op:tci.fication (f=e count): TIM! 3 flow (open squares), 
TIM! :::;2 (drcles), and clinical events (solid squares). There is a coi'TC!a· 
tion between dist:ll /\PV and the ft:lme count. Posunyocardi:ll infarction 
(solid squares) occurred in 9 of 11 jXltients with n.vu flow <20 cmJ.-.cc. 
(From Kern MJ, DuPuoy P, Drury JH, et al: Dctermin:ttion of angiogr.:tphic 
[TIM! grade] blood flow by intr:lcoronary Doppler flow velocity during 
<~Cute myocardial infarction. Circulation 94:1545-1552, 1996.) 
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~'tenosis severity and potential myocardial viability (microcircu· 
l:ttory integrity) was examined by Claeys and associates.'~' Distal 
coronary blood flow velocity before and after angiopla!ity in 36 
patients 13 :t 7 days after acute myocardial infuretion was 
examined, :md 38 patients with similar coronary artery disease 
but without myoClrdi.:t! infarction served as controls. Residual 
coronary stenosis severity was analy-..:ed by QCA and infarct size 
\V:lS assessed by myocardial perfusion scintigraphy. For similar 
degrees of angiographic stenosis severity preangjopl:tsty and 
postangioplasty, CFR was signifiClntly lower in patient.<; with 
myocardial infarction compared with controls without myocar-
dial infarction (1.22 :.'.: 0.26 vs. 1.50 ± 0.45 and 1.72 ± 0.43 
vs. 2.21 ± 0.74, respectively, before and after PTC.A). AJthough 
CFR increased significantly after successful angiopla!ity in both 
groups, abnormal CFR was present in 80"!6 of infarct patients 
and 44% of patients without infarct. Angjographic stenosis se-
verity was the most important determinant of CFR in both 
!>"tudy groups. The investigators concluded that CFR is signifi-
cantly lower in patients with recent myocardial infurcrion both 
before and after intervention. In addition to the presence of 
postreperfusion coronary microcirculatory responses, CFR is 
related mainly to stenosis severity rather than to residual myo. 
cardia! viability. These findings suggest that limiting residual 
luminal narrowing by stenting in acute myocardial infarcrion 
may immediately improve the physiologic responses. 
Postmyocardial/nfarction Risk Predictiou 
Intracoronary Doppler assessment of poststcnotic rcperfusion 
CFR may be useful as a marker of postinfarction risk. ~1illcr and 
colleaguc..-s'"'' l--xamined coronary Doppler flow and postmyocar-
dial infarction risk stratifiCltion marl:ers in 41 consecutive pa-
tients after primary angjoplasty. Coronary flow was measured 
15 minutes after the intervention and SPECI' perfusion imaging 
and stress electrocardiographic ST S<..-gment changes were mea-
sured 3 weeks following myocardial infarction. The infarct-
related artery diameter stenosis decreased from 97 :t 8% to 24 
± 10% with an improvement in TI.\11 grade flow from 0.5 to 
2.8. Average p~lk velocity increased from 7 ± 6 to 19 :± 8 
cmjscc. Postangioplasty, CFR was 1.6 :± 0.6 and left vemricular 
ejection fraction was 48 ± 14%. At a follow-up period of 19 ± 
12 months, a multivariate R-grcssion revealed that following 
successful primary angjoplasty for acute myocardial infarction, 
coronary flow-velocity reserve failed to prediCt future cardiac 
events, whereas residual postpcrfusion left ventricular ejection 
fraction and SPECI' perfusion imaging ll.'ld incrementa!Jy de· 
fined prognostic c..·vents. It should not be surprising that immedi-
ate postinfarction CFR is impaired and that the 3-week follow-
up result may have significance for myocardi:Jlrl--perfusion bene-
fi<. 
Study of Collateral Circulation 
Flow-Velocity Measurements in the Recipient 
Vessel 
Quantification of coronary coll:tteral flow has been performed 
in cx:periment:Il animal studk-s by direct mca.suR-ment of retro-
grade flow and prcssure<>r.<, "'''or radionuclide microspherc flow 
techniques.'"?·<~' In patients, only a qualitative and subjective 
angiographic determination of ma.turc epicardial collateral chan-
ncls'?2· '''·' or acutely rccruitable collateral vessels during angie-. 
plasty''"'-""' has been achieved. The use of a Doppler guide'Wire 
permits quantitative measurement of coronary blood flo~· veloc-
ity beyond severe and totally occluded arteria.! segments""' '?II so 
that collateral flow velocity c:tn be measured. Although acutely 
recruitable and mature collateral flow has been shown during 
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angiopl:i.sty by both hemod)namic (coronary occlusion wedge 
pressure)'""· zoo and angiographic methods,'~'·,., neither tech-
nique is sufficiently quantitative to assess collateral function 
during hemodyrumic or pharmacologic perturbations. During 
routine coronary angioplasty, retrograde collatcr:tl flow velocity, 
observed during multiple cororury balloon in.ful.tions as a repro-
ducible phenomenon. is associated \vith acutely recruited angio-
grnphic collateral supply."'· '''M To :c;sess qu:mtifiettion of the 
coronary collateral circulation, flow-velocity d:lta were obtained 
during angioplasty and compared with both angiograpbic grade 
of collateral flow and the spectrum of norm:li antegrade flow 
patterns. 
Twenty-one patients undergoing routine cororury an.gioplasty 
had <.-vidence of angiographically established collateral flow 
(n = 10) or had acutely recruiuble collateral flow velocity 
during balloon inflation (n = 11). 20 ' 
After a lesion was cros..o;ed with the guidewi.re and balloon 
otheter, the balloon was inflated and flow-velocity d:lu wert 
continuously recorded before, during, and for 120 seconds after 
balloon deflation. Collateral blood flow wa.s defined as r<."tro-
gr:tde or persistent anregnde flow during balloon occlusion. A 
typical. retrograde collateral flow-velocity resporu;e is shown in 
Figure 40-15. In some patients, continuous antegrnde flow 
during to ttl a.rteri::tl occlusion of balloon inflation \v.lS recorded. 
These patients had sept:ll to LAD or L\D to posterolaternl 
branch flow, wherdn the flow \V:lS measurc:d disUl to d1c 
cont:r::il:lter-.J.l collater.tl input origin. 
The angiogrnphic collateral supply was assigned a coll:tteral 
score based on opaciJication according to Rentrop :tnd cowork-
eD,''"'· ,.,. whc:rcbv a ~core of 3 i.s dense, 2 i.s moder:tte, 1 b 
faint, :tnd 0 is no :.,isiblc tilling of collatet:tl channels. 
Retrogrnde collateral flow \v.lS observed in 1 i patients. TI1ere 
were no differences between left-to-right coll:ttet:tl tlow pat-
LAD with Collaterals 
terns :tnd no difference between ~)'Stolle or diastolic velocity 
between the RCA or d1e LCA. TI1ere W$ a poor cocrc!.a.tion 
between magnitude of coll:tteral flow velocity and :tngio-
gr:tphic score. 
The coronary coUater:tl. flow-velocity response wa.s ch=cter-
ized by flow reversal or persistent antegrade flow during coro-
nary balloon occlusion."'·,.,. The phasic n:1ture of d1e reversed 
flow pattern appeared related tO source artery and pathway of 
d1e colliter:tl. channels. Large. completely epicardi:t.l coll:tter:tls 
with grade 3 :tngiographic flow had the most clearly demarcated 
phasic components. Coronary flow velocity rcver~:ll was identi-
fied showing peak negative flow velociti<."S of 10 to 25 cmJ 
sec and flow patterns that recurred during multiple b:tlloon 
occlusions. At d1c conclusion of the :l.tlgiop!:tsty, rt:!>tor:ttion of 
the norm:tl coronary flow-velocity pattern \v.lS clearly evident. 
TI1e quantitative Il:lture of collateral flow velocity provides an 
excellent tool to eva.luate pha.rmncologic interventions postu-
lated to :llter collateral supply, such as was reported by Do-
nohue and a....;soci:.Ltes. 20~ 
Sevet:tl potenti:t.l applicatioru; are immediately apparent for 
collater::tl flow measurement in patients with iscl1emic h~ 
dis~e. The documentation of collater::tl flow in patients in 
\Vhom :tngiographic appearance i.s poor or absent might provide 
an increa...;cd margin of safety for patients undergoing coronary 
angiopbsty, A Doppler guidcw'irc may identify patients in whom 
adequate collateral flow may obviate more invasive and poten-
tially complicating hemodynamic support measures. 
Measurement of Flow Velocity in the Donor 
Vessel 
As described in the previous section, Dow-velocity changes 
in the recipient vessel during coronary occlusion provide intOr-
Balloon Occlusion Hyperemia 
Collateral 
Flow 
FIGL'RE 40-15. Spectr:tl velocity (SC\le 0 to 200 cm/:<e) :<ho,ving norr=l :mtey;rade (upward directed from b~c) 
flow pattern with ph.:l._~ic systolic and dia..~tollc flow pdor to cororury balloon occlu~ion, At balloon occlusion. 
coronary flow goe~ to zero. AJter 10 second.~. colb.teral flow appear~ a..-. rever.-.ed flow toward the guidewlre tip 
(Inverted phasic signal beneath the baseline). On balloon dell:ttlon, antegrade flow is restored with postischcrnic 
hyperemia. During balloon occlusion, the coll:i.t=I flow velocity can be q\J:tl1tltatcd. (From Kern :'11], Donohue 1), 
Bach RG, d: :11: Quantitating coronary colb.teral llow velocity ln patients during coronary :mgioplasty ~lng a 
Doppler guidewire. A.mJ C:u'd.lol17:34D-40D, 1993.) 
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mation on coll:tter.d flow in a !:><:miquantit:ttive fashion. Expt:ri· 
mental <J:~.ta, howt.•ver, have in<Jicate<J that flow-velocity alter-
ations of the contrJ.lateral :trtery <Juring sud<Jen coron:try 
occlusion can be u.'ie<.l for assessment of collater..tl flow.""·' Collat-
eral vascular growth was induce<.! in these <.-xperiments by 
rept.-ated brief coromry occlusions. After co!later..tl ves..<iels ha<J 
developed, a reduction of electrocJ.rdiogr..tphic and hemody-
namic signs of ischemia during coronary occlusion w-..ts note<.!, 
related to a tr.tnsient increa.<;e in flow vdocity of the contr.tlat-
eral artery. A model \Vas <.lt.-velop<."<.l to t.--xpress the growth of 
the colbter..tl circulation in terms of flow and resistance in the 
setting of coronary angioplx;ty. It was base<.! on recordings in 
23 patients with singte-vessd di:>eal'><:. '" 
Angiography of the contr.tlater.tl :trtery ,.,-as performed before 
ami during balloon coronary occlusion to :tssess recruitlbility of 
collater.d ves.sds using Rentrop's classificttion.''"" Flow-velocity 
as.-;;essment of the comralater..tl :trtery was performed with a 3-
French Doppler catheter (model DC-20 I, Millar Instrument_-.;, 
Inc.) <Juring the second and subsequent balloon inflations. 
As.."t:ssment of flow-velocity change.s in the contr.tlateral ar-
tery by spectral :tn:tlysis was performed by determining maxi-
mal <Jiasto!ic flow velocity before (V,), <Juring (V;), an<J after 
(V_,) balloon in!l:t.tion. Collateral flo\v wa._-.; determined by the 
decrease of maxim:tl diastolic flow velocity after balloon defla-
tion (V~ to V,), exprcsse<J as :t percentage of the maximal 
<Jja._qoJic flow velocity before balloon inflation (V, to V.jV1), 
:~ccording to a pr<.'-viously described method.''" Flow-velocity 
changes of the contr.Jhteml artery were used, in combination 
with the aortic and coron:try wedge pres._~urc. to calculate the 
relative rt.-sistance of the collateral v:tscular bed.~'"·"'" 
TI1e transient flow-velocity incrca.-.;e of the cont.r..tlateral artery 
during coronary occlusion was significantly less in the eight 
patients without colbter..tl vessels, as compared with the pa-
tients with coll:tter.tl vessels. A lower ratio between r<:sb"tance 
of the collateral v<.--ssels :tnd arteriol:tr resiscmce of the donor 
:trtery \Vas observed in the presence of coll:tter.tl vessels during 
coronary occlusion. Furthermore, when coll:tter.tl ves..~ds wcre 
present during coronary occlusion, the coronary wedge pres--
sure w:ts higher (24 ± 6 mm Hg vs. 40 ± 14 mm Hg) and less 
st.·vere electrocardiographic signs of ischemi:t were observed. 
The positive predictive v:tlue of a low relative collateral v.IScu-
l:tr resistance (ratio between the resi..-;;t:tnce of the collater:tl 
vessels an<J :trteriol:~r resist:~nce of the <.lonor artery <10), :t 
contr:tlateral flow-velocity change greater than or equ:tl to 10%, 
or a coronary wedge pressure gre:tter than 30 mm Hg, for the 
presence of coll:tter.tl vessels during coronary occlusion \'-"aS 
100%, I 00%, :tnd 78%, respectively. TI1e negative predictive 
value W;J.S 88%, SO%, and 55%. respectively. 
The authors concluded that coll:tteral vessels are important 
for prevention of elcctroc:trdiographic signs of ischemi:t during 
1-minutc coron:tl)' occlusion. The benefici:tl dfect of collater.tl 
vessels is exerted by a significant incr~L"<.' in flow of the. contra-
lateral artL·ry in combination with a reduced resistance of the 
collateral va._<,cular bed. Flow-velocity :tssessment of the contr:t-
later.tl art:CI)' is a technique provid~g quantit:ttivc inform:ttion 
on the development of the colbteral v:tscular bed in obstructive 
coronary artery dise'J.Se. Similar results were alSo reported by 
Y:~mada"~' and Bach~"'" and their associ."ttes. 
More recently, Pick and colleagues!"" studied the clinical, 
angiogmphic, and hemodyn:unic predictors of rccruit:tble coll:tt-
eral flow using thiS method in 105 p:~tients. Duration of angina 
(~3 months), lesion :><:verity, and proximal lesion location were 
independent factors positively associated with recruit:tbility of 
coll:ttcrnl vessels in a multivariate Jogi..<>tic :~nalysis, 'With an 
over.tll predictive accuracy of 80%. Conversely, nitr:ltes exerted 
an independent negative effect. Presence of recruit:tble coll:tt-
eral vc.~ls during ba.Jioon infl:ttion resulted in a higher coro-
nary wedge-to-aortic pressure rntio (0.35 ± 0.13 vs. 0.27 ± 
46 
0.12), :tlower rd:ttive collateral vascular resist;tnce (6.- = 7.4 
vs. 21.3 ± 10), and a reduction of electrocardiographic sign:-; 
of ischemia. How<.""Ver, the relative coll:tter.tl va.-.;cular resi:-;tance 
W'.lS the best predictor for recruiubility of coll:tter.:tl vessel:-; 
comp-..tn:d with the other variables related to co!Iater.:tl vascu-
lar growth. 
Measurement of Flow Velocity itl tbe Donor 
and tbe Recipient Vessels 
Tron and coworkers~"' t.--xamined the flow-velocity patterns 
of human coronal)' collate:ral circulation and charncterized the 
ipsilateral coronary blood flow during coronal)' :~nsioplasry. In 
49 patients, angiographic co!l:tteral filling: w-.ts c:ttegorized by 
the Rentrop grading sy::;tcm :~nd by anatomic pathway ( epicar-
dial, intr:tmyocardi:tl, or unknown, th:tt w-.ts :tcutdy recruited). 
Collater.tl bloo<J flow velocity \Vas measured distal to the bal-
Joon--occlu<Jed segment du;ing balloon inflation. Collateral 
blood flow vclocitv w·.ts characterized as predominant!\' svstolic 
or diastolic flow, biph:tsic or monophasic (only :,;ystolic ~r dia-
stolic), :tnd :tntegrade or retrograde. Biphasic flow ,-.,·as found in 
47% of the patients, and predominantly ~-ystolic flow signal was 
seen in 73%. Epicardial collateral p:tthways had the highest total 
flow-velocity integr:ll. There were no differences in the flow-
velocity integral-.; :tmong the Remrop :mgiographic grades of 
collateral filling. 
Pick and :tssociatesn" have :tlso reponed :t comparis-on of 
colbter.tl vascular responses asses~d in the donor and the 
recipient coronary artery during transient coronary occlusion 
in 57 patients with single-vessel disea._-;e. Flow analysis was 
performed with a Doppler cathet<."r in the contral:~teral donor 
:utel)· or the ipsil;J.teral recipient artery or both using a Doppler 
catheter or wire. Ischemi:t was eva!u:tted by ST S(.."gnlent shift on 
a 12-lc:td ekctroc:trdiogram at 1 minute of coronary occlusion. 
Recruit:tblc collateral flow was present in 39 p:tticms and \"\':IS 
a.-<.soci:tted with an increase in blood flow velocity in the donor 
:trtery :tnd in the recipient :trtcry, rebted to a reduced n:lariv.:: 
coll:tteral v:tscular resistance. Collateral flow in tl1C recipient 
artel)' \V:lS a better predictor for ischemia than was collateral 
flow in the donor artery or angiographic grading of collaternl 
v<."s.sels. 
Pharmacologic Modulation of Humau 
CoUateral VascuUtr ResisUmce 
Pkk and colle:tguesm recently C\'aluated the pharmacologic 
r<.-sponsiveness of the coron:try collateral circulation in patients 
w:ith recruitabk or spontaneously visible collateral ...-essels dur-
ing balloon coronary occlusion using a Doppler v.ire in the 
recipient coronary artery distal to the balloon. In 38 patient.~. 
one guiding catheter wa._-.; used for the introduction of the 
Doppler wire and t!le balloon in the recipient art:ery :~nd an-
other guiding CJ.thcter -was used for angiogr:tphy of the donor 
coronal)' :trtel)' :tnd the administration of adenosine (12 to 
18 jJ.g) or nitroglycerin (0.2 mg). Diastolic blood flow-...-elocity 
integra.! (dVi), :lOrtic (PAo) and coron:ll)' wedge(!>\\) pres..-;ures 
were used tO compute the collaternl vascular resistance index 
RCOLL = (PAO - Pw")/dVi 
and the peripheral v:tscular resisunce index of the recipient 
coronary artel)' 
R4 = Pw/dVi 
Using these definitions, the coron:ll)' wedge/aortic pressure 
r.ttio can be expressed by 
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P\lir/PAo = R4/(Rcou. + R4) 
The effect of bolus injections of adenosine :md nitroglycerin in 
the donor vessel on these v:tri:tbles W:tS :tSSessed during b:illoon 
inflations. In patients with recruitable coliater:tl vessels, there 
'W':I.S no ch:tnge in dVi :md Pw-to-PAO rntio with adenosine or 
nitroglycerin. In p:ttients with spont:tncously visible coll:tter:t! 
vessels. dVi incre:tsed :liter :tdenosine :md nitroglycerin. The 
Pw-to-PAO rntio remained unch:tnged, but Rcou. md R4 d<."-
creased. This study '\V:tS the fin;t one to directly :tSSess the 
pharm:tcologic responsiveness of the colbter:tl circul:Ltion. It 
demonstrnted that coron:try coli:tter.tl. blood flow em be in· 
cre:t.Sed with :tdenosine and nitroglycerin in patients with sin-
gle-vessel dise:1se when spont:tneously visible coll:tter.tl. vessels 
are visible. This effect is :t result of a reduction in the col!:ttern.l 
V:J.SCUI:J.r resistmce and pcriphcr.tl. V::t.->Cul:J.r resistance of the 
recipient coronary artery. Bec:tuse of the importance of the 
coll:tter.ll vessels in the outcome of acute coronary syndromes, 
these findings might stimul:lte further res<::u-ch for the (..-valua-
tion of other ph.1nnaco!ogic agents th:tt are effective in modub.t-
ing coron:u-y collater:tl vascular resistance. 
Coronary Blood Flow Velocity During Aortic 
Balloon Counterpulsation 
Controversy exb'tS regarding the ability of intra-aortic b:illoon 
pumping to incre:J.Se coronary blood tlow in patients with 
obstructive coronary artery disc:J.Se. To ::t.-.scss the effects of 
intra-:tortic b:tlioon pumping on coronary hemodynamics, coro-
=ry blood tlow velocity W:tS me:lSured with :t Doppler guide-
wire in 15 patients who received an intr:t-:1.0rtic balloon pump 
for typic:tl clinic:tl indications.z'~- ~'-' In nine patients before 
:mgiopb.:;ty, peak diastolic coronary flow velocity beyond the 
stenosis was unaffected by imra-aortic balloon pumping. After 
:tngiopl:J.Sty, the improved coronary luminal diameter narrowing 
W:tS a..-.sociated with incr<.-ascd dist:tl flow, further increased 
with intra-aortic b:tlloon pumping. In the five no!TI'l:ll reference 
arteries, intra-aortic balloon pumping incre:J.Sed flow. 
These data demonstrated a lack of significant flow improv<.'-
ment beyond the most critical stenoses with intr:l-aortic balloon 
pumping. despite augmented dia.stolic pressure and the un-
equivocal restoration and intrn-aortic balloon pump-mediated 
augmentation of both proximal and distal coronary blood now 
velocity after amelioration of severe coronary obstructions in 
patients :liter successful coronary angiopla.sty. The question of 
whether a 25% augmentation of distal mem coron.:u-y flow by 
intrn·aortic b:tlloon pumping provides substantial cliniol bene-
fit cannot be completely answered. However, a modest incr<.':J.SC 
in distal velocity often is :tccompanied by a shift in the plusic 
relationship of flow, with :t decrement in systolic flow and 
a significant incre:tse in dia.stolic flow. Previous studies have 
demonstrated th:tt subendocardi:tl perfusion occurs during di:L· 
stolic epic:trdial coronary flow :md that the :.-ystolic component 
provides little contribution tO subendocardi:tl perfusion. By 
shifting flow to diastole, the physiologic benefit of increased 
flow may be more dr:unatic than can be inferred from a 25% 
increase in mean flow. Enh:mced coronary blood flow velocity 
in the setting of angiopl:J.Sty for acute myoordial infurction 
may ::t.-.sist in m:tintaining or promoting a reduced incidence of 
postprocedural :tbrupt closure when intra-:tortic b:tlloon pump-
ing is used as adjunctive ther.tpy.~''· z,~ 
More recently, Bach md coworkers"'' studied the effectS of 
aortic counterpulsation on coronary flow through coronary 
perfusion b:tlloon catheters. Intra-aonic balloon pumping in-
cre:J.Sed avernge peak :md mean diastolic velocities. The investi-
gators concluded th:tt intra-aortic bal!oon pumping significantly 
augmented distal coronary blood flow during b:illoon pumping, 
which may provide a mech:mism to further reduce ischemia 
and increase the s:tfety of high-risk coronary angiopl:J.Sty in 
patients with hypotension who require perfusion balloon cathe-
ters. 
Assessment of Endothelial Function 
The in vitro observations of Furchgott and Zawadzki, 7 
:md the in vitro and in vivo reports from the group of Mon-
cad:tz'"' "'' have shown that :m endothelium-derived relaxing 
fuctor, identified :ts nitric ox.ide.~'x modulates va..;cular tone i~ 
response to physiologi.c and p:tthologic stimuli (e.g., inCr<.':tSe 
in wall shear stress, serotonin, brndykinin. symp:tthetic stimula-
tion, acetylcholine, endotoxins). Endotheli:tl damage, leading to 
:t decrc:t...;ed formation or rek-ase of nitric oxide from its precur-
sor L-arginine, or reduced penetration due to the presence of 
subendothelial intimal thickening, is :t possible expl:tn:ttion of 
the imp:tirment of endothelium-mediated vasodi!:ttion observed 
in p:ttients \vith systemic hypertension,~~o hypercholesterol-
emia. diabetes mellitus.""' and atherosclerosis.~~~ 
The presence of p:trndoxic va.<;OConstriction induced by ace-
tylcholine ha.s been shown in coron:try patients at sites of 
severe stenosis or modernte ·w:tll irregularities~~.' :md in angio-
graphic:tlly normal segments.~~ .. -~"" Coronary sp:tsm :liter :tcctyl-
choline infusion has also been demonstrated in patients with 
V:t.riant angin:t, with :tnd without angiographic:tlly visible 
ch:tng~s."-...,., "'" The observed vasoconstriction or vasodibtion 
after acetylcholine is the net effect of the conflicting action of 
this substance on the endothelial cells (stimulation to the re-
le:tse of endothelium-derived rd:t.xing fu.ctor) :tnd on the smooth 
muscle cells (vasoconstriction due to the direct cffect on the 
cholinergic receptors). \'V'ith the usc of intrncoronary Doppler, 
an impairment of the endothelium-derived vasodibtion w::~..-. ob-
served also after physiologi.c stimuli such a.s the incre:t....;e in 
blood flow.~"''·~:l' The flow-dependent vasodilation is an essenti:tl 
mech:tnism of adjustment of coron:try tone to prevent endothe-
lial damage due to a pathologic incre:tse in \vall she:1r stres."'. An 
abnormal vasoconstriction in n:sponse to symp:tthetic stimul:t· 
tion~·" or release of pl:ttdet-derivcd vasoconstrictors~·'"· """ \V:t.S 
observed if the direct effect of these substances on the muscu!:tr 
media W:tS not antagonized by a preserved endothdium-medi-
:tt~d vasodilation. :-Jitric oxide has also a powerful :tntiaggrega-
tory activity. Y:to and :tswciatcs~·" showed a protective effect of 
endogenous nitric oxide in the prevention of cyclic flow varia-
tions due to platelet aggregation at the site of the endotheli:tl 
injury. Garg and Hassid~c'o(. demonstrated also th:tt nitric oxide 
inhibits smooth muscle cell proliferation. Endothelial dysfunc-
tion, therefore, not only potentially aggravates ischemia in p:t-
tients with coronary :ttherosclerosis but also increases the ri.sk 
of endothelial injury and impairs the :mtithrombotic reaction, 
thus fncilitating the development of :~cute coronary ::.)'ndromes 
and the rele:tse of platelet-derived gro\Vth factors that may 
predispose to progression of atherosclerosis. An impairment of 
endothelium-mediated vasodilation ha.s been shown in p:ttients 
with risk factors for coronary atherosclerosis but without an~io­
graphically visible atherosclerotic changes.»~,L·'' A possible limi-
tation of these studies is the poor sensitivity of angiography in 
the detection of c:trly atherosclerotic chan~es. More recently. 
the presence of endothelial dysfunction also in patients with 
structurally norm:tl coronary arteries but with hypertension, 
hyperlipidemia, family history of coronary dise:J.Ses, or :t history 
of smoking ha.s been confirmed using two-dimensional intracor-
onary ultrasound.~-"' A progressive impairment of endothelial 
function W:l.S observed in patients with different stages of ath-
erosclerosis. A complete Joss of endothelium-mediated vasodila-
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tion wa.o.; pre~nt in arteries with mgiogr.tphica!ly visible athero-
sclerotic changes, where-.u; a more selective impairment wa.s 
present in angiographic-.t!!y normal arterks of patients with 
hypcrchokstero!emia, showing normal respon~s after flow in-
cre-.tse and :tbnormal v-.u;oconstriction after acetylcholine.~·''' 
The possible presence of opposite effects of acetylcholine 
infusion on epic-.trdia! and resistance coronary arterk-s has been 
reported by Hodgson and Marsh:dV''' The observed increase in 
coronary flow after acetylcholine W'..lS pn.-v<.·nt<;:d by the pretre-.tt-
ment with methylene blue, an inhibitor of endothelium-derived 
re!:txing factor. Zciher and coworkers:"' reported a significantly 
lower !low increase after :tcetylcholine in p:~.ticnts with coro-
nary artery di:;e-.tsc than in control subjects. These findinJ;S 
confirmed pn..-vious L-xperimental results showing that thc im-
p:~.irmcnt of endothdbl function in atherosclerotic arteries mav 
involve also the coronary microcircul:.ttion.'"·t•-' The presenc~ 
of an impaired cndothelium..Oepcndent vasodilation of the resis-
tance v<.-ssels may induce or facilitate the development of myo-
cardial bchemia in response to nemohumor-.tl stimulation or 
increased myocardial work. 
Using tw<Xlimensional intr.tcoronary ultr.tsound and Doppler 
measuremcnts, Reddy and a.-.;.sociates"'·' have demonstrnted that 
patients with one or more risk factors had an abnormal epicar-
dial artery cros..v:;ectional area va.~oconstriction response to acc-
tylcholinc infusion. How~..-ver, the patit:nts who presented mini-
m:tl di.sc;tsc on ultrasound (intimal thickcning or small eccentric 
plaque) did not respond difli:rentJy from the patients \Vithout 
demonstr.tb!c disease on ultr.tsound. 
The effect of the subsdective imrncoronary infusion of in-
creasing doses of acetylcholinc \V..lS studied in our labornrory in 
coronary :trterics without significant coronary stenosis ( < 30% 
diamt:ter stenosis) in 29 patients undergoing PTCA of a different 
artery.:~. The changes in coronary diameter over a proximal/ 
middle ~gment and a distal segmcnt of the studied artery were 
assessed with QCA and correlated with thc changes in tone of 
the reshtance ves:;ds, whid1 in turn was ass<."Ssed from the 
flow velocity continuously monitorcd using an intracoronary 
Doppler gt1idev.•ire. All vasoactive medications, with thc exclu-
sion of short-acting sublingu:tl nitf'.ttes, wcre withhdd at !ea.~t 
48 hours before thc c-.ttheteri:t~1.tion. 
A sig.nificant incre:t.<:.e in flow velocity \-vas observed within 
30 seconds aftcr the beginning of the infu.->ion of the two 
highcst concentf'.ttions of acetylcholine (10~7 and IQ-" M) in 
most cascs. Cyclic varia.tions of flow velocity were observed in 
the following minutes despite the constant rate of infusion 
and the stablc hemodynamic conditions. A large increa.•.;e was 
observed after papaverine injection. with a peak velocity 2.8 :::: 
0.8 times higher than in ba.-.:.U conditions. The injcction of the 
two Jo,vest concentrntions of acctylcholine induced a modernte 
but significant reduction of the mean cros..vsectional area in 
both the proximal and the distal st:gments. A larger decrease 
\V'J.S observed after the highest concentration of acetylcholine 
(- 24 :::: 20"/o), at which almost all the studicd arteries showed 
a \-aria bit: degree of vasoconstriction. In no cases was a gre.1.ter 
than 75% mean cross-sectional area reduction observed. A nor· 
mal vasodibtion of the studied artery was observed after bolus 
injection of an endothelium-independcnt vasodilator such as 
isosorbide dinitf'.tte ( + 16 ± 26%). 
A significant increa.<:.e in coronary flow wa.s observed only 
after the m:t.ximal concentrntion of acetylcholine ( + 43 ± 83%), 
but with a large interindividual variability. At thc peak concen· 
trntion of acetylcholine, 10 patients showed a dccrease in abso-
lute flow and an increase in coronary resistance. The flow 
velocity, cross-sectional ar~..-a, and flow changes after acetylcho-
line showed no correlation with age, sex, presence of systemic 
hypertension. total cllolcstero!, high-density lipoprotein (HDL) 
cholcsterol, HDL cholesterol-to-toul cholesterol rntio, plasma 
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trygliceridcs, type of studied artery, :md b:tS~I coronary luminal 
diameter. The presencc of wall irregularities wa..--; associated 
Vlith a larger dccreasc in luminal cross-~ectional area and a 
smaller flow incn..-ase after thc la.'it concentrntion of acetylcho-
!inc. 
Acetylcholine is the prototype and the most frequently used 
pharmacologic ::.1imulus, with a primary endothelium-indcpcn-
<.lent contrnctilc action on the vascular smooth muscle cells and 
an opposite endothc!ium-mediatcd vasodilatory activity that is 
predominant in norma! condition.-. and at physiologic concentrn-
tions. ~-·~. ~""' Acetylcholine W'..lS used in the in vitro experimcnts 
in which the role of int:tct endothelium in the regulation of 
vascular tone \v:ts established"'' and in the .first in vivo studies 
showing that acetylcholinc inducL-s severe vasospasm in human 
coronary arteries with significant ::."tenoses.m The induction of 
an endothelium-ckpendent v-.tSodi!ation in caninc femornF-07 and 
coronary2"» artcrics after thc application of acetylcholine on the 
arterial adventitia suggests a role of acctylcholine, the mediator 
of the parJ.S)mpathetic stimulation, in thc modulation of va..-.;cu-
lar tone. The predominance of the parasympathetic activity has 
bccn advocated to explain the circ-.tdbn rhythm of acute coro-
nary s-yndromes such a.o.; vasospastic angina and myocardial in· 
farction. Selectivc intrncoronary infusion of ac~..·tylcholinc clic-
ited vJ.SCular r1.."Sponses comparable to tho:;e observed after 
serotonin, a substance that is released after intracoronary plate-
let :tctivation and that may contribute to the development of 
myocardi:tl ischemia in acute coronary ::.-yndromes. "-'·'· , ... ,.,_, 
Experimental data. have demonstr.tted that atherosclerotic ani-
mals show an abnomlal cndothclium..Ocpendent vasodilation of 
the coronary resistance arteri<."S despite the absence of struc-
turnl athcrosclerotic Jesions.z« The comparison of the flow 
r<.-sponsc to acetylcholine in patients with coronary artery di.v 
e-.tSC and in control subjects has confirmed an impaired flow 
increase in the coronary patients, despite the absence of sig-
nificant lesions of the epicardial coronary arteries."·"' In this 
study, a large vari:lbility in the flow changes \V:lS ob.scrvcd after 
the highest doses of :tcL·tylcholine. A dose-dependent vasodila-
tion after acetylcholine \V:tS pr1..-scm in most cases, with flow 
increase up to three times the ba.--;cline flow. In 10 paticnts, 
however, a flow dccrease was ob:;erved after the maximal con-
centra.tion of acetylcholine. No clinical or angiographic pre-
dictors of these large individual differenc<;.'S could be observed. 
A reduction of the endothelium-dependent rel:t..'X:ltion is pr~..-sent 
in animals fed an atherogcnic diet with a high content of 
dlolest~..-ro!. ::~::."~~In hypercholcsterolemic patients without angi-
ographic evidcnce of coronary artCf)' disease, an impaired endo-
thelium-mediated vasodilation of the epicardial coronary arter-
ies and of thc resistance coronary vessels has been 
demonstrated. ~2''· '·'' Thirteen of the s1udied patients had a total 
cholesterol k-vel of 6.4 mmoi/L (250 mg/dL) or higher. This 
study showed no significant Jiffcrcnces in terms of flow in· 
cn..":t.-.c and vascular diamt:ter chang<.-s after acetylcholine. The 
import::Lnce of the relative amount of HDL and low-density 
lipoprotein cholesterol has recently been reported to correlate 
more closely than total cholesterol \Vith the degree of impair-
ment of the endothelium-mediated vasodilation."" In the study 
group, however, the additional u.--.c of the HDL-to-total choks-
terol rntio did not individu.1.te a subset of patients with a differ-
ent rt."Sponse to acetylcholine. 
The flow increa.-.;e or flow r~..-sistance deCrease after the ma..'<i-
mal concentrntion of acetylcholine showed only a poor correla-
tion with the corresponding cross-sectional area changes. The 
discrepancy between flow and cross-sectional area changes after 
acetylcholine reflects a different response of the conductance 
and resistance arteries to acetylcholine. TI1e large arteries are 
the preferential ta.rget of the atherosclerotic process. At this 
level the presence of intimal thickening may constitute a b::u:rier 
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to the diffusion of nitric oxide from the endothelial cells to the 
muscular media.~"' A macrophagic infiltr:ltion or t11e presence 
of a lipidic component of tl1e intimal pbque may :tlso accelerate 
the degracbtion of nitric oxide and prevent its action on tl1e 
undt.-rlying muscular lay cr.'"'~ Tile importance of these mecha-
nisms in atherosclcrotic human arterks is indirectly confirmed 
by d1e possible dt.-vdopment of focal vasoconstriction observed 
after acetylcholine also in arteries with minimal wall irregulari-
ti~::s. Myocardial pt.-rfusion is regulated prcdomin:mtly by r~::sis­
t:lllce arteries less tl= 200 fJ.ffi in diameter.'~~ These arterie:-> 
do not show signs of atherosclerotic involvement at hbo:olo)!;y. 
suggesting: that biochemical or ultrastructur:tl changes are the 
most likely m~::clunisrru; underlying the abnormal endothelium-
dependent rebxation. 
These ob~rvations have potential clinical implications. A 
prolonged treatment aimed at the regression of the atlleroscle-
rotic intimal changes may be required to restore an impaired 
endotl1dium-mediated response when tl1e presence of an inti-
m:tl b:trrier b ti1e m.'lin operativ<:: mecll:l!lism.2"' On tll<:: contrary, 
acute pharmacologic interventiom; O!." a short-lasting tl."eatment 
may be sufficient to nonn:tlize the cndoti1elial function when 
mcubolic abnormalities are involved, as occurs fO!." ti1e microcir-
culation. The possibility of norm:ili7ing ti1e endoti1elial response 
in hype!."cholcsterokmia witil a short-term infusion of L-argininc 
ha." been shown in :mima.l experiments"- as well as in human 
coronary arteries.'"' Similarly, different cL't!>ses of drugs have 
shown the ability to restore a norm:.tl endotllelium-mediated 
vascular reactivity in experimental animals.,.,.,_,&, In hum:lllS, 
beneficial effectS on endothelial function, evalu:ned by a reduc-
tion of acetylcholine-induced vasoconstriction, have been dem-
onstrated for inhibitors of IDIG-CoA reductase"•'-'"" and '-vith 
angiotensin-converting: enzyme inhibitor.~M The possibility of 
delaying or even reversing the atherosclerotic process and im-
proving endothelial function is being studied in different ongo-
ing trials by the combined use of intr:lvascubr ultr.JSound, QCA. 
and flow measurements with Doppler wire. 
FLTIJRE DIRECTIONS 
New Intracoronary Volumetric Blood Flow 
Mea:,-urcmcnt Method with Intravascular 
Ultrasound 
Because of the already discusst.!d limitations of true volumet-
ric flow estimation from the combined use of Doppler wir~:: 
flow measurements and angiographically derived cross-section:tl 
area evaluation, an alternative metl10d has recently been devel-
oped in our Jaborntory. Tills method is b:L'it:d on a unique 
feature of the rvus technique: the direction of blood flow is 
almost normal to the imaging plane, and when blood p:lrtic!cs 
move across it, the received radiofrequency echo signals decor· 
FIGURE ·~0-16. Volumetric blood !low mea-
~urement in a rigllt coro~· artery with an 
intrava.-;cu!:lr ultrJ..,ound (IVUS) catheter u~int; 
the :malr.-b of the decorrelation of the !':l.dio[re-
quency ~ign:tb, Top r/gbr, A convcntion:U IVUS 
!mage with the calculated coron:Ll.")· blood How 
vdodtic~ 1n ~tole supcrirnpo~ed over the 
cro~~ectional ar~::a. T11c color ~cherne u">Cd 
goc~ from <:b.rk red (10 cmhec) to yellow (100 
cm/~ec). Top !£ft. TI1e decrea'>C of coron;l'1' 
1low in ~y~tole can be vbualized with lower 
vclocitk:, recorded over the arteri:U lumen. The 
c:Uculated Jlow from the 6o con.-.ecutivdy ;~c­
quirc<l fram~ b plotted (in white) bdo\v, to-
gether with the ln~t:Lntaneou.' peal-: Doppler 
velocity (DOP) (in blue. measured with a Dop-
pler wire advanced 3 em more dbtally in the 
:trterv), the ;~ortlc blood pre!-~ure (PRES) and 
the etectrOClr<liogr.un (ECG). Thi.' recording 
w~ made during an intr:tvenou~ infusion of 
:tdeno~lne. TI1e corresponding Doppler ~pee­
truro is ar the bottom right. T11e Doppler aver-
age peak velocity,,':!..., 30 crnhec. Thc coronary 
cro~~~ectional :rrea mea.,urcd with qwmiutive 
coronary angiography at the kvd of the tip of 
thc Doppler wire wa.' 7A2 mm". The Doppler· 
derived coronary blood llow (134 rnL/rnin) b 
in :~greement with the mean llow m=ured 
with the I\fl:"S !':l.diofrequency proce~ing (1·18 
ml/min). TI1e coronary !low rel-crve dL-rived 
from thc IVCS method ~va.' 3 (b:~.,eline tlow not 
illw;tr:ttcd: 48 mL/min). clooe to the Doppler 
c~timation: 2.8 (lower left comer). Sec color 
p!:~tc 2. 
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relate at a rate proportional to flow velocities.::<~· Blood flow 
vdocity is ~timatcd by decorrc!ation processing on a series of 
acquired r.tdiofrequency signals. Characteriza.tion of the rcL1-
tionship between the correlation of echo signals and the scat-
ten.-r motion across the ultra..'>Ound beam ha$ been <.-va.l.uated.~"' 
For 100 angular positions over the cross-sectional arterial 
lumen area, the decorrelation rate is estimated in small (-200 
JJ-m) consecutive range windows, and the derived local trans-
verse velocity is plotted using a color--coded scale, as illustrated 
in Figure 40-16. Volume flow is calculated by integrating the 
local tran:,;versc velocity with its corresponding an:a element 
over the complete imaging plane. Because the motion of wall 
tissues has much lo\ver velocity than blood, the contribution of 
tissue velocities can be automatically removed by setting a 
threshokl, ancl thus, no contour tracing of the arterial lumen i:; 
needed. Although the catheter modilies the velocity profile, 
because all the velocities in the imaging plane arc imegr:tted, 
the true volumetric flow across this plane can be estimated."''" 
Figure 40-16 shows, during intravenous administration of aden-
osine (140 'Y ·kg-' -min-'), the ma.."Ximal flow pn:.-sent in 
di;tstole (top right) and the lower flow in systole (top left) in 
an RCA of a patient. The good phasic response of this method 
can be appreciated with the simultaneously acquired im;tanta-
neous peak velocity melSured with a Doppk-r wire 3 em more 
distally (blue curve). The mean flow measured was 148 mL/ 
min, in agreement with the flow estimated with the Doppler 
recording (134 mL/min, shown in the bottom of the figure). 
1l1is method has been calibrated in vitro on a flow phantom 
and in a carotid porcine model""' using an electromagnetic 
flo-.\meter. This method, presently under clinical evaluation in 
our laboratory. offers a unique opportunity to simultaneously 
:L.."'."CSS physiologic and anatomic parameters in coronary aneries 
with the same catheter and should be useful during coronary 
interventions. 
CONCLUSIONS 
1l1e last f<...-.v years have ~en r.tpid advanc<..-s in coronary 
Doppler and pressure probes technology and the d<....,'clopment 
of new approaches to the interpretation of intracoronary hemo-
dynamic measurements. A complex technique reserved to a 
few research laboratories has been tr.tnsformed into a reliable 
diagnostic tool that can be used for the ass~sment of stenosis 
severity, for the evaluation of the results of coronary interven-
tions, and for the study of coronary circulation. Combined flow 
and imaging ultrasound can be applied for measurement of 
absolute coronary flow a.s well as for the simultaneous study 
of morphologic and functional characteristics of the coronary 
::.)'Stem. The d<..-velopment of combined Doppler-pressure sen-
sors on guid<.'Wir<..-s should fucilitate a more complete assess-
ment of stenosis hemodyn.1!11ics. 
Technical improvements alone, however, arc insufficient. 
Knowledge of the recent adv:mc~ in coronary flow physiology 
is a prerequisite for the interpretation of the flow-velocity 
changes and the development and the application of new meth-
odologic approaches. A dose collaboration between clinicians 
and basic scientists is essential for the future development of 
these techniques in the study of coronary artery dL'ie:tSC. 
Presently, with the refinements of pressure and Doppler 
guidewire technology, the superiority of one technique is not 
established, because pressure and flow repres<.-nt the two sid~ 
of the same coin-that of coronary flow r~istance. Ambiguous 
values obtained with one technique can be reduced or elimi-
nated using the corresponding alternative method. In the 25% 
of the current angiopla.sty population with stable ch<..-st pain 
::.-yndromes in whom evidence of ischemia is la.cking, using 
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coronary physiology, one might modify a widely practiced dic-
tum, ~When in doubt, dilatew to M\Vhen in doubt, mc-.t:>ure and 
decide.~'"'" 
A>.J<.:NOWI.lOIX .. \1E~'l>: The contribution of the medical, tcchni~1. ;:tnd 
n ur.:<ing staffs of the Catheteri.-;:Hion L:lboratory of the 11lor.t..,.center and 
of the G. Mudd CathcK-ri7.:ttlon L:lbor:ltory of the St. l..oui~ Univcr.:<ity i::. 
t:r.tt<:fullr acknowlcdgo::d, as well..._.,. the contribution of Dr.s. R. Kr-~m::.. 
C.). Sl:~{.:er, R. L. Kirkeeklc, G. B.). :>1:~ncini. :~nd ). ). Pick. 
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Chapter 2 
Decreased coronary flow reserve in hypertrophic cardiomyopathy 
is related to remodeling of the coronary microcirculation. 
R Krams. MJM Kofflard, DJ Duncker. C Von Birgelen. S Carlier, M Kliffen. 
FJ ten Cate, PW Serruys. 
Circulation 1998;97:230-233. 
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Brief Rapid Communications 
Decreased Coronary Flow Reserve in Hypertrophic 
Cardiomyopathy Is Related to Remodeling of the 
Coronary Microcirculation 
R. Krams, MD, PhD; MJ.M. Kofflard, MD; DJ. Duncker, MD, PhD; C. Von Birgelen, MD; 
S. Carlier, MD; M. Kliffen, MD, PhD; FJ. ten Care, MD, PhD; P.W. Serruys, MD, PhD 
Background-Ischemia occurs frequently in hypertrophic cardiomyopathy (HCM) without evidence of epiCLrdi:U stenosis. 
This study evaluates the hypothesis clue the occurrence of ischemia in HCM is related to remodeling of the 
coronary microcirculation. 
Methods and Results-End-diastolic septal wall thickness was significantly increased in patients with HCM (25.8:±::2.9 nun) 
in comparison with cardiac t:r:l.nSpl:mt recipients (control subjects: 11.4:±:3.0 nun; P<O.OS). Although the di::uneter of the 
left: anterior descending coronary artery was simihr in both groups (3.0::!:0.8 versus 3.0±0.5 mm, P=NS), the coronary 
resist:mce reserve (CRR=CRRt.._.,/CRRhwr=Jc), corrected for extnV:lScuhr compression (end-diastolic left ventricular 
pressure), was reduced tO 1.5:!:0.6 in HCM (P<.05; control, 2.6:!:0.8). Aneriolar lumen (AL) divided by will area was 
lower in HCM (21:!:5% versus 30:::±::4%; P<.05), and capillary density tended to decrease (from 1824::!::424 co 1445:::±::513 
per mmz, P=.ll) in HCM. CRR was linearly related to normalized AL according to the formula CRR=0.1 AL-0.45 
(r=.57; P<.05). Further analysis revealed th:lt CRR, AL, and capillary density were all linearly related to the degree of 
hypertrophy. 
Conclusions-Decrements in CRR were related to changes of the coronary microcirculation. Both the decrease in CRR and 
these changes in the cororury microcirculation were related to the degree of hypertrophy. All these &ctors might 
contribute to the well-known occurrence of ischemia in this patient group. (Circulation. 1998;97:230-233.) 
Key Words: cardiomyopathy • arteries • capillaries • ischemia 
Anginal symptoms and signs of ischemia occur frequently in patients with HCM without detectable lesions of the 
major epicardial arteries.t-> suggesting that the presence of 
ischemia is the result of abnorm:ilities of the coronary micro-
circulation. Indeed, postmortem analysis of HCM he:trts 
showed the existence of :trterioles with :tbnormally thick 
walls.6•7 Furthermore, in e..-.:perimentally induced hypertrophy, 
it has been shown th:J.t the hypertrophic process is accompa-
nied not only by decrements in CFR but also by structural 
ch:tnges in the coron:try microcirculation (coronary remodel-
ing), including :t decre:J.Sed capillary density.H-to The resulting 
increased diffusion dist:ulces for o:-..ygen and the disturbed 
perfusion of the capillary bed have been forw:trded as an 
e..,.-pJanacion for ischcmi:t.. K-to 
Although the CFR is decre:tSCd in HCM, in :tccord:mce 
with the findings of e:-..-perimentally induced hypertrophy,'1•10 it 
is unknown at present whether the decreased CFR is related to 
the abnormal arterioles :md whether a decrease in capillary 
density :tccomp:mies this decrease in AL. To that end, we 
me:J.Sured CFR in combination with a qu:mtit:ttive analysis of 
AL, W:tll :trea :md e:tpilhry density in myoe:trdial tissue ob-
tained during surgery (HCM) and obtained from endomyo-
cardial biopsies (HTx). 
Methods 
Subjects and Protocol 
Studies were performed in a group of patients with hypertrophic 
. obstructive cardiomyopathy (HCM; n=lO) who were referred for 
ordi:tc othcterizltion. The control group consisted of .asymptonutic 
cardiac trwsplant recipients (HTx group; n""'S) undergoing follow-up 
coron:try :tngiognphy :tfi:er =planution. Informed consent w.a:; 
obtalned from all patients. Patients in the HCM group were ~ymp­
tomatic (NYHA class II or III) despite ,B-blockade thempy (n =-5) or 
ther:tpy with calcium mugonists (n=5). These patients were consid-
ered c:mdidates for surgery (myotomy/myectomy). Medical thcmpy 
was continued in both groups. Right heatt otheterization was 
performed with a 7F balloon-tipped flow-directed thermodilution 
catheter. A 7F tempor:try p:tcemaker was positioned into the right 
atrium. Left he:ttt catheterizltion was carried out, after which left 
ventricular angiography and coron:try :ttteriography were performed 
with st:md:u:d techniques. A 0.014-in Doppler guidewire with a floJ?pY 
dist:tl. end (Cardiometries, Inc) was introduced through an SF guiding 
catheter and positioned :tt the midsegment of the LAD to me:l5ure 
Doppler flow velocity at rest and mer hyperemia. In both groups, 
hearts were p:tced at a constant he:ttt rate of 100 bpm to :.void 
meubolic vasodilatation during determination of the CFR. Mer 
optimiz:ttion of the settings of the velocity sign;U and 3 to 5 minutes 
mer intracoronary injection of a bolus of 2 to 3 mg isosorbide 
dinitrate, baseline recordings of flow velocity and perfusion pressure 
were collected :tnd digitized :tt :t sample rate of 125 Hz for oJf-line 
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Sdected Abbreviations and Acronyms 
AL = nonm.lized arterioLar lumen 
CFR = coronary flow re:;e!'Ve 
CRR = coronary resistance resel'Ve 
HCM = hypertrophic cardiomyopathy 
HTx = eardiac tr;l.llSplant 
LAD = left anterior descending coronary artery 
~nJ.!ysis. Ma:-:im.1.l hypcremi~ wa.~ induced by :m in=coron~ry bolus 
injection of 18 J.l-S adenosine. w 
Doppler Measurements 
The s~mple volume of the Doppler wire wJ.s po~itioned ~t ~ di.~t;mce 
of 5.2 mm from the transducer and w:~s =2.25 mm wide. After power 
spectnl :malysis based on a fist Fourier tnnsform ~lgorithm, the 
m~xim~l Doppler shift (kHz) \vas automatically tr:~cked :~nd converted 
to the in.~tant:tncous velocity v:Uues (cmh). CFR w:~s defined as 
hyperemic divided by b:1.d velocity 01",). Cororury resisunce w:~.~ 
defined as (P ~·-P ,J/V ~.-· where P..., is :~ortic pressure :md P r.J is end 
di:~stolic pressure. P"' w:~.~ sub=cted to account for increments in 
extr.~v:~.<;eubr comprc:;sion. CRR w:~.~ defined as the ntio of ba.~~l 
divided by hyperemic resi=ce. 
Quantitative Angiographic Measurements 
A vilid.J.ted on-line ~nalysis system operating on digiul images 
(ACA-DCI, Philips11) was used during the c:J.theteriz:tcion procedure. 
With this system, the end-diastolic dilmeter of the LAD was deter-
mined in the M"gmem of the LAD in which the =pie volume of the 
Doppler wire was loc~ted. 
Echocardiographic Measurements 
Two-dimensional echoc:trdiographic studies were performed (HP 
Sones 1500) with the he~rt being visualized from st:md.J.rd cross-
section~] phnes while itn:lges were recorded on videoupe (VHS) for 
off-line :~nalysis. Septal wall thickness \v;JS measured in diastole from 
both the p~r.J.Stemal short-axis :md long-mcis views. From the record-
ings on vidCQt:tpe. rcpresent:ttive stop-frames &om the various cross-
sectional pl:mes were acquired to determine septal wall thickness with 
the aid of :1 computer and a dedic.1.ted softl.v:u-e progr:un. To obtain an 
avenge for septal wall thickness, the v:~riou.~ cross-sectional pl~nes 
were pooled. One patient from the control group was not analyzed 
because of insufficient im~gc quality. Thickness of the septal w:\11 for 
the HCM :md the control groups was defined as the degree of 
hypertrophy. 
Histological Measurements 
The myocardial tissues from the HCM group (n-=9) and from the 
control group (n""8) were obtained from surgical myectomy Qeft 
ventricuhr septal tissue; weight, 0.3 to 1 g) :~nd myocardial biopsies 
Qeft ventricular septal tissue; weight, 0.5 to 1 mg:), respectively. 
During: catheteriz:J.tion, one HCM patient presented \vithout ~ subv:U-
vubr pressure gradient and w-as not opented on. The tissue W:15 fi.xed 
with paraldehyde and immersed in 10% buffered form:Uin. van Giesen 
st:tining was used for idencifio.tion and analysis of in~r.Unyoc~rdlal 
small ::Lrtcr:ies. Arterioles were identified on the basis of the appear.:tnce 
of :1 byer of medil and di:uneter <tOO p.m. Only :u-terioles with 
round cross sections and without side br.:tnches were analyzed. 
Ca.pill~ries were identified with specific antibodies (CD34) ag:ain.~t 
endothelium. Quantitative morphometric analysis of the histological 
sections occurred with an in-house-developed soft\Vare program 
:~pplied to a morphometric system (Clemex Technology Inc) that 
calcuhted density of o.pilhries (apill~ries per squue millimeter), 
taking tissue shrinkage into account. Five cross sections per patient 
(=1000 capilhries) were analyzed. In addltion, software was available 
that allowed us to =ce the :u-teriolar lumen-intinu and adventicia-
media borders, which defined the lumen :md wall thickness regions. 
The are:~S of these regions were obtained from the number of pixels in 
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the two regions. Normalized wall are:~ is given by circuhr wall 
an:a/Qumen area+wall area). This v:Uue was calcuhted for 10 :~.rte­
rioles per patient. D~u :tee presented as mcan:!:SD. Regression 
analysis, ANOVA, and I tests were performed \vith sundard sutistical 
software (SPSS). A v:Uue of P<.OS W:l5 considered s:ig:nific:mt. 
Results 
The HTx recipients, who served as control subjects, had no 
c:u-di;J.c complaints, ;J.nd all of them had normal coronary 
arteriogra.ms. The time interval of c:~thcteriz:ttion after trans-
plmtltion was 4:::!::2 ye;J.rs. Medication of HTx patients at the 
time of catheterization was immunosuppression (n=8) u=+ 
antagonists (n=8), aspirin (n=5), md dipyridamole (n=4). No 
member of the control group had signs of rejection on the basis 
of the biopsies. Age distributions between the HCM 
(45.5::!:14.6 years) and control (48.7::!::6.0 years) groups "vcre 
similar. HCM patients were symptomatic (NYHA class IT or 
III), whereas all members of the control group were symptom 
free (NYHA class I). HCM patients had a subvalvular gradient 
of88:::!::31 mm Hg ;J.nd a lower aortic pressure (103:::!::14 \'ersus 
120::!:15 mm Hg. P<.OS), ;J. higher end-diastolic left ventric-
ular pressun: (22::!: 1 versus 12::!:6 mm Hg, P<.OS), a lower 
cardiac index (2.7:::!::0.5 versus 3.5:::!::0.7 Lim~. P<.OS), :and a 
lower he;J.rt rate during baseline conditions (70::!:13 versus 
97::!::13 bpm, P<.OS) th;J.n the control group. 
End-diastolic septal wall thickness was signific:~ntly increased 
in patients with HCM (25.8:::!::2.9 mm) compared with mem-
bers of the control group (11.4::±::3.0 mm; P<.05). All HCM 
patients had normal ;J.ngiogr:tms. The di;J.mcter of the LAD was 
simil:rr in both groups (3.0::!:0.8 versus 3.0:::!::0.5 mm). Coro-
nary velocity during baseline conditions was highet for HCM 
patients (34::!:11 versus 20:::!::11 cm/s, P<.05). whereas veloc-
ities during hyperem.i;J. were similar (49±20 versus 53::!:22 
cm/s). As a consequence, the CFR was reduced from 2.6:::!::0.8 
in the control group to 1.8±0.9 in the HCM group (P<.05). 
Coronary resistance v:J.lues, corrected for o:travascular com-
pression (sec above), were lower (3,7::±::2.1 versus 6.5::!:2.2 
mm Hg • s • em -t, P<.05) during baseline conditions and were 
simibr during hyperem.i;J. (2.6::!: 1.5 versus 2.6::!:::1.0, P=NS) in 
HCM. Consequently, the CRR was lower (1.5:±0.6 versus 
2.6:::!::0.8, P<.OS) in HCM than in the control group. Arte-
riolar wall area W;J.S similar (5720::!:2130 versus 
7107:::!::3544 p..m~; P=NS), but lumen are;J. (1273:::!::688 venus 
2260:::!::1165 p..m2; P<.OS) and diameters were signific:~ncly 
lower (19.6:::!::4.5 versus 25.9:!:4.3 p..m; P<.05) in HCM 
comp:rred with control v:J.lucs. Consequently, AL was lower in 
the HCM (21 :::!::5%) than in the control group (30::!:4%; 
P<.OS), and capillary density tended to decrease from 
1324±424 to 1445:::!::513 per square millimeter in HCM 
{P=.11). In addition, both the CFR md the CRR were 
linearly related to AL according to the formula CFR=O.l 
AL-0.45 (r=.57; P<.OS) and CRR=0.07 AL+0.35 (r=.SO; 
P<.OS; Fig 1A). Further analysis revealed that the degree of AL 
(AL=-0.85 Hyp+43.7; r=.71; P<.OS; Fig 1B), the CFR 
(CFR=-0.17 Hyp+5.9; r=.80; P<.OS), the CRR 
(CRR=-1.2 Hyp+4.7; r=.7; P<.OS; Fig !C), and the 
c:1pillary density (CD=-51 Hyp+2750; r=.53; P<.OS; Fig 
1D) wen: all inversely related to the degree of hypertrophy 
(Hyp). In addition, a line:tr relationship between AL and 
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capillary density was measured (AL=42 CD+577; r=.54; 
P<.OS). 
Discussion 
In symptomatic patients with HCM without evidence of a 
functional stenosis of the epicardial vessels, decrements in 
CFR were detected, confirming earlier studies. H Similar 
decrements in CRR were me::tsured, implying that these 
findings could not be explained by increments in extravas-
cular compression.9•10 Abnormal arterioles with decreased 
lumen were detected in HCM patients, suggesting that a 
str.lctur:Ll change in the coronary arterial vascular tree might 
be rebted to this finding. Indeed, a positive relationship 
between both CFR ::tnd CRR and AL, corrected for tissue 
shrinkage by normalization to the wall area/ was detected. 
Furthermore, an inverse relationship waS noted between AL 
and the degree of hypertrophy, confirming e::trlier postmor-
tem studies. 7 Bec::tuse of this relationship, an inverse rel:t-
tionship between CFR and the degree of hypertrophy could 
be measured. Again, a similar relationship was found be-
tween CRR and degree of hypertrophy, implying that 
extravascular compressive forces were not essential for these 
findings. In large-animal models of pressure overload-
induced left ventricuhr hypertrophy, vascular medial hy-
pertrophy has been observed only when the coronary 
circulation was exposed to high perfusion pressures. The 
present arteriolar abnormalities were obtained at normal to 
low aortic pressures and might imply that hypertrophy of 
the arterioles, in par:allel to the hypertrophy of the myocar-
dium, is :~n independent process.7 
A decreased capillary density has been me::tSured in several 
animal studies with experiment:illy induced secondary hyper-
trophy and recendy in humans with secondary hypertro-
phy. 1::.13 Although differences between the groups in capillary 
density did not reach levels of statistical significance, there 
cle::trly was an inverse relationship between capillary density 
and degree of hypertrophy. Furthermore, the decrements in 
capillary density and decrements of AL are related in HCM. 
These findings may imply that the decreased AL induces 
periods of ischemia, which results in increased angiogenesis. 
This angiogenesis nonn.alizes the decrements in capilhry den-
sity. However, because we did not analyze HCM myocardial 
tissue without hypertrophy, we cannot exclude the possibility 
that the occurrence of changes in the coronary microcircub-
tion in HCM is a more independent phenomenon and not 
directly reb.ted to the degree ofhypertrophy.~-7 
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In conclusion, septal hypertrophy is associated with decre-
ments in CFR :md CR.R in HCM patients. Arterioles of 
HCM patients exhibited a sm:iller lumen at similar w.ill 
thickness, which correlated well with decrements in CFR :md 
CR.R. These findings suggest that abnormal arterioles might 
contribute to the perfusion abnormalities found in these 
patients, resulting in recurrent myocardial ischemia. 
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Abstract 
!ntracoronary investigations using Doppler-tipped 
guidewires are now performed routinely to assess 
severity of stenosis. Maximal peak velocity and average 
peak velocity computed on-line are used to this end, but 
when the quality of the Doppler signal is poor, the 
contour recognition fails to follow maximal velocity. 
We describe a system a_llowing the acquisition of 
intracoronary raw Doppler signals (! and Q 
componenls) with pressures, ecg, ... for recording and 
postprocessing. The technique of multiple beats 
averaging allowed for obtaining improvement of signal 
to noise ratio. 
In-vitro experiments on steady and pulsatile flows in 
small tubes were performed Influencing factors such as 
depth of measurements, rotations, quality of the signal 
ha\le been investigated 
Our system may help collect high quality Doppler 
signals along with pressures which is useful for 
coronary blood flow assessment. 
1. Introduction 
Coronary angiography was thought to allow precise 
anatomic evaluation of the extent of coronary artery 
disease. Moreover, quantitative angiography has been 
proved to atlow repeat measurements to analyze 
evolution of coronary atherosclerosis [I]. But an 
anatomical approach, even based on computed 
geometrical indexes, fails to give a reliable functional 
assessment of coronary stenosis in unselected patients 
with diffuse lesions [2,3]. Technological advances have 
allowed the development and the availability in 
catherization laboratories of very small Doppler and 
pressure devices mounted on guidewires in order to 
measure coronary velocities and pressures without 
hemodynamic perturbation. This has allowed functional 
assessment of the severity of coronary stenosis which 
could be well correlated with clinical evaluation of 
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myocardial ischemia [3,4]. These approaches have been 
proved to even allow deferring safely angioplasty of 
stenosis which were not hemodynamically significant 
[5]. 
By definition, coronary flow reserve is the ratio 
between coronary flow during maximal vasodilatation 
and baseline values. It is estimated with the Doppler 
guidewire by the ratio of the velocities during 
pharmacological hyperemia and baseline state. It has 
limitations because of its dependency on hemodynamic 
conditions [6]. Recent developments integrating 
simultaneous measurements of aortic pressure and 
intracoronary velocities have tried to overcome these 
problems [7]. Such relation should be further 
investigated, with assessment of the pressure-flow 
relation distal to a coronary stenosis, in order to fully 
describe its hemodynamic influence compared to a more 
diffuse alteration of the distal vasCular bed [8]. 
2. Aim of the study 
Our aim was to develop a system allowing 
acquisition of intracoronary raw Doppler signals along 
with pressure, ECG and other signals. With raw Doppler 
signals, all the information of the complete spectrum is 
still available and can be stored for postprocessing. We 
wanted to be able to investigate alternative maximal 
frequency detection, power spectrum estimation 
(autoregressive modeling e.g.) and also to improve 
Doppler measurements by multibeats averaging in order 
to improve the signal to noise ratio. This should allow 
finally more precise determination of functional severity 
of stenosis then those achievable with conventional 
technique. 
3. Material and methods 
The Doppler system unit investigated is used 
everyday for clinical cath-Iab investigations and has 
been validated in-vitro and in-vivo [9}. It is based on a 
0.014 inch angioplasty guidewire, 175-cm-long flexible, 
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steerable guidewire with a floppy distal end with a 15 
MHz piezoelectric transducer mounted at the tip 
(Cardiometries Inc). It is basically a pulsed Doppler 
system with a pulsed repetition frequency (PRF) ranging 
from 15 to 120kHz. allowing to measure velocities up 
to ± 2.4m/s. The depth of the sampling volume can be 
adjusted. The clinical usual setup uses a depth of 5 rnm, 
which gives a width of2.2 mm for the sample, due to the 
diverging shape of the ultrasound beam. We have 
compared two depths: 5 and I 0 mm. A real time fast-
Fourier transform (FFT) computes the power spectrum, 
plotted on the screen with a conventional gray-scale. A 
maximal frequency estimation is performed also on-line 
for each spectral line to give the instantaneous peak 
velocity (IPV). With IPV, the maximal peak velocity 
(MPV) and the average peak velocity (APV) over the 
last 2 cardiac cycles are computed. 
Fig 1: Hardcopy of the Cardiometries screen during one 
in-vitro experiment. The instantaneous peak velocity 
plotted in white dots presents jittering and does not 
follow the maximal contour of the spectrum in this case. 
For the acquisition of the raw I and Q Doppler signals 
coming after conventional quadrature demodulation in 
the Cardiometries system. we used a system previously 
described [I OJ but improved by using a high speed (1 
MHz) AID acquisition board (Wavebook 512, JOTech 
Inc). I and Q are sampled at the PRF, but with only a 
period of 1 ).lS between them, minimizing mirror artifacts 
(between forward and reverse flow occurring during 
computation of the power spectrum, unless one uses 
expensive sample and hold on the AID board) [10]. Up 
to six other channels were free to record ECG, 
pressures, ... Power spectrum is computed off-line, after 
the acquisition, by FFT. The maximal frequency of each 
spectral line is estimated with an improved method 
proposed by Mo [ 11] and the maximal contour 
recognized can be filtered, using information from 
adjacent points to smooth it. For pulsatile flow, the 
variance of the power spectrum can be reduced by 
66 
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averaging multiple cycles (up to 20), in order to improve 
the contour recognition [12,13]. 
For preliminary tests, we have developed a simplified 
in~ vitro model of a coronary artery, with tubes ranging 
from 2 to 5 mm in diameter. Steady or pulsatile flows, 
obtained with a roller pump from which a 
synchronization signal was available, were used. The 
fluid was a 4 % by volume of hardened red blood cells 
in physiological saline, which gives roughly the same 
Doppler power as that obtained with 45 % hematocrit 
[14). To estimate the flow, we have used a simple 
collecting bag suspended to a weighting system with an 
analogic output which could be digitized simultaneously 
with the synchronization signal and the I and Q Doppler 
signals, up to 60 kHz, directly to the hard disk, allowing 
thus to record continuously seconds of signals, which 
could be then easily archived. reviewed, zoomed on 
screen and processed on a PC. 
4. Results 
Although the use of depth of 10 mm should allow to 
increase the width of the sample volume in straight tube 
(because of the diverging angle of the ultrasound beam) 
in order to detect more easily the maximal velocity in 
the insonified profile, the quality of the Doppler spectra 
was lower and the system failed to detect correctly the 
ma'\imal contour. This gave a statistically significant 
difference (paired t-test) ben:veen APV (91±47 vs 81±36 
cm/s) and MPV (109±51 vs 100±41) recorded 
respectively for a depth of 5 and 10 mm in a set of 12 
flows. 
Figure 2 shows a pulsatile flow recorded with its 
synchronization signal and the flow measurement. 
Fig 2: Presentation of the raw Doppler spectrum 
recorded along with pseudo~ecg and the weight of the 
collecting bag. with possibilities to zoom, to select, to 
detect ecg. 
We could verify in this in-vitro system with 
transparent tubes that the alignment of the guidewire 
with the flow is a major problem . .MPV could change up 
to 50% during a 360 degrees wire rotation, sometimes 
abruptly, just because the wire was looking towards the 
edge of the tube. This might lead to significant 
underestimation of flow, and stenosis, under study 
Figures 3 and 4 compare one selected pulsatile cycle 
and the improvement in the signal to noise ratio, with a 
decrease of the variance of the Doppler spectrum with 
an averaging of 10 cycles. The contour detection was 
dramatically improved. On a subset of flows where the 
Cardiometries system failed to recognize correctly the 
maximal contour (because there was not a sharp, well 
defmed spectrum like in figure l where underestimation 
and jittering is present in the IPV recognized), this 
postprocessing allowed with our system to improve the 
contour detection (figure 4 compared to 1 ). 
lililliiil iiiiiliii i"ZE'7 iiiillllllliiii iiiiillll!iiiil 
Fig 3: Selection of one cycle, with a noisy maximal 
contour detected because poor quality of Doppler signal. 
~-- MSE5jjf ~iii ~ 
Fig 4: Improvement of variability and signal to noise 
ratio allowing a better contour detection thanks to an 
averaging of ten consecutive cycles. 
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5. Conclusions 
This system seems a valuable tool to study coronary 
blood flow. It offers viewing, archiving and 
postprocessing utilities for Doppler intracoronary 
studies. It can improve direct on-line measurements. It 
should allow extensive studies of intracoronary fluid 
dynamics for physiological assessment of stenosis for 
example, thanks to the possibilities of simultaneous 
recordings of pressures. 
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Randomized Comparison of Primary Stenting and 
Provisional Balloon Angioplasty Guided by Flow 
Velocity Measurement 
Patrick W. Serruys, :MD; Bernard de Bruyne, MD; St6phane Carlier, MD; Jose Eduardo Sousa. MD; 
Jan Piek, MD; Toshiya Muramatsu. MD; Chris Vrints, :MD; Peter Probst, MD; 
Ricardo Seabra-Gomes, MD; Ian Simpson, MD; Vasilis Voudris, 1\1D; Olivier Gurne, :MD; 
Nico Pijls, MD; Jorge Belardi, MD; Gerrit-Anne vanEs, PhD; Eric Boersma. PhD; 
Marie-Angele Morel, MS; Ben van Hour, PhD; on behalf of the Doppler Endpoints Balloon 
Angioplasty Trial Europe (DEBATE) II Study Group 
Background--Coronary stenting improves outcomes compared with balloon angioplasty, but it is costly and may have 
other disadvanuges. Limiting stent use to patients with a suboptimal result after angioplasty (provisional angioplasty) 
may be as effective and less expensive. 
Methods and Results-To analyze the cost-effectiveness of provisional angioplasty. patients scheduled for single-vessel 
angioplasty were first randomized to receive primary stenting (97 patients) or balloon angioplasty guided by Doppler 
flow velocity and angiography (523 patients). Patients in the latter group were further randomized after optimization to 
either additional stenting or termination of the procedure to further investigate what is "optimal." An optimal result was 
defined as a flow reserve >2.5 and a diameter stenosis <36%. Bailout stenting was needed in 129 patients (25'7t) who 
were randomized to balloon angioplasty, and an optimal result was obtained in 184 of the 523 patients (35%). There was 
no significant difference in event-free survival at 1 year between primary stenting (86.6%) and provisional angioplasty 
(85.6%). Costs after 1 year were significantly higher for provisional angioplasty (EUR 6573 versus EtJR 5885: 
?=0.014). Results after the second randomization showed that stenting was also more effective after optimal balloon 
angioplasty (1-year event free survival, 93.5% versus 84.1 %; ?=0.066). 
Conclusions-After 1 year of follow-up, provisiorol angioplasty was more expensive and without clinical benefit. The 
beneficial value of stenting is not limited to patients with a suboptimal result after balloon angioplasty. (Circulation. 
2000;102:2930-2937 .) 
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0 ver the last 2 decades. percutaneous transluminal coro-n::uy :mgioplasty has proven to be a safe and effective 
option for treating patients with coronary artery disease. 1 
However, treatment results may be transient because of 
recoil, rcstcnosis. and reocclusion. Although these disadvan-
tages arc partly overcome by coronary stenting.2- 6 the costs 
of coronary stcnting arc high compared with balloon angio-
plasty, and the long-term outcome remains a matter of 
conccm.7.S 
It has been suggested that optimal balloon angioplasty 
could yield a clinical outcome similar to stcnting,9-12 The 
Seep 2910 
Doppler Endpoints Balloon Angioplasty Trial Europe (DE-
BATE) I results support this hypothesis in that the outcome 
for patients with both a diameter stenosis (DS) S:35C)(: and a 
coronary flow reserve (CFR) >2.5 was comparable to that 
achieved with stcnting in the Belgian Netherlands Stcnt 
(BENESTENT) trials.J,IJ Thus, the following pro ... ;sional 
approach emerges: stent only those patients likely to reap an 
additionol benefit. Such an approach challenges the inter-
vener who must decide on overall patient care. "Pro ... ;sional 
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Figure 1. Study flowchart. R1 indico.tes first ro.ndomizotion; R2 , 
second ro.ndomization; and BA, balloon angioplo.sty. Patient 
groups with provisional stenting are framed in bold. Actual num~ 
bcr of patients in clinical subsets lie between parentheses; theo-
retical assumptions ore denoted by n. Twelve patients were 
excluded from study between randomizations 1 o.nd 2 (10 due 
to inconsistencies between randomizotion service and investigo-
tors, and 2 duo to missing CFR values}. 
angioplasty" refers to a status of ungioplasty that satisfies 
predefined criteria of optimal results based on pressure 
gradients. 11 early loss of minimal lumen diamcter. 10 or 
intravascular ultrasound me:l.Surcments. 12 A failure to meet 
the criteria would change the intended treatment and results 
in stent implantation. 
DEBATE II was a prospective. randomized study that used 
criteria identified in DEBATE I. It addressed the following 
questions. (I) Should elective treatment be by stenting or 
balloon angioplasty (provisional :mgioplasty being guided by 
the stated criteria)? (2) What is the relative costlbcncfit ratio 
of these strategies? (3) Do patients with optimal balloon 
:mgioplasty obtain an additional benefit from stenting? 
Methods 
Patient Selection 
Patients were eligible for the study if they were scheduled to undergo 
::mgioplasty for strtblc or unstrtble angina pectoris (excluding Braun-
wald classification III), 14 documented myoc;:rrdial ischemia due to a 
single de novo coronary stenosis potentially amenable to stent 
imp!anution, or both. The t;:rrgct lesion was to supply viable 
myocardium and be <25 mm long. Excluded patients marllfcsted 
toul coronary occlusion: lesions that were ostial or at a bifurcation: 
lesions in vessels that were previously bypassed, tortuous, or 
conuincd thrombus: or previous Q-wavc inf:u-ction (in the target 
vessel tcnitory or from an evolving myocardial infarction of the 
previous week). The study was perfonncd according to the principles 
in the Declaration of Helsinki. Every patient provided written, 
infonncd consent. 
Study Objectives and Trial Design 
The primary trial objective was to compare the cost-effectiveness of 
elective stcnt implanution (primary stenting) with provisional ba.J.-
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TABLE 1. Baseline Clinical and Angiographic Characteristics 
Rrst Randomization 
Primary Guided Balloon 
Stenting Angioptasty 
97 523 
Male sex 72 73 
Age, y 60:':10 59=11 
Previous conditions 
0-wave myocardial Infarction 6 10 
Non Q~wave myocardial Infarction 18 17 
Coronary artery bypass grafting 
Angloplasty 11 
Diabetes mellitus 10 10 
Insulin-dependent 
Hypertension 46 39 
Hypercholesterolemia 48 53 
Family history 43 33 
History of stroke 2 2 
Peripheral vascular disease 7 5 
Smoking history 
Never smoked 35 36 
Previous smoker 38 37 
Current smoker 27 27 
Stable angina 59 5.9 
Canadian cardiovascular Society classification 
1 5 5 
32 3-; 
3 19 20 
4 
Unstable angina 39 
" Braunwald classification'4 
IB 8 12 
118 24 17 
IC 4 
IIC 3 3 
Silent Ischemia e 
No. of diseased vessels 
1 91 90 
2 
3 2 
Target vessel 
Right coronary 26 3Q 
Left anterior descending 61 53 
left circumflex 13 18 
Lesion type27 
A 12 18 
81 23 26 
B2 59 51 
c 
os:% 70:':12 70=11 
Values are mean:::so or % of patients, unless otherwise indicated. 
.. Assessed by the lnvestlgator during the procedure. 
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TABLE 2. Angiography and CFR During the Procedure 
Initial OS, % 
Initial CFR 
OS before second randomization, % 
CFR before second randomization 
Lesion length, mm 
Reference diameter, mm 
Final OS, % 
Stent length, mm 
Balloon length, mm 
Final CFR 
Rrst Randomization 
PS 
97 
70:!::12 
9:!::8 
GBA 
523 
70:!::11 
1.6±0.6 
GBA 
Bailout 
129 
72:!::11 
1.6±0.6 
stent: 
Optimal 
77 
67:!:11 
1.7=0.6 
22:!:8 
3.1::::0.5 
9:'.:4 
2.78:!::0.42 
8:!::8 
15:!::4 
3.3:!::0.7 
GBA: Second Randomlzatlon 
Stent: Balloon: BallOon: 
Suboptimal Optimal SUboptimal 
112 107 86 
70::!:11 69::!:12 69:!:11 
1,5::!:0.6 1.7:!::0,6 1.4::!:0.4 
22±9 23::!:8 24::!:11 
2.0±0.4 3.1::::0.6 2.0=:0.4 
9:!::4 9::::3 9=4 
2.73:!::0.44 2.71 :!::0.47 2.62::::0.45 
7::'::8 
16:!::4 
20:!::2 20::::4 
2.4:!::0.7 
Values are mean:!::SO. PS Indicates primary stentlng; GBA, guided balloon angloplasty. 
Twelve patients were excluded from the study after the first randomization: 10 patients due to inconsistencies between randomization service and investigators, 
and 2 patients due to missing CFR values. 
loon angiopl.:lsty guided by qu::mtit:ltive ::~.ngiography :1nd Doppler 
flow velocity me::~.surements. The str:ltegy after provisional angie~ 
plasty was to limit stent impl.:lntation to bailout situations and cases 
in which an "optimal result" (DS :S35% and CFR >2.5)' 3 was not 
achievable. The second:uy objective was to evaluate the benefit 
differences from :ldditional stenting in patienl~ with and without an 
optinul result. Therefore, double randomization was required (Fig· 
ure 1). 
It would be incorrCct to estimate the costs and benefits of 
provisional angioplasty using average costs and benefits combining 
(1) patients with bailout stents, (2) patients with optimal balloon 
angioplasty. and (3) patients with stenting after a suboptimal result. 
Patients left after bailout stenting would then receive too much 
weight, because the bailout decision was made before the second 
randomization. leading to 4 groups instead of the 2 created by the 
provisional angioplasty str::ttegy. Therefore. a weighted average was 
used that weighted bailout stcnting by the probability of bailout 
stenting and stenting in patients who did not require bailout stcnting 
by the probabilities of belonging to either the optinul balloon 
%of Patients 
Figure 2. Relative role of OS and CFR in classifying patients in 
balloon angiopi.J.sty group (bailout po.tients not included). 
angioplo.sty or suboptimal angioplasty groups. Thus. the pro,·isional 
angioplasty group is a constructed or virtual group. 
Primary Stenting 
A convention:J.! guidewire was used in patients r:.mdomizcd to 
primary stenting, and predilatation was performed in all p:uients 
before stent implantation. 
Guided Balloon Angioplasty 
During guided balloon angioplasty. quantitative angiognphy and 
CFR measurements were made using standardized proto.::ols' 3· 15 to 
achieve an optimal result (criteria defined earlier in article). 
A 0.014-inch Doppler guide'-Yire (Cardiometries AoWtre. EodoSon· 
ics) was advanced distal to the lesion. and velocity recordings were 
obtained under basal and hyperemic conditions. Maxi.nul hyperemia 
was induced by adenosine, which was administered as an int:rO...-oronary 
bolus (right coronary :lrtcry, 12 }-lg: left coronary artery, 18 ;;.g) or as an 
intravenous infusion (140 }-lg· kg-• • min- 1).'t.·" These 2 mcthOOs were 
proven to be equivalent. 
If an optimal result was not achieved, the opemtor was urged to 
perform itcmtive dilatations by upsizing the balloon, increasing the 
inflation pressure, or both. Bailout stenting was allowed in the 
presence of residual stenosis >50%; dissection types D. E, or F: 
persistent myocardial ischemia with dissection type C; reduction of 
TIMI flow'x by ~ l grade; or the existence of TIMI grades 0 or l. 
The final DS and CFR were assessed after an optimal result was 
achieved or when the ope!'ltor considered further improvement 
attempts unsafe. A second randomization was then performed that 
disregarded the measurements. 
Efficacy End Points 
The efficacy end point compiled major adverse cardiac events within 
12 months of the procedure; these included death from any cause. 
nonfatal myocardial infarction. and percutaneous or surgic:ll target 
lesion rcvascularization. Myocardial infarction was defined as the 
development of a new Q-wave or a rise of serum creatinine kinases 
with an abnormal plasma concentration of myocardial isoenzymes. 
Enzymes were sampled twice in the first 24 hours. Patients visited 
the outpatient clinic 1, 6. and 12 months after hospital discharge. At 
each visit, records were kept of anginal status, cardiac medication. 
12~lead ECG, and complete physical examination. No follow~up 
angiogram was performed unless clinically indicated. 
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TABLE 3. Frequency of Primary Clinical End Polnts at 12 Months in Descending Order of Severity 
R<St 
Randomization GBA: Second Randomizatlon 
GBA Stent: Stcnt Ba11oon: Balloon: 
PS GBA Bailout Optimal Suboptimal Optimal SUboptimal 
97 523 129 77 112 107 86 
Death 2.1 1.3 0.8 2.6 0.9 0.9 2.3 
Ml 4.1 3.6 7.0 0.0 3.6 1.9 3.5 
a-wave 2.1 ,. 3.1 0.0 ,. ,. 1.2 
Non-Q-wave 2.1 1.7 3.9 0.0 1.8 0.0 2.3 
CABG 0.0 1.1 2.3 0.0 0.9 0.9 o.o 
TLPR 7.2 9.8 7.8 3.9 5.4 12.1 20.9 
MACE-free 86,6 84.1 82.2 93.5 89.3 84.1 73.3 
Any MACE 13.4 15,9 17.8 6.5 10.7 15.9 26.7 
All values except n are percent Ml Indicates myocardial Infarction; CABG, coronary artery bypass grafting; TLPR, target lesion 
percutanoous revascularisation; MACE, major adverse clinical events; PS, primary stentlng; and GSA, guided balloon angioplasty. 
Twelve patients were excluded from the study after the first randomization: 10 patients due to Inconsistencies between the 
randomization servlce and Investigators, and 2 patients due to missing CFR values. 
Costs 
Cost analysis was limited to direct medical costs, which were 
calculated as resource utilization volume X unit costs in 1999 at the 
University Hospital Rottcrdam-Dijkzigt, the Netherla.nds. 19 Re-
sources included the materials used in the initial procedure (eg, 
stents, balloons, and Doppler wires): length of stay in the intensive 
care unit, coronary care unit, or general ward; major cur:Jtivc and 
diagnostic procedures; and rehospitalization within 12 months of the 
initial procedure. Although it could be expected that a guided 
strategy would lengthen procedures, we decided not to estimate the 
cost consequences of such an action. We hypothesizl!d that the 
increased duration would not reduce the number of procedures 
possible per day: thus, the "fixed costs" would remain fixed. Also. 
the data may be biased by the time taken for a second randomization, 
thus breaking the continuity of procedures. 
Cost Effectiveness 
The balance between costs and benefits was addressed by calculating 
incremental cost-effectiveness ratios (ie, additional costs per addi-
tional event-free survivor after 1 year) and by estimating the 
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Figure 3. Event-free survival (Kaplon-Meier curves) at 12 months. 
Patients with suboptimal and optimal balloon ongioplasty were ran-
domized to additional stcnting or no further trcutment OS indi-
cates optimal stenting (n = 77); SOS, suboptimal stenting (n= 112); 
08, optimal balloon angioplasty (n=107); SOB, suboptimal balloon 
an9oplasty {n=86}; FE, Fdler's exact test and LR, log-ronk test. 
For definitions of optimal and suboptimal, see text. 
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probabilities that the provisional angioplasty was (I) more effective 
and cost saving, (2) more effective and more costly, (3) Jess effective 
and cost saving, or (4) less effective and more costly. 
Sample Size 
Assumptions for sample size calculation were based on 
BENESTENT-1. BENESTENT-2 pilot, and DEBATE I expericnc-
es.V·13 All additional benefits of stenting were attributed to patients 
with suboptimal results. With these assumptions, it was calculated 
that for the randomization scheme in Figure I, 600 patients were 
needed to detect, with SO% power, a difference (a:=0.05) of El 'R 
6SO between provisional angioplasty and primary st_enting in cost-
effectiveness per survivor (no major adverse cardiac event) after I 
year.~c 
Statistical Analysis 
Continuous variables arc expressed as mcans±SD. Differences 
between patient groups were studied using Student's unpaired t test 
or 1-way ANOV A, whichever was appropriate, Categorical variables 
arc presented as percentages, and differences between groups were 
evaluated using Fisher's exact test. Kaplan-Meier event-free survival 
curves were calculated, and differences between patient &roups were 
compared by a Jog-rank test. 
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Figure 4. Event-free survival (Kaplan-Meier curves) at 12 
months 'tn patients who had primal)' stenting (PRIM; n=97) or 
provisional angioplasty (PROV; n=523), 
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TABLE 4. Costs and Event~Free Survival After 12 Months 
Unit Cost per Optimal Optimal Sulxlptlmal Suboptimal 
Patient, € PS PA" stenting Balloon stentlng Balloon 
"'"'"' No. of patients 97 523 77 107 112 86 129 
Procedure and initial 
hospitalization 
Axed procedure costs, € 1167 1167 1167 1167 1167 1167 1167 
Resource use, Unit per 
patient 
Guiding catheter 82 1.20 1.20 1.19 1.24 1.21 1.14 1.13 
Guldewire 95 1.03 0.55 0.40 0.42 0.56 0.44 0.70 
AoWire 483 0.26 1.09 1.12 1.11 1.07 1.07 1.07 
Balloon 368 1.52 1.55 1.52 1.27 1.67 U1 1.78 
Mounted stent 817 0~8 0.41 0.57 O.Q4 0.49 0,07 0.82 
Nonmounted stent 454 0.56 0.37 0.49 O.Q4 0.60 0,05 0.49 
Reoperation 1021 0.02 0.03 0.04 0.01 0.04 0.03 0.05 
lVUS catheter 545 0.05 0.04 0.03 0,02 0.06 0.09 0.05 
Contrast medium, ml 249 284 333 253 301 307 307 
CCU days 856 058 0.62 0.53 0.49 0.58 0.84 0.86 
ICU days 941 0.00 0.01 0.00 0.00 0.00 0.03 0.05 
Non-CCUJ1CU days 305 3.36 2.76 2.43 2.27 3.06 2.40 3.00 
Follow-up, Unit per patient 
Second Interventions 2800 0.16 0.16 0.12 0.19 0.15 0.22 0.15 
CABG 8622 0.00 0.02 0.00 0.01 0.01 O.Q1 0.05 
Recatheterization 1934 020 0.23 0.27 0.21 0.27 0.31 0.22 
Vascular surgery 1157 0.00 0.01 0.00 0.00 0.00 0.00 0.02 
CCU days 856 0.22 0.21 0.09 0.18 0.15 0.40 0.35 
ICU days 941 0.00 0.03 0.00 0.03 0.02 0.01 0.05 
Non-GCU/1CU days 305 1.38 2.62 0.82 2.55 2.72 2.11 2.56 
Costs of Initial hospitalization, € 4456 4486 4493 3606 4769 4084 5305 
Costs of follow-up, € 1420 2055 1139 1927 1995 2352 2330 
Total cost, € 5885 6573 5632 5533 6764 6519 7763 
Event-free survival, % 86.6 85.6 93.5 84.1 89.3 73.3 82.2 
CCU Indicates coronary care unit; ICU, Intensive care unit; CABG, coronary artery bypass grafting; PS, primary stenting; and PA, provisional angtoplasty. 
~costs and effects of the provisional angioplasty group were assessed by calculating a weighted average. 
Because the costs and benefits of provisional angiopl:l:,;ty were 
calculated as weighted averages. bootstrapping techniques were used 
to evaluate differences in the balance between costs and benefits 
after primary stcnting and provisional angioplasty.::t,ll A total of 
3000 bootstrap samples were drawn iteratively, with replacement 
when s:unple sizes equalled the total number of patients studied. 
Odds ratios and 95% confidence intervals are presented: a Breslow-
Day test for homogeneity of odds ratios between subgroups and K 
tests were also applied. 
Statistical tests were 2-tailed, with significance stated at the 0.05 
leveL Uncertainties surrounding cost, benefits, and cost-
effectiveness were addressed by probability ellipses in the "cost-
effectiveness plane.»::1 
Results 
Patient Characteristics 
Baseline characteristics of the patients in this trial are 
presented in Table 1. There were no significant differences 
between patients allocated to primary stenting and to guided 
balloon angioplasty. Of the 523 patients randomized to 
guided balloon angioplasty, 129 (25%) underwent bailout 
stenting at the time of initial dilatation (n=103) or during the 
optimization process (n = 26). Of the remaining 394 patients. 
382 undcnvcnt the second randomization. Twelve were not 
subrandomized for technical and logistical reasons. 
Procedural Results 
Table 2 summarizes the procedural results, and Figure 2 
shows the relative roles of DS and CFR in classifying 
patients. Optirn:l.l. results, with an average DS of 22:::!:::8% and 
a CFR of 3.1 :::!:::0.6, were achieved in 35% of patients. In the 
suboptimal group, OS was 23:::!:::10% and CPR was 2.0:::!:::0.4. 
Additional stcnting in patients with optimal balloon angio-
plasty resulted in a OS of 8:::!:::8% and a CFR of 3.3:::!:::0.7; in 
patients with suboptimal balloon angioplasty, additiooal 
stenting resulted in a DS of 7:::!:::8% but a CPR of 2.4::!::0.7. 
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Figure 5. Incremento! cost-effectiveness of provisionol angio-
plosty vs primory stonting. Outer ellipse defines smollest orca 
(95% probobility) contoining incremento! costs ond effectiveness 
of provisionol angioplosty com pored with primory stcnting. Mid-
dle ond inner ellipses define smollest areos (50% and 5% prob-
abilities, respectively). Center of ellipse represents point esti-
mate of incremental costs ond effects. Prob indico.tes estimoted 
probobility that cost ond effect oro in respective quodront; 
MACE, mojor odverse cordioc events. 
Primary Stenting Versus Provisional Angioplasty 
Table: 3 shows the incidence of major adverse cardiac events 
in both the initial groups and the 4 subgroups, ranked in 
hierarchical order. In general. patients with optimal results 
experienced fewer major adverse cardiac events than patients 
with suboptimal results, and stcntcd patients fared better than 
those undergoing balloon angioplasty alone (Figure 3). 
Freedom from these events. which were calculated as 
weighted averages, was similar for patients undergoing pri-
mary stenting (86.6%) and provisional angiopl:J.Sty (85.6%) 
(Figure 4). The weight for patients needing bailout stcnting 
was 129/(129+107+112+86-!-77) or 25.2%; the weight for 
patients stented after a suboptimal result was 3S.7% (calcu~ 
latcd as the probability of not needing a bailout stent 
[100.0o/o-25.2%=74.S%] multiplied by the probability of a 
suboptimal. result {[112+86]/[77+ 107+ 112+86]=51.8% }); 
and the weight for patients with a stcnt after an optimal result 
was 36.0% (calculated as the probability of not needing a 
bailout stcnt [74.S%J multiplied by the probability of an 
optimal result [1 00%-51.8%=4S.2%J). 
Table 4 presents cost estimates for the 2 initial groups and 
4 subgroups. The cost of Flo Wire in the initial procedure was 
only partially covered by the lower stent usc. Costs for the 
provisional angioplasty group during follow~up were higher 
due to longer hospitalizations and surgical rcvascularization. 
After 1 year, the costs of provisional angioplasty outweighed 
those of direct stenting by EUR 6S8. Figure 5 presents the 
estimates of costs, benefits, and cost effectiveness. The point 
estimate of the incremental cost-effectiveness ratio suggests 
that provisional angioplasty is less effective and more 
expensive. 
Stenting Versus Balloon Angioplasty After the 
Second Randomization 
The analysis of subrandomized patients in the balloon angio~ 
plasty group (Figure 6) indicates that stcnting was associated 
with fewer major adverse cardiac events than balloon angio~ 
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2.71 
2.65 
Alll'aticnt> 
0 2 3 4 • 7 • 
Balluon bettor Stent~ttcr 
Rgurc 6. Relotive risk ro.tios at 12 months for potients with sub-
optim;:~l or optimal b;:~lloon ongioplosty who survived event-fre€ 
ond were ~ndomized to additioml stenting or no further treat~ 
mont. Bors indicate 95% confidence intervols. 
plasty alone in both patients with suboptimal (10.7% versus 
26.7%~ odds ratio. 3.0: ?=0.005) and optimal results (6.5% 
versus 15.9%: odds ratio, 2.7; ?=0.066). The Breslow-Day 
test for homogeneity of odds ratios was not significant 
(?=0.865). The higher cumulative costs of balloon angio-
plasty alone during the follow-up period almost matched the 
high initial costs of balloon angioplasty followed by steming. 
Discussion 
The main result of this study was a lack of significant 
difference between clinical outcomes when comparing pri-
mary stcnting and provisional balloon angioplasty. Ho ... vc ... ·er. 
with the current unit costs of Flo Wire and stents, a strategy of 
provisional angioplasty is more costly than primary stcnting. 
Relevance and Critical Appraisal of 
Cost-Effectiveness Analysis 
Cost considerations dominate many decisions about therape-u-
tic interventions and arc very relevant from a societal view-
point. As emphasized in the literature. an independent person 
without commercial affiliations must analyze cost-
effectiveness in such studies to avoid financial bias.~ How-
ever, cost-effectiveness analyses arc limited by multiple 
factors. First, cost data arc transient and arc affected by 
product acceptance, market dynamics. and reimbursement 
systems. Second, changing patterns of practice affect the 
selection of treatment devices, how they arc used, and OYcrall 
procedure time. Thus, the costs used here represent only a 
snapshot in time. For example, direct stcnting without predi-
latation (an increasingly used technique) will undoubtedly 
affect cost-effectiveness in the future. but this method of 
treatment was not applied here. 
Two crucial factors in the present study exerted a major 
influence on overall costs: the costs of Flo Wire and those of 
stcnting. When the study was designed. its power calculation 
was based on market prices in 1996 and the cost estimates 
related to bleeding complications and the longer hospital 
stays associated with stcnting. The reported cost estimates 
were based on unit costs in 1999 (costs of primary stcnting 
versus provisional angioplasty. EUR 5916 versus EUR 6724; 
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?=0.029). However, an application of 1996 unit costs does 
not change the conclusion. The absence of expected differ-
ences is mainly because in the year 2000. stcnting is no longer 
associated with bleeding complications and longer hospital 
stays. whereas the bailout rate with the balloon angioplasty 
group has increased from 15% to 25%. 
Moreover, we did not take into account differences in 
procedure time. The time for guided angioplasty in the 
present study was 26 minutes longer (mean) than that of 
stcnting, which further tipped the cost-effectiveness balance 
in favor of primary stcnting. 
The Additional Value of Stenting After Optimal 
Angioplasty: A Flow~Mediated Phenomenon? 
An unexpected observation in this study was a further 
reduction in the rate of major adverse cardiac events in 
patients stented after optimal balloon angioplasty. This ob-
servation was made possible by the trial" s double randomiza-
tion design. On the basis of stent-likc angioplasty results in 
other trials.9•13•24 we had hypothesized no such additional 
benefits. However, the perceived benefits of additional stcnt-
ing may have resulted from a selection process that ignored 
the outcome of patients with unsatisfactory or complicated 
balloon angioplasty (ic, bailout and suboptimal groups). 
Although a similar OS was achieved in all patients stcntcd 
after angioplasty (7%), a diminished CFR persisted after 
stcnting in the suboptimal group (2.4) compared with the 
optimal group (3.3). Fewer major cardiac events were ob-
served in the latter group (10.7% versus 6.5%). Further 
investigations arc needed to fully understand the underlying 
mechanisms. 
Clinical Relevance of the Findings of This Study 
The present study failed to demonstrate a favorable economic 
profile for provisional angioplasty (guided by quantitative 
angiography and Doppler flow velocity measurements) com-
pared with primary stenting. Indeed. although there was no 
significant difference in clinical effectiveness. the data 
pointed to higher costs with provisional angioplasty. Thus, 
the current data do not provide economic arguments to switch 
from primary stenting. even though clinical benefits result 
when stenting follows optimal balloon angioplasty. A limita-
tion of our study was the inclusion of patients with only a 
single. relatively short lesion. However. it would seem from 
a literature survey that the patients studied represented 
possibly up to 70% of patients presently treated by percuta-
neous techniques worldwide.::.:;,::~; 
Appendix 
Study Investigators, Their Location, and Number 
of Patients Treated 
The Netherlands: P.W. Serruys, M.v.d. Brand, S.G. Cartier, P. de 
Fcytcr, D. Foley. W.v.d. Gicsscn, J. H:1mburger (n::=67); J.J. Pick. 
F.v.d. W:l.l (n==36); N.H.J. Pijls, J.P.M. van Asseldonk (n::=20); 
V.A.W.M. U~mns (n=l3): G.J. La.:uman, F. Kicmcncij (n=l3); 
Belgium: B. de Bruync, W. Wijns. G.R. Hcyndrickx (n==60): C. Vrints 
(n=29); 0. GumC (n=24): C. Hanet. N. Dcbbas. D. Huyberechts 
(n= 13): Brazil: J.E. Sousa. I. Pinto. L Mattos, A. Chaves. A. Abiz:lld, 
A. Sousa (n=43); Japm: T. Muramatu (n=32); K. Kurogane (n=5); S. 
Mizuno (n""3): Austria: P. Probst, G. Porenta. (n=28); Porwgal: R 
Scabra-Gomcs, J. Baptista. J.L. Palos, F.P. Machado (n==:28): l'nitcd 
Kingdom: I.A. Simpson, K.D. Dawkins. H.H. Gray (n=28); P..M. 
Schofield (n=l4); C. l!s!cy, M. Mason. M. Bustami (n"'l3): K.G. 
Oldroyd (n=4): Greece: V. Voudris. J. M:l.bkos. D.Y. Cokkinos 
(n=27); Argcntinx J. Belardi. L Guzmin. Ruben Piraino, F. Cura 
(n=l7): France: J.-L.Gucnnonprez. F. Lcdru (n=l5); P. Dupouy 
(n=7); M. Bory (n=4); J. Puc! (n=3); F. Tmag:mo (n::=2); Italy: E. 
Vema (n"'13); Gerrrony: A.W. Frey, A. Grove. A. Henning. V. 
Bassigm.na (n""l2); E. Fleck. E. Wellnhofcr (n=ll); R. Simoo.. M. 
Lins. P. Papechrysanthou (n=lO); lsr:l.el: R Bcyar, M. K3pcJ:io,ich 
(n=IO); M.S. Gotsrmn, M Mosscri (n=4); Denmark: P. Thayssen 
(n=7); Czech Republic: P. WidimsJ..:y (n=5). 
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Editorial 
Provisional Versus Routine Stenting 
Routine Stenting Is Here To Stay 
H. Vernon Anderson, MD; Blase A. Carabello, MD 
The introduction of coronary artery stents into wide-spread clinical usc in the mid-l990s was a significant advance that almost rivals the introduction of balloon 
angioplasty itself 15 years earlier. It is noteworthy that the 
success of stcnts required several paradigm shifts. For exam-
ple, higher-pressure balloon inflations and slight oversi7ing 
were needed to achieve full stcnt expansion (anathema in 
balloon angiop!asty), and anti platelet therapies were required 
rather than anticoagulation, including a reduction and now 
almost elimination of heparin. Yet, these changes were 
quickly accomplished. Technical advances in equipment also 
occurred, and now stcnting. quite literally, has become the 
stand:ll'd in clinical practice when it can be performed (which 
is most of the time). 
See p 2930, 2938, and 2945 
One curious and intriguing question that arises with any 
new device. and stcnts :ll'e no exception, is whether they arc 
needed in all situations where they arc being used. Is it 
possible that balloon angioplasty alone might be sufficient for 
excellent immediate and long~term benefit, provided the final 
procedural result is good enough? If one could determine this 
to be true, then such a strategy would avoid the additional 
cost of a stcnt and the problem (or pscudo~problcm) of 
in~stcnt restenosis. However, a provisional stent strategy 
raises the further and not .inconsiderable question of how to 
decide when balloon angioplasty results arc ··good enough." 
The limitations of standard angiography notwithstanding. is 
there anything better than the eyes and minds of experienced 
angiographers? Additional "objective" measures to assess 
procedural results have long been sought. A number of 
investigators have championed intracoronary ultrasound as 
one approach, whereas others suggest alternative methods. 
In this issue of Circulation, 2 separate groups report their 
findings using combined anatomic and functional coronary 
measures to assess balloon angioplasty results for the purpose 
of provisional stenting.L2 These measures arc on~line quan~ 
titative coronary arteriography (QCA) and coronary flow 
reserve (CFR) measured with a Doppler wire. In addition, as 
a worthy companion to these 2 reports on provisional stent~ 
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ing. this issue also contains a report from a l:ll'gc-scalc clinical 
registry. the National Heart, Lung, and Blood Institute 
(NHLBI) Registry,J detailing the substantial improvements in 
the outcomes of coronary interventions in the years 1985/ 
1986 through 1997/1998, during which time coronary stems 
were introduced. We offer some analysis. interpretation. and 
opinions on these reports. 
The NHLBI Dynamic Registry 
First established in 1979 at the dawn of coronary angioplasry. 
the NHLBI Registry has been a continuing source of valuable 
information tlrrough the years. The data reported by Williams 
et al3 compare the in-hospital and l~ycar outcomes in patients 
treated in I997/l998, which include those treated with stcnts. 
with the outcomes of patients treated in l985/I986, before 
stents were used. Let us begin with the in-hospital outcomes. 
The Registry report documents dramatic reductions in the 
frequencies of adverse events occurring during index hospi~ 
talization for coronary intervention. The frequency of the 
combined triple end point of death, myocardial infarction. or 
coronary bypass surgery (CABG) fell from 9.8% in 1985/ 
1986 to 5.9% in 199711998. This decline was due entirely to 
reductions in myoc:ll'dial infarction (from 4.9% to 2.8%) and 
especially CABG (from 6% to 1.5%). because in~hospital 
mortality was unchanged (l.4% versus 1.9%). The frequency 
of stcnt usage in the 199711998 Dynamic Registry was 70'K: 
no stcnts were used in 1985/1986. 
These findings arc consistent with other recent, l:ll'gc-scale 
reports and deserve brief elaboration here. Using Medicare 
data from 1994 and 1996. Ritchie et al4 found in patients 
without acute myocardial infarction that the frequency of 
same-admission CABG was cut in half after the introduction 
of coronary stents. In patients with acute myocardial infarc-
tion, the difference was even greater. Similarly, Hannan ct 
al,s using the New York State Coronary Angioplasty Regis-
try, found that stents reduced the frequency of same-
admission CABG at hospitals in New York by more than 
onc~third but did not change in-hospital mortality. 
If the data from these 3 large reports,:>-5 representing 
293 000 patients. are combined. the introduction of stents 
reduced the already low CABG rates of the mid-I990s by 
50% (from 2.55% to 1.26%) and the in-hospital mortality 
rates by 15% (from 1.28% to 1.08%). These are impressive 
numbers. Practicing intcrvcntionalists and clinicians have 
many anecdotes that reinforce these statistics. Clearly, the 
widespread use of stents has favorably influenced early 
outcomes. The mechanisms for this benefit relate to the 
stent's ability to prevent or treat threatening dissections and 
abrupt closures. These are the most conunon causes of failed 
balloon angioplasty leading to urgent bypass operations and 
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TABLE 1. Routine and Provisional Stenting in 4 Trials 
Routine Stenting Provisional Stenting 
FROST OEST!NJ DEBATE· II OPUS·1 FROST DESTIN I DEBATE~ll O?US·1 
No. of patients 125 370 97 230 126 365 523 249 
Women,% 17 25 28 25 19 27 27 28 
Diabetics, % 18 18 10 18 13 19 10 18 
Unstable angina, % 67 46 39 72 62 52 34 69 
LAD lesion, % 56 41 61 32 43 38 53 33 
Type C lesion, % 66" 56! 65! 68. sot 57! 
Lesion length, mm, mean 9.7 12.7 9 10 10.0 12.7 10 
Refewnce diameter, mm, mean 3.07 3.09 2.6-2.8 3.32 3.09 3.03 3.34 
Flnal MLO, mm, mean 2.64 2.92 2.50 2.29/2,87+ 
Final stenosis, %, mean 13.8 9~ 9 18.8 24.8/10.2+ 9 
End points 
Interval, mo 6 12 12 6 12 12 6 
Event (frequency) Angiographlc TLR TLR TLR Anglographic TLR TLR TLR 
restenosls (14.9%) (7.2%)# (5.2%}# restenosls (15.6%) (10.9%)# (14.9%}# 
(21.4%) (27.1%) 
MACE MACE MACE MACE MACE MACE 
(17.8%) (13.4%) (6.1%) (18.9%) (15.9%) (14.9%) 
LAD Indicates left anterior descending coronary artery; MLO, minimum lumen diameter. 
*B or C. 
tB2 or C. 
:t:Values for nonstented group/stent~ group. 
#Percutaneous coronary Intervention and CABG. 
deaths. In addition to these immediate benefits, the initial 
reports of 6~month and l~ycar outcomes with coronary stents 
were favorable. and these also contributed to the eagerness of 
stent adoption. However, keen observers during these years 
noted that when balloon angioplasty results were good 
("stcnt~likc"), then both short~ and long~tcrm outcomes were 
favorable. Provisionalists used this to urge a cautious ap~ 
proach to stenting: if balloon angioplasty results were good 
enough. then stop: if they were not good enough. then stent. 
Provisional Stenting 
DiMario ct al,1 for the Doppler End Point Stcnting Intema~ 
tiona! Investigation (DESTIN!) study group, report no benefit 
at I year with a provisional compared with a routine stenting 
approach. Serruys et al.~ for the second Doppler End Points 
Balloon Angioplasty Trial Europe (DEBATE~II) investiga~ 
tors, report that provisional stcnting has less favorable 1-ycar 
outcomes and is more expensive than routine stcnting. These 
2 new reports closely parallel another recent report on 
provisional stcnting by LaFont et al6 for the French Random~ 
izcd Optimal Stcnting Trial (FROST) study group. Taken 
together, these 3 studies constitute a uniform approach to 
provisional stcnting: they use similar technologies (on~linc 
QCA and Doppler CFR) and nearly identical definitions. In 
FROST, optimal balloon angioplasty that would not require a 
stent was defined as a final diameter stenosis <35% by QCA 
and a CFR >2.2. In DESTIN!, the definition of an optimal 
result was a final diameter stenosis <35% and a CFR >2.0, 
and in DEBATE~II, it was a final diameter stenosis <35% 
and a CFR >2.5. Table I lists some of the important clinical 
features of patients enrolled in these 3 provisional stcnting 
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studies and the reported outcomes. For additional compari~ 
son. we also included data from another recent provisional 
stcnting trial, the Optimum Percutaneous Tmnsluminal Cor~ 
onary Angioplasty Compared With Routine Stem Strategy 
Trial (OPUS~l),7 
In FROST, the study end point was angiographic rcstcnosis 
at 6 months. This occurred in 21.4% of the routinely stented 
group and in 27.1% of the provisionally stentcd group 
(?=0.37). Importantly, 48.4% (61 of 126) of the pro\isional 
patients required stcnts. In DESTINI and DEBA TE~II. the 
cnd points were 12~month clinical outcomes. as determined 
by a combination of major adverse cardiovascular events 
(MACE). Target lesion rcvaseularization (TLR) was also 
important. Overall in both DESTIN! and DEBA TE~II. the 
frequencies of TLR ranged from 7% to 16%, and the 
frequencies of MACE ranged from 13% to 19%. In OPUS~ I. 
clinical outcomes were obtained at a shorter, 6~month follow~ 
up, and both TLR and MACE were significantly less frequent 
in the routine stcnt group compared with the provisional stcnt 
group (5.2% versus 14.9% for TLR and 6.1% versus 14.9% 
for MACE: both P<O.Ol). The clinical event rates, as 
expected. arc somewhat lower than the angiographic rcstcno~ 
sis rates found in FROST. Of interest, all event rates in the 4 
studies are uniformly lower in the routine compared v.;th the 
provisional stcnt groups. Furthermore, a quick calculation 
reveals that the primary end points of either ang:iog:raphic 
rcstenosis or MACE occurred in 14.5% (liS of 813) of 
routinely stentcd patients in these 4 studies and was more 
frequent (17.6%; 221 of 1254) in provisionally stented 
patients (2~sided ?=0.062). 
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TABLE 2. Use of Stents in Provisional Arms of 3 Trials 
Lesions Criteria Justifying Provisional Stent % of Stents Recctvcd 
Randomized to Lesions 
Provisional Receiving Diameter Doppler Both Diameter 
Trial A<m," stents, n Bailout Stenosis CFR am! Doppler 
FROST 126 61 28 18 33 21 
DESTIN! 384 218 11 10 35 44 
DEBATE-II 511 241~ 25 4.5 51! 52! 
Total 1021 520 
•includes only stents deployed for bailout purposes or suboptimal results. 
tNot mutually exclusive. 
The small differences in angiographic and ctinicnl out-
comes between these 4 studies might easily be explained both 
by lhc slightly different criteria for success (in terms of CFR. 
where it was used) and the slightly different clinical charac-
teristics of the patients. Overall, there is a sense of harmony 
in almost all respects in these 4 studies. The randomized 
lesions were short (=9 to 12 nun) and were located in 
medium-to-large arteries (=2.6 to 3.3 nun). The left anterior 
descending coronary artery may have been somewhat under-
represented in the provisionally stented groups. The OPUS-I 
and DEBATE-II trials arc the only 2 with economic analyses. 
and both conclude that a provisional stenting strategy is more 
expensive than routine stenting. 
Frequency of Stenting in Provisional Arms 
The important point about these provisional stcnt trials is this: 
stenting was exceedingly common. even in these large and 
sophisticated centers seeking to avoid it. Table 2 lists the 
frequency of stcnt deployment in the provisional arms of 
FROST. DESTINI. and DEBATE-II. which used similar 
methodologies for decision-making. Overall. stents were 
needed for 520 of 1021 lesions (51%). which is more than 
half of the provisional lesions treated. In OPUS-1. stents were 
used in 37% of the 249 lesions randomly assigned to a 
provisional strategy. The proportions of stents deployed 
according to the specific provisional criteria arc also listed in 
Table 2. Often (ll% to 2S% of lesions), a stent was used for 
a "bailout" condition. which was defined as either threatening 
dissection or abrupt closure. Furthermore, it is apparent that a 
failure to meet angiographic diameter stenosis criteria alone 
was not that frequent (only ""'5% to IS% of lesions stented): 
CFR criteria accounted for most of the provisionally stcnted 
lesions. In other words. in these situations, the operators were 
happy with the angiographic results and no threatening 
dissections were seen, but the CFR criteria were less than 
desired. The physiological and clinical meaning of this is 
presently unknown. 
An evaluation of the immediate results of balloon angio-
plasty and stcnting by anything other than standard angiog-
raphy (meaning the eyes and minds of experienced operators) 
is not yet fully understood and accepted. The only technique 
that comes close is intravascular ultrasound, and its role has 
mainly been to confirm full stent expansion. Only recently 
have studies comparing variouS methodologies, including 
on-line QCA, fractional flow reserve using a pressure wire, 
intravascular ultrasound, and CFR using a Doppler wire, 
begun to appcar.s-13 Very importantly. these technologies arc 
not widely available. and there is as yet little agreemenL even 
among the cognoscenti (like us) who use them occasionally. 
The desire to avoid stcnting even an acceptable b:llloon 
angioplasty result on the basis of its having a good CFR result 
seems unwarranted at this time. Whether or not a stem can 
actually be placed technically is another matter. 
Optimal and Suboptimal Results 
The DEBATE-II investigators included a second randomiza-
tion in their trial; it yielded some new insights on the meaning 
of good results and raised new questions. After excluding the 
129 patients that required stents for bailout situations. they 
were left with 382 patients that either met the criteria for 
optimal balloon angioplasty or had suboptimal results but no 
threatening dissections or closures. These 382 patients were 
then randomly assigned either to required stenting or w no 
further treatments. This created 4 subgroups, 2 of which are 
very interesting: a group with "optimal" balloon angioplasty 
that was stcntcd anyway and a group with "suboptimal"' 
balloon angioplasty (but no threatening dissections) that 
received no further treatment. This last group would have 
received a mandated stent in the FROST or DESTI::--.'1 trials. 
Table 3 lists the clinical outcomes of these 2 interesting 
groups from DEBATE-II along with the outcomes of the 
bailout stcnt group from DEBATE-II and parallel groups 
from DESTIN!. For the patients in DESTINI and DEBATE-II 
with optimal balloon angioplasty and no stents (ie. acceptable 
results with balloon angioplasty alone), the rates of TLR 
(17.6% and 13%, respectively) and MACE (20.l'K and 
15.9%, respectively) were similarly good. However. for the 
77 patients in DEBATE-II with optimal balloon angioplasty 
that were stcnted anyway (achieving a final mean diameter 
stenosis of 8%), the rates were significantly better: only 3.9% 
underwent TLR and only 6.5% experienced MACE. Unac-
ceptable results with balloon angioplasty alone are also 
revealing. In DESTIN!. the provisional stent arm had a TLR 
rate of 14.1% and a MACE rate of 18.0%. The equivalent 
groups in DEBATE-II would be the suboptimal balloon 
angioplasty group that was stcnted and the bailout group. 
Interestingly, both had TLR and MACE rates lower th:m the 
rates in DESTIN!. Finally, there were 86 patients in 
DEBATE-II with suboptimal results after balloon angioplasty 
(again. mostly on the basis of CFR criteria, because the final 
diameter stenosis was no different from that of the optimal 
balloon angioplasty group). These patients received no fur-
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TABLE 3. Treatment of Patients With Optimal and Suboptimal Results and 1-Year Outcomes 
Acceptable Results With BA 
DEBATE-II, DEBATE-II, 
Optimal Optimal 
DESTIN I, BA and No BA With 
Optimal BA Stcnt Stent 
No. of patients 159 107 77 
Final OS, %, mean 24.8 23 
TLR,% 17.6 13.0 3.9 
MACE,% 20.1 15.9 6~ 
BA indicates balloon angioplasty; OS, diameter stenosis. 
thcr treatments, and they had the highest event rates of all: 
20.9% required TLR and 26.7% experienced MACE. 
Re-examining these numbers leads to the conclusion that 
stcnting after optimal baJloon angioplasty is best (MACE rate 
of 6.5%), optimal balloon angioplasty without a stcnt or 
suboptimal balloon angioplasty with a stent is next best 
(MACE rate of 11% to 20%), and suboptimal balloon 
angioplasty with no stcnt is the worst (MACE rate of 27%). 
This clearly means that when a stent cannot be used (for 
whatever reason), achieving an optimal balloon angioplasty 
result is the next best thing. We all know and accept this. But 
why should scenting a patient who has an optimal balloon 
angioplasty result produce a more favorable Iong-tcnn out-
come than leaving well enough alone? The answer to this 
goes right to the core of whatever it is that stcnts do, whether 
that means mechanically supporting small and invisible 
dissections, preventing bte clastic recoil. or somehow alter-
ing the biological course ofrcstcnosis. Using a stent to obtain 
a large. smooth (some would say "cosmetically pleasing") 
lumen visualized by standard angiography to the satisfaction 
of the operator seems to provide the best results yet nchicvcd. 
Long~ Term Outcomes 
A final perspective on the long-term benefits of stcnting in 
the real world comes from a reconsideration of the NHLBI 
Dynamic Registry that we started with, along with the 
prcvlousJ y mentioned New York State Rcgistry5 and a recent 
study from the British Columbia Cardiac Registries in Can-
ada.14 Table 4 lists the odds ratios for the long~tcnn benefits 
of stcnting compared with balloon angioplasty for each of 
these 3 reports. Both the Canadian and New York State 
Registries noted significant long-term benefits with stcnting. 
In the Dynamic Registry, the 1-ycar outcomes of the 1997/ 
TABLE 4. Long-Term Outcomes of Stenting and Balloon 
Angioplasty in 3 Studies 
Canadian New York state NHLBJ Dynamic 
Reglstry Registry Registry 
No. of patients 9594 19 792 3990 
Follow-up Interval 1 year 2 years 
1 '"' Odds ratio for 
Death 1.14 0.78 0.9 
TLR 0.72 0.65 0.6 
Favors stem stem stent era 
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Unacceptable Results With 8A 
DEBATE-II, OESTINI, DEBATE-II, 
Suboptimal BA Provisional DEBATE-II, Suboptimal 8A and 
With stent stent Bailout Stent No stent 
112 206 129 86 
7 10.2 24 
6.3 14.1 10.1 20.9 
10.7 18.0 17.8 26.7 
1998 collection (stcnt era) were significantly better than those 
in the 1985/1986 collection, Admittedly. these arc retrospec-
tive data. However, the studies are methodologically sound. 
and the results arc consistent. The routine usc of coronary 
stcnts is associated with improved clinical outcomes at 1 to 2 
years compared with performing conventional balloon 
angioplasty. 
Limits of Technology 
The reasons why provisional stenting has not become com-
mon, and likely never will, are 4-fold. First, the proven results 
of routine stenting arc excellent. Second, a large number 
(-50%) of the lesions where stents ntight wish to be avoided 
under a provisional strategy must be stented anyway. Third. 
the technology required to undertake provisional stenting is 
uncommon, and its applicability is unclear. This docs not 
mean that intravascular ultmsound, QCA. and Doppler arc 
not useful. They clearly can be valuable on an individualized 
basis. However, for the purpose of deciding whether to stenL 
nt the present time and for the foreseeable future, they have 
not yet been proven to add anything of value to the eyes of 
experienced angiographers. Finally, 2 current studies indicate 
that routine stcnting is less costly than provisional stcnting. 
The increased procedure time required to usc the additional 
technology and the greater numbers of repeat procedures in 
the provisional strategy probably account for this. Given the 
dramatic reductions in adverse clinical events that stcnts have 
brought about, the indications that long-term stent results arc 
more favorable than balloon angloplasty, the high percentage 
of provisional strategy patients that ultimately receive stcnts.. 
and the reportedly favorable cconontics of routine compa.red 
with provisional stcnting, it is fair to say that routine stenting 
wins. 
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Chapter 5 
In vitro study of FFR, QCA and IVUS 
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In Vitro Study of FFR, QCA, and IVUS for the 
Assessment of Optimal Stent Deployment 
K. Matthys, MSc,i* s. earlier, MD,2 P. Segers, MSc, Phd,1 J. Ligthart, BSc/ G. Sianos, M0,2 
P. Serrano, Mo,2 P. Verdonck, MSc, Pho,1 and P.W. Serruys, MD, Pho2 
We tested whether fractional flow reserve (FFR) discriminates between suboptimally and 
optimally deployed stents. Latex tubes (4 mm in diameter) with stenosis 40% (n=3), 50% 
(n = 3) and 60% (n = 3) were tested in a pulsatile flow system, using water. Measurements 
were done at baseline (n = 9; FFR!QCA) and after suboptimal (SOD; 3~mm balloon at 8 
atm) and optimal (OD; 4 mm balloon at 16 atm) deployment of a 35~mm stent (n = 6; 
FFRIQCAIIVUS). Varying Q from 150 to 50 ml/min increased FFR by 2-7%. Conversely, at 
100 ml/min, FFR increased by only 0.8% from SOD to OD (P < 0.05). Extrapolating data to 
blood flow, the gain in FFR from SOD to 00 is less than 5% for Q = 100 ml/min, while FFR 
may increase by 15-20% by changes in blood flow from 50 to 150 ml/min. We conclude 
that IVUS and QCA are more appropriate for the assessment of optimal stent deployment. 
Cathet Cardiovasc lntervent 2001;54."()(}()-000. '" wo1 Wll(!y.Uss. Inc. 
Key words: flow reserve; intravascular ultrasound; angiography; suboptimal stent de~ 
ployment 
INTRODUCTION 
Fractional flow reserve (FFR) is defined as the ratio of 
myocardial flow in a stenosed coronary segment during 
hyperemia (Q) to hyperemic flow through the same seg-
ment in the hypothetical case that there is no stenosis 
present (Q'') [1.2]. Pijls et al. [3] and De Bruync et al. [4] 
have shown that FFR can be obtained from pressure 
measurements proximal and distal to the stenosis only 
and that it assesses the physiologic significance of a 
coronary stenosis [5]. The pressure~based FFR is easily 
measured during transluminal interventions and normal 
and cutoff values have unequivocally been detennined 
[6.7]. 
The availability of ultrathin pressure wires, permitting 
accurate pre~ and poststenotic pressure measurements, 
has increased the use of FFR in clinical practice. Xever-
thcless, FFR has some important limitations. as FFR is 
detennined by the pressure drop over the lesion. First. 
this pressure drop is function of flow. FFR is thus by 
definition sensitive to the flow level in the coronary 
artery. Myocardial infarction may have a large impact on 
maximally recruitable flow during hyperemia and. con-
sequently. on the calculated values of FFR. Second. FFR 
has been proposed as a valuable tool to assess optimal 
stcnt deployment during intervention [8]. This implies 
that the difference in pressure drop over a sub~ and 
optimally deployed stent is large enough to allow dis-
crimination between both situations. 
In this study. we usc an in vitro setup to address both 
raised concerns regarding FFR. (1) testing the flow de-
D 2001 Wiley~Liss. Inc. 
pendency of FFR. and (2) investigating whether FFR is 
able to discriminate between suboptimally and optimally 
deployed stents. 
METHODS 
Concept of FFR 
The simplified model of the coronary circulation as 
proposed by Pijls and De Bruyne and their coworkers 
consists of a resistance representing the stenosis (R,) 
placed in series with the myocardial resistance R (Fig. 1, 
top). Pressure drops along these resistances are defined 
as: 
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where P., stands for mean aortic pressure. Pu for mean 
distal coronary pressure. and Pv for mean central venous 
pressure. P.,. Pd. and Pv need to be measured during 
maximal coronary hyperemia when myocardial resis-
tance is minimal and assumed to be constant [6]. This 
condition is imperative for the calculation of flow in the 
model of Pijls-De Bruyne. as. in the case of constant 
myocardial resistance. flow is directly proponional to the 
pressure drop causing the flow movement. Maximal 
myocardial flow (Q) can then be written as: 
O = !:::.? "'yocur<iium Pd - P,. 
- R R 
In the absence of a stenosis. Pu would approximate P, 
(Fig. L bottom). In this hypothetical case. flow (Qx) is 
given as 
ON=P(J-P,, 
- R 
and FFR can be expressed as 
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In Vitro Setup 
Fig. 1. Simplified model of the coronary cir-
culation as proposed bY Pijls and De Bruyne, 
consisting of a resistance representing the 
stenosis (RJ in series with the myocardial 
resistance (R). AO: aorta; P ,: aortic pres-
sure; Pd: pressure distal to the stenosis; P": 
venous pressure; Q: flow (QN = Q when R.. = 
0); RA: right atrium. (Modified from Pijls and 
De Bruyne [6].) 
(Pd-P,.) ·R 
R·(P"-P,.) 
(P,-P,.) P, 
(P"- P,.) ~?, 
The experimental setup comprises a cardiovascular 
simulator to generate physiologic aortic pressures in a 
closed hydraulic circuit. using water as the test fluid. 
Water viscosity is roughly three times lower than blood 
viscosity. In order to fulfil the requirements of fluid-
dynamic similarity between the experimental model (wa-
ter) and the real (blood) flow in the coronary circulation. 
experiments are performed at low water ·flows (range: 
50-200 ml/min). corresponding to blood flows of 150-
600 ml/min. largely covering the normal physiological 
range of hyperemic coronary blood flow. The conversion 
is further addressed in detail in the discussion and in the 
Appendix. Stenosed Latex tubes. representing cllseased 
epicardial coronary segments with different degree of 
stenosis severity. were inserted in this circuit. We tested 
nine Latex tubes (0 = 4 mm) with stenosis length of 15 
mm and a target diameter stenosis (DS) of 40% (n = 3). 
50% (n = 3). and 60% (n = 3). 
I 
I 
I 
•[ 
L 
l 
Fig. 2. Schematic drawing of the in vitro setup. Top right: the cardiovascular simulator gen" 
crating physiologic aortic pressures. Middle: coronary artery phantom (h) mounted on a 3D 
shape of a human heart (b). together with active (i) and passive (j) resistance models. Left: 
afterload circuit (k). 
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150mm 
~41 1 ( 140%DU.4mm ~ 50% DS: 2.0 mm :::~ 60%DS:l.6mm 8 ~======~~2~~~~~~~2~~n~z7~~~~;~T~:======~ Fig. 3. Drawing of the coronary artery phantom. A plasf1c substance is introduced at the site of the narrowing (filling). The eTas~ tic Latex compound is used solely for the healthy part of the coronary segment. De~ pending on the degree of diameter stenosis (40%, SO%, and 60% OS, respectively), dif~ 
fcrcnt inner diameters (2.4, 2.0, 1.6 mm, rc~ 
spcctively) had to be accounted for. / "" Latexwall Filling 
The cardiovascular simulator. The cardiovascular 
simulator was described in earlier work [9-11] and is not 
discussed in detall. Figure 2 shows a schematic drawing of 
the setup of the heart (a) and coronaries. To simulate the 
tortuous pattern of the coronary tree in an anatomically 
correct way. the Latex coronary artery phantoms were 
mounted on a thrcc~dimcnsional (3D) shape of a human 
heart. a thin-walled Latex "cpicarctial surface" (b). We con~ 
nected the aortic outlet of the original simulated heart. to the 
inlet of this Latex epicarclium. The normal flow path of 
blood within the heart wo..<: bypassed by a V-shaped PVC-
tube (c). To have coronary inflow immediately distal to the 
aortic valve. a bileaflet aortic prosthetic valve (d) (St. Jude 
.Yiedical. St. PauL M:'\J) wa" placed at the V -tube outlet. 
Int:rn~arterial pressure measurements show realistic aortic 
pressure wave contours distal to the aortic valve at the 
outlet (sec Fig. 5. bottom). which justifies this interven~ 
tion in the afterload of the simulator. 
At the aortic outlet. a Latex aorta model (e) and tv-.ro 
epicardial coronary vessels can be connected (f.g). In this 
study. we only used the connection in the LAD position 
(g) to mount one of nine Latex coronary artery phantoms 
(h). The epicardial segment is connected downstream to 
a computer-controlled time-varying resistance (i). which 
impedes coronary flow in systole. representing the myo~ 
cardial resistance vessels. This myocardial resistance is 
then. in turn. connected to a passive resistance clement 
(j). modeling the capillaries of the myocardium. 
Coronary artery phantoms. The stenotic epicardial 
coronary segments were modeled as Latex tubes molded 
in several layers on three tubular molds (0 = 4 mm). 
with different narrowing sizes in the middle according to 
the desired stenosis severity (DS = 40%. 50%. and 
60%). [n previous attempts to dilate 100% Latex tubes by 
means of a balloon catheter. the stenosed segment re-
turned completely to its original dimensions due to clas-
tic recoil. Therefore. we introduced a plastic substance at 
the site of the narrowing. and used the clastic Latex 
compound solely for the healthy part of the coronary 
segment (Fig. 3). The elastic-plastic model thus obtained 
suited the purpose of the tests of which the results are 
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commented below. W c also refer to the discussion for 
further details on the coronary artery phantoms. 
Passive and active myocardial resistance. The pas-
sive resistance element is composed of 29 capillaries 
captured in a water~filled reservoir [10] (Fig. 4. right). 
The resistance can be changed by increasing the pressure 
in the water reservoir and thus occluding the capillaries. 
Coronary flow. however. is inhibited during systole due 
to the mechanical contraction of the heart muscle. and 
myocardial blood delivery is maximal during relaxation 
[6.12]. We therefore connected the passive resistance in 
series with a time-varying resistance. which impedes the 
flow during systole. and is minimal during diastole. A 
10-m.l syringe is used as an air~fillcd reservoir. with one 
Latex tube (representing a myocardial resistance vessel) 
on the inside (Fig. 4. left). The air-filled reservoir of the 
resistance is connected via an electromagnetic on/off 
valve to a buffer reservoir in the pneumatic circuit of the 
cardiovascular simulator. This way. the Latex tube is 
collapsed-and myocardial flow impeded-in phase 
with myocardial contraction. Figure 5 (top left) clearly 
shows that without the myocardial resistance, ma--.;:imal 
flow is delivered during systole, which is not physiolog~ 
ically correct. Maximal blood delivery shifts to dia..,tole 
when the resistance is activated (Fig. 5. top right). 
Measurement Protocol 
Intra-arterial pressure was measured proximal (PJ and 
distal (P d) to the stenosis at a sampling rate of 200 Hz. 
using epidural catheters connected directly to piezoclec~ 
tric pressure transducers (Becton Dickinson. Franklin 
Lakes. NJ). The pressure catheters do not cross the stc~ 
nosis. Flow was measured proximal to the stenosis by 
means of a two~channel ultrasonic flowmeter (Transonic 
Systems. Ithaca. ~Y). A second flow probe was mounted 
distal to the capillary resistance as control. Heart rate was 
s.et to 60 bpm and initial mean aortic blood pressure to 
100 mmHg. Throughout a single experiment. flow was 
varied stepwise from 50 ml/min to about 200 mllmin by 
changing the capillary resistance value. 
TO!!! Fluid 
...,. Myocardial Resist:mce: 
C:.pill:uy ~istanc~:: 
Fig. 4. The capillaries of skeletal muscles, tissue, and organs 
arc modeled as a passive resistance clement (right side). The 
contraction of the myocardial muscle is simulated by a time~ 
varying resistance Qcft side). When an electromagnetic (EM) 
on/off valve closes, the time~varying resistance becomes inac~ 
First, baseline (BL) measurements were done in all 
nine stenotic Latex tubes (0 = 4 mm). A 35-mm ACS 
Multilink stent (GuidantJACS, Santa Clara. CA) was 
deployed in 6 tubes. with a 3-mm balloon at 8 atm. This 
allowed us to simulate conditions of suboptimal stcnt 
deployment (SOD). After hydraulic tests in the hydraulic 
bench, the tubes were taken to the catheter laboratory for 
intravascular ultrasound (IYUS) and biplane QCA with 
the tubes tested under static pressure conditions at 100 
mmHg. Stents were then further optimally deployed 
(OD) under angiographic guidance using a 4~mm balloon 
at 16 atm. QCA and IVUS were repeated. and the OD 
tubes were taken to the hydraulic bench for flow mea-
surement and assessment of FFR. 
Data Analysis 
Fractional flow reserve. Intra-arterial pressure mea-
surements P ,_, and P 0 were averaged over five heart cy-
cles. Fractional flow reserve (FFR) was calculated for 
each tube as P JP ,_,. Values were averaged over three 
tubes per target stenosis severity and are given as mean 
±SD. 
QCA. The reference diameter (RD) measured in the 
fTontal and lateral view with the biplane QCA was aver-
aged. as well as the frontal and lateral minimal lumen 
diameter (MLD). Diameter stenosis (DS) percentages 
were then calculated with: 
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tive, and flow passes through the Latex tube, enclosed in the 
syringe (full line contour). When the time~varying resistance is 
activated, pressure is delivered from a buffer reservoir through 
the opened on/off valve into the syringe and the Latex tube 
collapses (dotted line contour). 
DS = lOO. RDuvr.- MLDuvr. 
RDav1_~ 
Intravascular ultrasound The IVUS images were 
used in a qualitative way to verify whether or not the 
coronary stcnt was well opposed to the vessel walL NUS 
procedures were done following clinical guidelines as 
published by DiMario eta!. [13]. The data were analyzed 
using two-way repeat-measurement analysis of variance 
(ANOY A) to study the effect of flow and stenosis level 
on pressure-flow relations and FFR. QCA data were 
analyzed using one-way repeat-measurement AL"l"OV A. 
The Bonferroni !-test was used as a post hoc test if 
significance was reached (P < 0.05). FFR data were 
analyzed at 100 mllmin. pooling data from all nine tubes. 
Differences between BL. SOD. and OD were assessed 
using paired r-tests. 
RESULTS 
Baseline QCA yielded effective DS values of 40%. 
54%. and 59%. respectively (Table I). There was signif-
icant residual stenosis after SOD as confirmed by IVUS 
and QCA (DS = 35 ± 3%. 32 ± 1% and 39 ± 2%. 
respectively). OD reduced DS values down to 13 ± 4%. 
10 ± 2%. and lO ± 2%, respectively. and IVUS images 
confirmed overall contact of the stent with the vessel wall 
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TABLE J. QCA Analysis Results 
BL 
I 
I 
I I I I I I 1 ~v 
5 
I 
I 
1 I 
) 
?I" ~ 
6 
SOD 
Fig. 5. Intra-arterial pressure and flow 
waves, measured distal to the aortic valve 
(see Fig. 2d). Without the time-varying (TV) 
resistance {on/off valve closed), max-Imal 
flow is delivered during systole (top left). 
Maximal blood supply shifts to diastole 
when the TV resistance is active {top right). 
OD 
Turgct OS ]'k] Tub<.: -11 RD[mm] MLD [mm[ OS l'/01 RD [rnm] MLD [mml OS l%J RD [mm] MLD :mm] OS [S~! 
3.9 2.6 33 4.2 3.5 15 
40 2 3.2 1.9 40 
4.2 2.6 37 4.3 3.9 10 
4 3.9 2.6 33 4.1 3.6 II 
50 5 3.3 1.5 54 
6 4.2 2.9 31 4.1 3.8 
7 4.1 2.5 38 4.2 3.8 9 
60 4.0 1.6 59 
9 4.2 2.5 41 4.2 3.7 II 
Reference diamctcr (RD). minimullumen diamder (MLO) and diam<.:tcr ~teno"'is p.:rcenL:lgc~ (OS) :lfc ~hown for b:J.\clin<.: conditions {BL). suboptimally 
dL-ploycd (SOD) and optimally deployed (00) stcnts. 
(Fig. 6). The differences between BL. SOD. and OD 
were significant (one~way A:.JOVA) when a...;scssed by 
means of QCA and IVUS. except for 40% DS (no dif-
ference between BLand SOD). 
At BL. for Q = 100 ml/min. FFR was 0.964 :!: 0.005. 
0.947:!: 0.004 and 0.923 ~ 0.012 for40%. 50% and 60% 
92 
DS. respectively. FFR varied inversely with Q (P < 0.001, 
2-way RM A:-!OY A) at BL. SOD and OD (Fig. 7). At BL. 
varying Q from 150 to 50 ml/min increased FFR by 2-7%. 
For OD. variation is less than 5%. Pooling all data at 100 
ml/min, FFR increased from 0.955 :!: 0.009 after SOD to 
0.963 :!: 0.005 after OD ( + 0.8%: P < 0.05: paired t-test). 
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Fig. 6. Top: IVUS and QCA images for a suboptimally deployed (SOD) stent. The minimal lumen 
diameter is clearly detected via the QCA analysis; IVUS shows the loose struts of the malap· 
posed stcnt. Bottom: IVUS and QCA for the same stcnt after optimal deployment (00). There is 
a minor residual stenosis; IVUS shows stent struts, well apposed against the coronary artery 
wall. 
DISCUSSION 
In this study. we have used a hydraulic coronary artery 
model to address some limitations of FFR in clinical 
practice. We have demonstrated its flow dependency. and 
assessed its (in)sensitivity to optimal stcnt deployment. 
From a hydraulic point of view. the flow dependency 
of FFR is easily demonstrated if Pct is replaced in the 
formula for FFR by its equivalent, Pct = P.., - ~P. where 
~p is the pressure drop over the stenosis. FFR then 
becomes 
1 - AP(Q) ~ FFR(Q) 
p" 
~p is always function of flow. In the case of laminar 
Poiscuilh:: flow. there is a linear relation between Q and 
~P. Over a stenosis. this relation is quadratic [14]. P" is 
often taken the (mean) central aortic pressure; it is rela-
tively insensitive to the flow level in the investigated 
coronary artery. Note that ~pis also function of blood 
viscosity. For the same flow. ~pis higher if viscosity is 
higher: the hematocrit or fibrinogen concentration may 
therefore modulate FFR. A solution to enhance tbe flow 
independence of FFR might be to measure pressure prox-
imal to the stenosis and not in the aorta (FFR = PiP P 
instead of P ct!P..,). One should also realize that in clinical 
practice. catheters cross the stenosis. disturbing the flow 
93 
15 40% Q-M 15 50% Q-M 30 60% Q-M 
0 BL ~ i 12 ,. SOD 12 24 f i 0 OD i Oil 9 i 9 = 18 s 2 s ~ 0 s s ..§, s { - 6 6 - 12 ~ J ~ 0 !>; ? ~ <I 3 ~ 3 % 6 ? rj !) r:r 
0 0 0 
0 50 100 150 200 250 0 50 100 150 200 250 0 50 100 150 200 250 
Q [mlfmin] Q [mlfmin] Q [mlfmin] 
1.00 40% Q-FFR 1.00 50% Q-FFR 1.00 60% Q-FFR 
'D ~ OJ f 0.95 0.95 s 0 0.95 ~ ~ ~ ~ <t 0 ~ ? f ~ 0.90 0.90 ? 0.90 { 0 BL 
0.85 ,. SOD 0.85 0.85 
0 OD 
0.80 0.80 0.80 
0 50 100 150 200 250 0 50 100 150 200 250 0 50 100 !50 200 250 
Q [mlfmin] Q [mlfmin] Q [mlfmin] 
Fig. 7. Top: measured flow values (Q) and pressure drops (.UP) for baseline {BL), suboptimal (SOD), and optimal (OD) deployment conditions. Values are shown for each of the 
target diameter stenosis percentages separately (40%, 50%, and 60%, respectively). From these data, we derived the Q-FFR relationships (bottom). These data clearly 
demonstrate the flow dependency of FFR. 
pattern and contributing to .:lP. Even for ultrathin wires 
commonly used, their influence is not always negligible 
[15.16]. 
In clinical practice. FFR is useful to assess the severity 
of a coronary stenosis and to decide whether to perform 
an intervention. A threshold value of 0.75 is used. This 
value was assessed in patients with stable angina [5.17]. 
In patients with postmyocardial reperfusion or unstable 
angina, maximal hyperemic flow could be lower than in 
stable angina patients. As FFR is function of flow, the 
0.75 threshold might not hold in these patients. This was 
reccndy shown by Jeremias et al. [18]. who demonstrated 
that the FFR measured post balloon occlusion was lower 
than post-adenosine hyperemia (0.58 ± 0.2 vs. 0.63 ± 
0.23. P < 0.001). This difference was related to a higher 
hyperemic flow obtained after balloon occlusion than 
after intracoronary administration of adenosine [18]. 
Our study shows little discriminating power of FFR 
between suboptimally (SOD) and optimally deployed 
(OD) stent. Given the definition of FFR, this means that 
the pressure drop over the tested stenosed Latex tube 
docs not differ significantly between SOD and OD (at the 
same flow level). In hydraulic terms, the pressure drop 
over an SOD stent may arise from (1) pressure losses due 
to the higher residual stenosis. or (2) pressure losses due 
to flow turbulence around the loose struts in the flow. We 
found little effect of the difference in residual DS (11 ± 
2% for OD. 35 ± 4% for SOD) on the pressure drop and 
FFR. This is not surprising. and confirms other studies 
showing effects of stenosis on pressure drops only for 
high stenosis values [14]. More remarkable is the obser-
vation that the pressure losses attributable to loose stent 
struts arc not significant either. Some interesting studies 
on flow turbulence due to the positioning of the stent 
struts were performed by Peacock ct al. [ 19] and Berry et 
al. [20]. Unfortunately. these studies emphasized mainly 
flow visualization and characterization. rather than the 
quantification of pressure losses. 
In recent work. Hanekamp ct al. [8] tested the feasi-
bility of FFR for the assessment of optimal stcnt deploy-
ment. A cutoff value of 0.94 was proposed. with FFR 
=:0.94 indicating optimal deployment. The agreement 
between optimal stent expansion by IVUS. with (1) com-
plete apposition of all struts. (2) symmetry index >0.7, 
and (3) in-stcnt minimal cross-sectional area >90% of 
reference area. and an FFR of >0.94 was 91%. 
Hanekamp et al. concluded that IVUS and FFR were of 
similar value to assess optimal stent deployment and that. 
for this purpose. coronary pressure measurement can be 
used as a cheap and rapid alternative for IVUS. Although 
the mean reference diameter (RD) in the study by 
Hanekamp and colleagues is not given. it is expected that 
it was -3.0 mm, the most common size of a stented 
coronary vessel [21.22]. In these conditions, a subopti-
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mal stent expansion with a suboptimal residual diameter 
stenosis (DS) of 30% gives a minimal lumen diameter 
(MLD) of 2 mm, whereas an optimally expanded stent 
with a residual DS of 10% is associated to aMLD of 2. 7 
rom. In our in vitro experiments performed with Latex 
tubes presenting a mean RD of 4 mm, SOD stcnts, with 
a mean residual DS of 36%, had a MLD of 2.6 mm. and 
the OD with a mean DS of 11% had a :MLD of 3.6 mm. 
This may explain the discrepancy between our results. 
demonstrating minimal change of the FFR between SOD 
and OD stent expansion and the clinical data of 
Hanckamp et al. However. our IVCS pullbacks demon-
strated that although a sufficient :MLD was restored to 
give an FFR value of >0.9. large segments of stents were 
still malapposed and were not detected by abnormal FFR 
values. These extensive segments would have surely had 
clinical implications such as (sub)acute thrombosis in a 
clinical setting. 
In previous configurations of the cardiovascular sim-
ulator, the arteries were mounted in a horizontal plane. 
neglecting the 3D component of the peripheral vascular 
bed. The coronary arteries. however. arc particularly 
tortuous. In order to respect their 3D anatomical shape, 
we had to mount them on a Latex epicardial surface. as 
shown in Figure 2. This setup more closely resembles 
coronary anatomy but is still a merely static supporting 
structure. A dynamically moving structure would further 
decrease model limitations. 
For the Latex coronary artery phantoms. we performed 
a feasibility study comparing phantom fills of 100% 
Latex with various types of plastic substances. We sim-
ulated a PTCA procedure. as well as the deployment of 
(home made) stcnts [23]. As a criterion. we used the 
residual stenosis percentage of the stenosed segment and 
compared it to that what is usually observed in clinical 
practice immediately after PTCA or (optimal) stent de-
ployment. Experiments led to the currently used config-
uration. Nevertheless. optimal stent deployment still 
yielded average residual DS of =:10%. which. in clinical 
practice, is an upper limit for OD deployment [24]. Thus, 
further and more elaborate investigation of an appropri-
ate stenosed coronary artery phantom may be required. 
With the time-varying resistance. we obtained more 
realistic flow patterns. realizing flow impediment during 
systole. However. there arc still some limitations leading 
to perturbations during activation of the myocardial re-
sistance (Fig. 5). Replacing the simple on/off valve with 
a regulating actuator would probably smooth out the flow 
wave. Furthermore, we only simulated one coronary ar-
tery with no side branches. In vivo. the heart is irrigated 
by a dense network of arteries. arterioles. and capillaries. 
Extending our Latex model in greater detail. i.e .. more 
epicardial branches and more myocardial resistance vcs-
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Fig. 8. Relationship between fractional flow reserve (FFR) and minimal lumen diameter (MLD) (len) and between FFR and diameter stenosis percentage 
(OS) (right). Data shown for baseline (Bl), suboptimal (SOD), and optimal (OD) deployment conditions at two different flow (Q) levels (50 and 100 ml/min). 
Top: measured values with water. Bottom: same data, but with values converted to blood. 
scls, would also improve the physiological relevancy of 
the simulated coronary flow pattern. 
QCA and IVUS tests were done in the catheter labo-
ratory. while the hydraulic tests were performed in the 
hydraulic laboratory. For practical and technical reasons. 
it wa..:; impossible to usc the cardiovascular simulator in 
the catheter laboratory. We therefore used a 2D static 
setup in the catheter laboratory, in which the coronary 
phantom was inserted after previous testing in the hy-
draulic bench. There was no 3D supporting structure, nor 
was there a pulsatile flow regime during QCA and IVCS. 
The coronary artery phantoms were however filled with 
water and contrast agent and then pressurized to 100 
mmHg. similar to mean aortic pressure (P J in the hy-
draulic tests with the cardiovascular simulator. 
Another limitation of our work is the usc of water for 
test fluid. Being Newtonian. water has no shear-thinning 
effects. but this aspect is less important as the dimensions 
of the coronary phantoms largely exceed those of blood 
particles. and velocity and shear rate are high enough to 
neglect non-:•kwtonian effect<;. More important is the 
fact that the viscosity of water is 3 to 4 times lower than 
blood. Consequently. pressure drops arc 3 to 4 times 
lower a<; well. and calculated FFR values arc higher than 
the values for blood at the same flow level. Nevertheless. 
our results can be converted to blood flow using dimen-
sionless numbers and the theory of dynamic similarity 
[25]. For each FFR value at a certain flow level with 
water experiments. there is a corresponding lower FFR 
value for blood at a (higher) blood flow level. A detailed 
outline of such a conversion is given in the Appendix. As 
an example. for a coronary artery phantom with target 
diameter stenosis of 60%. we found that after optimal 
stent deployment (OD). FFRwat<:r = 0.98 for Gwat<:r = 
50.54 ml/min. These values correspond to a blood flow 
(Qb1ood) of 168.47 mllmin. and FFRbJood = 0.81 (sec 
Appendix). The water experiments. covering a range of 
50-200 ml/min. cover a blood range of 150-600 ml/ 
min. Figure 8 illustrates FFR values for water (upper 
panels) and the converted values for blood (lower panels) 
for BL. SOD. and OD as a function of MLD and DS. 
Note that changes in flow have a much larger effect on 
FFR than going from SOD to OD. 
In conclusion. we demonstrated that FFR is con-
founded by the blood flow level and the blood viscosity. 
Further. we found only small differences in FFR between 
a suboptimally and an optimally deployed stent assessed 
by IYUS (complete stent apposition). Anatomical param-
eters postpercutaneous coronary intervention remain 
strong predictors of restcnosis. for example. and assess-
ing optimal stcnt deployment is more dependent on an-
atomical measures than measures of functional perfusion. 
Thus. we believe that IVUS and QCA arc more appro-
priate for the assessment of optimal stent deployment 
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than FFR when a minimal lumen diameter has been 
reached. normalizing the FFR to >0.9. In clinical con-
ditions such as unstable angina/postmyocardial infarction 
rcpcrfusion. cautious interpretation of FFR measure-
ments should be based on potential low-flow conditions. 
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APPENDIX 
Converting flow and pressure measurements for water 
to results for blood requires two steps. First. extra pa-
rameters have to be calculated for water in order to derive 
two nondimcnsional numbers: Reynolds (Rcwatcr) and 
Euler (Swatcr). Second.· applying the theory of dynamic 
similarity. we express that Rcwutcr equals Rehloo<i and 
~water equals ~hlooJ· From these two equations. it is then 
possible to obtain flow and pressure values for blood, as 
demonstrated below. 
Step 1: Rew:Jtcr and ~atcr 
Internal diameter of the coronary artery phantom. as 
well as the physical properties of water is given in Table 
AI. Cross-sectional area Aphant<>m is calculated with : 
A= 'Tt • D2 /4 
TABLE AI. Measured and Derived Parameters for Water 
Parameter Symbol [unit~] 
Internal diameter Dr"""'""' lml 
Cro~~-~ectional :.trea Arh"""''" [mm~J 
Wutcr density p,.,,,., [kg/m:<l 
Water vi~co~ity f.'.w.,toc [Pa ~J 
Water velocity UW,l10f lm/~1 
Wmcr now Q'"'"'"' lml/minl 
Proximal stcnosi~ pressure PI'"'·""' immHgi 
Di~tal steno~is pressure ?,1 "'·''''' ;mmHg] 
Pres~ure drop ilP'"'k' [mmHgl 
FFR,..,,~, (OD} FFR"""'"' 
Reynolds"'"''"' Re"''""' 
Euler""'"' EwH1>'f 
98 
Formula 
A 11" • Dl (4 
U-Q 
A 
AP = P,, - P,, 
FFR-~ 
P,, 
U·D•p 
Rc----
" ;p 
<--, p·U· 
Value 
0.004 
12.6 
1000 
0.001 
0.067 
50.54 
106.55 
104.79 
1.76 
0.98 
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TABLE All. Corresponding Parameters for Blood 
PZ~mmo.:tcr 
Reynolds01,»<.~ 
lntcrnul Diameter 
Blood Density 
Blood Viscosity 
Blood Velocity 
Cross-~ctional area 
Blood Flow 
Euler h'-~><.1 
Prc:;~un: drop 
Proximal stcno~is prc~~urc 
Di~tul ~lcno~i:; pro.:s~urc 
Symbol [units] 
Rch,.,><J 
Drl'·'""'"' jmj 
Phi" ><.I I kglm" I 
fJ.hi·~.J [Pas] 
uhk>U<.I )m/s] 
A1,,,,,1.,m )mm"J 
Qhi".J lml/min] 
f;OI<~»l 
fl.P,,,»J lmml-lgj 
P 1,"1'-"'<llmmHgl 
P,1 , 1,,,1 jmmHgj 
Formula 
!J.hl'"" 
uhlmo- Rc'"'". D. Pl>l"" 
A"" To·U"/4 
Q = U·A 
' -' 
""''"><,] - "''""''' 
fl.phln<xl '"'f;,l,-.xt' p,,,.w' U~l•><xl 
P,,h~<><><J - P,w"" 
P,1 P1,- fl.P 
FFR- P_c!_ 
P, 
Value 
26l:i 
0.004 
1050 
0.0035 
0.22 
12.6 
168.47 
52 
20.5S 
106.55 
85.97 
0.81 
while water velocity Uwmcr is derived from the measured 
flow Qwatcr ( = 50.54 ml!min) with 
blood arc given in Table All. Blood velocity (Unlood) is 
calculated using 
Pressure drop b..P W'tl"r and FFR walcr arc derived from the 
measured proximal and distal stenosis pressures with 
and 
FFR=~ 
P,, 
resulting in b..P water = 1.76 mmHg and FFRww"r = 0.9S. 
Finally. the Reynolds and Euler number (Rcwatcr. ~wm._,,) 
are calculated using 
U·D·p 
Rc=--- and 
f.' 
!1P 
<---· 
'='- p· u2 
52 (Table AI). 
with Rehlood = RCwmcr = 268. Blood flow (Qhlood) is then 
obtained via 
Q ~ U·A 
resulting in Qhlood = 168.47 ml/min. 
As ~w"t"r equals ~blood• it is possible to derive D..Pblood 
with 
giving 20,58 mmHg. Finally. stating that PP bloW equals 
P p w"to:r• P d blood can be found 
Pd=Pp-b..P 
and also FFRblood 
Step 2: Qblood and FFRblood FFRotooct 
Calculations arc to be done in an 'inverse· way, start-
ing from Re and S. Necessary physical properties for yielding a value of 0.81. 
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Flow estimation using an intravascular imaging catheter. 
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Abstract 
Coronary flow assessment can be useful for determining the hemodynamic severity of a stenosis and to evaluate the outcome 
of interventional therapy. We developed a method for measuring the transverse flow through the imaging plane of an intravascular 
ultrasound (IVUS) catheter. This possibility has raised great clinical interest since it permits simultaneous assessment of vessel 
geometry and function with the same device. Furthermore. it should give more accurate information than combination devices 
because lumen diameter and velocity arc dctcnnincd at the same location. 
Flow velocity is estimated based on dccorrelation estimation from sequences of radiofrcqucncy (RF) traces acquired at nearly 
the same position. Signal gating yields a local estimate of the velocity. Integrating the local velocity over the lumen gives the 
quantitative flow. 
This principle has been calibrated and tested through computer modeling, in vitro experiments using a flow phantom and in 
vivo experiments in a porcine animal model, and validated against a Doppler clement containing guide wire (Flowire~) in humans. 
Originally the method was developed and tested for a rotating single element device. Currently the method is being developed 
for an array system. 
The great advantage of an array over the single element approach would be that the transducer has no intrinsic motion. This 
intrinsic motion sets a minimal threshold in the detectable velocity components. Although the principle is the same. the method 
needs some adaptation through the inherent different beamforming of the transducer. In this paper various aspects of the 
development of IVUS flow arc reviewed. © 2000 Elsevier Science B.V. All rights reserved. 
K<:ywords: Blood flow; Decorrdation; Intravascular ultrasound; RF data processing: 
1. Introduction 
Currently, intravascular ultrasound (IVUS) is the 
only clinically available technique capable of providing 
real-time cross-sectional images of coronaries at high 
resolution in vivo. It delivers information that is not 
available from X-ray angiography. As the number of 
available interventional techniques for treatment of 
atherosclerotic luminal narrowing increases, specific 
diagnostic information that can aid in the selection 
becomes increasingly important. For this reason, NUS 
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A. der Steen) 
is more and more routinely used for guiding intcrven-
tional procedures [1] and for studying the mechanisms 
for restenosis [2]. 
In the last couple of years the possibilities of accessing 
a sufficient amount of RF data at adequate speed have 
improved significantly. This has allowed us to study 
IVUS data in a totally different way [3,4]. Traditionally, 
the emphasis was on imaging itself, while RF analysis 
also allows tissue characterization [5,6], elasticity 
imaging [7-10], flow estimation and enhanced boundary 
detection. 
Assessment of blood flow has long been recognized 
as an important approach to evaluate the functional 
status of a diseased artery. lntracoronary Doppler is a 
conventional ultrasonic method for measurement of 
blood velocities, and has been applied for coronary flow 
reserve assessment and to evaluate the severity of core-
004J-624X/OO/$- see front matter© 2000 Elsevier Science B. V. All rig:hts reserved. 
PII: S004I-624X(99)00213-9 
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nary lesions [11]. The use of Doppler velocimetry alone. 
however, does not allow direct measurement of flow 
volume. For quantitative measurement of flow volume, 
the vessel cross-sectional area and the blood velocity 
must be assessed coincidentally in time and space. IVUS 
is a tomographic imaging technique that allows accurate 
measurement of the vessel cross-sectional area, irrespec-
tive of vessel geometry [12]. The feasibility of simulta-
neous use of intracoronary Doppler for velocity 
measurement and IVUS imaging for area measurement 
to estimate blood flow has been demonstrated [13]. One 
potential limitation of this approach is that the flow 
volume is estimated from the mean Doppler velocity 
with an assumed velocity profile. Additionally, the simul-
taneous use of multiple ultrasound transducers could 
cause cross-talk between the Doppler and IVUS trans-
ducer [14]. 
A unique feature of IVUS techniques is that the 
direction of blood flow is almost normal to the imaging 
plane. As blood particles move across the imaging plane, 
the received echo signals decorrelate at a rate propor-
tional to flow velocities. In this paper, we review a 
method that allows a direct measure of local velocity as 
well as volume flow by means of analysis of the intravas-
cular RF echo signals. The flow measurements obtained 
with the decorrelation method (IVUS-fiow) are com-
pared with the data of an electromagnetic flow meter 
(EM-flow) in vivo under various flow conditions in an 
animal model. Furthermore, clinical data are presented. 
Since a rotating single element transducer suffers 
from some inherent motion artifacts, we are currently 
developing the method for an array transducer system. 
These transducers get their inherent resolution and 
image quality by synthetic aperture focussing techniques. 
Since this is based on reconstruction of the image from 
multiple pulses from different directions towards the 
same ·static' object, this technique is not directly suited 
for flow estimation, because the blood particles are 
moving in the time course of the acquisition. The 
scanning protocol of the array had to be changed. In 
this paper another scanning protocol is described, based 
on a computer model of the array and included in an 
intravascular ultrasound system. Preliminary patient 
data using this catheter are presented. 
Finally possibilities to use this method for automatic 
boundary detection in IVUS are discussed. 
2. Methods 
2.1. Decorrelation of blood echoes 
The displacement of an ultrasound-scattering mate-
rial such as blood moving through the beam of an 
ultrasound transducer results in decorrelation in the 
received echo signal. The decorrelation phenomenon can 
106 
ultrasound beam 
Fig:. 1. The coordinates of the IVUS imaging set-up. The scanning 
plane is perpendicular to the direction of blood flow. 
be clearly observed in the intravascular environment in 
which the ultrasound beam is transmitted perpendicu-
larly to the arterial tissue and blood flow (Fig. 1 ). In 
IVUS, it is commonly observed from real~tirne display 
that the scattering pattern of flowing blood varies rapidly 
over time. This is due to the fact that the flow stream 
drives the randomly distributed blood particles con-
stantly in/out of the image plane, causing the received 
echo signals to decorrelate with time. 
Correlation has been found to decrease approxi-
mately linearly with increasing floW velocity. This result 
suggests that if the velocity-correlation relation is pre-
quantified for the type of transducers used, the measured 
decorrelation value from blood scattering signals can be 
converted into flow velocity. 
2.2. Decorrelation-to-fiow quantification 
The method is based on decorrelation processing of 
a series of RF signals (time RF sequence) acquired at 
approximately the same transmission angle. 
2.2.1. Spatial decorrelation model 
Unlike most other medical imaging techniques. the 
majority of IVUS signals arc acquired in the near field 
of the ultr:isound beam (0.1-4 mm). The relationship 
between the correlation of echo signals and the scatterer 
motion across the ultrasound beam (lateral decorrela~ 
tion) can be approximated with a linear model in the 
near field [15,16]. The slope. termed the displacement 
decorrelation slope (mm- 1), is characterized by the 
beam pattern. The linear dependence of signal correla-
tion upon the scatterer lateral disp~acement has been 
validated in both computer simulation and in vitro with 
a flow phantom. Our results show. that, because the 
beam pattern may change significantly in the near field, 
the displacement correlation slope must be calibrated 
for the type of transducer used [15,16]. 
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2.2.2. Time decorrelation measuremen1 
At each transmission angle, a sequence of RF traces 
separated by a fixed time interval is acquired at a high 
pulse repetition rate. The decorrelation rate of the range-
gated echo is evaluated in two steps. 
I. Align the RF traces across the sequence, using axial 
cross-correlation. This procedure removes the decor-
relation due to the axial displacement (along the 
ultrasound beam) of blood scatterers. 
2. Compute the correlation coefficient between aligned 
RF pairs. A slope is obtained by fitting a linear 
model through the correlation versus displacement. 
The slope ::~~, tem1ed the time decorrelation slope 
(s - t), is related to the transverse blood velocity 
(normal to the ultrasound beam) for a given beam 
position. 
2.2.3. Velocity es1imcuio11 
Thus, the transverse velocity can be estimated at each 
window position from the ratio between the calibrated 
decorrelation function and the measured dec01-relation 
slope from a time RF sequence. Note that the calibration 
procedure needs to be carried out only once for a specific 
type of transducer. 
2.2.4. Volume flow integration 
Local velocities in small range windows can be 
obtained throughout the lumen cross-section to provide 
two-dimensional flow mapping. As illustrated in Fig. I, 
the volume flow is calculated by integrating the local 
transverse velocity with its corresponding area element 
over the complete imaging plane. Because wall tissues 
move more slowly than blood, the contribution of tissue 
ve-locities can be automatically removed by setting a 
threshold. Thus, no contour tracing of the arterial lumen 
is needed. 
3. Results 
The methods described above have been implemented 
on a rotating single element IVUS system 
(DuMed(Endosonics Inc.) and validated in a number 
of ways. ln vitro data showed good agreement with a 
calibrated electromagnetic Bow meter [ 16] . In the 
carotid artery of a pig the lVUS Bow showed good 
agreement with electromagnetic Bow estimation 
(Fig. 2) [ 17,18]. 
The relation , under a variety of flow conditions, 
approached unity. In patient studies the IVUS flow is 
compared with the values obtained by a Doppler flow 
wire [ 19]. Again a good agreement was fou nd. This 
method has been evaluated extensively in the catheteriza-
tion laboratory [ 17.20 ] (Fig. 3). 
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Fig. 2. Flow curves of phasic EM-Row (doncd line) and IVUS-Bow 
(solid line) in a pig carotid artery. showing an aJmost identical beat· 
to-beat change in blood volume flow (17, 18]. 
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Fig. 3. Upper panel: coronary How mapping obtained in patient for 
low ( lert) and high (right ) Row rates during the cardiac cyd e. Lower 
panel: IV US flow curve showing a typical two-phas ic diastolic flow 
pattern of a coronary artery. 
3.1. flljlue/lce of catheter 
One important issue in this flow measurement is the 
question of whether the catheter itself influences the 
flow measurement. There are three important aspects 
that should be addressed. 
I. Is the flow profile changed by the ca theter? 
2. Does the catheter cause secondary fl ow? 
3. Does the catheter impede the flow? 
(I) This is indeed the case, b ut it does not a Aect the 
Bow estimation, since the values of the transverse veloc-
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Fig . ..J Intensity plots at a distance of 2 mm from an array transduct-r 
that is open:ncd in linear array mode using one. five or nine clements 
1241. 
ity profile are integrated over the full cross-section and 
the exact profile is not important. 
(2) The method is able to discriminate between axial 
and transverse flow. but incapable o f d iscriminating 
transverse motion through the plane from in-plane 
transverse motion. The latter is referred to as secondary 
flow and a significant presence of this could cause a bias 
in the flow estimation. This secondary flow has been 
studied using finite element modeling [21). The flow 
through a curved vessel with a catheter inside at a 
variety of positions is compared with the flow without 
a catheter present. The main conclusion of the study 
was that the secondary flow with a catheter inside has 
only a minor influence on the flow estimation [22). A 
peculiar fact is that secondary flow with a catheter inside 
is even less than without a catheter. The catheter seems 
to have a regulating effect on the secondary flow. 
(3) The impediment of the catheter on the flow is 
also under study. This is done in an in vitro set-up 
where tubes with several stenoses are studied. The 
pressure dro p over the stenosis is established without a 
catheter. with a guide wire and with a catheter. 
This pressure drop is a direct measure of the imped-
ance of the flow. P reliminary results show that if the 
stenosis is severe enough. there is an influence of the 
catheter o n the flow. The exact influence still has to be 
determined. 
3.1. Flo II' esrimarion using an array lransducer 
Although the flow estimation seems to work well on 
a rotating single element catheter there are certain 
disadvantages. One is the fact that motion of the catheter 
with respect to the blood cannot be separated from 
motion of the blood with respect to the catheter. In 
principle. the decorrelation d ue to element rotation can 
be corrected for. but two problems remain. 
I. If the now becomes very slow the relative decorrela-
tion due to rotatio n becomes significant. Therefore 
only velocity components above a certain threshold 
can be used. 
2. The correction is based on a uniform rotation of the 
Fig. 5. IVUS Row Image (right) and automated detected boundar) from flow ( left) obtained with an array catheler. Note that the resolution or 
the imugc is limited b..'Cause no SAFT was used (lSI. 
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element. If this is not the case the results may 
be biased. 
For these reasons the methods are currently evaluated 
on a phased array system. The tip of the catheter consists 
of 64 static elements. The image is constructed using 
synthetic aperture focusing techniques (SAFT) [23]. 
This is based on sequential excitation and receiving of 
individual clements. For the reconstruction it is essential 
that the imaged object does not move during the acquisi-
tion time. For blood flow estimation this mode is not 
suitable. The array needs to be operated in linear array 
mode. This means that a number of clements are excited 
simultaneously and the same clements arc used for 
receiving. The influence of the number of elements that 
need to be used for this has been studied extensively 
[24] (Fig. 4). If the number is too low, the resolution is 
poor and the ultrasound energy will be concentrated 
close to the transducer. If the number is too high the 
ultrasound beam will split. This is because, due to the 
curvature of the surface. the far field of the transducer 
can never be reached. For the 64-eiement catheter, an 
optimal number would be four or five clements. Another 
aspect is the shape of the decorrelation curve of the 
array system in linear array mode. For the ncar field of 
the single element transducer it had proven to be close 
to linear [15], but for the array transducer this is not 
necessarily the case. Computer modeling has shown that 
for four elements the decorrelation at varying distance 
is fairly linear, although a different calibration has to 
be performed at different distances to the transducer 
[25,26]. It seems that. in principle, the array is suited 
for flow estimation. Currently it is evaluated in the 
catheterization laboratory (Fig. 5) [20]. 
3.3. Automated boundary detection 
Because the flow usually has a higher velocity than 
wall motion. blood echo signals decorrelate significantly 
faster than those of tissues. The different correlation 
time in the received RF signals between blood and tissue 
has been documented in vivo in our earlier studies [27]. 
The time in which the blood RF signals maintain a 
correlation above 0.2 is less than 1 ms, which is signifi~ 
cantly shorter than that measured in wall echoes 
(»6 ms). In this way the regions that are potentially 
identified as blood are distinguished from those that arc 
potentially identified as vascular wall. After this, addi~ 
tiona! image filtering is applied [4]. The result of this 
automated detection of the arterial lumen boundary 
based on RF processing techniques is illustrated in 
Fig.5. 
Other methods of assessing the flow area have recently 
been described [28-30]. Although not capable of quanti-
tative flow measurement, these are very capable of 
detecting areas with or without flow. making them well 
suited for guidance of stent placement [31 ]. 
4. Conclusions 
A method has been developed and tested for quantita~ 
tive flow estimation using an IVU£ imaging catheter. 
This method is currently under development for a phased 
array system. A useful spin·off is the possibility for 
automated boundary detection. 
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Chapter 7a 
Preliminary clinical experience: 
Blood flow assessment with intravascular ultrasound catheters: 
the ideal tool for simultaneous assessment of the coronary haemodynamics 
and vessel wall? 
SG Carlier. EI Cespedes. W Li. F Mastik, AFW van der Steen. N Born. PW Serruys. 
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Blood flow assessment with intravascular 
ultrasound catheters: the ideal tool for 
simultaneous assessment of the coronary 
haemodynamics and vessel wall? 
S. G earlier*, E. I. Cespedest, W Li*,:f:, F. Mastik*, 
A. F. W. Van Der Steen*,:f:, N. Bom*,:f: & P. W. Serruys*,:f: 
"'Erasmus University RoHerdam, Thoraxcentre, The Netherlands; tEndoSonics Corp., Rancho Cordova, CA, USA; 
=Flnteruniversity Cardiology Institute of The Netherlands 
We present the potentials of a novel method of intracoronary flow visualization and quantification that is 
based on conventional intravascular ultrasound (IVUS) imaging catheters. The quantification of flow ·Is 
obtained from analysis of the rate of decorre!ation of digitized radiofrequency ultrasound echo signals. Flow 
information is superimposed on the !VUS image using a colour scale. Integration of the blood velocity 
components normal to the scan plane permits calculation of the volume flow. Validation using !VUS and 
electromagnetic (EM} flowmeter recordings were obtained in vivo from instrumented pigs. JVUS flow (IVUS1} 
compared favourably to EM flow (EM1): !VUS1= 1.0 EM1+5.72 cc/min, ?=0.98. Clinical results for the first 
five patients investigated are reported. A Doppler wire was used to measure the flow in four coronary 
arteries and one renal artery in baseline and hyperaemia conditions. JVUS flow and derived coronary flow 
reserve (CFR} demonstrated a very good agreement with the data derived from the combination of 
quantitative angiography and velocity when measured with the Doppler wire (OOP 1): IVUS1= 1 .01 
DOP1-20 cc/min, ?=0.90 and JVUScfr=1.03 00Pc1r-0.03, f=0.93. This demonstrates that simultaneous 
morphological and physiological assessment of coronary or peripheral arteries with one IVUS catheter is 
feasible. This method should be very useful for the evaluation of intermediate coronary stenoses or the 
results of revascularization procedures. 
Key words: coronary flow, intravascular ultrasound, radiofrequency signal 
Introduction 
The limitations of quantitative coronary arteriography 
(QCA) for the physiological assessment of intermediate 
coronary lesions in unselected patients with extensive 
coronary atherosclerosis have been recognized [l, 2]. 
The haziness of the borders of the vessel after PTCA 
also limits the use of QCA for the assessment of the 
acute results of an intervention. Intravascular ultrasound 
(IVUS) assessment allows for a better characterization of 
the vessel wall morphology and of the atherosclerotic 
plaque and for a direct assessment of the arterial 
remodelling process, which cannot be seen on the 
luminograms obtained with conventional angiography 
[3-5]. Although IVUS has already revolutionized the 
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visualization of atherosclerotic disease and of the re-
stenotic process, the benefit in clinical outcome remains 
under evaluation in ongoing trials. However, IVUS is 
simply another, albeit improved, tool to assess a lesion 
morphology, and does not permit a precise evaluation 
of the physiological importance of a coronary stenosis 
[6]. Conversely, intracoronary velocity and pressure 
measurements, derived from miniaturized Doppler or 
pressure sensors mounted on 0.014-inch wires, permit 
the evaluation of physiological parameters like the 
coronary flow reserve (CFR). The agreement of these 
measurements with non-invasive scintigraphic or 
echocardiographic stress tests is very good, and has 
been extensively reported [7-10]. It has recently been 
demonstrated that the association of a CFR> 2.5 and a 
residual diameter stenosis <35% after PTCA is a 
prognostic factor for the recurrence of symptoms and 
for the restenosis rate [11]. The safety of not performing 
© 1998 W.B. Saunders company Ltd 
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Figure 1. SchemJtic reprc~cnt.:ttion of the JVL'S cJthctcr in a coronJry Jrtcry showing the ~owing red blood cells cros~ing the ult~<:~sound 
im.:~ging pbnc, together with J rcprcscnt.:tlivc IVUS imJgc. 
an angiopl<~sty for intermediate stenosis without a 
functional significant severity assessed by flow or pres~ 
sure measurements hJs 01lso been demonstrated [12, 13]. 
Intracoromry physiologic assessments of coronary 
lesions and interventions <l.ppe<:tr more and more to 
complement coron<Jry lumenology and morphology 
Jsscssments obtained with angiography and IVUS [14]. 
The possibility to obtain guantitJ.tive flow informa-
tion using an IVUS cJthcter hJs recently been investi-
gated in our laboratory. This approach could be the 
ide~] one ~llowing simult<meous morphologic~] ~nd 
physiological assessments of coron~ry arteries in the 
catheterization laboratory. Blood flow quantification is 
based on the measurement of changes in the received 
radiofrequcncy (rf) IVUS signal as red blood cells 
transverse the ultrasound scan plane [15-17]. 
Principle of flow estimation based on 
the decorrelation approach 
Jn essence, this approach quantifies changes in the rf 
echo signals that result from flow of red blood cells, the 
predominant scatterers in blood, through the ultrasound 
beam (Fig. 1). This approach is tot~lly different from 
velocity estimation b~sed on the Doppler effect, where 
the ultrasound beam ond the flowing red blood cells 
must be optimolly aligned. The detoils of the technique 
have been previously reported [17-19]. The underlying 
hypothesis is that the rate of rf signal decorrelation is 
reloted to flow velocity: for a given ultrasound beam, 
the foster blood portides move across the imaging 
plane, the higher the decorrclation rote of the received rf 
signals. This hypothesis was tested by computer simu-
l~tion and in an in vitro experimental set-up where the 
echo correlation of a blood mimicking phantom was 
measured at various flow velocities. The relationship 
between echo decorrelation <md flow velocity observed 
was approximately linear, suggesting that if the 
velocity-correlation relation is pre-quantified for the 
type of transducers used, the measured decorrelation 
value from blood scattering signals can be converted 
into flow velocity. Since blood moves rebtive to the 
stationary vessel wall, automatic discrimination of the 
114 
arcJ of flow <md guantificJtion of flow velocity is 
feJsible based on echo signol <mJlysis. 
We modified the triggering mode of an Jvaibble 
IVUS scJnner in order to obtain imJges comparable to 
those of conventional echographic M-mode scanning, 
the same position in space being sampled successively 
by consecutive ultrasound bursts. We obtained the 
velocity measurements for the corresponding angubr 
position of the beJm. The calculotion of flow involves 
the estimation of echo decorrclation after removal of 
echo shifts along the direction of the ultrasound beam. 
This separation procedure isolJtes axial (along the beam 
axis) and tr<msverse (Jcross the scan pl<me) velocity 
components. The procedure is performed in smJll rf 
signol windows and repeated for all angular positions of 
the bcJm. Velocity estimates are superimposed on the 
conventional IVUS imJgc using a colour scale. The 
resulting colour flow images can be displayed by video 
animation. 
A representative IVUS image with the corresponding 
M-mode acquired at one angular position arc shown in 
Fig. 2. Note in the M-mode that the echo signal 
undergoes little change in the arterial wJll {W), since 
tissue is relatively static. However, the echoes from 
blood change within the M-mode and particularly 
toward the centre of the lumen, between the catheter 
(C) and the walL Qu<mtification of these changes in 
small regions of interest is used to estimate local blood 
velocity. Integration of the spatial blood velocity distri-
bution over the entire lumen yields the volume flow; 
that is, the volume of blood crossing the image plane 
per unit of time. Because the lateral motion of wall 
tissues has a much lower velocity th<m blood, this 
contribution can be automatically removed by setting a 
threshold. Thus, no contour tracing of the arterial lumen 
is needed. 
The RF acquisition set-up 
Radiofrequcncy echo signals were obtJined in each 
experiment using 4.1 French (L~6 mm diameter), 
30 MHz center frequency Princeps~':'! IVUS catheters 
(EndoSonics/Du-Med, Rijswijk, The Netherlands) 
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Figure 2. At one ~gulor position, successive radiofreguency (rf) 
signals ore ocquired for correbl:ion amlysis. On the ca!cubted 
M-mode, the decorrelation rate can be estimated: nearly constant 
echoes ore found in the vessel wall 0/V). The calculoted correiation 
values behveen rf pairs will be high in this region, wi~h a 
corresponding slow decorrebl:ion rate olong time. On the contrary, 
rapid changes ;;~re observed in the lumen, moinly in its centre, 
corresponding to the rapidiy flowing red blood cells. At that level, 
there will be o iow correlation between successive rf traces, and an 
high decorrebtion rate along t:me. The position of the catheter is 
m;;~rkcd by C. 
driven by a modified EndoSonics/Du-Med scanner. We 
obtained 1000 rf echo lines per revolution, at a frame 
rate of 16 s- 1 and :vi-mode pulse repetition frequency 
of 15.6 kHz, with a corresponding pulse repetition 
interval of 64 1-LS. The rf signals were digitized at 
200 MHz and 8 bits, using a Signatec PC board 
(Signatec, Corona, CA, USA), and stored in computer 
memory for off-line processing of flow with subsequent 
animation of the flow image frames. The memory 
capacity of the acquisition system permits recording of 
a total of 3.75 s of rf data at 100 angles per revolution. 
The system is also capable of simultaneous digitization 
of the signal from an electromagnetic flowmeter or 
other low-frequency signal sources (ECG, blood 
pressure, etc). 
Flow velocity was measured using the described 
principle. The axial velocity component was removed 
by aligning the rf traces before calculation of decorre-
lation as well as the decorrelation comoonent due to 
beam rotation related to the mechani~al transducer, 
giving only a pseudo<'v1 mode. Decorrelation estima-
tion was performed on d<~ta windows (40 samples long) 
with 50% overlap corresponding to an axial resolution 
of 0.19 mm. A temporal median filter was used to 
reduce the number of spurious flow estimates. 
Animal validation experiment 
Mean and phasic measurements of carotid flow were 
measured in vivo in two 30-35 kg Yorkshire pigs [20]. 
The experimental procedure was approved by the 
Committee on Animal Experiments of the Erasmus 
University Rotterdam. Following overnight fasting, the 
pigs were sedated and subsequently intubated and 
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mechanically ventilated. Under sterile conditions, the 
left femoral artery and vein were cannulated for infusion 
of drugs and blood pressure monitoring. A pacemaker 
lead was advanced to !:he right atrium via a jugular vein. 
An electromagnetic (EM) flow probe was fitted on the 
contralateral, exposed common carotid artery and 
adequately calibrated. A 9-F guiding catheter was 
advanced under fluoroscopy up to this carotid artery. A 
sterile IVUS catheter was advanced into it to the 
common carotid artery under fluoroscopic guidance and 
positioned 5 em proximal to the EM probe. The dis-
tance corresponds approximately to I I radii of the 
artery, allowing near laminar flow at the location of the 
E:vt probe. Data from the EM flowmeter was digitized 
synchronously with the RF echo signals. Zatebradine 
(UL-FS 49) 0.5 mglkg was given to produce complete 
A V block, and the pacemaker was set to approximately 
60 bpm. In order to induce high-(hyperaemic) and 
low-flow conditions, adenosine {0.5 mg.kg/min, i.v.) and 
ergotamine (20 j.lg/kg) were infused, respectively. 
Preliminary clinical experience 
We studied five patients referred for percutaneous 
coronary intervention with stable angina pectoris 
related to a single vessel lesion (n=4) or with medically~ 
uncontrolled hypertension related to an ostial lesion of 
the right renal artery (n= I). All the patients signed an 
informed consent. 
After intravenous administration of 10 000 IU 
heparin and 250 mg acetylsalicylic acid, an 8-F guiding 
catheter was advanced up to the ostium of the artery to 
be studic;,d. After the intervention, a Doppler guidewire 
(Flowire''31, Cardiometries Inc.) was positioned into the 
mid-segment of the vesseL After coronary injection of a 
bolus of 3 mg isosorbide dinitrate, the Princepsf""!1' IVUS 
catheter was advanced on this wire. The imaging 
transducer was positioned approximately 5 em proximal 
to the tip of the Doppler wire, to allow recovery of a 
fully developed velocity profile at the site of the 
Doppler measurement. Simultaneous Doppler and IVUS 
flow measurements were performed in baseline condi-
tion and during hyperaemia produced by an intravenous 
infusion of adenosine (140 j.J.g/kg/min) to evaluate the 
coronary flow reserve (CFR). 
A cineangiogram was performed in two orthogonal 
views, in order to estimate the lumen cross-sectional 
area at the measurement site of the Doppler. The 
guiding catheter, filmed devoid of contrast medium, was 
used as a scaling device. A previously validated analysis 
system (CAAS If, Pie Medical) was used for the 
quantitative coronary analysis (QCA). The two 
measured diameters, 5 mm down the Doppler tip, were 
averaged to compute a mean cross-sectional area at the 
level of the velocity measurements. The Doppler 
derived flow was computed as the product of the 
cross-sectional area and the average peak Doppler 
velocity (APV). 
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Figure 3. Sc;~Hcr plot of !VUS and EM Aow mcJsurcmcnts in the 
vJ.lidation study rcJ.lizcd in the porcine carotid model, for !:he low 
(x), normal (o) Jnd high Flow(+) condilions.!Vt.JS,.=I.O EM1+5.7; 
SEE=25.2 cdmin; ?=0.9S. 
Results 
Figure 3 shows a scatter plot of EM vs IVUS phasic 
How me<1surements for five recordings in the pig modeL 
One hyperaemic response was discarded because the 
EM probe lost contact with the artery due to vaso-
spasm. Overall, the instantaneous volume flow ranged 
from 20 to 557 cdmin. Each recording corresponded to 
3-4 heart cycles. The overall mean values of the EM 
and IVUS measurements were 175.S and 181.7 cdmin, 
respectively. The mean cross-sectional velocities ranged 
from 3 to 79 cm/s. The mean vessel diameter was 
4.3 mm with IVUS. As shovvn in the scatter plot, IVUS 
and EM flow measurements were in good agreement 
for low~, basal- a.'1d high-flow conditions. The linear 
regression equation relating IVUS to EM flow was 
IVUS,=r.o EM,+5.72 cdmin, ..'=0.98 (p<O.OOOl) and 
the st<1ndard error of the estimate (SEE) was 25.2 cdmin. 
No complic<1tions related to the IVUS flow measure-
ment were seen in our patients. Figure 4 illustrates the 
recording after <.1 stent implantation at the ostium of a 
renal artery [21]. Three IVUS frames (1, end systole; 2, 
diastole; and 3, pe<lk systole) demonstrate the change in 
the colour velocity mapping corresponding to the 
change in the measured flow, with a maximum flow at 
pe<lk systole. The corresponding flow measured for 
all the successive IVUS frames is plotted below, 
together with the derived area, and the simultaneously-
recorded blood pressure, ECG and Doppler instan-
taneous pe<lk velocity. A very good phasic response 
of the IVUS flow can be appreci<lted. The mean 
flow in this recording was 214 cdmin. The recording 
obtained with the Doppler wire appears at the bottom 
right of Figure 4, with an average peak velocity (APV) 
of 28 cm/s. The area at the level of the Doppler 
!!6 
S. G. earlier et a/. 
recording was 11.2 mm;: (derived from the diameters 
measured in two orthogonal angiographic viev .. ·s by 
QCA). The Doppler derived flow was 2S crn/s 
x 0.112 cm2 x 60=1SS an3 /min. 
Figure 5 illustrates the assessment of the coronary 
flow reserve in a right coronary artery. The difference 
between the lower flow at end-diastole (on the left) and 
the mid-diastole (on the right) is well appreciated with 
the mapping of the velocities in the arterial lumen. This 
recording was obtained during hyperaemia (adenosine 
140 ).lglkg/min). The IVUS derived flow was 1-18 cd 
min. In baseline condition, the IVUS flow (not illus-
tr<.lted) was 48 cdmin, giving a coronary flow reserve of 
3.1. The corresponding Doppler recording is on the 
bottom right of the figure, baseline APV was 11 cm.s 
and during hyperaemia APV reached 30 cmfs. The 
Doppler derived coronary flow reserve was 2.8. 
For the first five patients investigated, there was a 
linear correlation between the IVUS derived and 
Doppler derived flow (average of two measurements of 
each whenever possible): IVUSf= 1.01 Dopr- 20, 
~=0.90. The mean difference between the two flow 
estimations following Bland-Altman was 19 ± 29 cd 
min, for a mean flow of 113 cdmin, ranging from 
30-305 cdmin (in one patient, the IVUS flow •·:as 
assessed in two positions, once in the left main artery). 
There was also a linear correlation between IVUS and 
Doppler-derived coronary flow reserve: IVUScfr ": 1.03 
Dopdr- 0.03, r2 =0.93. The agreement between the 
two methods was very good, with a mean difference 
between the CFR estimations of -0.01 ± 0.21, for a 
mean CFR of 1.9, ranging from 1.3-3.2. The mean 
vessel diameter measured by QCA at the level of the 
Doppler tip was 3.3 ± 0.7 mm. 
Discussion 
We have evaluated a technique for velocity imaging 
and volume flow quantification and demonstrated appli-
cability in the catheterization laboratory. The quantifi-
cation capabilities of the decorrelation approach were 
validated in vivo by comparison of the results to 
simultaneous readings from an electromagnetic flow-
meter, the gold standard in flow assessment. Preliminary 
clinical data demonstrated the feasibility of this method 
and a good agreement with flow estimated by the 
combination of intracoronary Doppler and quantitative 
angiography. 
In the current implementation, rotation of the ultra-
sound beam during acquisition of the M-mode intro-
duces an undesired source of motion and gives only a 
pseudo-M mode recording. Additionally, the variability 
of this rotation exacerbates the problems, further limit-
ing the ability to reliably measure low-flow velocities. 
In mechanical IVUS, such unavoidable velocity non-
uniformity in the rotation of the driving shaft is a 
result of the typically tortuous path followed by the 
catheter inside the arterial tree [22]. An improved 
Blood flow assessment with intravascular ultrasound catheters 
implementation of our flow measurement technique, 
based on array-catheter technology that permits elec-
tronically scanned M-mode operation, is currently being 
implemented [23]. Electronically-steered array transduc-
ers for IVUS offer the ideal scanning configuration for 
flow measurements, since the ultrasound beam is static 
during acquisition of a rf true M-mode. 
A number of limitations of the technique are cur-
rently being addressed. One is the influence of the 
catheter itself on the flow: the Princeps catheter used is 
a 4.1-F device. This corresponds to a diameter of 
1.36 mm and a cross-sectional area of 1.45 mm2 . In a 
proximal coronary artery with a diameter of 3.5 mm, 
the catheter occupies approximately 10% of the lumen 
area, and should not increase the resistance of this 
epicardial segment. On the contrary, once advanced 
more distally, e.g. across a 50% diameter stenosis, two 
potential problems arise: (i) the friction of blood along a 
longer portion of the catheter; and (ii) in the stenosis, 
the catheter occupies 55% of the free lumen area. There 
will be limitation of the flow, mainly in hyperaemia. 
However, this problem could be overcome in the future 
with the development of a smaller catheter. This trend is 
observed with ·the newly developed IVUS devices. The 
smallest systems available today are imaging core wires 
which can even be advanced in the free lumen of 
balloons [24]. 
The presence of the catheter in a curved artery 
creates secondary flow components that are in the 
imaging plane. This contributes to the decorrdation 
rate among successively-recorded rf traces, but does 
not participate in any net flow across the imaging 
plane in the artery. Preliminary simulations by finite 
element modelling in our laboratory have shown that 
the relative proportion of theses recirculating flows 
is in the order of 1% (25]. The presence of turbulence is 
another limiting factor, because it also induces a signifi-
cant decorrelation rate of the rf signaLs. In proximal 
coronary segments, no significant turbulence has been 
observed in an idealized set-up [26]. Depending 
on the flow and the shear rate, the effect of red 
blood cell aggregation could also potentially modify-
the backscattering properties and the decorrelation rate 
as a function of flow [27, 28]. This issue is currently 
under evaluation in our laboratory by nwnerical 
simulation. 
In the catheterization laboratory, there is no true gold 
standard for the invasive assessment of coronary blood 
flow. Doppler velocimetry with miniaturized wires has 
emerged, but there are two crucial steps required to 
accurately calculate absolute volume: (1) the calculation 
of the mean blood flow velocity in a given vascular 
cross-section; (2) the accurate measurement of this 
cross-sectional area [29]. 
(1) The ultrasound beam must be optimally aligned 
parallel with the centerline of flow, and the entire 
flow profile or at least a significant proportion that 
includes the maximal velocity must be insonified. 
Moreover, the physical presence of the Doppler 
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probe should not modify the velocity profile at the 
site of the Doppler sample volume. During our 
recordings, care was taken to have a distance of 
approximately 5 em between the tip of the !VU$ 
catheter and the Doppler crystaL The Doppler 
sample was 5 mm beyond the tip of the Doppler 
wire. This permits recovery of the velocity profile 
[30]. According to the Poiseuille equation, when 
considering a parabolic flow profile, the mean vel-
ocity is the maximal velocity (V maJ divided by two 
[29]. But the non-Newtonian characteristics of blood 
and the pulsatility of the flow induce a blunted 
velocity profile, so that the mean blood flow vel-
ocity may be underestimated by V,.,)2 [26, 31, 32]. 
Nevertheless, validation studies have shown a high 
correlation both in vitro and in vivo between volu-
metric flow measured with an electromagnetic 
flowmeter [33] or with a transit-time ultrasound 
flowmeter [34] and flow derived from Doppler 
measurements using V,,.,)2. Conversely, other 
in vitro and in vivo data using a 3-F Doppler system 
(Millar) or the Doppler Flowire also demonstrated a 
very good correlation between the flow calculated 
as cross-sectional area x V max and the measured 
reference [35-38]. Since, in most of the recordings in 
human coronary arteries, the assumption of a para-
bolic velocity profile is rarely encountered, no 
definitive value can be defined and we used simply 
V,.,..,. In most clinical situations, it is the ratio of the 
hyperaemic flow over the baseline flow that is 
clinically relevant to estimate the coronary flow 
reserve. In that case, CFR assessment could be 
considered insensitive to a velocity profile that may 
be assumed constant. 
(2) A high-quality angiogram, suitable for measure-
ments of the cross-section at the site of the Doppler 
sample volume, must be performed. It must be 
noted, however, that more accurate measurements 
are obtained when the probe is positioned in an 
arterial segment of uniform caliber, so that a mean 
cross-sectional area over a short arterial segment 
immediately distal to the Doppler probe can be 
obtained. However, any error in the diameter 
measurement will be squared in the cross-sectional 
area estimate. Moreover, QCA is performed on an 
end-diastolic frame and the variation of the cor-
onary diameter during cardiac contraction is 
ignored. An alternative method is the combination 
of intracoronary Doppler and NUS. The approach 
was first described by the sequential use of a 3-F 
Doppler catheter followed by an NUS catheter [37, 
39]. The introduction of the Doppler guidewire 
permitted easier simultaneous assessments with the 
IVUS catheter advanced over the Doppler wire [34]. 
We did not use the NUS cross-sectional area, 
because a long distance between the IVUS plane 
and the Doppler measurement is present with the 
Princeps catheter we used. Indeed, there is a rather 
long distal monorail system separating the imaging 
crystal from the tip of the catheter (......, 35 mm) and 
117 
26 s. G. earlier et a/. 
Figure 4 
Figure 5 
118 
Blood flow assessment with intravascular ultrasound catheters 
an additional distance was required to avoid turbu-
lence downstream of the IVUS catheter in the 
Doppler sampling region (5-6 X the catheter diam-
eter [40]). For the same reason, it was crucial to 
perform our recordings in long segments without 
major side branches. An alternative, when flow in 
the left main artery was evaluated, was to first 
perform Doppler and QCA measurements, and then 
advance the IVUS and record the rf signals. 
As reflected by our data, the Doppler measurements 
were perhaps not the most robust gold standard for the 
clinical evaluation of our method, in comparison to 
the measurements obtained in the porcine validation 
experiments. Nevertheless, the limitations related to 
the unknown velocity profile and the exact cross-
sectional area at the Doppler tip are simplified when 
computing the coronary flow reserve. We observed a 
good correlation (dose to identity) and a very good 
agreement between the IVUS and Doppler derived CFR. 
One of the advantages of our IVUS flow method is 
the reduction in the number of intracoronary devices 
introduced. The results of coronary interventions could 
be ideally monitored, and this approach could be more 
cost-effective, offering simultaneous information on 
both the selection of balloon or stent size pre-
intervention, and concerning optimization of the mor-
phological and functional results. Evaluation of the 
significance of intermediate lesions may also be poss-
ible, as well as the assessment of endothelial function 
and arterial distensibility. Presently, most of these 
studies have used QCA and/or intracoronary Doppler 
during administration of acetylcholine (AcCh) [41-43]. 
As a consequence of its higher resolution, IVUS has 
been used to measure changes in cross-sectional area 
during similar pharmacologic challenges [44]. At the 
same time, the visualization of atherosclerotic lesions 
not visible on angiography allows for a better under-
standing of the response to the AcCh infusion [45]. The 
assessment of the contribution of different mediators, 
such as nitric oxide or endothelin, have been studied in 
complex protocols with simultaneous intracoronary 
IVUS and Doppler recordings during specific infusion of 
inhibitors and/or precursors [46, 47]. We believe that 
our simultaneous capabilities to assess flow and lumen 
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area would constitute the ideal tool for such studies of 
coronary haemodynamics and vessel walL 
Presently, IVUS flow is not obtained on-line: 3.75 s 
of acquisition represents 128 Mbytes of data in the 
computer memory that are first stored on the hard disk 
in "'90 s and then processed in ,..,., 3 min, thanks to a 
newly implemented algorithm [48]. It is expected that 
with the increasing speed and power of new computers, 
processing time will go down. Implementation of a 
digital signal processing board for on-line performance 
is currently under study. 
Finally, even in the cases in which the true flow is 
being impeded with the IVUS catheter in a narrow artery, 
a semi-quantitative assessment associated to colour-flow 
imaging could improve visualization of plaque dis-
sections, false lumens, automated lumen area quantiRca-
tion or detection of improperly expanded stents, as 
recently reported [49, 50]. With conventional !VUS, 
detection of plaque fractures and dissections remains 
challenging: frequent saline flushes are often required. 
Conclusion 
Auxiliary use of echo signals available from conven-
tional imaging IVUS catheters can provide blood flow 
information in addition to the structural information 
depicted by the echo image. Morphological and 
physiological information may be simultaneously 
obtained with a single ultrasound catheter. 1'\otwith-
standing the preliminary nature of these developments, 
we have demonstrated· the potential of IVUS flow-
metry for sufficient accuracy and reproducibility to 
warrant clinical applicability. Preliminary clinical data 
have demonstrated the feasibility of the technique in the 
catheterization laboratory. 
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Figure 4. Recording performed in J ren.:~l .:~rtery .:~fter osti.:~l stcnt impbnt.:~tion. Three represcnt.:~tive JVUS fr.:~mes (1-3) during one c.:~rdi.:~c 
cycle .:~rc depicted with J colour mapping of the intralumim! blood velocity. High velocities (yellow) at pe.:~k systole (3) .:~re cbrly seen in 
the centre of the lumen. The NUS flow CJ!cubted on <:~ll the conscrutive frJ!Tlcs (16/s) is plotted in white, together with the simult.meously 
acquired ECG, blood pressure and insbntaneous peak velocity me<:L..;ured with <1 Doppler wire. The me.:m !VUS flow w.:~s 241 cdmin The 
recorded Doppler signal is shown in the bottom right, The .:~verage pe<~k Doppler velocity (APV) wJs 2S cm/s. By quo.ntit.:~tive angiography, 
the cross-scdiofl;lllumcn are.:~ at the Doppler tip WJS 11.2 mmz. Doppler derived flow WJ.S ISS em·'/ min. 
Figure 5. Volumetric blood flow measurement in a right coron.:~ry artery. Top right frJme shows, during hyperaemiJ, mid-diJStole high flow. 
On the top left, the decrease of coronary flow at end diJ.stole is well visu.:~lized. The calculated IVUS flow on the 60 consecutively-acquired 
IVUS fr.:~mes is plotted together with ECG, pressure and Doppler datJ Js in Figure 4. The corresponding Doppler spectrum is sh0\'.'1'1 .:~t the 
bottom right. The Doppler aver.:~ge pe<~k velocity wJs 30 cm/s. The coronary cross-section.:~! area measured with quantitative coronary 
.:mgiography .:~t the level of the tip of the Doppler wire was 7.42 mmz. The Doppler derived meJ.n coronary blood flow (134 cdmln) is in 
.:~grecment with the me.:m flow measured with the NUS RF processing (14S cdmin). The coronJ.ry flow reserve derived from the NUS method 
was 3 (baseline flow, not i!lustr.:~ted, was 4S cdmin), close to the Doppler estimation: 2.8 (lower left comer). 
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Chapter 7b 
Preliminary clinical experience: 
Simultaneous morphological and functional assessment of a renal artery 
stent intervention with intravascular ultrasound. 
SG Carlier, W Li, El Cespedes. AFW van der Steen, JN Hamburger. N Born. PW Serruys. 
Circulation !998:97:2575-2576. 
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Images in Cardiovascular Medicine 
Simultaneous Morphological and Functional Assessment of a 
Renal Artery Stent Intervention With 
Intravascular Ultrasound 
Stephane G. Cartier, MD; Wenguang Li, PhD; E. Ignacio Cespedes, PhD; 
Antonius F.W. van der Steen, PhD; Jaap N. Hamburger, MD; 
Nicolaas Born, PhD; Patrick W. Serruys, MD, PhD 
A 73-year-old woman with a history of high b lood pressure and hypercholesterolemia developed medica II y 
uncontrolled hypenension (200/100 mm Hg). Serum creati-
nine level was 145 JLmOIIL, and creatinine clearance was 34 
mUmin. Renal ultrasound demonstrated a small right kidney 
(80 mm long) compared with the left one (92 mm long). Left 
ventricular hypenrophy was present on the ECG and was 
confirmed by echocardiograpby. On isotope radiography with 
~c-mercaptoacetyltriglycine after oral intake o f 25 mg 
captopril, the right kidney was small. with delayed excretion 
and impaired function (36%). Renal aneriography showed 
subocclusive ostial stenosis of the right renal anery. 
The lesion was related to a calcified plaque extending from 
the aonic wall into the renal anery ostium (angiogram I in 
Figure I. arrow). After an unsuccessful angioplasty attempt in 
the interventional radiology depanment (fai lure to cross the 
stenosis). the patient was investigated in the cardiac catheter-
ization laboratory. The lesion was crossed with a hydrophilic 
guidewire and predilated. A shon (9-mm) stent was then 
implanted by use of a 4.5-mm balloon inflated up to 18 atm 
for postdilatation (angiogram U). 
The immediate result of the intervention was assessed by 
both biplane angiography (angiogram ill. anteroposterior 
projection) and intravascular ultrasound (TVUS). Distal to the 
stent. IVUS shows a normal anerial waU (panel 1 in Figure 
I). A cross section within the stent (panel 2 ) demonstrates 
good expansion and apposition of the struts (arrows). The 
lumen area measured at this level was 18.9 mm2• The arrows 
in panel 3 demonstrate the highly calcified plaque at the 
junction with the aona. 
The top of Figure 2 shows images obtained with a newly 
developed method to quantify the blood flow with an IV US 
imaging catheter. They were recorded distally to the stent 
at different times (a through e) during the cardiac cycle. 
This blood flow measurement method has recently been 
validated and calibrated in vitro against electromagnetic 
flowmeter data and in vivo in porcine carotid arteries.' The 
principle is based on the analys is of decorrelation of the 
IVUS radiofrequency (RF) signa ls. Red blood cells flow-
ing in the ultrasound beam result in a decorrelation of 
successively received RF signals. The rate of decorrelation 
is proportional to the local blood flow velocity.'·3 These 
are then converted into color maps representing local 
instantaneous blood flow velocity in the arterial cross 
section. The color scheme used goes from dark red ( 10 
cm/s) to yellow (I 00 cm/s). Flow velocities are measured 
at 100 angular positions, with a depth resolution of 
160 JLm. Cross sections with color flow data can be 
recorded during a 4-second period at 16 frames per second. 
The moment of each IVUS image with flow information in 
the cardiac cycle is indicated at the bottom right of Figure 2. 
showing flow traces recorded simultaneously with the ECG. 
The instantaneous flow calculated with the fVUS method is 
I m 
II 
Fig ure 1. Angiograms before Q), during (II), and after (Ill) stent 
Implantation in right renal artery. Tight stenosis is indicated by 
arrow in angiogram I. Intravascular ultrasound (IVUS) images (1 
through 3) obtained after stenting at corresponding levels indi-
cated by arrows In angiogram Ill. Arrows in IVUS panel 2 show 
well-apposed struts of stent, and in panel 3, calcified plaque at 
junction with aorta (Ao). 
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2576 Blood Flow Measurement With IVUS 
100 cm/s 
Figure 2. Color mapping of blood flow velocity Inside arterial lumen after procedure, at different phases of cardiac cycle {a through e), 
calculated from Intravascular ultrasound (IVUS) radiofrequency signal analysis. IVUS volume flow {green trace) and Doppler-based vol-
ume flow (blue trace) with corresponding ECG {black trace). Doppler-based volume flow Is calculated from depicted Doppler sonogram 
(range, 0 to 120 cm/s) and diameter measured by quantitative coronary angiography on angiogram Ill at level of tip of Doppler wire. 
IVUS volume flow is calculated by Integrating velocity components over arterial lumen area. The two flow estimations are In good 
agreement. 
represented in green and the flow derived from an intravas-
cular Doppler wire in blue. ln panel a, very low blood flow 
velocities at end diastole are not encoded, because they fall 
below the sensitivity threshold level, which is = I 0 cm/s. 
With increasing flow in early systole (b), the color map shows 
homogeneous blood flow velocities encoded in red. Maximal 
velocities are reached at peak systole (c). The decrease in 
blood flow in diastole is seen in panels d and e. Integration of 
the velocities over the lumen area allows the computation of 
instantaneous volumetric blood flow (green curve) during a 
4-second period. The measurements are in agreement with the 
blood flow simultaneously measured with the Doppler wire 
(in blue: Doppler instantaneous peak velocity times the 
cross-sectional vessel area at Doppler wire tip). The mean 
IVUS flow was 238 mUmin, whereas the flow derived from 
the Doppler wire measurements was 208 mUmin. This 
demonstrates the feasibility of simultaneous assessment of 
morphological and physiological parameters during interven-
tional procedures with an intravascular imaging catheter. The 
method is presently being evaluated in coronary arteries. 
This patient was discharged 2 days after the procedure and 
is doing well. Good early and long-term results of stenting 
126 
ostial renal lesions have been reported recently; with a 
restenosis rate of I 0%, making this procedure the best current 
therapy for renovascular disease related to critical ostial 
stenoses. 
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Figure 2. Color mapping of blood flow velocity inside arterial lumen after procedure, at different phases of cardiac cycle (a through e), 
calculated from intravascular ultrasound {IVUS) radiofrequency signal analysis. IVUS volume flow (green trace) and Dopplervbased vol-
ume flow (blue trace) with corresponding EGG (black trace). Doppler-based volume flow is calculated from depicted Doppler sonogram 
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IVUS volume flow is calculated by Integrating velocity components over arterial lumen area. The two flow estimations are In good 
agreement. 
represented in green and the flow derived from an intravas-
cular Doppler wire in blue. In panel a. very low blood flow 
velocities at end diastole are not encoded, because they fall 
below the sensitivity threshold level, which is -10 cm/s. 
With increasing flow in early systole (b). the color map shows 
homogeneous blood flow velocities encoded in red. Mxcimal 
velocities are reached at peak systole (c), The decrease in 
blood flow in diastole is seen in panels d and e, Integration of 
the velocities over the lumen area allows the computation of 
instantaneous volumetric blood flow (green curve) during a 
4-second period. The measurements are in agreement with the 
blood flow simultaneously measured with the Doppler wire 
(in blue: Doppler instantaneous peak velocity times the 
cross-sectional vessel area at Doppler wire tip). The mean 
IVUS flow was 238 mL/min. whereas the flow derived from 
the Doppler wire measurements was 208 mL/min. This 
demonstrates the feasibility of simultaneous assessment of 
morphological and physiological parameters during interven-
tional procedures with an intravascular imaging catheter. The 
method is presently being evaluated in coronary arteries. 
This patient was discharged 2 days after the procedure and 
is doing well. Good early and long-term results of stenting 
126 
ostial renal lesions have been reported recently.4 with a 
restenosis rate of 10%. making this procedure the best current 
therapy for renovascular disease related to critical ostial 
stenoses, 
Acknowledgments 
The cxccllent technical support of J. Honkoop :md F. Mastik was 
of paramount import:mce for the reali7..ation of this work. 
References 
1. Cartier S. Li W, Mastik F. Honkoop J, v:m der Steen AFW. LuncCe CT, 
de Zccuw S. v:m Bremen R. C<:spcdcs EI. Scrruys PW, Bom K. ::-!ew 
intr.tcoronury volumetric blood flow measurement method vvi!h lntr.1· 
vascul:rr ultrasound: in-vitro nssessment :md first in vivo result.~. Eu.r 
Hean J. 1997;18:376. Abstrnct. 
2. Li W. v:m dcr Steen AFW, Umrec CT. CCspcdcs EI. Gu~enhoven ET. 
Bom N. Esti11lll.tion of local blood velocity :md volume flow with intrn· 
vascular ultrJ.-'Ound. Ultra.sound Med BioL In press. 
3. Li W. Im:.tgc :md Signal Processing in IntrJvaseul:rr Ultr'JSound [PhD 
the~is]. Rotterdum. Ketherl:!nds: Erasmus University; 1997. 
4. Blum U, Krumme B,FlUgel P. Gabelm:mn A. LehnertT. Buitrnga..Tcllcz 
C. Schollmeyer P, Lunger :v:l. T=tmem of ostia1 rena1-:rrtel)' stenoses 
with vn.<.eul:rr endopro!heses after unsucce~ful balloon :mgioplasty. 
N Enr:;l J Med. 1997:336:459-465. 
Chapter 8 
Effect of catheter placement on 3D-velocity profiles 
in curved tubes resembling the human coronary system. 
R Krams, JJ Wentzel, EI Cespedes, R Vinke, 
S Carlier, AFW van der Steen, CT Lancee, CJ Slager. 
U!rrasound in Medicine & Biology, /999; 25:803-810. 
127 
SZ! 
~ Ultra_,ound in Med. & Bioi., Vol. 25. No.5. pp. 803-810, 1999 Copyright© 1999 World Fcdcr.ltion for Ultr ..... ,m.tnd in Medicine & Biology Printed in the L:SA. All righl~ m.erved 030t-5629199/$-sce front ma.ttcr 
ELSEVIER PII $0301-5629(99)00018-6 
411 Original Contribution 
EFFECT OF CATHETER PLACEMENT ON 3-D VELOCITY PROFILES IN 
CURVED TUBES RESEMBLING THE HUMAN CORONARY SYSTEM 
R. I<RAMs,'" J. J. WENTZEL.i·* I. CESPEDES," R. Vr"KE,'~' S. CARLIER,' 
A. F. W. VANDER STEEN,** C. T. LANCEE' and C. J. SLAGER' 
~Laboratory Hemodynamics and "Experimental Echocardiography, Thoruxccntcr. Erasmus University Rotterdam, 
Rotterdam, The Netherlands: *ICIN, Utrecht, The Netherlands: and *Endosonics Corporation, 
Rancho Cordova, CA. USA 
(Received 1 I November 1998: in Ji=l form 28 January 1999) 
Abstract-Novel measurement techniques based on intravenous ultrasound (IVUS) technology ("IVUS-Fiow-
mctry') require the location or a catheter inside the coronary bed. The present study quantifies disturbances in 
the 3~D velocity profile induced by catheter placement inside a tube.. applying computational fluid dynamics. Two 
curved. circular meshes (radius K = 0.025 m and K = 0.035 m) with and without a catheter inside the lumen were 
applied. The catheter was located at the inner curve, the outer curve and at the top position. Boundary conditions 
were: no slip on the wall, zero stress at the outlet, uniform inflow with entrance velocities of 0.1, 0.2 and 0.4 m/s. 
Curvature-.associated centrifugal forces shifted the maximal velocity to the outer curve and introduced two 
symmetrical vortices. Additional catheter placement redistributed the 3~D axial velocity field away from the 
catheter, which was accompanied by the appearance of multiple low~strength vortices. In addition, peak axian 
velocity increased, peak secondary velocities decreased. axial pressure drop increased and shear stress increased. 
Flow calculations simulated to resemble IVUS~based fio'"'metr)' changed by only 1% after considering secondary 
velocity. In conclusion. placement of a catheter inside a curved tube resembling the human coronary system 
changes the velocity field and reduces secondary patterns. The present study supports the usefulness of 
catheter~based flowmetry during resting flow conditions. During hyperemic flow conditions, flow measurements 
might be accompanied by large axial pressure drops because the catheter, itself, might act as a significant 
stenosis. €) 1999 World Federation for Ultrasound in Medicine & Biology. 
Key Words: CFD, Catheter placement, Coronary artery, Shear stress. 
INTRODUCTION 
Steady flow in cylindrical tubes distant from curved 
segments and side branches may be considered parabolic 
("Poiseuillc flow"). The velocity field. during these con~ 
ditions. is described by a velocity vector. oriented paral-
lel to the axes of the artery (Milnor 1982). The human 
arterial system. however, is a complex three dimensional 
(3-D) structure consisting of straight and curved seg-
ments with multiple side branches (Milnor 1982). During 
these circumstances, nonaxially directed velocity com~ 
ponents ('secondary velocity') have been identified (Kil-
ner et al. 1993; Moore et al. 1992). These secondary 
velocities might be implicated in the progression of ath~ 
erosclerosis, and might affect the ultrasonic measure~ 
ment of blood flow (Tortoli et al. 1995: Li et al. 1998. 
1997; Cartier et al. 1998). 
Address correspondence to: R. Kmms, M.D., Ph.D., DeptHemo-
dynamics, Room 2322, P.O. Box 1738, Er:tsmus University Rotterdam, 
Rotterd::un, The Netherlands. E-mail: krams@tch.fgg.eur.nl 
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In general, ultrasound blood flow measurement 
techniques measure blood velocity in the direction of the 
ultrasound beam and assume Poiseuille blood flow to 
evaluate flow (Tortoli et al. 1995). Recently, a novel 
technique for intravascular applications has been devel-
oped that applies a modification of the transit~time 
method to estimate local blood velocity (Li et al. 1997, 
1998). Due to its high in~plane resolution, this method 
not only enables calculation of complete 2-D velocity 
profiles but. due to its combination with intravascular 
ultrasound, one can also measure cross-sectional area. 
which allows the calculation of blood flow (Li et al. 
1998). 
Early results arc very promising (Li et al. 1997. 
1998). but limitations of the method are still under in-
vestigation. One of these limitations might be that ve-
locity in only two directions is estimated (i.e. along and 
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Fig. 2. (A) Example or the curved mesh with a catheter located in the outer curve. (B) The calculated 3-D velocity 
profiles in the axial direction (V • .,.,) and secondary velocities (V occondl· 
evaluated at the inner and outer curve of the curved rube. 
For each location, shear stress was normalized to the 
shear stress values obtained before catheter placement. In 
addition, a shear stress ratio is defined as the shear stress 
at the inner cu.rve divided by the shear stress at the outer 
curve. 
The pressure gradient was obtained directly from 
the output of the FEM package. Pressure difference was 
the total pressure drop and is reported in mmHg ( I kPa = 
7.5 mmHg). To compare different tubes with different 
lengths, we normalized the pressure difference per length 
unit (mmHg/1 0 em). 
Reynolds number (Re = (v*d*p)/T)) was calculated 
during fully developed conditions. In these formulas, v 
signifies the average velocity (m/s), d the tube diameter 
(m). p density (kg/m3 ) and 11 viscosity (Pa.s). 
RESULTS 
Fully developed flow conditions and adequacy of mesh 
The relative difference between the 3-D velocity 
fields at subsequent cross-sections in curved tubes with-
out catheter placement decreased from 7.5% at Cross-
section 2 to less than I% at Cross-sections ll to 14. In 
addition. increasing the mesh resolution by a factor of 
1.5 did not change the 3-D velocity field by more than 
I% at Cross-sections 11 to 14. A similar analysis after 
catheter placement revealed fully development of the 
velocity field at Cross-sections 5 to 15 and accurate 
solutions at Cross-sections 9 to 14. Hence. Cross-section 
12. which corresponds to an axial distance of 0.0295 m 
(± 10 times the diameter), was used throughout the 
present analysis. 
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Axial velocity 
In the absence of a catheter, the interplay of viscous, 
inertial and centrifugal forces in the curved tube redis-
tributes the 3-D velocity field so that maximal axial 
velocity (V mox ... ,) is shifted outward (Fig. I and Fig. 2. 
upper row and Table 1). The outward shift increases 
linearly with entrance velocity, but is unaffected by the 
radii of curvature as applied in the present study (Table 
I). insertion of a catheter modulates the distribution of 
the axial velocity field (Fig. 2 and Fig. 3. first column) in 
such a way that maximal axial velocity is shifted more 
outward when the catheter is in the inner and top posi-
tion. When the catheter is in the outer curve. the velocity 
field is shifted toward the inner curve, introducing high 
gradients on the tube wall (Figs. 2 and 3. first column and 
Table 1). The location (% shift) of the maximal axial 
velocity is hardly affected by entrance velocity after the 
insertion of a catheter (Table I). 
V ma.x.ax increased in parallel with entrance velocity 
and after catheter placement (Table I). The largest in-
crease of V max.ox• at a constant entrance velocity, was 
calculated when the catheter was located in the inner 
curve (22%, Table I); smaller increments were calcu-
lated when the catheter was in the top ( 18%. Table I) and 
outer position (12%. Table 1). 
Secondary velociry 
In the absence of a catheter, two symmetrical vor-
tices appeared at Cross-section 12 for both curvatures 
(Figs. I and 3, lirst row and second column). The distri-
bution of these secondary velocity patterns and the max-
imum of the secondary velocity field were affected both 
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evaluated at the inner and outer curve of the curved tube. 
For each location. shear stress was normalized to the 
shear stress values obtained before catheter placement. In 
addition, a shear stress ratio is defined as the shear stress 
at the inner curve divided by the shear stress at the outer 
curve. 
The pressure gradient was obtained directly from 
the output of the FEM package. Pressure difference was 
the total pressure drop and is reported in mmHg (1 kPa = 
7.5 mmHg). To compare different tubes with different 
lengths, we normalized the pressure difference per length 
unit (mmHg/10 em). 
Reynolds number (Re = (v*d*p)/1]) was calculated 
during fully developed conditions. In these formulas. v 
signifies the average velocity (m/s), d the tube diameter 
(m), p density (kg!m3) and 11 viscosity (Pa.s). 
RESULTS 
Fully developed flow conditions and adequacy of mesh 
The relative difference between the 3-D velocity 
fields at subsequent cross-sections in curved tubes with-
out catheter placement decreased from 7.5% at Cross-
section 2 to less than 1% at Cross-sections 11 to 14. In 
addition. increasing the mesh resolution by a factor of 
1.5 did not change the 3-D velocity field by more than 
1% at Cross-sections 11 to 14. A similar analysis after 
catheter placement revealed fully development of the 
velocity field at Cross-sections 5 to 15 and accurate 
solutions at Cross-sections 9 to 14. Hence, Cross-section 
12. which corresponds to an axial distance of 0.0295 m 
(:±: 10 times the diameter), was used throughout the 
present analysis. 
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Axial velocity 
In the absence of a catheter. the interplay of viscous. 
inertial and centrifugal forces in the curved tube redis-
tributes the 3-D velocity field so that maximal axial 
velocity (V =.ax) is shifted outward (Fig. 1 and Fig. 2. 
upper row and Table 1). The outward shift increases 
linearly with entrance velocity. but is unaffected by the 
radii of curvature as applied in the present study (Table 
1). Insertion of a catheter modulates the distribution of 
the axial velocity field (Fig. 2 and Fig. 3. first column) in 
such a way that maximal axial velocity is shifted more 
outward when the catheter is in the inner and top posi-
tion. When the catheter is in the outer curve. the velocity 
field is shifted toward the inner curve. introducing high 
gradients on the tube wall (Figs. 2 and 3. first column and 
Table 1). The location (% shift) of the maximal axial 
velocity is hardly affected by entrance velocity after the 
insertion of a catheter (Table 1). 
V ma.x.u.x increased in parallel with entrance velocity 
and after catheter placement (Table 1). The largest in-
crease of V m(!X,a.'(· at a constant entrance velocity. was 
calculated when the catheter was located in the inner 
curve (22%. Table 1): smaller increments were calcu-
lated when the catheter was in the top (18%. Table 1) and 
outer position (12%. Table I). 
Secondary velocity 
In the absence of a catheter. tvvo symmetrical vor-
tices appeared at Cross-section 12 for both curvatures 
(Figs. I and 3, first row and second column). The distri-
bution of these secondary velocity patterns and the max-
imum of the secondary velocity field were affected both 
Influence or c~thcter placement on velocity profiles e R. KRA).IJS d a/. 805 
equations are solved with a standard, finite clement 
method, implemented in the finite element package Se-
pran (Sepra, Lciden, Netherlands). The non-linear con-
vective term in the Navier-$tokes equations is linearized 
with a Newton-Raphson approach and solved with a 
cut-off error of 10-4 (m/s). To obtain the pressure un-
knowns from the discrete Navier-$tokes equations, a 
penalty function approach was used. Eliminating the 
pressure unknowns with the penalty method and linear-
izing of the convective term results in a set of linear 
equations with velocity unknowns. A numerical solver, 
applying a direct profile method, of the well-validated 
(Bovendeerd et al. 1987), commercially available finite 
clement package, which was implemented on a worksta-
tion (HP 715/80), solved the resulting matrices. 
The following boundary conditions were imposed: 
uniform steady inflow at the entrance of the vessel: 
constant zero stress at the outlet:and no-slip conditions at 
the tube wall (Bovendeerd et al. 1987). We further as-
sumed that blood behaved as a Newtonian fluid with a 
density of 1050 kg/m3 and a viscosity of 3*10-3 (Pa.s) 
(Bovendcerd et al. 1987). 
Protocols 
Adequacy of mesh resolution and fully developed 
flow condirions. To determine the cross-section where 
flow was fully developed, we calculated the relative 
velocity difference, defined as (v;-V;./v;_1)*100%. V; sig-
nifies the points of the 3-D velocity profile at cross-
section i and Y;.r the velocity profile at the previous 
cross-section. A root means squared difference smaller 
than 1% between successive 3-D velocity profiles was 
defined as fully developed. 
Second, subsequent increments in mesh resolution 
by 50% were applied to evaluate if the lowest mesh 
resolution was adequate to obtain accurate solutions. A 
solution (3-D velocity field) in a given cross-section, was 
defined as accurate when the 3-D velocity field did not 
change more than 1% after increasing the mesh resolu-
tion. The difference between the 3-D velocity fields of 
both meshes was defined as (vcvh/v1)*100, where I and h 
refer to the low and high-resolution mesh. 
Absence of catheter. 3-D velocity vector fields were 
calculated in curved tubes with radii of curvature of 
0.035 m and 0.025 m, and a tube diameter of 0.003 m .. 
To cover a wide range of Reynolds values, three different 
entrance velocities (0.1 rnls, 0.2 m/s and 0.4 m/s) were 
applied to each radius of curvature, adding up to six 
different conditions. 
Presence of catheter. We also evaluated to what 
extent placement of a catheter inside the lumen of a 
curved tube affected the 3-D-velocity field. As idealiza-
tions for the real situation, we positioned the catheter at 
the inner curve (9 o'clock), the outer curve (3 o'clock) 
and at the top (12 o'clock) position of the curved tube. 
These catheter positions were studied at two differem 
curvatures (0.025 m and 0.035 m) and at three different 
entrance velocities (0. l, 0.2 and 0.4 m/s). This adds up to 
18 different conditions. 
Effect of tube size. To study the effect of tube size. 
we used tubes with diameters of 0.003 m and of 0.002 m. 
but catheter diameter was kept constant at 0.001 m .. The 
catheter was located at the outer wall and the radius of 
curvature was 0.025 m .. Entrance velocities were 0.1 
m/s, 0.2 m!s and 0.4 rnJs. 
Analysis 
The three components of the velocity field (u, v and 
w) were calculated. U and v are the cross-sectional in-
plane velocity components and ;v the axial velocity com-
ponent (i.e. along the tube). The in-plane velocity vectors 
u and v were added (vector addition) and are presented as 
secondary velocity components. Ma.ximal axial (V max.a. ... ) 
and maximal secondary velocity (V m:~x.s=) were calcu-
lated for each condition and normalized to mean entrance 
velocity. In addition. the location of the maximal axial 
velocity component with respect to the center of mass of 
each cross-section was calculated. This location was 
subsequently normalized to the radius of the tube, and 
presented as percentage shift (%shift). 
Comparison between meshes of different size and 
resolution was accomplished by interpolating the data 
points of the mesh with the lowest resolution to the 
resolution of the mesh with the highest resolution. ap-
plying a linear interpolation method (MATLAB, Math-
works Inc., Natick, MA. USA). 
To simulate conditions resembling IVUS fl.ow-
metry. we calculated_ flow in two ways: Total flow was 
defined as the magnitude of the velocity vector multi-
plied with the cross-sectional area. Axial flow was the 
product of axial flow and cross-sectional area, in which 
axial velocity was defined as the magnitude of the 
velocity vector multiplied with normal on the cross-
section. Due to the discretization of the mesh, we defined 
both parameters locally and summarized over the ele-
ments of the mesh. Regional area was calculated as 
0.5(lcross(a,b)l + jcross(c,d)l). where a, b. c and dare 
the sides of a quadrangle in the cross-section of interest 
(cross signifies the vector cross product). Local velocity 
was calculated from the average of magnitudes of the 
four velocity vectors located at the vertices of the local 
area. The error in flow estimation was defined as ((total-
flow - axialflow)/totalflow)*lOO. 
Shear stress, calculated from the product of viscos-
ity and the local gradient of the velocity field. was 
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Fig. I. (A) Example of the curved mesh with the catheter absent. (B) The calculated velocity profiles (V .. ,.1) and 
secondary velocities (V sccon<J>· 
across the ultrasound beam), thereby missing the circum-
ferential component in the plane of imaging (Li et al. 
1997). Hence. velocity components in the axial and in-
plane direction cannot be completely separated. Conse-
quently, significant secondary velocities could lead to an 
overestimation of the true blood flow. One other inherent 
limitation of the technique is introduced by the presence 
of the catheter, which might increase the pressure differ-
ence or disturb the velocity patterns and preclude the 
possibility of obtaining physiological velocity profiles in 
vivo (Wentzel et al. 1997). 
The aim of the present study was multiple. First, the 
relative contribution of the secondary velocity compo-
nents to blood flow was evaluated in curved tubes re-
sembling the curvature of the human coronary arteries 
(Krams et al. 1997), before and after placement of a 
catheter. Second, the axial pressure difference is reported 
and, because the axial pressure difference is affected by 
flow. vascular resistance was evaluated. Third, due to the 
reported effect of shear stress on atherosclerosis. we also 
evaluated how shear stress is affected by the introduction 
of a catheter inside the lumen. Finally. to understand the 
nature of these disturbances in more detail. tbe modulat-
ing effect of the degree of curvature. tube diameter to 
catheter radius and Reynolds number are evaluated on 
these parameters. 
MATERIAL AND METHODS 
Simulated fluid flow can be studied in detail if the 
equations of motion are solved. Analytical solutions of 
these equations are only possible under certain simplified 
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conditions (Bovendeerd 1987). For the present study, 
these simplified conditions are not met and the full 
non-linear partial differential ('Navier-Stokes') equa-
tions have to be solved numerically (Bovendeerd et al. 
I 987). The numerical technique is based on the discreti-
zation of the region of interest with finite elements ('3-D 
mesh'). 
3-D mesh formularion 
To resemble the human coronary arteries (K.rams et 
al. 1997), we generated a 3-D geometry consisting of a 
curved, circular tube with a radius of curvature of either 
0. 025 or O.Q35 m and a diameter of 0.003 m (Fig. I). The 
resulting vessel segments, which occupied a quarter of a 
circle, were represented by 16 cross-sections along the 
tube. This resulted in an axial resolution of 2.45*10'3 m 
and 3.45*10-3 m for radii of curvatures of 0.025 and 
0.035 m. ln the absence of a catheter, 32 elements were 
placed in each cross-section. When a catheter was lo-
cated inside the tube, 80 elements were located in each 
cross-section to account for the increased geometrical 
complexities. The cross-sectional in-plane resolution was 
2.2*10- 7 m2 for the 3-D-mesh without a catheter and 
8.9*10-8 m2 for a 3-D-mesh with a catheter. 
Complllational fluid dynamics 
Each 3-D element of the mesh consists of an 
isoparametric hexahedral element with 27 nodes per el-
ement. At each nodal point, the nonlinear partial differ-
ential equations ('Navier-Stokes equations') for incom-
pressible. isothermal fluids are implemented. These 
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Table I . Characteristic parameters obtained from the 3-D velocity field obtained from the solut ions of the Navier-
Stokes equations. 
Curvature 0.025 m Curvature 0.035 m 
Shift,,(%) V m~." (m/s) V m~ . .,c (m/s) Shift~(%) v m~.~' (m/s) V ma<.rec (m/s) 
No calheter 
10 cm/s 8 0.19 0.0115 8 0. 19 0.0088 
20 cm/s II 0.36 0.0334 I I 0.37 0.0260 
40 cm/s 15 0.68 0.0730 15 0.69 0.0586 
Catheter out 
.1 m/s 14 0.22 0.0092 14 0.22 0.0070 
.2 m/s l4 0.40 0.0254 14 0.41 0.0197 
.4 m/s 17 0.74 0.0578 17 0.76 0.0451 
Catheter in 
.I m/s 16 0.23 0.0094 16 0.23 0.0074 
.2 m/s 20 0.44 0.0274 20 0.44 0.0226 
.4 mls 20 0.83 0.0677 20 0.83 0.0571 
Catheter top 
.I m/s 17 0.22 0.0097 16 0.22 0.0075 
.2 mls 20 0.43 0.0311 17 0.44 0.0232 
.4 m/s 17 0.81 0.0710 17 0.83 0.0572 
% shifl ;::; relaLive posilion of maximal axial velocity with respect to the center of the tube(%); V,noa;,. ::~.~ = magnitude of maximal 
axial velocity (m!s); V'"~-= = magnitude of maximal secondary velocity (mls). 
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by entrance velocity (V max.s• Table 1) and by curvature 
(Fig. 3, second column). Placement of a catheter either at 
the inner wall or at the top position shifted the vortices 
further outward; placement at the inner curve moved the 
vortices toward the inner curve (Fig. 3, second column). 
Relative secondary velocities (i.e., normalized to 
mean axial velocity) varied between 11 to 19% in the 
absence of a catheter and between 9 and 18% after 
introduction of a catheter (Table l ). Hence, the catheter 
reduced secondary velocities. 
No 
Out 
In 
Top 
Vsecond 
i
O.CE 
O.G 
O.ll! 
0.03 
0.01 
0.01 
Fig. 3. Color map and isocontour lines of the 3-D axial velocity field (first column) and 3-D secondary velocity field 
(second column) at a curvature of 25 mm. The upper row is in the absence of a catheter (NO), a catheter in the outer 
position (OUT), the third row in the inner position (IN) and the bottom row for a catheter in the top posi tion (TOP). V "";, 1 
is the axial velocity (m/s): Vsecono signifies the secondary velocities (m/s). 
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Table 2. Shear stress and axial pressure difference calculated from the solutions of the Navier-Stokcs equations 
Cur~aturc 0.025 m -I Cur~o.turc 0.035 m -I 
SS,n (N/m2) SS""' (N/m~) Ap3 (mmHg) Ap:.:_ (mmHg) ssm (~/m~) SSQ"' (:-.l/m~) Ap3 (mmHg) 
No cothetcr 
.I mh 0.727 !.049 0.40 NA 0.727 0.996 0.53 
.2 rnls 1383 2.766 0.95 NA 1.380 2.635 1.22 
.4 rnls 2.679 6.411 2.35 NA 2.700 8.199 2.97 
Catheter out 
.1 m/s 1.1 17 0.225 0.72 3.55 1.200 0.231 0.96 
.2 m/s 2.052 0.482 2.02 7.27 2.098 0.491 2.11 
.4 m/~ 3.818 1.107 3.86 15.28 3.890 1.094 4.91 
Cothcter in 
.I m/s 0.240 1.564 0.68 NA 0.2057 1.517 1.01 
.2 m/s 0.513 4.057 1.73 NA 0.441 3.863 2.36 
.4 mh. 1.167 10.010 4.14 NA 1.051 ]0.010 5.27 
Cotheter top 
.l m/s 1.119 1.271 0.75 NA 1.1 I I 1.243 0.98 
.2 m/s 2.116 3.484 1.70 NA 2.100 3.291 2.20 
.4 m/s 4.024 8.595 4.23 NA 4.124 8.393 5.33 
SS,, "' shear stress at inner cur~e (N/m~): SSQ"' "" shear stress at outer cur~c (1\/m~): Ap3 ond t.p~ "" denote the axial pr~sure 
differences (mmHg) for wbcs of 0.003 m and 0.002 m diameter, re;;pectively; NA = not available. 
Flow calculations 
The ratio of axial regional flow over flow varied 
between 0.5 and 1% and remained in this range after 
catheter placement. Neither the different entrance veloc-
ity nor the placement of a catheter affected these values. 
Shear stress 
In the absence of a catheter, shear stress was higher 
in the outer curve as compared to the inner curve, leading 
to shear stress ratios of 1.44 for 0.025-m and 1.37 for 
0.025-m curvatures for entrance velocities of 0.1 rrv's. In 
addition, the shear stress ratio increased to 2.00 and 2.39 
with entrance velocity to 0.2 mfs and to 0.4 m/s for 
0.025-m curvatures and to 1.90 and to 2.30 for 0.035-m. 
curvatures. Catheter placement decreases shear stress in 
its own vicinity and increases shear stress at the opposite 
free wall (Table 2). Consequently, the shear stress ratio 
increases to values of 6.67, 7.87 and 8.55 for a catheter 
located at the inner wall of a 0.025-m curved tube at 0.1, 
0.2 and 0.4 rrv's entrance velocity. Changes to 1,14, 1.65 
and 2.14 for a catheter located in the top position for a 
0.025-m curved tube was calculated at 0.1, 0.2 and 0.4 
m/s. For a catheter in the outer position, inner curve shear 
stress values increased over outer curve shear stress 
values, leading to shear stress ratios of 0.19, 0.23 and 
0.29 (Table 2). Minimal additional differences in the 
effects were noted for 0.035-m curved vessels. 
Pressure difference and tube resistance 
The pressure difference calculated along the entire 
tube varies linearly with entrance velocity from 0.4 to 4.2 
mmHg (Table 2). For comparison, between 0.025-m and 
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0.035-m curved tubes. we corrected the pressure differ-
ence for the different length of the tubes (Fig. 4). Cath-
eter placement approximately doubles the normalized 
pressure difference at each entrance velocity for tubes of 
0.003 m. For tubes of 0.002 m in diameter. a 7-fold 
increase in normalized pressure difference was noted 
(Fig. 4). Note that tube resistance. which is the ratio of 
pressure difference over flow. increases with entrance 
flow: 6.8. 8.7 and 10.4 mmHg.s!m2 (i.e. 267%.271% and 
259% at 0.1. 0.2 and 0.4 m/s entrance velocity for tubes 
'E 40 
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Fig. 4. Normalized pressure difference vs. ent:r.mcc velocity for 
different conditions. !::::. and .A. denote absence of catheter; 'V and 
T denote catheter in outer curve; 0 and + denote catheter in 
the inner curve; 0 denotes catheter in the upper position. G 
Catheter in outer position in 0.002-m tube. Open enclosed 
symbols signify 0.025- and 0.035-m curvatures. respectively. 
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of 0.003 m. independently of catheter location). For the 
0.002-m tube. resistance increases up to 38.2 mmHg.slm2 • 
DISCUSSION 
The complex velocity patterns that have been iden-
tified in the arterial bed of humans (Milnor 1982: Kilner 
et al. 1993: Moore et a!. 1992) are of significance be-
cause specific characteristics of those velocity patterns 
have been associated with the progression and regression 
of atherosclerosis (Kilner et al. 1993: Moore et aL 1992). 
At present, the Doppler-based methods assume Poi-
seuille flow conditions to calculate particle velocity from 
the Doppler shift. Recently, a novel technique. based on 
IYUS technology, has been developed that overcomes 
the simplifications induced by the Doppler methods (Li 
ct al. 1998). 
Some potential limitations of this novel method are 
currently under investigation. In this paper, we consider 
the fact that secondary velocity is not fully taken into 
account (Li et al. 1998) and, second. that the catheter 
itself disturbs the velocity profile. We applied a compu-
tational fluid dynamic (CFD) technique to quantify these 
effects. We will first discuss disturbances induced in the 
3-D velocity field, followed by the effect on shear stress. 
flow and the pressure difference. 
3-D velocity field 
With laminar flow in a long straight tube with a 
Newtonian fluid. the velocity profiles are parabolic with-
out secondary velocity components. In curved vessels, 
the 3-D velocity profile is distributed toward the outer 
curve, a phenomenon that is accompanied by secondary 
velocities. These secondary velocities arise as a conse-
quence of the curvature-related centrifugal forces acting 
on the fluid elements in combination with viscous and 
inertial forces (Bovendccrd et al. 1987: Chang and Tar-
bell 1988: Nosovitsky ct al. 1997). These forces induce 
pressure differences perpendicular to the axial direction 
of the tube, which induces the in-plane velocity ('sec-
ondary velocity'). In the present study, secondary veloc-
ities in the order of 10-15% were calculated. which is 
large compared to the values reported by Perktold et al. 
(1991). However, these authors used smaller curvatures 
than we did to simulate the coronary epicardial bed. We 
derived representative curvature values from 3-D recon-
structions obtained directly from the coronary system of 
humans (Krarns et al. 1997). 
Secondary velocities decreased after inserting a 
catheter in the curved tubes. Insertion of a catheter also 
induces a shorter entrance length for flow development. 
These observations might be due to the existence of an 
additional boundary layer surrounding the catheter, 
which reduces the "freedom" to induce in-plane pressure 
differences. Support for this explanation is found in the 
fact that the effect of the catheter is the smallest where 
the boundary layer is minimal (i.e. when the catheter is 
located at the outer curve). 
The observation that maximal axial velocity in-
creases after catheter placement, even when nonnalized 
for mean velocity, might be explained by similar argu-
ments. Due to the additional boundary layer of the cath-
eter. the 'effective' flow region decreases more than is 
expected on basis of decrements in cross-sectional area 
caused by the insertion of the catheter. Hence. a similar 
flow has to pass through a smaller region and the fluid 
clements need a higher velocity. 
Because the secondary velocities do not add to the 
forward flow, we also evaluated their effect on potential 
errors in volume flow measurements based on transit-
time velocity measurement technique ("IVUS-Flow-
metry"). We calculated that, under the present condi-
tions, the secondary velocity components were in the 
order of 5-15% of total velocity. We calculated a devi-
ation in the flow smaller than 1% when flow calculations 
based exclusively on axial velocity were compared to 
flow calculations based on the magnitude of the entire 
velocity vector. The small error arises because the mag-
nitude of axial velocity is a projection (cosine) of total 
velocity vector. The estimated angle of the cosine was 
approximately 8°, which leads to an error of below 1%. 
Shear stress and pressure difference 
The catheter acts as a long stenosis and. conse-
quently. it affects the pressure difference in our flow-
driven system. We calculated an increase in pressure 
difference of 2 mmHg for an area stenosis of 11% 
(0.001-m catheter in a 0.003-m tube) and of 15 mmHg 
for an area stenosis of 25% (0.001-m catheter in a 
0.002-m diameter tube). This highly nonlinear effect can 
be reconciled by the nonlinear relationship between pres-
sure difference and area stenosis. which is due to the 
fourth order relationship between resistance and diame-
ter (Milnor 1982). 
Shear stress at the wall decreases near the catheter, 
but an increase in shear stress opposite to the catheter 
position was noted. The latter finding may be explained 
again by the existence of an additional boundary layer. 
Therefore. velocity and shear rate decrease near the 
catheter and increase distant from the catheter. At con-
stant viscosity. shear stress changes in parallel with shear 
rate. 
Limitations of the method 
Entrance and outlet conditions and the grid resolu-
tion may affect computational fluid dynamics. We tested 
if the flow was fully developed to evaluate if restrictions 
imposed by the boundary conditions were of importance. 
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It could be shown that the flow field at Cross-section 12 
(60° of the bend) was fully developed and, hence, inde-
pendent of axial location in the tube. This finding is in 
accordance with theoretical estimates of 6 times the 
radius of the tube for full flow development, which is 
equivalent to 0.018 m of arc length (Olsen and Snyder 
1985; Bovendcerd et al. 1987). The cross-section of 
anaiysis (i.e., Cross-section 12) was positioned at ap-
proximately 0.032 m of arc length. Hence, the present 
analysis is independent of in- and outlet conditions and 
pertains to steady-state conditions. Increasing the reso-
lution of the mesh did not affect the 3-D velocity vector 
field at Cross-section 12 under our conditions; hence, the 
axial velocity component is accurately calculated by this 
approach. 
Although blood is a shear thinning viscoelastic fluid 
(Bovendcerd et al. 1987), as a first approach we assumed 
the fluid applied in the present calculations to be New-
tonian. This assumption is not very restrictive, because 
the velocity gradients of the present calculations are 
high, especially after catheter placement. Blood can be 
considered Newtonian for shear rates higher than I 00 
s- 1• Consequently. nonNewtonian effec~ are expected 
to be minimal under the present conditions. 
Coronary flow and not coronary velocity is kept 
relatively constant by the impedance of the microcircu-
lation, due to autoregulation. However. the pressure dif-
ferences calculated in the present conditions were so 
high that autoregulation would not be able to keep flow 
constant. Furthermore, the same autoregulation would 
induce a shear-dependent diameter expansion in the ves-
sel segment under study. Hence, to avoid these complex-
ities, we have assumed constant entrance velocity. Con-
sequently. our data should be interpreted with caution 
because. in practice, both above-mentioned factors (i.e .• 
velocity and shear stress) may change after catheter 
placement. 
We did not include side branches and elasticity of 
the walls to make the problem easy to solve analytically 
and numerically (Bovendeerd et al. 1987: Olsen and 
Snyder 1985: Berger and Talbot 1983). In addition, out 
of plane curvature has been measured in the human 
coronary system (Asakura and Karina 1990). The present 
analysis should, therefore, be considered as a first order 
analysis. 
In summary. placement of a catheter inside a curved 
tube resembling the human coronary system affects the 
distribution of the velocity field, and appears to have a 
secondary velocity-reducing effect. Because the effect of 
secondary velocity on flow calculations is already small 
in the absence of a catheter, the present study supports 
the usefulness of catheter-based flowmetry during resting 
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flow conditions. During hyperemic flow conditions, flow 
calculations might be accompanied by large axial pres-
sure drops because the catheter, itself. might act as a 
significant stenosis. This effect is particularly pro-
nounced in small tubes and in the presence of a stenosis. 
Consequently, hyperemic flow might be reduced despite 
accurate measurement of flow. 
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Abstract 
In recent years, we introduced a new method to measure 
transverse blood flow based on rhe decorrelation of the 
Radio Frequency (RF) signals of Intravascular Ultrasound 
(NUS) scanners. We report here in vitro testing to evaluate 
this decorrelation-based method using an intravascular 
array catherer. First. a calibration file was produced using 
a line-target moved transversally across the ultrasound 
beam. The autoconvolution of the measured acoustical 
beam was used as the calibration of the decorrelation-based 
method. Second. blood flow experiments were carried out 
with different catheters in tube with a diameter ranging from 
3 to 5 mm. Flow was measured with a calibrated Transonic 
flowmeter (range: 0 to 341 cc/min). Excellent linear rela-
tionships we refound beMeen the NUS derived flow and the 
calibrated flowmeter (all r>0.99). The catheter position 
within the tube and the si:.:e of the ring-down were experi-
mentally and theoretically analy:.:ed. These elements have 
an important influence on the NUS blood flow measure-
ments reflected by the offset and the slope of the linear rela-
tionships. Experimentally. the offset ranged from 6 to 182 
cc!min and the slope from 0.13 to 0.39. However. by cor-
recting the offset -that can be measured by processing the 
1VUS RF signals when the flow is interrupted- an excellent 
agreement benveen the estimation of the coronary flow 
reserve (CFR= flow I baseline flow) derived from the 
Transonic and the NUS measurements could be found: the 
mean ± standard deviation of the differences benveen the 
Mo methods was 0±0.19.for a mean CFR of2. 
In conclusion, rhe results of this in-vitro validation of the 
decorrelation metlwd of RF signals of an array NUS scan-
ner ro derive quantitative volume blood flow and coronary 
flow reserve are very encouraging and warrant further in 
vivo investigations. 
Introduction 
Intravascular ultrasound (IVUS) has been used for many 
purposes as it provides real-time cross-sectional images of 
blood vessels at a high-resolution (Roelandt ct al.. 1993: 
Erbel ct :l.l .. 1998: Nissen and Yock. 2001). As an imaging 
tool, IVUS allows to measure the lumen and vessel wall 
(von Birgelen et :l.l .. 1998) and the progression of athero-
sclerosis and restenosis (Di :Mario et al .. 1998). Furthermore, 
important applications of NUS are the guidance of thera-
peutic interventions such as coronary stcnts implantation 
(Schatz. 1989; Colombo et :l.l .. 1995: de Jacgcrc ct :l.l .. 1998: 
Schiele et al .. 1998) and the evaluation of intravascular 
intervention (Di Mario ct al., 1995: Blasini ct aL 1997: 
Schwarzachcr et al .. 1997). Current research in IVUS has 
focused on obtaining information concerning the acoustic 
and elastic properties of the vessel wall and plaque for the 
purpose of vascular tissue characterization (Bridal et :l.l., 
1997: Spencer et al .• 1997; Komiyama et al .. 2000). RF-data 
processing has significantly enhanced the potential ofiVUS 
(van dcr Steen ct :l.l., 1998) and aims now at obtaining infor-
mation concerning vessel wall and mechanical plaque prop-
erties (Brid:l.l ct al .. 1997: Cespedes et al., 1997: de Korte et 
al .• 1998: de Korte ct al .. 2000). In addition. IVUS has been 
applied to measure blood flow velocity and volumetric flow 
(Li ct aL 1996: Carlicr et al .. 1998: Li ct al., 1998). 
Methods to assess blood flow include Doppler processing 
and time-domain correlation techniques (Isner et al .. 1993: 
Chou et :l.l .. 1994: Carlicr et :l.l .. 1998). Intravascular volu-
metric blood flow can be assessed with configurations such 
as combined Doppler Flowire and IVL'"S or Doppler Flowire 
and Quantitative Coronary Angiography (QCA) (Scrruys et 
al .. 1993: Sudhir ct al., 1993: Doriot et al., 2000). A Doppler 
Flowirc is a guide wire with a Doppler transducer in the tip 
(Doucette et al.. 1992). However. these configurations do 
not easily allow the operator to assess blood flow velocity 
and lumen area simultaneously and at the same location. 
:Moreover. the mean blood flow velocity is derived fTOm the 
assumption of a parabolic flow profile that is rarely encoun-
tered in human coronary arteries (Carlier ct aL 1999). 
Recent research have rendered the measurement of blood 
flow velocity and the quantification of volume blood flow 
using a decorrelation-based method with a rotating single-
element catheter (Li et al .. 1998: Li et al .. 1998). The corre~ 
lation of the received IVUS RF signals could be evaluated 
as a function of time using a sequence of RF signals 
acquired at a fixed pulse interval from the same angular 
position. After gating the RF sign:l.ls with a fixed window 
length. the sequence of RF sign:l.l windows is phase-
matched to remove the axial motion of the seattercrs and 
then the correlation coefficients is calculated as a function 
of time. ~ext. in a controlled experimental environment. the 
correlation coefficients have been obtained as a function of 
transverse displacements of the scatterers to calibrate the 
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method. Thus, after the time and displacement correlation 
functions have been established, the correlation coefficients 
can be converted into velocity. Assuming that the only 
cause of decorrclation is the transverse displacement of the 
scattercrs (i.e. noise~less RF sign::Us), the velocity can be 
obtained from the ratio of the correlation coefficient as a 
function of displacement (calibration) and the correlation 
coefficient as a function of time (measured). First initial in 
vivo evaluations of volumetric blood flow assessment based 
on this method using o. rotating single~clcment catheter have 
been presented (Carlicr et al .• 1998: Cespedes et al., 1998: 
Carlier et al .. 1999). 
The use of mechanically rotated transducer to measure flow 
requires compensation for the intrinsic decorrelation due to 
rotation. This could be cumbersome if the rotation is not 
uniform. NUS array catheters arc not hampered by rota-
tional problems. The array transducer is capable of trans-
mitting and receiving many echoes at a fixed angle. The 
array is scanned electronically (Eberle. 1997). The decorrc-
lation properties of the NUS array catheter during trans-
verse blood flow have been simulated and recently reported 
(Lupotti et al .. 2000: Lupotti et ::U .. 2001). The mean decor-
relation pattern for scattering media containing only point 
scatterers, as red blood cells (RBCs). corresponded to the 
autoconvolution of the acoustical beam. 
During this study. in vitro recordings were performed to 
evaluate the dccorrelation-based estimation of quantitative 
volume blood flow using the autoconvolution of the meas-
ured acoustical beam as o. calibration file. The experiments 
were carried out for different lumen diameters. for several 
catheters, and for different catheter positions within the 
lumen. Coronary flow reserve was measured from the data: 
using a computer program. the influence of the catheter 
position and the ring-down size on the blood flow measure-
ments was also studied. 
Methods 
IVUS rransducer 
The NUS array catheter is formed by 64 elements mount-
ed on a circular surface of a catheter tip with a diameter of 
1.2 mm. The array transducer operates at a central frequen-
cy of 20 MHz and with a -20 dB bandwidth of 7.5 MHz 
(Eberle. 1997: O'Donnell ct al., 1997). The clement size of 
the array under study is 0.7 mm in length and 28 f.UU in 
width: the pitch of the elements was 59 Jlffi· The array trans-
ducer operates in synthetic aperture focusing mode for 
imaging and linear mode for flow imaging. Synthetic apcr~ 
turc focusing mode is not suitable for flow assessment since 
the acoustical beam is formed over a time frame on the 
order of milliseconds. during which. the red blood cells will 
move through the beam and will influence flow assessment 
based on correlation. Therefore. in flow imaging. four ele-
ments are electronically tied together and produce a burst of 
ultrasound pulses in linear array mode. Then, the selected 
elements are electronically shifted by one and the next burst 
is generated. The circular array is linearly scanned and 
pulsed 64 times to produce a frame. 
Experimental setup for measuring the Acoustical Beam 
The measurement system was formed by a water tank that 
held the motion system, the cchosystem (JoMcd Imaging. 
Rancho Cordova, California 95670) with the IVUS array 
catheter (20 MHz Vision 64FfXTM. JoMed Imaging). and 
the .A.JD~converter PC (Figure 1). The .A.JD~convcrtcr PC 
contained a Pentium computer with an acquisition board 
(Signatec. Corona. CA. USA) with 128 Mbytes to store the 
RF data at a sampling frequency of 200 !viHz in S bits. The 
water tank was filled with degassed water at room temperature 
(z 22° C). An ultrasound absorber was placed on the bottom 
and on both sides of the tank to reduce ultrasound reflec-
tions. The motion system. with a precision in the order of 
microns. was a manual micrometer fixed to the water tank; 
the micrometer was capable of moving a target in x (trans-
verse across the ultrasound beam) and : (along the ultra-
sound beam) directions. The target was a line reflector con-
sisting of a fiber of S ~ in diameter (Kevlar. Du Pont de 
Nemours Int. S.A .. Geneva. Switzerland). The line-target 
was held in a ring fixed to the motion system placed under 
the water level and positioned orthogonal to the axes of the 
array transducer. Supported by a fixing system. the IVUS 
array catheter was placed under the water level between the 
ultrasound absorber and the line-target (Figure 1). The dis~ 
tance between the line-target and the array transducer sur-
face was set by the motion system and depended on the 
acoustical-beam depth of interest. 
Measurement of the Acoustical Beam 
The line-target was moved across the ultrasound beam in 
I w~t<:TWwl I 
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Figure 1: Block diagram of the used set-up for measuring the ultrasound beam: the echOS)'l'tcm, the AJD~eonvcrter PC and the water tl.nk 
with the motion system; the IVCS array catheter connected to the echosystem and placed into the water tank. 
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the transverse direction using the micrometer (dx= 20 )lffi). 
At each displacement. three frames containing the backseat~ 
tcrcd RF signals (15 RF signals per angle for 64 angles) 
were acquired by the AiD-converter PC and then saved to 
hard disk. After the line-target was completely moved 
across the ultrasound beam. the 15 RF signals from the 
angle containing the ultrasound reflection from the line-
target with maximum amplitude were averaged to reduce 
the electronic noise. This was performed over the three 
frames and then an average of the three frames was calcu-
lated. The averaged RF signals were used to calculate the 
autoconvolution of the acoustical beam. The experimental 
setup allowed the rotation of the array catheter so different 
clements of the array transducer -angles- could look 
towards the line-target For the ncar field. the experiment 
was performed for 8 different catheters for 2 angles per 
catheter: and for the far field. the experiment was performed 
for 5 different catheters and for 2 different angles per 
catheter. A higher number of experiments was performed in 
the near field due to the observed irregularity of the acousti-
ca1 beam close to the array transducer. 
Calibration Method 
As it was explained in the introduction. the dccorrclation-
based method needs to be calibrated in order to convert the 
measured correlation coefficients as a function of time into 
transverse velocity. Obtaining the correlation coefficients as 
a function of transverse displacements docs this. The 
process to obtain such a calibration is time consuming since 
many experimental realizations have to be performed. A 
previous study (Lupotti et al .. 2000) showed good agree-
ment between RF correlation coefficients as a function of 
transverse displacements and the autoconvolution of the 
acoustical beam. Thus. the c:ilibration of an ultrasound 
beam for measuring quantitative volume blood flow using 
decorrelation-based method could be assessed by only a 
theoretical evaluation of the acoustical beam such as the 
autoconvolution of the acoustical beam. The acoustical 
beam was experimentally measured for depths ranging from 
0.5 mm to 6 mm with steps of 0.5 mm and then by per-
fanning the autoconvolution of the measured acoustical 
beam the calibration file was produced. 
Experimental Setup for Blood Flow measurements 
The experimental setup was formed by a water tank. the 
echosystem and the IVUS array catheter, the AiD-converter 
AD·Convcrtcr PC 
PC and a transonic flowmeter (30 MHz transducer. 
Transonic System Inc .. Ithaca, NY, USA) (Figure 2). 
The water tank (40 em long) was filled with degassed water 
at room temperature("' 22° C) and an ultrasound absorber 
was placed on the bottom and at both sides of the tank to 
reduce ultrasound reflections. The IVUS array catheter was 
placed inside four different 40-cm long straight tubes with 
inner diameters of 3.0, 3.5. 4.0 and 5.0 mm. The localion of 
the catheter inside the tubes was chosen to be preferably 
eccentric with respect to the lumen of the tube (i.e. against 
the tube wall). Laminar flow conditions were not required 
during the experiments since in coronary arteries this con-
dition is hardly reached and thus flow in· and outcome 
effects were not taken into account. A valve was placed just 
after the upper bicker to regulate the blood flow. The tran-
sonic flowmeter was connected to the tubing system just 
after the exit of the water tank. Fifteen full frames for each 
flow condition were saved to hard disk and then used to cal-
culate quantitative volume blood flow using the decorrcla-
tion-bascd method. The transonic flowmeter was previous· 
ly calibrated using the same human blood sample. for a 
range of volumetric blood flow from 0 to 250 cdmin, using 
the conventional time-volume approach. 
Blood preparation 
Outdated packs of concentrated red blood cells (RBC) from 
the blood bank of our hospital were used during the exper-
iments. The blood sample was diluted with Haemaecl solu-
tion to reach normal hematocrit and preserved normal blood 
viscosity. During the experiments. blood manipulation was 
performed in such way to avoid cellular damage and 
changes in the hematocrit and in the mean corpuscular vol-
ume (MCV). The blood temperature was kept low, around 
25° C. to avoid red blood cell destruction. A blood test for 
the RBC counts. hematocrit and MCY was performed just 
before and after the experiments and the results showed 
almost no change in both parameters. The hematocrit was 
0.249 LIL and 0.278 LIL and the MCV was 62.4 fL and 
62.2 fL. pre and post-experiments, respectively. 
Simulation of ::.era flow RF signals plus noise 
A computer simulation program (Borsboom ct al., 2000: 
Lupotti et al .. 2000). that simulates backscattcrcd RF sig-
nals for the IVUS array catheter, was used during this study. 
In the computer simulation program.. four elements were 
considered as one curved (convex) single clement: its area 
Lupottieral. 
Fi~e 2: Block diagram of the blood flow setup used during the experiments: the echosystcm. the AID converter PC and the water tank: the 
IVUS array catheter connected to the cchosystem and placed into the water tank. 
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Fi~c 3: Comparison between the simulated (solid line) and the mean autoconvolution of the measured acoustical beam (circles± std). 
a) Near field and b) Far field. 
was divided into a grid of small areas with dimensions less 
than a quarter of a wavelength. Thus. each small area trans-
mits an echo and the entire transducer receives the 
backscattered response. The simulation program was used 
to generate RF signals in order to produce frames with zero 
transverse blood flow (i.e. all identical RF signals per angle 
and per frame). Then. independent noise was added at each 
RF signal at a given signal-to-noise ratio (S!'<'R). The SNR 
is defined as the ratio of the average signal power to the 
average noise power. Next the data was used to obtain the 
mean flow over 10 frames for different region of interests 
-circular regions of 3.0. 3.5. 4.0 and 5.0 mm in diameter- in 
order to compare the results with the zero-flow offset 
obtained from the experimental measurements. 
Calculation of the coronary flow reserve 
Coronary flow reserve in patients is measured as the ratio of 
the hyperemic flow measured during e.g. an infusion of 
adenosine over the baseline flow. This parameter evaluates 
the physiological significance of a coronary stenosis (Gould 
ct al .. 1990). In our in vitro set up. with flow ranging from 
0 to more than 250 cc/min. we have arbitrarily computed 
the baseline flow for each catheter position and tube com-
binations as half the average of all the non-zero measured 
flows. The "simulated" coronary flow reserve for each 
recording was then computed as the measured flow over 
this defined baseline flow. 
Calculation of ring-down obscuring 
Through a computer program. we studied the effect of the 
so 100 150 
ring-down size and catheter eccentricity on the obscuring of 
the vessel lumen. The radius of the NUS catheter was 0.6 
mm and the ring-down sizes were assumed to be 0.3 and 0.6 
nun in depth. These ring-down sizes are representative of 
the limits in ring-down size from an NUS array catheter. 
The vessel lumen was considered circular vv:ith r:l.d.ius rnnging 
from 3.0 rom to 5.0 mm. The eccentricity of the catheter. in%. 
is defined as the distance between the center of the lumen 
of the tube and the center of the IVUS catheter divided by 
the radius of the lumen. Eccentricity 0 means a catheter 
placed in the center of the vessel lumen and thus maximum 
obscuring of the vessel lumen will occur. 
Results 
The mean autoconvolution of the experimentally measured 
acoustical beam is shown in Figure 3 compared to the sim-
ulated one (Lupotti et al .. 2000), for the near field and for 
the far field. respectively. In the near field. the autoconvolu-
tion of the measured acoustical beam is wider than the the-
oretical one. which may correspond to the effect of the ring~ 
down of the transducers. However. good agreement is cle::tr-
ly observed betvvecn curves in the far field. 
Figure 4 shows quantitative volumetric blood flow meas-
urements for different tube diameters versus calibrated 
Transonic flowmeter. Good linc::tr relationships (all r 
> 0.99) are observed betvveen the calibrated Transonic 
flowmeter and the volume blood flow measurement for all 
tube diameters (see also Table 1). However. the slope and 
the offset increase with increasing tube diameter. The slope 
200 251) 300 350 
Ollibr.at~d Trnn~onf~ Flowmeter [~c/min] Luponi eta!. 
Figure 4: Decorrelation-based method versus calibrated transonic flowmeter. results for different tube diameters (3.0. 3.5, 4.0 and 5.0 mm). 
Linear polynomial approximates to the points with a hlgh R'. The catheter wa.'> placed inside the lumen with ma.ximum eccentricity. 
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Figure 5: Offset in [eel min] from the experimental measurements plotted as a function of tube diameter. The offset values are shown below 
the 10 dB signal~to~noise ratio curve. 
Table 1 
Tube Catheter Eccentricity Catheter a b 
diameter position % 
(mm 
3 1 45 
3 2 45 
3 19 
3.5 45 
3.5 2 58 
3.5 1 60 
3.5 2 64 
4 65 
4 2 59 
4 37 
5 67 
is in all the cases lower than 1 and the offset can reach up 
to 182 cc/min for a 5 mm tube diameter. Table 1 summa~ 
rizcs all flow measurements for the different catheters, 
catheter positions and tubes (sec also figure 6 for eccentricity). 
There is a clear increase of the offset b (in cc/min, corres-
ponding to linear regression: IVUS-flow = a x Transonic-
flow+ b) as a function of tube diameter. In Figure 5, the off-
set in cc/min is plotted as a function of tube diameter. which 
clearly shows the increment of the offset as the tube diam-
eter increases. The curve for simulated data -no flow- with 
a SNR of 10 dB is presented here. The offset values from 
the experimental measurements are located below the 10 dB 
·~,-~--~~=--------, 
lOG'I 
~ 1jl!i\11il~;*i~l;,. ' • 
•!00 • - • ,_ " - ~ ••• ; • 
# 
a 
a 
b 
a 
a 
b 
b 
a 
a 
b 
b 
(cc/min) 
0.24 6.25 0.997 
0.18 8.99 0.995 
0.13 7.43 0.991 
0.26 51.36 0.997 
0.27 45.06 0.998 
0.28 12.95 0.996 
0.28 20.35 0.996 
0.36 147.14 0.994 
0.34 96.81 0.999 
0.19 50.06 0.99 
0.39 181.92 0.993 
curve, meaning that the RF signals from the experiments 
were acquired with a SNR higher than 10 dB. · 
Figure 6 illustrates the effect of the transducer ring-down in 
masking blood near the surface of the catheter. Two IVUS 
echograms are presented in the top of the figure. The ring-
down is less pronounced in the left one (estimated thick-
ness: 0.2 mm) than in the right one (thickness -0.4 mm). 
One RF signal per echogram is shown below each 
echogram. where at the beginning of the RF signals the 
ring-down is manifested by an increase on the amplitude. 
which shows amplitude saturation. 
Lupotti ct a!. 
Figure 6: top) Echograms of different catheters that show the ring-down size: the RF sign:ili: arc plotted showing the signals saturation. 
bottom) Curves from two different catheters where the ring-down produces a decrease in the offset; the catheters. low ring-down (dashed and 
dotted line) and high ring-down (solid line). were placed in the tube lumen with a ma:cimum eccentricity. 
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Fi~?;ure 7: Percentage of obscured area due to catheter eccentricity for different tube diameters when the eccentricity ranged from 0 (center of 
the lumen) to 60 %. Catheter radius of 0.6 mrn with a ring-down si7..e of0.3 (thin black linei\) :md 0.6 (thick gray linel'.) mm in depth. 
The results of percentage of the lumen area obscured by 
ring-down as a function of tube diameter arc presented in 
Figure 7 for five different tube diameters (3.0. 3.5. 4.0. 4.5 
and 5.0 mm) and for two ring-down sizes (0.3 and 0.6 mm 
in depth). In an artery of 35 nun in diameter, and for a 
catheter ring-down of 0.6 mm. the obstructed area goes 
from 25 up to 40 % of the lumen when moving the catheter 
from the centric (solid line) to the most eccentric position 
(dashed line). 
Processing of the IVUS RF signals when the flow is inter-
rupted (zero flow condition) gave values close to the offset 
of the linear regression in each case between the IVCS and 
Transonic flow values (e.g. as illustrated on figure 4 for the 
tube with diameter 5 or 3.5). These zero-flow recordings 
(IVUSO) were not performed in all the configuration 
tube/position/catheters. \\Then they were available. the 
IVL~S flow was corrected with this measured offset. and 
figure 8 shows (left. open diamonds) the excellent agreement 
existing then between the IVUS derived and the Transonic 
coronary flow reserve (CPR). The mean ± standard devia~ 
Coronaty Flow R....,,.,., (TmnaoniCB) 
" M 0•{)- •. ., 
~ 0 
% ~ 0 0 
oO 0 0 ~ M 0~ 0 
' Oo 
0 ,o 0 $ ,o 0 ,f. .0.1 0 0 ~ ., 0 0 00 ., 0 0 
•• ····----·-
., 0 
"""'" (CFR,-,.,.., CFRrwso) 
tion of the differences between the two methods was 
0±0.19. for a mean CPR of2. For all the recordings. we also 
approximated the offset to use to correct the IVUS flow by 
computing the linear regression between the IVUS and 
Transonic flows. Figure 8. right part (:ftlled diamonds) 
demonstrates that there was also then an excellent agreement 
between the IVUS and Transonic CPR. 
Discussion 
The mc::rn experimental and simulated autoconvolution of 
the acoustical beam were sho\VIl in close agreement. in both 
near and far field (Fig. 3a and 3b ). In the ncar field. a wider 
mean autoconvolution was observed. which could be 
explained by the presence of a ring-down (ultrasound rever~ 
bcrations from the array transducer) at the distance of interest 
("" 1 nun). The ring~down acts m a DC offset widening the 
autoconvolution curve. If not compensated. this widening 
will introduce an underestimation of the blood flow velocity 
and the volumetric blood flow. In general. the acoustic field 
along the axis of an ultrasound transducer exhibits rapid 
fluctuations in the ncar field and gradually decays in the far 
"1.028Gx • 0.0:139 • 
R',O.S844 .. 
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..• 
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Lupotti era/. 
Fi~rc 8: Comparison between the coronary flow reserve (CFR) derived from the flow estimated with the IVL'S decorrelation method and 
the true CFR computed on the measured Transonic flows. For each series of tube and catheter position. the baseline Transonic flow used to 
compute CFR was half the average of all flow measurements. On the left. the regression between both CFR is plotted (upper corner) as well 
as the Bl:md~A.ltman graph (difference versus mean). The baseline IVUS flow was half the average of all flows from which the zero-flow 
measurement (when available) was subtracted. On the right. similar relationships arc shown using all tubeg and catheter positions combina-
tions and where the IVUS flow was corrected by the zero-flow estimated from the linear regression between the Transonic and the IVUS 
derived flows (y~intcrcept.~ on figure 4). 
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field (Christensen. 1988). The standard deviations showed 
an increase that corresponds to this irregub.rity of the ul©-
sound beam in the ncar field (Fig. 3a). However. in the far 
field (Fig. 3b). a full agreement was shown between curves 
and smaller standard deviations were also shown. 
Results from experiments showed a good linear relationship 
for all tube diameters (Fig. 4 and Table I) meaning that the 
decorrelation-based system is not being influenced by the 
volume flow ranging from 0 to 250 cc/min. The relationship 
between offset and tube diameter could not be clearly esta-
blished. However. one could suggest that the reason for this 
is noise integrated over the lumen area. As the SNR is depth 
dependent. the blood flow offset will increase as a function 
of tube diameter. Simulated data were computed: frames 
with velocity zero were used in which noise at a given level 
was added to the RF signals. The measured data points m 
zero-flow condition were under the curve detennined by the 
zero-flow simulated data with a noise level of 10 dB. 
From the results. one could think that the ring-down is the 
reason of a slope lower than 1 (Fig. 4 and 7). The ring-
down. formed by the interaction of the ultrasound beam and 
the packing material. obscures part of the lumen vessel area 
where blood is flowing. which will produce an under esti-
mation of the measurements if the system is not compen-
sated for it \Vhen the amplitude of the RF signals is satu-
rated (Fig. 6). no change due to blood flow can be detected 
by the decorrelation-bascd method. Flow estimated in that 
region is then null. The catheter with a smaller ring down 
will give a higher offset and a higher slope for the relation-
ship between IVUS and Transonic flow values. The eccen-
tricity of the catheter was shown to have an important effect 
on the blood flow measurements when ring-down is present. 
From Fig. 7. the ring-down is shown to obscure up to 45% 
of the vessel lumen. Therefore. a maximum eccentricity of 
the catheter is important during in vivo recordings. 
Absolute coronary blood flow would be the optimal para-
meter for intracoronary physiological studies. However. 
intracoronary flow measurements have been simplified for 
clini-cal practice. The most useful clinical index at the end 
of an intervention such as a stcnt implantation is the coro-
nary flow reserve estimated from the ratio of the maximum 
flow velocity measured with a Doppler Flowirc during 
hyperemia to the baseline velocity (Di Mario et al .. 2000: 
Scnuys ct aL 2000). The results of our study suggest that 
the coronary flow reserve could be estimated in patients 
with an IVUS catheter. A limitation will be that the catheter 
must occupy a relatively stable position in the coronary 
lumen. ideally. at the most eccentric location. which can be 
achieved. With combined catheters including a balloon distal 
to the imaging transducer (Mudra et al .• 1994). it is foreseen 
that the recording of the zero flow condition. while the bal-
loon is inflated. will permit the estimation of the offset of 
the IVGS flow method during in vivo application. It would 
also be very interesting to assess the reduction of the maxi-
mal flow through moderate coronary stenosis. beside their 
conventional morphological NUS assessment. However. 
presently. the relatively large diameter of the IVUS catheter 
(> 1 mm) would cause a significant increase of the pressure 
gradient across the stenosis. since most of these lesions have 
a minimal lumen diameter ranging between 1.5 and 2.5 mm. 
Further miniaturization of the IVUS device will be neces· 
sary for this application, 
A factor. which was not considered here. is blood flow pul-
satility highly present in coronary arteries that produces 
changes in the shear rates across tl1e vessel lumen. In pul-
satile flow. the velocity profile changes significantly as a 
function of the cardiac cycle (Milnor. 1989). The velocity 
profile is nearly flat during early systole. becomes almost 
parabolic at peak systole. depending on the hematocrit. and 
then flattens again during diastole. In the case of transverse 
blood-flow. the change in blood velocity profile produces 
significant velocity gradients. which in the present situation 
seem to not affect the blood-flow measurements using a 
dccorrclation-bascd method. Aggregation of Red Blood 
Cells was also not considered here since previous results 
suggested that aggregation of RBCs. at random lengths and 
angles. does not affect the rate of decorrelation (Lupotti ct 
al .. 2001). Results from Cloutier (Cloutier and Shung. 
1993) suggested that prolonged diastole is necessary to 
observe an aggregate size enlargement in systole because 
no cyclic variation on the Doppler power was found during 
pulsatile flow at 70 beats/min and using whole porcine 
blood. Rouleaux formation. during systole and at 70 
beats/min. was not observed probably because the red cells 
do not have enough time in diastole to be brought into contact 
and to align themselves. As flow accelerates with a flat and 
more parabolic profile in late systole, the aligned red cells 
then probably form rouleaux until the shear rate within the 
Doppler-sample volume becomes sufficient to break them 
totally or partly. 
Conclusions 
We have characterized experimentally some of the limita-
tions of the IVUS quantitative blood flow assessment. The 
results clearly indicate dependence of the measure flow on 
the magnitude of the inevitable ring-down artifact. 
Additionally. the severity of this effect is dependent on the 
position of the IVC"S catheter within tl1e lumen. ln·place 
noise is also construed as flow and thus the noise character-
istics of tl1c entire system (IVUS instrument. catheter. 
catheterization laboratory environment) have to be measured. 
Despite the deleterious effect of the ring-down artifact. a 
practical solution is proposed for tl1e calculation of flow 
reserve. Since the position of the catheter is constant during 
CFR measurement. the slope bias can be considered con-
stant. This practical solution presents an intermediate and 
immediate solution to the limitation described in this paper. 
However. further advancement in IVUS transducer techno-
logy would be required to maximize the value of quanti-
tative IVUS-bascd flow measurements. In conclusion. the 
results of this in-vitro validation of the decorrelation~based 
method to derive quantitative volume blood flow and coro-
nary flow reserve using 1\IUS RF signals arc very encoura-
ging and warrant further in vivo investigations. 
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Summary 
Intravascular ultrasound elastography is a method for 
measuring the local elastic properties of coronary athero-
sclerotic plaques using intravascular ultrasound (IVCS). 
Mechanical properties of the different tissues within a 
plaque arc measured through strain. In the last decade, several 
groups have applied elastography intravascularly with 
various levels of success. In this paper, the approaches Df 
the different research groups will be discussed and the focus 
will be on our approach to the application of intravascular 
clastography. 
1. Introduction 
Sudden death is the leading symptom of coronary heart dis-
eases in early middle age and stands at the most dreadful 
end of the spectrum of acute coronary syndromes. More 
than 50% of sudden deaths are related to an atherosclerotic 
plaque rupture or ulceration triggering thrombus formation 
and coronary occlusionY Acute myocardial infarction and 
unstable angina arc also related to a similar mechanism. A 
coronary atherosclerotic lesion can evolve during years 
without any clinical symptom and flow limitation."·" Acute 
coronary syndromes frequently develop in arterial segments 
demonstrating only a mild stenosis on available prior 
angiograms.~·" The plaque morphology. its composition and 
the importance of the infiltration of macrophages and lym-
phocytes, more than the degree of stenosis. are the determi-
nants of acute clinical events. :c.'-'' One of the major limita-
tions of coronary angiography, the gold standard for the 
evaluation of symptomatic patients with coronary artery 
disease. is the inability to visualize the arterial wall 1" 
Several techniques have been developed and arc under 
development to characterize coronary atherosclerotic 
plaques. 11 The life-threatening plaques, prone to rupture. 
have been characterized by three major characteristics: 
i) the size and structure of the atheromatous lipid core. ii) 
the thickness of the fibrous cap ( < 65 )JIU) and iii) the 
inflammation within or adjacent to the fibrous cap. 
Catheter-based IntraVascular L1traSound (IVUS) is the 
only clinically available technique capable of providing 
real-time cross-sectional images of arteries in vivo. nP 
IVUS provides quantitative information on the plaque bur-
den and the lumen, as well as qualitative information on the 
plaque composition that has been compared with histo-
logy.14·1~ However, identification of the different plaque 
components is still limited: hard fibrous and soft plaques 
can show similar echo tcxture. 10•17 Especially, the sensitivity 
to identify lipid pools remains low. 1' Several IVUS-based 
methodologies have been proposed to improve tissue 
charactcrization'"·'0 and detect plaque vulnerability.1 '·:::-. 
However. IVUS, as well as other methodologies developcd11 
to detect rupture-prone plaques arc limited since they arc 
based on the measurement of indirect vulnerability para-
meters such as plaque geometry, content color or tempera-
ture. Plaque vulnerability is mainly a mechanical phenome-
non: using computer simulations, concentrations of circum-
ferential tensile stress were more frequently found in unsta-
ble plaques than in stable plaques.:o.'-Z4 For example. a thin 
fibrous cap shielding a lipid core from the blood may rup-
ture since it is unable to bear the high circumferential stress 
due to the pulsating blood pressure (mechanical fatigue). 
These high stress regions can be caused by the geometry of 
the plaquel> or by local weakening of the plaque due to 
macrophage infiltration.~" 
In 1991. a new technique was proposed to directly measure 
mechanical properties of tissue by ultrasound called elasto-
graphy.'7 This technique has emerged to improve tissue 
characterization since a close correlation has been observed 
between the modification of the clastic properties of a tis-
sue and the development of pathological processes. For 
example, it has been shown that the Young's modulus1"(thc 
ratio of a given force applied (stress) and the resulting 
deformation (strain)) of normal breast tissue is 20-40 k.Pa. 
but raises up to >500 k.Pa in breast carcinoma.~'' 
Elastography was developed using phantom studics-l{] and 
evaluated in vivo.J1 The underlying principle is that a force 
(stress) is applied on the tissue and that the resulting strain 
is a function of the local mechanical properties.'' The local 
strain of the material is obtained by means of comparing sev-
eral ultrasound images acquired at different stress levels. 
Currently, this technique is developed in our laboratory for 
intravascular purposes. The objective of this paper is to give 
a short overview of different implementations of el::tstogra-
phy. Next the methods and results of our intravascular clas-
tography work will be presented and discussed. 
2. Previous related work 
Several techniques have been proposed to study the 
mechanical properties of soft tissues using ultrasound. The 
m:lln differences are in the type of mechanical solicitation 
of the tissue (vibration at low or high frequency, or quasi 
static compression) and in the signal processing methods 
used for estimating the local clastic properties. 
2.1. Sonoelasticity: vibration amplitude imaging 
Lerner and Parker presented preliminary work on vibration 
amplitude 'sonoclasticity imaging' .n \Vith this method, a 
low-frequency vibration (20-500 Hz) is applied externally 
to excite internal vibrations within the tissue under study. A 
stiff inhomogeneity surrounded by soft tissue produces a 
disturbance in the normal vibration cigenmode patterns. 
Doppler detection techniques are employed to make a real-
time vibration image. In some organs, modal patterns can 
be created, revealing additional information to the shear 
wave speed of sound of tissue.-'-' Two real-time methods. 
static strain imaging and vibrography (using 0.1-20 Hz 
compressions) have been recently tested in phantom expe-
riments. Real-time performance with a PC is achieved 
thanks to an original algorithm (phased root seeking tech-
nique) to estimate the strain. faster than the cross-correla-
tion mcthods.-14 
Recently, Sandrin et al. have reported the results obtained in 
phantoms of a new method based on such a low-frequency 
shear wave (200 Hz) visualized by means of an ultrafast 
imaging system (up to 10.000 frames/s) composed of a linear 
array of transducers at 3.5 MHz.-'~ Sonoelasticity has not 
been evaluated for vascular tissue. but given the large wave-
lengths and the level of inhomogeneity in a diseased vessel. 
it seems not to be the technique of first choice. Ongoing 
research investigates the feasibility to usc magne-tic reso-
nance ebstography using propagating :1coustic shear 
waves. -11'.17 
2.2. kH=: dynamics: vibration amplitude imaging 
In this technique. the tissue is excited using a 15-25 kHz 
sound field and the amplitude of vibration is measured with 
a 30 MHz transducer." The amplitude of compression 
waves is related to the mechanical properties of the tissue 
but also on the size of the tissue inhomogeneities and reso-
nance phenomena. Because of the pOtential problems related 
to the in vivo intravascular application of a 20 kHz sound 
field. this approach has been abandoned for intravascular 
elasticity imaging. 
2.3. Ultrasound~stimulated vibro-acoustic spectrography 
Fatemi and Greenleaf have proposed an alternative method 
based on the acoustic energy emitted from solids and tissue 
in response to an oscillatory radiation force produced by 
interfering focused beams of ultrasound. Interference in thi:: 
intersection region of the two beams produces sinusoidal 
modulation of the ultrasound energy density that creates an 
oscillatory force vibrating the object at the selected region 
that can be measured some distrmce away. Using two coaxial. 
confocal transducer clements of a spherically focused annu-
l:lr array. they could image excised human iliac arteries and 
clearly detect calcified regions.)" 
2.4 Elastography: compression strain imaging 
Elastography is an imaging technique based on the static 
deformation of a linear isotropic clastic material. The tissue 
under inspection is externally compressed and the displace-
ment between pairs of A-lines with and without compres-
sion is dctennined using cross-correlation analysis. ::?.Jo From 
these data. the strain profile in the tissue under study can be 
determined. Whereas Ophir ct al did not explore intravascu-
lar application. our group has demonstrated the feasibility to 
perform in vivo coron:.uy elastography. The compression 
can be obtained from the systemic pressure difference or by 
using a compliant intravascular balloon:"' The following 
techniques me all more or less based on this excitation prin-
ciple. but use a variety of detection methods. 
2.4.1. Envelope based intravascular elastography 
Ryan and Foster developed a technique based on comparison 
of pre- and post-compression of vessel mimicking phan-
toms:'1 The displ:lcement in these phantoms was based on 
speckle tracking in the video signals. The strain is calculated 
from this displacement. It was shown that phantom compo-
nents of different hardness had different displacement mag-
nitude. For usc under physiological circumstances. the 
method still needs quite some adaptation. A big advantage 
of using the envelope is the f:1ct that the correlation function 
is smoother than the RF-based correlation function and that 
the video signal is commonly available from any commer-
cial echosystem. The disadvantage is the limited resolution. 
For intravascular applications. small tissue strains must be 
measured and therefore the usc of RF data dramatically 
improves the resolution. 
2.4.2. Spectral tissue strain 
Talhami ct al. introduced a technique that is capable of esti-
mating the global radial str:lln in a vessel.'~ The technique is 
based on the Fourier scaling property of the signals and uses 
the chirp Z-transform. The envelope data are used for this 
analysis. The result is displayed :lS a color-coded ring 
around the image of the vessel. Initial results on vascular 
tissue in vitro and in vivo have been described, however 
without a validation of the technique. 
2.4.3. Phase sensitive speckle tracking multicompression 
elasticity imaging 
Shape ct al. developed another technique that is based on 
cross-correlation of A-lines}-'-"' This group proposed a large 
deformation to maximize the signal-to-noise mtio of the 
displacement and strain estimation. However. a large dis-
placement will decorrelate the ultrasound signals to such an 
extent that correlation detection is unreliable. For this rca-
son. the cross-correlation is calculated in several intermedi-
ate steps of intraluminal pressure. For detection. they usc a 
phase-sensitive speckle tracking technique. The technique 
uses an NUS catheter that is inserted in a compliant bal-
loon. The balloon is used to str:lln the tissue up to 40%. The 
feasibility of this technique was demonstrated in simula-
tions and tissue mimicking phantoms. Currently the tech-
nique is validated in vitro. 
2.4.4. Broad-band radiofrequency-based elastography 
Radiofrcqucncy data arc acquired at two levels of intralu-
minal pressure. The estimation of the deformation remains. 
in general. a study of the correlation between signals 
acquired before and after the application of a stress. The 
most common signal-processing technique used in elasto-
graphy considers the local displacements within soft bio-
logical tissues as simple translations. Within the RF signal. 
these displacements will be translated by a delay of the 
acoustical signatures of the respective tissue regions. This 
results in a modeling of the post-compression signal as a 
locally delayed replica of the pre-deformation signal. The 
local tissue displacement is. in this case. a simple shift. It is 
computed as the location of the maximum of the cross-cor-
relation function of gated pre- and post-compression echo 
signals (time-delay estimation). The strain is then computed 
as the displacement derivative.4'-'" In the case of small defor-
mations [0-2 %], these techniques have proved to be effi-
cient and accurate. However, they fail rapidly with increas-
ing strains since then the signal is subjected to a variation in 
shape that has not been taken into account. 
Another approach taking into account the change in shape 
of the signals has been recently described (local scaling 
factor estimation).41_,j') The signal after compression is 
processed as a delayed and scaled replica of the signal 
before deformation. These methods have been shown to be 
more robust to large deformation. but the performance for 
small strain values (<2%) remains low. An adaptative strain 
estimation method based on the comput::Ltion of local scal-
ing factors has been successfully applied to compute elas-
tograms of cryogel phantoms mimicking vessels and of a 
freshly excised human carotid artery using a 30 MHz 
mechanical rotating single element ultrasound scanner 
(ClcarVicw. CVIS. Boston Scientific Corp.).~ 
We will focus the rest of this review on the intravascular 
elastography methods that have been developed in our lab-
oratory. Data arc acquired at two levels of intraluminal pres-
sure. Displacement and strain are calculated from broad-
band RF traces. The strain information is presented as an 
independent complementary two-dimensional image of the 
cchogram when it has been computed across the complete 
vessel wall (elastogram) or as one dimensional color-coded 
line congruent with the lumen perimeter when the strain is 
computed only for the inner layer of the arterial wall (pal-
pogram).~l 
3. Materials and methods 
3.1. Materials 
3.1.1. Phantom. 
Vessel phantoms with the morphology of atherosclerotic 
vessels were constructed from solutions of agar and gelatin 
with carborundum (SiC) particles used for scattering. A 
hard vessel containing a soft lesion with no cchogenicity 
contrast between the wall and plaque was measured with 
intraluminal pressures of 50 and 55 rnmHg.52 
3.1.2. Femoral and coronary arteries in vitro. 
Atherosclerotic human femoral (n=lO) and coronary (n=4) 
arteries obtained post mortem were measured in vitro. Two 
IVUS scans were acquired at 80 rnmHg and 100 mmHg. 
The vessel specimens were then fixed in a buffered 
formaldehyde solution (3.6%) and processed for routine 
paraffin embedding. For each segment cross sections were 
stained for collagen (picro-Sirius red stain). for smooth 
muscle cells (anti-a~actin stain) and for macrophages (anti-
CD68 stain). 51 
3.1.3. Coronary arteries in vivo. 
Data were obtained from patients (n=12) referred for per-
cutaneous coronary intervention. After intravenous admi~ 
nistration of heparin and acetylsalicylic acid. a 6 Fr guiding 
catheter was advanced up to the ostium of the involved 
artery. After coronary injection of a bolus of 3 mg isosor-
bide dinitrate, pre~intervention IVGS assessment of the 
lesion was performed. 54 
The acquisition and signal processing have been explained 
in detail elscwhcre-'5 and arc beyond the scope of this 
review. In summary. in vitro experiments on human femoral 
arteries were performed with a 4.3F Princeps"' 30 MHz 
catheter (Dumed) connected to a stepper motor. The in vitro 
and in vivo coronary recordings were performed using a 64 
F!X array IVUS transducer (EndoSonics/JoMcd). In vivo. 
lesions were crossed and imaged without complication. The 
pressure was measured at the level of the coronary ostium 
via the guiding catheter connected to a standard fluid~ line 
system. Ten microseconds ( ..... 7.5 nun) of the 64 angles (in 
Chromaflow mode) analog RF data output of the In Vision 
system were digitized at high fTequency (200 MHz. in 8 
bits). Ten frames per second were acquired at cross sections 
where the IVUS echogram revealed diseased vessel wall 
and plaque. Due to the contraction of the heart. the catheter 
is moving in the lumen. For large motions. the frames 
acquired at the different intraluminal pressures may be mis~ 
aligned thus hindering adequate displacement estimates. An 
algorithm to determine the similarity between sequential 
echo frames has been used as a figure of merit for the 
motion of the catheter in the lumen. Sequential frames with 
a high likelihood and a pressure differential large enough to 
result in strain levels of the order of 1% were processed to 
derive the elastograms. 
4. Results 
The principle of intravascular clastography is visualized in 
figures 1 and 2: the echo signal of the soft region (light 
gray) shows minute changes once the applied force has 
compressed this tissue. whereas the signal from the hard 
region (dark gray) remains nearly identical since the tissue 
thickness in that region did not change. Figure 2 shows the 
echogram of the phantom acquired at low pressure in the 
upper left corner. The cchogram acquired at high pressure is 
shown in the lower left comer. The soft plaque area is not 
visible in the echograms. The local strain determined using 
the cross-correlation based time delay estimation algorithm 
is shown on the right. The soft plaque region is clearly 
visible in the elastogram from 7 to 11 o ·clock. 
An cchogram, elastogram and histology of a human femoral 
artery segment are shown in figure 2. The echogram of this 
artery shows a slightly eccentric plaque with different echo~ 
genecities. Although the echogram perfectly reveals the 
geometry of this plaque. its composition remains uncertain. 
The clastogram reveals that the plaque can be divided into 
k .Soft. ' · 
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Fi~ 1: Principle ofelastography: the echo signals of a soft material (left panel) show minute deformation once the material i_, compreg;:.cd 
by the applied force. The distance DA", which can be measured by estimation of temporal shift~ in the radiofrcquency sign:ll. is decreased to 
DA'u'· On the contrary. with the absence of compression of the hard material (right panel). there is no change in the radiofrcquency signal and 
Dco-=Dco·· 
four quadrants: (a) and (c) demonstrating a low-compres-
sibility. (b) and (d) with a higher compressibility. The strain 
in the low-compressing parts (0.2%) indicates that this may 
be fibrous tissue. which was confirmed by histology. The 
histology of the regions with a higher strain values 
(O.S-1%) reveals fatty material with macrophage accumula-
tion. At each location investigated (n=45). 2 IVDS images 
were acquired at different intraluminal pressures (80 and 
100 mm Hg). Elastographic data and histology were 
matched using the IVUS echogram. The cross sections were 
segmented in regions (n=l25) that were based on the strain 
vclues on the elastogram. The dominant plaque types in 
these regions (fibrous. fibre-fatty. or fatty) were obtained 
from histology and correlated with the average strain and 
echo intensity. The strain for the 3 plaque types as deter-
mined by histology differed significantly (P=0.0002). This 
difference was mainly evident between fibrous and fatty 
tissue (P=0.0004). The plaque types did not reveal echo-
intensity differences in the IVUS echogram (P=0.882).'-' 
In all in vivo experiments. clastograms were determined 
from two echograms acquired near end-diastole. Analysis 
of the likelihood curves revealed that the minimal motion of 
the catheter was present in this part of the heart cycle for all 
patients. There was on average a pressure differential of 
approximately 5 mmHg between sequential frames in this 
part of the heart cycle. Figure 4 demonstrates an echogmm. 
an clastogram and a palpogram of a human coronary artery. 
The echogram reveals a large calcified area (from noon 
to 3 o'clock). The elastogram and the palpogram identify 
this area as being composed of hard material since low 
strain values arc found in this region. Among the 12 patients 
investigated. 3 demonstrated s-imilar calcified regions 
(104±70°). The corresponding average strain was 
0.20±0.07. Conversely. the average strain in all non-
calcified regions was 0.51±0.20 (p<O.OOI). 
5. Discussion 
Imaging tissue clastic parameters is rapidly drawing 
attention for its ability to provide new information on bio-
logical tissue. Intravascular elastography has been de-
veloped to assess the local mechanical properties of the vas-
cular wall. Knowledge of the mechanical properties may 
heip the clinician in choosing the proper interventional 
e 
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Fij!llre 2: Schematic representation of deriving clastograms. From 2 lVt:S images acquired at low (upper panel) and high pressure (lower 
panel). no detection of the soft inclusion in this phantom is possible. However. using cros.~-correlation techniques, the local strain can be 
mea.~urcd and plotted as an additional image on the right. showing the softer region between 7 and 11 o'clock demonstrating a higher strain. 
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Figure 3: lntrav:tscular echograrn (top left) and elastograrn (top right) of u diseased human femoral anery with corresponding histology: bot-
torn left. picro-Sirius red with polarized light microscopy (for collagen staining). bottom right. anti-CD68 antibody (for macrophage stain-
ing). Echograrn shows n slightly eccentric plaque with different echogenecities. Elastograrn reveals two son regions (b and d) and two hard-
er regions (a and c). Histology reveals that the soft regions b and d contain mainly fauy material and shows macrophage accumulation in d. 
technique and in detecting rupture prone plaques. 
The phantom experiments demonstrate that hard and soft 
material can be identified by IVUS elastography. inde-
pendently of the echogenicity contrast of the materials. 
The results of the in vitro experiments on human femoral 
arteries support these lindings. Fibrous material was identi-
fied by the low strain values as observed from the elas-
togram. In the specimen containing two plaque types. the 
elastogram clearly revealed the librous and the fatty plaque 
regions. This identitication was not possible using the 
echogram since both regions demonstrated the ~arne 
echogenicity. 
These findings make the technique promising for the iden-
tilication of rupture-prone plaques characterized by a 
necrotic core and a thin. fibrous cap.' The rupture of a 
plaque oflen occurs at places with a high stress concentra-
tion."' The clas togram does not provide information on the 
source of this high strain region that can be caused by soft 
material present in this region or by a stress concentration 
caused by the geometry. Figure 3 shows that in this parti-
cular case. the high radial strain was related to the accum u-
lation of fauy material. Additionally. an increased 
macrophage concentration has been observed in regions 
with high strain values. The sensitivity and specificity of the 
technique remain to be investigated to identify different 
plaque components and vulnerable regions. 
For in vivo elastograms of diseased human coronary 
arteries. :1 dynamic instead of static pressure differential is 
used to strain the tissue. The advantage is that this exci-
tation source is naturally present in the arterial system. 
Using gated acquisition. different levels of intravascular 
pressure are obtained. Our preliminary results indicate that 
reproducible elastograms and palpograms can be obtained 
with this acquisition set-up scheme. The elastographic fin-
dings could not be validated using histology during the in 
vivo experiments. Therefore. only a parlial validation has 
been performed using the low resolution echogram 
(64 angles of the Chroma flo imaging mode) to differentiate 
between calcified and non-calcified material. Since echo-
graphy gives no information regarding the presence of lipid 
or fibrous material. further validation has not been possible 
at this point. A dramatic improvement in the RF signal 
acquisition scheme has been obtained recently with a direct 
digital interface incorporated in the Endosonics In-Vision 
console that communicates directly with a PC in which long 
sequences of RF echo frames at full rate can be stored in 
random access memory. High-resolution IVUS images 
( 12 bits resolution. S 12 phased-array angles) are now 
avai !able for comparison with the elastograms. 
Compared with the in vitro experiments on human femoral 
arteries, the pressure differential between the two frames b 
smaller: 3-S mmHg instead of 20 mmHg. A smaller pres-
sure differential will immediately result in lower strain 
values. However. the strain values found during the in vivo 
experiments are in the same range as the ones found in the 
in vitro experiments indicating that the tissue during in vivo 
examination is softer. A possible explanation is that the 
elastic moduli of tissue will be elevated after excision of the 
Cartier l!t al.. J of Cardiovascular Risk 
Figure 4: /11 vivo echogram (left panel). ela~togram (center) and palpogram (right panel) of a cross section in the left anterior descending 
anery of a patient. The cchogram reveals calcified material between noon and 3 o"clock. ln this region. a very low strain vutue was assessed 
on both the elastogram and the palpogram (color-coded in red). 
tissue'7 and may even further increase after cold storage, 
Additionally, since the in vitro study was performed at 
room temperature, fatty tissues will be harder at room 
temperature than at body temperature resulting in decreased 
strain values. 
One of the limitations of intravascular clastography present~ 
ly is the computing time required and the use of only one-
dimensional echo~tracking. Elastographic methods to com~ 
pute both lateral and axial strains have recently been report~ 
ed.3" The palpograrns have been developed in order to 
improve the clinical applicability and the robustness in 
presence of catheter movements in vivo as well as to 
advance coronary elasticity to real-time imaging.~ 1 This 
technique produces compound images of the strain obtained 
of the first part of the arterial wall (user de:fined, typical 
600 )..lm) and conventional sonographic information. 
Palpograms arc computed by applying a two-dimensional 
echo tracking technique, an outlier rejection filter and a 
finite difference strain estimator. A composite palpogram, 
as illustrated in figure 4 (right panel), reconstructed for each 
cardiac cycle of a 6-sccond acquisition can presently be 
computed in less than one minute.''' 
A fin::U limitation of intravascular elastography to stress in 
is that so far we have computed maps of the strain inside the 
arterial wall, but not of the Young's modulus. Theoretically, 
the reconstruction of the Young's modulus would improve 
the accuracy of tissue characterization and would be inde-
pendent of the local stress magnitude and its inhomogenous 
distribution. This final step in elasticity imaging has been 
described for non~ vascular applications~""{) but is still under 
preliminary investigation in our laboratory. 
6. Conclusion 
Intravascular elastography encompasses techniques based 
on conventional IVUS providing a means for remote palpa-
tion and elasticity quantitation of the vessel w::Ul. We have 
obtained the first elastograms of disc:1sed arteries in vitro 
and in vivo. The results show that tissue characterization 
based on elasticity information from regions with various 
pathologies may be feasible. This method could potentially 
improve the detection of rupture-prone plaque based on the 
assessment of locally increased strain. This information. 
which is useful for diagnosis and for guiding interventional 
procedures, is frequently inconclusive or unavailable from 
NCS echograms or x-ray angiograms. 
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C. L. de Korte', S. G. earlier', F. Mastik', M. M. Doyley1 •2 , A. F. W. van der 
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Aims Plaque composition is a major determinant of cor-
onary related clinical syndromes. In vitro experiments on 
human coronary and femoral arteries have demonstrated 
that di!Terent plaque types were detectable with intra-
vascular ultrasound elastography. The aim of this study 
was to investigate the feasibility of applying intra-
vascular elastography during interventional catheterization 
procedures. 
Methods and Results Data were acquired in patients 
(n== 12) during PTCA procedures with an EndoSonics 
In Vision echoapparatus equipped with radiofrequency out-
put. The systemic pressure was used to strain the tissue. and 
the strain was determined using cross-correlation analysis 
of sequential frames. A likelihood function was determined 
to obtain the frames with minimal motion of the catheter in 
the lumen. since motion of the catheter prevents reliable 
strain estimation. Minimal motion was observed near end-
Introduction 
There is a great variation in the stability of coronary 
atherosclerotic plaques. When coronary flow is limited 
by plaque, patients develop angina. which can be stable 
for years. However. disruption of coronary plaques with 
superimposed thrombosis is the main cause of acute 
coronary events. such as unstable angina pectoris. sud-
den coronary death and acute myocardial infarction1 1· 31. 
There are two major mechanisms underlying plaque 
disruptionH.GI: rupture of a fibrous cap of a lipid-rich 
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diastole. Reproducible strain estimates were obtained 
within one pressure cycle and over several pressure cycles. 
Validation of the results V..'as limited to the information 
provided by the echogram. Strain in calcified material 
{0·20±0.07 %) was lower {P<O·OOl) than in non-calcified 
tissue (0·51±0.20 %). 
Conclusion In vivo intravascular elastography is 
feasible. Significantly higher strain values were found in 
non-calcified plaques than in calcified plaques. 
~) 2001 The European Society of Cardiology 
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plaquciGI and denudation and erosion of the endothelial 
surface171 . 
It is now widely accepted that the propensity of a 
lesion to rupture is poorly predicted by coronary angi-
ographi6·81. A major problem is that vulnerability of 
plaque is not directly related to plaque size:7.n1 but that 
the plaque composition is a major determinant181. Using 
intravascular ultrasound, the geometry of lumen, plaque 
and vessel wall can be obtained and is closely correlated 
to clinical anginar 10:. However. identification of the 
different plaque components is still limitedlll.Jll 
although some promising ultrasound based techniques 
are currently being developed! 13 - 151. 
A wide range of techniques have the potential to 
visualize or characterize the plaque. Csing scintigraphy. 
detection of plaque instability remained confined.lb-I:>J. 
·n 2001 The European Society of Cardiology 
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Other potential techniques may be magnetic resonance 
imagingl 19•20J or optical coherence tomographyiZtl. With 
spectroscopy!221 as well as with angioscopyi231 and 
Raman spectroscopy certain plaque components may be 
detectable 12~· 25 1. Promising new techniques are electrical 
impedance imaginglzG; and thennal examination127•281 of 
plaque surfaces. since a positive correlation between 
plaque vulnerability and parameters obtained using 
these techniques were found. 
The main disadvantage of the techniques described 
above is that plaque vulnerability is associated with 
indirect parameters, such as plaque geometry, content, 
colour or temperature. although plaque vulnerability is 
mainly a mechanical phenomenon: using computer 
simulations. concentrations of circumferential tensile 
stress were more frequently found in unstable than in 
stable plaquesi29·30J. For example. a thin brous cap 
shielding a lipid core from the blood may rupture since 
it is unable to bear the high circumferential stress due to 
the pulsating blood pressure. These high stress regions 
can be caused by the geometry of the plaquel30•311 or by 
local weak.~ning of the plaque due to macrophage 
in ltrationiJZI, 
In 1991. a new technique was proposed, called elas-
tography, which directly measures mechanical proper-
ties of tissue by ultrasound1331. This technique was 
develofed using phantom studies13~ 1 and evaluated in 
vivo13.:;. The underlying principle is that tissue is strained 
and that the strain rate is related to the local mechanical 
properties. The local strain of the material is obtained by 
comparing several ultrasound images. Currently, this 
technique is developed for intravascular purposesi3G 381 
and was recently applied in human coronary and fem-
oral arteries in vitro:39 ·~ 01 • These experiments revealed 
that the local strain, as measured with intravascular 
elastography is signi cantly different for brous and 
fatty plaque components. Furthermore. this technique 
had the potential to identify plaque vulnerability. Since 
the radial strain can be obtained. the technique may 
detect regions with elevated stress: increased circumfer-
ential stress is associated with an increased radial strain 
of the materiaL 
In this study. the feasibility of obtaining elastographic 
images in vivo has been investigated. Elastograms were 
determined, using data obtained from arteries. where a 
PTCA procedure was planned. The pulsatile intracoro-
nary pressure was used to obtain different levels of strain 
in the arterial wall. Since the catheter was moving in the 
lumen due to the contraction of the heart, an algorithm 
to determine the echo frames with minimal motion 
artefacts was applied on the data. The elastographic 
results were compared with echographic results. 
Patient description and intravascular 
ultrasound examination 
Intravascular ultrasound data was obtained in patients 
(n= 12) referred for percutaneous intervention (Table 1). 
Eur Heart J 
Table I Baseline clinical and intravascular ultrasound 
clun·acteristics 
Patients, n 
Age. years 
:vtale,% 
Systolic blood pressure (mmHg) 
Diastolic blood pressure (mmHg) 
Stable angina,% 
Cnstable angina. % 
Prior MI.% 
Risk factors. % 
Diabetes mellitus 
Hypercholesterolaemia 
Hypertension 
Smoking history 
Artery.% 
Left main 
Left anterior descending 
Circum ex 
Right coronary 
Renal artery 
Lesion characteristics. % 
De novo 
Restenotic 
Concentric 
Eccentric 
12 
56± 12 136- 751 
7 (58%) 
132± 18 [98-156] 
79 ± 14 [57- 107] 
5 (42%) 
7 (58%) 
IJ (33%) 
1 (8%) 
7 (58%) 
4 (33%) 
4 (33%) 
1 (8%) 
3 (25%) 
3 (25%} 
4 (33%) 
1 (8%) 
10 (83%) 
2 (17%) 
7 (58%) 
5 (42%) 
All the patients signed an informed consent. The culprit 
lesion to be treated was situated in the left anterior 
descending artery (n=3), the circum ex (n=3) and the 
right coronary artery (ne:o4). The left main coronary 
artery was investigated in another patient and the renal 
artery in the nal patient. After intravenous admin-
istration of 10 000 ru heparin and 250 mg acetylsalicylic 
acid. a 6 Fr guiding catheter was advanced up to the 
ostium of the involved artery. After injection of a bolus 
of 3 mg isosorbide dinitrate. pre-intervention intravas-
cular ultrasound assessment of the lesion was performed 
with a 3 5 Fr 64F/X intravascular ultrasound catheter 
(n=S) or a MegaSonics(g (EndoSonics. Rijswijk. The 
Netherlands), a combination device consisting of an 
angioplasty balloon (3- 3 5 mm diameter. length 
20 0 mm) and a 64 FIX array intravascular ultrasound 
transducer proximal to the balloon (n=7), Lesions were 
crossed and imaged without complication. With the 
catheter crossing the lesions without inducing sympto-
matic ischaemia. a stable position was sought for the 
transducer in the centre of the lumen, offering visualiza-
tion of signi cant plaque. The radiofrequency data were 
acquired as described below. The pressure was measured 
at the level of the extremity of the guiding catheter 
connected to a standard uid-line system (Ohmeda, 
Bilthoven. The Netherlands). 
Methods 
The 64-element phased array catheter was connected to 
an EndoSonics In Vision system. The system is equipped 
with analog radiofrequency data output. This output 
provides the data for a ChromaFlo@ ow mode 
imagel41 r. In this mode. the catheter operates in linear 
instead of phase array mode. thus providing low~ 
resolution images1421 • Each frame contains 64 angles. 
including a radiofrequency signal of 10 ~s (correspond~ 
ing to 7 5 mm). These data were digitized in a 
custom-made acquisition system, containing a Pentium 
computer with an acquisition board (Signatec. Corona. 
CA. U.S.A) with 128 Mbyte to store the radio frequency 
data at a sampling rate of 200 MHz in 8 bits. 
Ten frames per second were acquired at cross-sections 
where the intravascular ultrasound echogram revealed 
diseased vessel wall and plaque. For determination of 
the strain, cross-correlation techniques were applied to 
the data13!l1• First the movement of the tissue along the 
ultrasound beam was determined. The local strain was 
obtained from this displacement. Due to the contraction 
of the heart, the catheter was moving in the lumen1431. 
For in-plane motion (catheter moving in the imaging 
plane). correction algorithms were developedl44 1. For 
large longitudinal motion (i.e. motion along the cath-
eter), the frames acquired at the different intraluminal 
pressures may image different tissue. In this case. the 
echo signals are not correlated. thus hindering adequate 
displacement estimates. 
An algorithm to determine the similarity between 
sequential echo frames was used as a gure of merit for 
the motion of the catheter in the lumen. The normalized 
absolute difference between two sequential echo frames 
was determined using the likelihood between the frames: 
0% corresponding to no similarity between the frames 
and 100% was obtained when both frames were exactly 
the same. Sequential frames with a high likelihood and a 
pressure differential large enough (5 mmHg on average) 
to result in strain levels between 0 and 1% were taken to 
calculate the elastograms. The determined strain values 
were tested on validity. using the relation between strain 
and peak-value of the cross-correlation function1 3!l·451, 
Erroneous strain estimates were replaced by the median 
value of the surrounding strain estimates. The typical 
number of erroneous strain estimates was 10%. Elasto-
grarns with more than 35% erroneous strain estimates 
were considered unreliable. 
Since validation of the experimental results using 
histology was not available, the elastographic exper-
iments could only be partially validated using the echo-
gram. Strain values for calci ed material, accurately and 
speci cally identi ed using the echogram by the bright 
echo and the distal shadowing, were compared to the 
values corresponding to plaque accumulation and nor-
mal coronary segments. Low strain values were expected 
in the calci ed segments. 
Statistical analysis 
Values are reported as means± SD. Analyses were 
accomplished using a standard software package (SPSS 
9.0. SPSS Inc. Chicago. IL. U.S.A). Differences in 
strain between calci ed and non-calci ed regions were 
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evaluated by an unpaired Students t-test Comparison 
betv.reen groups of patients was evaluated by one way 
analysis of variance. 
Results 
Intra-cardiac cycle reproducibility 
The acquisition of intravascular elastograms in vivo is 
illustrated in Fig. 1. The pressure curve (in blue) shows a 
diastolic pressure of 105 mmHg and a systolic pressure 
of 135 mmHg. The curve representing the resemblance 
between the sequential echo frames is in green. Relating 
this likelihood curve to the pressure curve reveals that 
the sequential frames have the best match near end-
diastole. The maximum likelihood is present just before 
the P wave of the ECG (in red). The minimal motion of 
the catheter in this phase corresponds well to the 
absence of movement and contraction in this phase of 
the heart cycle. As can be appreciated, the pressure 
differential between frames at this point in the pressure 
curve is in the order of 4 mmHg. 
The intravascular ultrasound echogram (upper right 
corner) reveals a concentric plaque in this artery. The 
echogenicity of the plaque is lower than the echogenicity 
of the wall. A strong re ection of the lumen- plaque 
boundary is observed between 4 and 8 o clock. Between 
11 and 1 o clock the echogenicity is low and the 
thickness of the plaque is small. 
Three frames near end-diastole were taken to deter-
mine two elastograms. The pressure dlfferential of 
4 mmHg is large enough to strain the vessel wall and 
plaque between 0 and I% (colour coded from red to 
green). Both images indicate that the region between 11 
and 2 o clock has high strain values indicating soft 
tissue. The region at 3 o clock is relatively hard. The 
region between 3 and 6 o clock has intermediate strain 
values at the lumen vessel wall boundary and high strain 
levels distal to this region. The region between 6 and 11 
o clock has low strain values. The similarity between the 
two frames is high. indicating that the determination of 
the strain values in one pressure cycle is reproducible. 
Inter-cardiac cycles reproducibility 
Data from another patient is presented in Fig. 2. Blood 
pressure was between 100 and 150 rmnHg. The likeli-
hood curve (in green) again demonstrates that during 
systole the resemblance between the frames is small but 
that near end-diastole the similarity between frames is 
high. The pressure differential between sequential frames 
near end-diastole is approximately 5 mmHg. 
The echogram of this cross~section shows an eccentric 
plaque between 3 and 9 o clock. At 8 o clock. a calci ed 
deposit is visible in the plaque. In all the elastograrns. 
low strain values are observed in the corresponding 
region. The arterial wall between 9 and 3 o clock has 
moderate to high strain levels. The plaque area between 
3 and 7 o clock has low strain estimates. It can be 
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Figure I T he principle of acquiring an intravascular elastogram in vivo. The likelihood curve (green line) 
reveals a maximum near end-diastole_ Three echoframes (9, 10 and 11) were taken to detennine two 
elastograms. Bod1 reveal soft material between 10 and 2 o'clock, hard material between 7 and 10 o'clock and 
mixed (soft material distal to hard material) between 2 and 7 o'clock. 
appreciated that the elastograms have a similar appear-
ance over the sequential pressure cycles. At 3 o clock, 
erroneous strain estimates can be observed caused by 
not properly working transducer elements. This artefact 
was also visible when the ChromaFio@ mode was 
activated. 
The mean strain pro le with error bars is shown in 
Fig. 3. Errorba rs increase with increasing mean strain 
value. For low strain values (<0 4%). a standard 
deviation of 0 08% is present. The standard deviation 
increases to 0 25% for strain values o f I%. 
S train estimates in j imction of plaque 
mo1phology 
In Fig. 4. two echograms and an elastogram are pre-
sented. The data for determining the elaswgram were 
Eur Hean 1 
acquired near end-diastole. The left echogram is the 
original echogram as produced using the EndoSonics 
In Vision system. The echogram reveals a highly calci ed 
wall between I and 9 o clock with distal shadowing. The 
region between 9 and I o clock contains no calci ed 
material. T he low-resolution echogram in the middle is 
the echogram determined directly from the radiofre-
quency data. Since the radiofrequency da ta is acquired 
in ChromaFio@ mode. only 64 angles are available at 
low resolution. The elastogram (Fig. 4left) shows very 
low strain values (average=O 15%) between 2 and 9 
o clock corresponding to the calci eel area. T he region 
between 9 and 2 o clock has high stra in levels (average = 
0. 76%) . indicating soft material in this region. 
Among the 12lVUS cross-sections acquired in the 12 
patients investigated. three demonstrated similar calci-
ed regions (104 ± 70'). The corresponding average 
stra in values was 0 20 ± 0 07. Conversely. the average 
100 
Strain (%) 
1·0 
0·0 
Figm·<' 2 Reproducibility of the clastograJJhic acquisition over severaiJmlsations. Five elas tograms arc acquired at end-diastole in sequential hear t 
cycles. T he elasto~:,rrams show similar features in a ll the elaslograms. 
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Figure 3 Mean strain and standard deviation of five clastograms acquired nver five sequential pulsations 
(Fig. 2). The standard deviation increases for higher mean strain values. The high standard deviation ncar 
elements I and 64 can be explained by the poor sensitivity of the elements at this side of the catheter. 
Strain(%) 
l·O 
Figure 4 Echogram (acquired in image and ChromaFio mode) and elastogram of a cross-section in the LAD. The 
echogram (left) reveals calcified material between 12 and 9 oclock. The cchogram acquired in ChromaFio@) (middle) 
reveals the decreased resolution of this acquisition mode. The elastogram shows low compression in this area and high 
compression in the remaining region (between 9 and 12 oclock). 
strain value in all non-calci ed regions was 0 5 1 ± 0 20 
(P<O 001) . 
Patients characteristics are given in Table I. No 
s tatistical differences in average strain value over each 
cross-section were found in function of these character-
istics (concentrideccentric, stable/unstable angina. etc.) . 
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Discussion 
ldenli calion of plaque vulnerabi lity is crucial. Cur-
rently. there is no clinica lly available tool for reliably 
detecting vulnerable plaque. Elastography is a promising 
technique. capable of assessing the local mechanical 
properties of the vessel wall and plaquei~OI: in vitro 
experiments demonstrated that strain values obtained 
with intravascular elastography differ signi cantly for 
brous and fatty plaque components. It was also shown 
that fatty regions with an increased macrophage content 
were co~localized with high strain values. 
In this study. in vivo elastograms of diseased human 
coronary arteries are presented. Contrary to a previous 
in vitro studyl401, a dynamic instead of static pressure 
differential is used to strain the tissue. The advantage is 
that this excitation source is already present in the 
arterial system. Using gated acquisition, different levels 
of intravascular pressure were obtained. These prelimi-
nary results indicate that reproducible elastograms can 
be obtained using this acquisition scheme. 
Compared to the in vitro study. the pressure differen-
tial between the two frames is smaller: 4-5 mmHg 
instead of 20 mmHg. A smaller pressure differential will 
immediately result in lower strain values. However, the 
strain values found in this in vivo study were in the same 
range as the strain values found in the in vitro study 
indicating that the tissue in this study is softer. A 
possible explanation is that the elastic moduli of tissue 
will be elevated after the tissue is excisect14 61 and may 
even further increase after cold storage. Additionally, 
since the in vitro study was performed at room 
temperature, fatty tissues will be harder than at body 
temperature1471 resulting in decreased strain values. 
Another way to strain the tissue is to use a compliant 
angioplasty type of balloon with the transducer in the 
balloon. as proposed by Shapo et a/. 1381 • Although the 
motion artefacts due to the contraction of the heart are 
minimized, this technique has several disadvantages 
(interruption of the blood ow. non-radial expansion of 
the artery when the lumen is not circular. movement of 
the transducer in the balloon due to in ation of the 
balloon, balloon dilatation in an artery segment which 
may not require an angioplasty). 
Contrary to the in vitro validation study. a phased 
array transducer. used every day in our catheterization 
laboratory for clinical purposes. was used for the data 
acquisition. This monorail catheter presents better 
trackability and pushability than single element cath-
eters and there is no artefact from the guidewire. 
Moreover, the use of an array catheter removes the 
artefacts due to non-uniform rotation. Therefore. 
two-dimensional instead of one-dimensional cross~ 
correlation techniques might be applied to determine the 
strain values. These techniques are currently being 
implemented. In principle. two-dimensional cross-
correlation techniques are more robust and should lead 
to more reliable strain estimatesl181. 
Limitations 
A major problem of advancing intravascular elastogra-
phy to cardiac in vivo applications is the acquisition of 
data in a pulsating artery located in a contracting heart. 
The catheter will move in the lumen and this will result 
Retrieval of coronary artery information 7 
in a mismatch of the data acquired at the low and high 
pressure. Correct strain estimates are only obtained 
when the two echoframes (at low and high pressure) 
image the same cross-section. This study revealed that 
the motion of the catheter is minimal near end-diastole 
in the relaxed phase of the cardiac cycle. Figure 3 shows 
that the standard deviation of the strain estimate in-
creases with increasing mean strain. This increased stan-
dard deviation is caused by decorrelation effects at 
higher strain rates1451 • The use of the high resolution 
beam-formed data will improve the signal to noise ratio 
and thus decrease the standard deviation. 
Useful data were not obtained during all measure-
ments. In four other patients. the motion was still too 
large even near end-diastole. This large motion resulted 
in an increased number of erroneous strain estimates 
(more than 35%). Currently, improved signal processing 
tools are being developed to increase the robustness of 
the method:~81 • Another possible solution to this prob-
lem is to obtain data during in ation of the angioplasty 
balloon of the Megasonics catheter: by in ating the 
balloon. the position of the transducer is xed in the 
artery. 
In this study. the pressure is measured in the ostium 
using a uid lled line. Therefore. the pressure at the 
cross-section of interest may have a delay and may 
deviate from this pressure. For reconstruction of 
Youngs modulus images and to investigate the in uence 
of a severe stenosis between the measured cross-section 
and the ostium, the pressure would have to be measured 
using a high delity pressure wire. 
The elastograms presented in this study could not be 
validated using histology. Therefore. the elastographic 
ndings were compared with the echographic ndings. 
Intravascular ultrasound echograms have proven to be a 
useful tool for the detection of calci ed regions and 
assessment of the morphology of the plaque and vessel 
wall149- 51 1. However recent intravascular ultrasound 
studies revealed that the correlation between echogenic-
ity and brous. bra-fatty or fatty plaque components is 
lowl 1 1 •12·401, Additionally. intravascular ultrasound echo-
grams present limited information for the detection of 
microcalci cation accumulationi~ZI. Therefore. no vali-
dation of the high strain regions in the elastograms was 
performed. Currently, the technique is validated using 
an atherosclerotic yucatan minipig animal model. Vali-
dation of the elastographic ndings in humans could be 
performed using a directional atherectomy device. How-
ever, the correlation of the excised plaque with the 
intravascular ultrasound image in a radial and longitu-
dinal direction will be extremely difficult. Validation of 
small spots would need a system that is able to deter-
mine the tissue type with a higher resolution. The 
current developments in optical coherence tomogra-
phyl211 and Raman spectroscopi531 may allow perform-
ing such validation of intravascular elastography in vivo 
in the near future15 ~ 1 . Plaque unstability detected by 
elastography will be compared in the future with 
thermographic recordings. recently demonstrated as a 
potential useful methodl:tSI. 
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The resolution of the described system is 200 f.liD in a 
radial direction. This resolution is above the thickness of 
caps of rupture prone plaques that are typically thinner 
than 100 f.liD. Therefore. the thickness of the brous cap 
will be over-estimated. However. a cap that is rupture 
prone will have increased circumferential stress val-
ues1551. The resulting increased radial strain is obtained 
using elastography. The power of elastography is that 
the actual strain is measured and is not based on 
assumptionsl55·561 . 
We could demonstrate a signi cantly lower strain 
value in the calci ed regions of the cross-sections re-
corded among these 12 patients than in the rest of the 
vessel wall. as expected. However. no further differen-
tiation among these segmented regions in function of the 
plaque composition (normal!neointimal thickening. soft/ 
brous plaque)l 111 could be performed because of the 
poor resolution of the acquired cross-sections in the 64 
angles ChromaFlo® mode. as illustrated on Fig. 4. This 
is being currently improved on the new high-speed 
digital interface available for the EndoSonics In-Vision 
platform. It was also not possible to demonstrate strain 
differences in function of the clinical presentation. 
This will be investigated in the future among a more 
important study population. 
Conclusions 
It is feasible to apply intravascular elastography in vivo. 
Using the pulsatile pressure as a mechanical stimulus. 
different strain levels were measured for different tissue 
components. The strain in non-calci ed material is 
signi cantly higher than in calci ed material. 
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their experienced ultrasound assistance. This work is supported by 
the Dutch Technology Foundation (STVV). C. L. de Korte is a 
J\WO fellow. 
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Abstract 
This paper describes the first reported attempt to develop a 
real-time intravascular ultrasonic palpation system. We 
also report on our first experience in the catherization labo-
ratory with this ne•v elastographic imaging technique. The 
prototype system was based on commercially available 
intravascular ultrasound scanner that was equipped with a 
20 MH::. array catheter. Digital beam-formed radio-frequency 
(RF) echo data (i.e. 12 bits, 100 H::.) was captured at full 
frame rate from the scanner and transferred to PC memory 
using a fast data acquisition system. Composite palpograms 
were created by applying a one-dimensional echo tracking 
technique in combination with global motion compensation 
and multi-frame averaging to several pairs of RF echo 
frames that were obtained in the diastolic phase of the car-
diac cycle. The quality of palpograms was assessed by con-
ducting experiments on vessel phantom:,; and on patients. 
The results demonstrated that robust and consistent pal-
pogroms could be generated in almost real-time using the 
proposed system. Good correlation was observed ben-veen 
low strain values and regions of calcification as identified 
from the TVUS sonograms. Although the clinical results are 
clearly preliminary, it was concluded that the prototype ;-.ys-
tem perfonned sufficiently well to warrant further and more 
in depth clinical investigation. 
Key words: Atherosclerosis, clastography, elasticity 
imaging. intravascular ultrasound, multi-frame averaging. 
palpation, palpogram, and tissue characterization. 
Introduction 
Catheter based intcrvcntional techniques that arc used for 
treating atherosclerotic lesions such as angioplasty, stcnting, 
and athcrcctomy arc predominantly mechanical in nature. 
Therefore the morphology and composition of atheroscle-
rotic lesion could influence their outcome. Additionally, cir-
cumferential stress is known to concentrate in the fibrous 
cap overlying the lipid pool making it prone to rupture 
(Richardson ct al., 1989; Cheng ct al., 1993). Additionally, 
it should be possible to identify vulnerable plaques by 
imaging the clastic properties of vascular tissues. 
Currently, intravascular ultrasound (IVUS) is the only 
medical imaging modality that is able to produce real-time 
cross-sectional images of the arterial wall in vivo at high 
resolution. Consequently. attempts have been made to clas-
sify the composition of different plaque types based on tl1cir 
backscatter signal strength (i.e. their cchogenicity) (Di 
Mario ct-al., 1998). The problem with this approach is that 
the cchogenicity of soft tissues is highly dependent on scan-
ncr settings. A problem that is circumvented by normalising 
the echogenicity of the intima to the cchogenicity of the 
adventia (Hodgson et al., 1993). Thus, an intimal thickening 
with less cchogenicity than the adventitia is considered as 
soft plaque. whereas those with equal or higher.echogenic-
ity is perceived as hard plaques. However. it has been 
demonstrated that many plaques, which arc classified as 
being soft, arc often resistant to dilation (Hiro ct aL 1997). 
thus indicating that there is no direct relation between tissue 
stiffness and cchogcnicity. The presence of acoustic shad-
owing and reverberations are specific landmarks that indi-
cate the presence of calcification. However, densely fibrot-
ic plaques often produce bright echoes, and a high attenua-
tion of the echo-signal can easily be misinterpreted as 
acoustic shadowing (Di Mario ct al., 1998). Furthermore, 
de Korte et al. (2000) have recently demonstrated that no 
correlation exists between mean ccho-
gcnicity and tissue elasticity for non-calcified plaques. In 
addition to these problems large operator variability is 
generally associated with such qualitative tissue characteri-
sation approaches. 
It is envisaged that these limitations can be overcome using 
a system that is capable of imaging tissue elasticity. 
Unfortunately, none of the established medical imaging 
modality such as Magnetic Resonance Imaging (MRI). 
:rvt:S and X-ray angiography can provide a direct measure 
of vascular elasticity. However, most can provide informa-
tion regarding induced mechanical response (i.e. strain or 
displacement) that is related to tissue elasticity. Several 
groups (Talh:uni ct aL 1994: Shapo ct al .. 1996; Ryan and 
Foster, 1997) including ours (C6spcdes ct al., 1997: de 
Korte ct al., 1997b: de Korte et a!., 1998; CCspedcs ct al., 
2000) have proposed various IYUS based elasticity-
imaging techniques for characterising the composition of 
different plaque types, and potentially for detecting vulner-
able plaques. The elasticity images of the intra-coronary 
artery produced using these techniques generally possess 
better contrast compared to standard IVUS images. This 
occurs because the ultrasonic properties of soft tissues arc 
related to bulk clastic properties, which generally does not 
vary widely between different plaque types: Whereas, the 
elastic property (i.e. Shear or Young's modulus) of different 
tissue types generally spans several orders of magnitude. 
In spite of this. more widespread clinical utilisation is cur-
rently limited by lack of a real-time intravascular elasticity 
imaging system. 
The long-tcnn objective of this work is to develop a real-
time clinical intravascular elasticity imaging system. 
Currently, we are investigating the possibility of developing 
such a system based on the intravascular ultrasonic palpa-
tion approach proposed by Cespedes et al. (2000). This is 
basically a low axial resolution intravascular clastography 
technique. In rvus palpation radial strain is estimated 
using large non-overlapping* kernels and processing is 
restricted to tissues within the inner layer of the arterial 
wall. Furthermore. the radial strain information is colour 
coded and superimposed on the IVlJS cchogram at the 
lumen-vessel interface to produce a compound image that is 
known as a strain palpogram. The primary advantage of this 
technique is that it is simple enough to be implemented in 
real-time using relatively inexpensive hardware and in 
exchange for reducing axial resolution we expect it to be 
more robust compared to IYUS elastography. 
Despite these desirable features catheter motion presents 
problems in clinical utilisation of IVUS palpation. 
Decorrclation noise due to catheter motion will either 
degrade image quality or may even result in failure to esti-
mate radial strain. One of the primary objectives of this 
work was to develop an elasticity imaging system that is 
able to cope with this problem. 
In addition to catheter motion there is also structural decor-
relation noise (Varghese and Ophir. 1997), which occurs 
because the underlying tissue structure displaces in all co-
ordinate directions when soft tissues are deformed. 
Structural decorrelation noise will corrupt the signature of 
the post-deformed echo signal. and thus will limit our 
ability to accurately track tissue motion in the presence of 
large internal strain (i.e. internal tissue strain exceeding 
2 %). The following techniques have been proposed to cope 
with this problem: (a) temporal stretching (CCspcdes and 
Ophir. 1993: Var<>dlesc et al .. 1996). (b) adaptive stretching 
(Alam et al .. 1998). (c) global and local companding 
(Chaturvcdi et al., 1998a: Chaturvcdi et al.. 1998b ), (d) 
envelope tracking (Doyley et al .. 1996: Shiina et al .. 1996), 
and (c) multi-compression processing (Varghese and Ophir. 
1996). 
Finally. there is random noise. which dominates in the 
presence of low internal strain. The main contributors of 
this source of measurement noise are: a) quantisation noise. 
which occurs during digitis:1tion. b) electronic noise, which 
is associated with the ultrasonic imaging system. and c) bias 
errors that arc introduced by the curve-fitting interpolation 
methods that are used for estimating sub-sample time-
delays (CCspcdes et al .. 1995). Quantisation errors can be 
minimised by digitising RF echo signals to large number of 
significant bits. whilst electronic noise can be minimised 
using either a band-pass filter (Haykin. 1989) or by per-
forming signal averaging. Sampling noise associated with 
the curve fitting interpolation methods that are used to 
improve the resolution of time-delay estimation can be 
reduced using a reconstructive interpolation filter proposed 
by Cespedes et al. (1995). 
* Non-overlapping kernel~ arc used because this generally produced 
more robust (i.e. ~maller variance) strain estimates butut the expense of 
re~olution (Co!spede~ et al .. 1995b) 
1bis paper described the first reported attempt to investigate 
the feasibility of developing a real-time clinical intravascu-
lar elasticity imaging system. We also report on our first 
clinical experience intravascular ultrasonic palpation. 
Materials 
Phantom 
A 15 em long vessel phantom. which had inner and outer 
diameters of 3 mm and 20 mm, respectively was fabricated 
from 8 % by weight porcine skin gelatine (Type A. approxi-
mately 175 bloom. Sigma chemical St. Louis, MO) and 1 % 
by weight Agar (Boom BC. Meppel. The ::--Jetherlands) as 
described by de Korte et al.. (1997a). Carborundum 
particles (I % by weight. 3-10 f.UU mean diameter) were 
added to create acoustic scattering centres. 
Patients 
Elasticity measurements were performed with the informed 
consent on patients whom were referred for percutaneous 
coronary intervention. 
Methods 
Data acquisition system 
A schematic diagram of the equipment used for acquiring 
data is shown in Fig. 1. Echo imaging was performed using 
an InVision intravascular ultrasound scanner (JO:MED. 
Imaging. Rancho Cordova, CA. USA). which was equipped 
with a 20 MHz 64 FIX Visions catheter (J0).1ED, Imaging. 
Rancho Cordova. CA. USA). This scanner was equipped 
with a RF interface to provide direct access to the high reso-
lution digital beam formed RF echo frames. and three syn-
chronisation signals: start of frame (SOF). start of line 
(SOL) and pixel clock. A fast data acquisition system was 
developed based on a modified PCI bus Corcco Viper digi-
tal frame grabber (Corcco Inc. Quebec. Canada) and inter-
faced to the IVGS imaging system. Sequences of beam-
formed radio frequency (RF) echo frames were transferred 
at 30 frames per second (fps) from the scanner directly in 
random access memory using this system. All RF echo 
frames were digitised to 12 bits at a sampling rate of 100 
MHz. Eo.ch digitised echo frame contained a total of512 RF 
A-lines. each consisting of 1024 sample points (correspon-
ding to scan depth of 7.5 mm). The pressure within the 
lumen was measured using a pressure sensor. which was 
connected to a standard fluid line system (Ohmeda. 
Bilthoven, The Netherlands). The resulting physiological 
signals (i.e. electrocardiogram and pressure signals) were 
digitised to 12 bits at a sampling frequency of 5 kHz per 
channel using a multi-channel input-output (I/0) PCI card 
(National instruments). Both sets of data (i.e. low frequency 
physiological signals and RF echo frames) were stored on a 
450 MHz Xeon based PC. 
Phantom study 
The aim of this part of the study was to evaluate the 
performance of the motion compensation and multi-frame 
averaging procedures. which we have developed to mi-
nimise the primary noise sources incurred during IVUS 
assessment. All measurements were performed in an 18 em 
(long) by 8 em (high) by 10 em (wide) water tank. which was 
equipped with two sheaths (8 F). one was located at each side 
of tank. The phantom was connected between both sheaths. 
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Figure 1: Schematic dia.gmm of the equipment used, for clinic:l.l elasticity imaging. 
EvaluatWn of nwtion compensation 
Data acquisition 
The catheter was inserted in the proximal sheath and posi-
tioned approximately in the centre of the lumen. before 
pressurising the vessel to 50 mmHg (i.e. reference pres-
sure), with a column-based system (de Korte et al., l997a). 
The pressure within the phantom was further increased to 
produce applied strain of 0.2 %. 0.5 %. and 1.5 %. Eight 
sets of RF images were obtained at the reference and all 
subsequent pressure increments. Rotational catheter motion 
was simulated in software by rotating the echo frames 
obtained at each strain increment clockwise between 0 and 
6° in steps of 0. 7o. The backscatter signal strength is rota-
tional invariant for a phase array catheter:; therefore the 
simulated RF echo-fnunes were representative of that 
incurred if the actual experiment was performed. 
Pre-processing (motion compensation) 
A localised motion compensation technique was applied to 
pairs of RF echo frames prior to strain estimation. The aim 
was to determine the in-plane translation T(r) and rotation 
R (a) vector, which maximises the similarity between a 
series of kernels that were defined in pairs of IVUS sono-
grams, which were acquired at different pressures. The 
similarity between a given pair of kernels was evaluated 
using the sum-of absolute difference (SAD) method (Bohs. 
1994). This method has proven to be effective for intravas-
cular elasticity imaging (Janssen et al., 2000). Furthermore. 
the accuracy of the SAD approach is similar to that of the 
cross-correlation approach when performing 2D displace-
ment estimation (Bohs. 1994). However. the SAD approach 
has the distinct advantage over the normalised cross corre-
lation approach of being relatively easily implemented in 
hardware and computationally less demanding. 
To illustrate our motion compensation method lets consider 
a pair of NUS images. X and Y that were obtained at 
different intra-coronary pressures. First, a small region of 
data was selected from image X, which is generally called 
the reference kernel. The degree of similarity between the 
reference kernel and similar size kernels within a pre-
defined search kernel that was defined in Y (i.e. the test 
image) was calculated as follows: 
C M 
''"= 2:2:1x•.,-Y, ... ,~I (1) 
owl J•l 
where L and M represents the dimension of the kernel in 
polar co-ordinates. and r and represents the offsets in the 
radial and angular direction. respectively. Finally. the 
co-ordinate in Y was adjusted so as to minimise the SAD 
function. This procedure was repeated for several kernels to 
produce a vector of radial and angular offsets. which were 
subsequently used to correctly position the observation 
sight in the post-deformed RF echo frame (i.e. that corres-
ponding to a high intra-coronary pressure) during strain 
estimation. All echo tracking was perfonned in the polar co-
ordinate system, since this allowed us tO define rectangular 
kernels. 
Processing (strain estimation) 
The technique that was used to create palpograms can be 
summarised into the following steps. 
a) Detect the lumen-vessel interface automatically by 
applying a simple threshold algorithm to the digitised RF 
echo frames. 
b) Estimate induced radial displacements of tissue within 
the inner layer of the artery by performing one-dimen-
sional cross-correlation analysis on RF echo frames that 
are obtained at different intracoronary pressure. 
c) Compute induced radial tissue strains by applying a 
finite difference strain estimator (Ophir et al .. 1991) to 
the measured displacements. The least squares 
strain estimate approach proposed by Kallel and Ophir 
(1997) generally produced better strain estimates (i.e. it 
doesn't amplify displacement errors). However, it is not 
meaningful to apply it for only two displacements esti-
mates. 
d) Reject erroneous strain estimates by applying an outlier 
rejection filter to the strain estimates (see below). 
e) Colour code valid strain estimates using a traffic light 
notation (where red, amber and green represents low. 
medium and high strain. respectively). and erroneous 
strain estimates as purple. 
f) Super-impose the colour coded elasticity information on 
the IVUS sonogram at the lumen vessel interface. 
The outlier rejection filter was based on decorrelation 
model proposed by (C6spcdcs et al., 1999). The general 
idea was to compute a theoretical estimate of the peak 
cross-correlation coefficient using the following expression 
jJ,h ""sinc(.ifcT) (2) 
where e represents the measured strain, T represents t11e 
length of the kernel used during cross-correlation analysis, 
and fc represent the center-frequency of the ultrasound 
transducer. A strain estimate was considered erroneous 
when the difference between the peak value of correlation 
coefficients measured at two locations within the arterial 
wall (i.e. [31 and [32 ) was greater than 20 % of the computed 
peak value of cross-correlation function for the measured 
strain. This threshold represents the 95% confidence inter-
val that was determined by conducting experiments on 
phantoms (Cespedes et al.. 1995) for the range of strain that 
are generally incurred in intravascular applications(::::: 2 %). 
All cross-correlation analysis performed in both studies was 
conducted using non-overlapping kernels that had an optimum 
kernel size of 05 mm. which was detennined empirically. 
Evaluation of multi-frame averaging procedure 
Data acquisition 
Pulsatile pressure (1Hz) was generated in the vessel using a 
programmable peristaltic pump (Watson and Marlow 5000). 
that was connected to the proximal sheath. One hundred and 
twenty-five subsequent RF echo frames were captured from 
the scanner at 30 fps. 
Frame selection 
Processing was restricted to RF echo frames that were 
acquired in the diastolic phase of the cardiac cycle using the 
negative derivative of the intra-coronary pressure signal as 
the primary frame selection criterion. The decision to limit 
the processing to these frames was based on observation 
that the contraction of the heart and therefore catheter 
motion is relatively small in this phase of the cardiac cycle. 
Additionally, in this phase of the cardiac cycle the intra-
coronary pressure decays relatively slowly and approxi-
mately constant compared to other regions (i.e. systole). 
which should enable us to cope with structural decorrela-
tion noise. 
Processing (multi-frame averaging) 
A series of radial strain profiles were measured by applying 
the single-step strain estimation produced described in the 
previous part of the study to the selected RF echo frames. 
All cross-correlation analysis was conducted using 1 mm 
long kernels. 
Composite strain profiles were measured at each cardiac 
cycle by computing the arithmetic mean of the valid strain 
estimates at each angular position. The composite strain 
profiles were colour coded as before and super-imposed on 
the IVUS sonogram at the lumen vessel interface to produce 
a compound image. 
Data analysis 
Performance was assessed using two different criteria: 
a) qualitatively by viewing the palpograms and b) quantita-
tively by assessing the elastographic signal to noise ratio. 
which was defined as follows: 
SNR= ,us 
as 
(3) 
where J..Ls and crs represents the mean and standard deviation 
of the radial strain estimated within an elastically homoge-
neous tissue region. 
Patient study 
The aim of this preliminary clinical study was to gain 
insight into the performance of the strain estimation 
approach before conducting large-scale clinical trial. 
Data acquisition 
A 6 Fr. guiding catheter was advanced up to the coronary 
ostium of each patient after 10,000 IU heparin and 250-mg 
acetylsali-cyclic acid was administrated intravenously. A 
bolus injection of 3 mg of isosorbide dinitrate was adminis-
tered prior to IVUS assessment RF echo frames were cap-
tilTed for 4 s from the scanner at a frame rate of 30 fps. The 
arterial pressure was measured at the level of coronary ostium 
via the guiding catheter, which was connected. to a standard 
fluid line system (Oluneda, Bilthoven, The Netherlands). 
Frame selection 
RF echo frames corresponding to the diastolic phase of the 
cardiac cycle were selected using the negative derivative of 
the intra-coronary pressure signal. 
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Figure 2: Meun elastographic signal to noise ratio computed from palpograms tlmt were crea.ted using a simple strain estimation approach 
when the catheter wn..~ rotated, and the vessel phantom was defonned using applied strain of 0.2% (circle). 0.5 %(square). and 1.5 % (ilia-
mood), respectively. The dotted lines denote the elastographic signal to noise ratio measured when palpograms were computed using a motion 
compensated strain estimation approach. 
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Figure 3: St.rain filters measured from p:l.lpogram~ computed using multi-fr.une averaging (circle) and single-step (square) strain estimation 
approach. 
Processing 
Composite palpograms were computed by applying the 
multi-frame averaging strain estimation procedure 
described in the phantom study to different combination of 
RF echo frames before and after compensating for rotational 
catheter motion. Cross-correlation analysis was performed 
using kernel size of 0.6 m.m (long) and 0. 7 mm (long) for 
case 1 and 2. respectively. The size of the kernel was 
chosen based on the plaque thickness, which was 
evaluated by visual inspection of the IVUS sonogram. 
Results 
Phantom study 
Evaluation of motion compensation procedure 
Figure 2 shows the effect of rotational catheter motion on 
the elastographic signal-to-noise ratio (SNR) for different 
tissue strain values, which were computed before and after 
the motion compensation procedure were applied. The 
mean and standard deviation was computed from 512 inde-
pendent strain estimates, which were equally distributed 
between 0 and 2II.Note the rapid decrease in SNR that 
occurred in cases where the motion compensation proce-
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dure was not applied prior to strain estimation. This rapid 
degradation in image quality represents the change in the 
beam pattern (i.e. deeorrelation) that occurs as one moves 
across the beam in the angular direction. It is also apparent 
that increasing the tissue strain compromised the quality of 
both sets of images (i.e. those computed before and afier 
global motion compensation). This behaviour represents the 
effect of structural dccorrelation noise, which increases in 
the presence of large internal tissue strain. 
Evaluati()n of multi-frame averaging procedure 
Figure 3 shows examples of strain filters that were derived 
experimentally from palpograms, which were created using 
the multi-frame averaging approach. and single-step 
approach (i.e. without frame averaging). The characteristic 
trade off that exists between structural decorrclation and 
electronic noise can clearly be seen in both cases. At low 
strain the quality of the palpograms is limited predominantly 
by random errors, and thus increasing the magnitude of the 
internal tissue strain (i.e. the differential pressure) results in 
a rapid increase in elastographic Sl\.'R. However. because 
structural decorrelation noise also increases with increasing 
so 100 120 
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Figure 4: The pressure signal U with the corresponding similarity function ( .... ) of patient 1. The similarity function shows that catheter 
motion L~ small near end-diastole. 
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Figure 5: Examples of composite palpograms computed for patient I. These palpograms were performed by applying the multi-frame strain 
estimation approach before (A) and after (B) correcting image;, for catheter motion to consecutive pairs of RF echo frame;, (with an average 
pressure difference of 2 mmHg) obtained near end-diastole. Showing a calcified spot at 6 o'clock. 
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Figure 6: Example of composite palpograms computed for patient I . These palpograms were produced by processing RF echo frames using 
an inter-frame strain of 4 and pressure difference of 8 mmHg with the mu lti-frame strain estimation approach before (A) and after (B) cor-
recting images for catheter motion. Regions where it was not possible to compute valid strain estimates are denoted in purple. 
applied strain there is an upper limit on the maximum SNR 
that can be achieved by increasing tissue strain. Further 
increase in tissue strain beyond the upper limit results in a 
rapid degradation in the clastographic SNR (Varghese and 
Ophir. 1997). Nevertheless, it is apparent that better images 
were produced at all strain increments when palpograms 
were computed using the multi-frame averaging approach. 
Preliminary in vivo assessment 
Patient 1 
Figure 4 shows the pressure signal and the similarity curve 
that wa.s obtained in patient J. Figure 5 (A-B) shows typical 
examples of composite palpograms. which were computed 
1.0 
0 .8 
,...... 
~ 0.6 
.5 
"' 
-= 
"' 
0.4 
~ 
:l 
~ 02 
0.0 
0 2 
by processing pairs of RF echo frames using a pressure dif-
ference of 2 mmHg and an inter-frame interval of two. It is 
clear from the IV US sonogram that the catheter was eccen-
tric. Consequently. since we didn't correct for catheter 
eccentricity the palpograms also appeared eccentric. 
Nevertheless. it is interesting to note that we were able to 
produce complete palpograms that possess good contrast 
resolution in both cases (i.e. before and after correcting for 
in-plane rotational catheter motion) using this inter-frame 
increment and pressure difference. Additionally. no signifi-
cant difference was observed in the visual appearance of 
palpograms that were created using both approaches. 
A calcium spot can clearly be seen at 6 o'clock in the IV US 
3 5 
Angular position (radian) 
Dayley e1 at. 
Figure 7: Mean radial strnin profile corresponding to Fig. 6. The error bar represents ± one standard deviation computed over four cardiac 
cycles. 
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Figure 8: Pressure curve of palicm 2. 
sonograms, which appears as a localised region of low 
strain (the mean strain computed in this region was 0.13% 
± 0.07 ) in the palpograms. Regions of high strain can clear-
ly be seen on the palpograms between II and 2 o'clock. 
which could represent fauy material. An increased strain is 
also found at 7 o ·clock that corresponds to a transition area 
between calcified and non-calcified material. ll is known 
that increased circumferential stress and thus increased 
radial Strain is present at these junctions. Furthermore, from 
the global appearance of palpogram this plaque would 
appear to be composed predominantly of a harder material 
such as fibrous tissue. 
Figure 6 (A-B) shows examples of palpograms produced 
using both strain estimation approaches using a differemial 
pressure of 8 mrnHg and an inter-frame increment of four. 
Note that in this case it wasn't possible to produce a com-
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plete palpograms (as indicated by purple area) without first 
correcting for in-plane rotational catheter motion. Figure 7 
shows the mean radial strain profile computed from four 
palpograms (i.e. one palpogram was computed at each car-
diac cycle) that were produced using the motion compen-
sated strain estimation technique. 
There is a region of elevated strain next to the calcified spot 
(also visible in Fig 5A-B and Fig. 6A) but is not visible in 
Fig 6B. Note that at each angular position the mean and 
standard deviation was computed from four independent 
strain estimates. Increased error bars are observed for 
inc-reasing strain values. From Figure 3 it is known that for 
strain values between 0.25 % and 1.5 %. the elastographic 
signal to noise ratio is similar. Therefore, larger etTor bars 
are expected for increased strain values. 
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Figure 9: Examples of composite palpogmms computed for patient 2. These palpograms were produced by processing con,ecutive pai~ of 
RF echo fmmes (i.e. using an inter-frame increment of I and a pressure difference of 3 mmHg) using the multi-frame >tmin estimation 
approach. before (A) and after (B) correcting images for in-plane catheter motion. A large region of calc!lied m:uerial can c learly be ~een 
between 12 and 2 o'clock. 
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Figure 10: Examples of composite palpogmms computed for patient 2. which were produced by processing RF echo frames using an inter· 
frame ;train of 3 and a pressure difference of 7 mmHg with the multi-frumc strain estimation approach. before (A) and ofter (B) correcting 
images for catheter motion. Regions where it wasn1t possible to compute vnlid strain estimntc!o. are denoted in purple. 
Patient2 
The pressure curve of this patient is shown in Figure 8. 
Figure 9 (A~B) shows examples of composite palpogram 
computed using a pressure difference of 4 mmHg and inter-
frame interval of one within diastole. before and after cor-
recting for in-plane catheter motion. Compared to the pre~ 
vious case this patient had a concentric plaque, and thus the 
palpogram appeared concentric. In addition. no significant 
difference can be observed in the quality of the palpograms 
produced using the two strain estimation approaches. A 
large region of calcification can clearly be seen in the NUS 
sonograms between 12 and 3 o'clock, which corresponds to 
a region of low strain (mean strain of 0.15% ± 0.06) in the 
palpograms. 
Figure 10 (A-B) shows examples of palpograms that were 
created using an inter-frame increment of three and a 
pressure difference was 7 mmHg. As in the previous case 
(i.e. patient 1) it wasn't possible to produce a complete pal-
pegram without applying the motion compensation proce-
dure. Increased strain values were found between 7 and 9 
o ·clock. This corresponds to a hypoechoic area that can be 
observed between 7 and 9 o ·clock. It was apparent from a 
visual assessment of the rvcs cine-loop that this was due 
to the presence of a side branch. This side branch may result 
in increased strain values and thus an artefactual represen-
tation of the mechanical properties. Figure 11 shows the 
mean radial strain profile computed over four cardiac cycles 
from palpograms that were produced using a pressure dif-
ference of 4mmHg and an inter-frame increment of one 
with the motion compensated strain estimation technique. 
Catheter motion was quite severe in this case. since we were 
unable to correct for out~off plane catheter motion. It is rea-
sonable to assume that the apparent degradation in the 
repeatability of the palpograms reprc:>cnts the effect of out-
off-plane catheter motion. 
Discussion 
In this paper we describe a prototype elasticity imaging 
system, which was developed based on the intravascular 
ultrasonic palpation approach that was proposed by 
OSspedes ct. al .. (2000). The system was based on a com-
mercially available Endosonics In Vision IVtJS scanner that 
was equipped with a 20 MHz array catheter. A fast data 
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acquisition system was used to capture sequences of RF 
echo frames from the scanner directly into PC memory at 
full frame rate. 
A novel strain estimation strategy was developed and 
incorporated on the system to minimise the primary noise 
sources. incurred during clinical application. Decorrelation 
noise incurred as a result of in-plane rotational catheter 
motion was minimised using a motion compensation proce-
dure, which was developed based on the SAD approach. 
Despite the effectiveness of this technique. which is demon-
strated in Fig. 2. compensating for catheter motion using 
this technique significantly increases the computational 
load. For instance. it took 8 s to compute a compo·site pal-
pegram when the motion compensation procedure was not 
employed. This is assuming all consecutive pairs of RF 
echo frames in diastolic cycle are processed (i.e. 15 frames 
processed, assuming a heart rate of 60 beats/min). Although 
this is not real-time the presentation speed is 
reasonable for most clinical applications. However. the 
computational load was found to increase tenfold when the 
motion compensation procedure was allowed to compen-
sate for rotational motion up to ± 6°. Note that computa· 
tionalload of the motion compensation procedure is highly 
dependent on size of the reference and search kernels. 
It was apparent from Fig. 2 that quality of the image de grad~ 
ed significantly in the presence of large internal 
tissue strain. Incorporating either a local and/or a global dis-
tortion compensation procedure (i.e. either temporal 
stretching or companding) prior to strain estimation should 
circumvent this problem. However. we envisage that it will 
be very difficult to implement such complex signal process-
ing methods in hardware. To cope with this problem pro-
cessing was restricted to RF echo frames that were obtained 
in the diastolic phase of the cardiac cycle. In this phase of 
the cardiac cycle the intra-coronary pressure decays slowly 
and approximately constant compared to 
systole. Therefore. by choosing appropriate pairs of frames 
for processing (i.e. those corresponding to small pressure 
difference) we were able to minimise structural decorrcla-
tion effects. 
A multi-frame averaging procedure was also developed and 
incorporated on the system since it has been demonstrated 
in elastography (O'Donnell et al .. 1994: Var<'Jlcse et al .. 1996) 
= 
1.0 ~ ·~ 0.8 ;;; = 0.6 "' " 0.4 :; 0.2 0.0 
-0.2 
0 2 3 4 5 6 7 
Angular position (radian) 
Doylcy et al. 
Figure 11: Mean radial strain profile corresponding to Fig. 10. The error bar represent~ ± one stand:rrd deviation, which was computed over 
four cardiac cycles. 
that this signal processing method has the distinct advan-
tage of improving the clastographic signal to noise ratio by 
factor of N". where ~ is the number of elastograms (or pal-
pogram.s in our case) that arc averaged. Figure 3 demon-
strates that the quality of palpograms produced using the 
multi-frame averaging procedure is superior compared to 
those produced using a single-step approach. The quality of 
both sets of palpograms was limited predominately by ran-
dom errors when the internal tissue strain was small. and 
thus increasing the magnitude of the applied strain results a 
rapid improvement in image quality. However. there is limit 
on the amount of improvement in image quality that can be 
achieved by increasing tissue strain since this also increases 
structural decorrelation noise. It was also apparent from 
Fig. 3 that palpograms should be created using larger inter-
frame interval (i.e. using strains on the order of 1 %) in 
order to maximise the clastographic signal to noise ratio. 
· Incorporating an optimisation procedure in strain estima-
tion technique should result in further improvement in 
image quality. This could be accomplished by computing a 
composite palpogram from a series of partial palpograms 
that arc created using all possible image combinations, but 
at the expense of further increasing the computation load. 
It is apparent from our preliminary clinical investigation 
that the proposed system is able to produce consistent pal-
pograms. which possess good contrast resolution and 
clastographic signal to noise ratio under physiological con-
ditions. We also demonstrated that because of structural 
dccorrclation. large variance will be incurred in region of 
high tissue strain. 
If this system is to be clinically useful. methods must be 
developed to reduce strain projection artefacts that occur 
when the radial strains and the sound beam are poorly 
aligned (de Korte ct al .. 1999). This is important since the 
catheter is generally eccentric in most clinical cases. A 
crude global measure of the degree of catheter motion 
incurred during pre-interventional IVUS assessment can be 
obtained by constructing a similarity function by computing 
normalised sum of absolute difference between consecutive 
pairs of IVUS sonograms. We have observed that this func-
tion generally has a relatively broad peak near-end diastole 
(Fig. 4). where the catheter is believed to be more stable 
(i.e. small catheter motion) compared to other regions of the 
cardiac cycle. Therefore. the computational efficiency of 
the technique could be improved by incorporating the 
similarity function as part of the fTame selection criterion. 
We estimate that it would take less than 4 s to compute a 
composite palpogram if additional constrains is imposed on 
the frame selection criterion using the similarity function. 
Finally. it is important to realise that the signal processing 
methods described in this paper can be applied to intra-
vascular elastography. but currently at a prohibitive com-
putational cost. 
Study limitation 
A limitation of the study is the absence of histologic vali-
dation. which was not possible since directional coronary 
atherectomy was not performed. Therefore. with the excep-
tion of calcified plaques. we could only speculate on the 
composition of the plaque based on the palpogram. For 
instance. regions of high strain can clearly be seen in the 
palpograrns corresponding to patient 1 (Fig. 5(A-B)) at 
11 and 12 o'clock and 1-2 o'clock. Based on the magnitude 
of the strain it is reasonable to assume that this represents 
fatty tissue since the strain incurred in fatty tissues arc 
higher compared to other tissue types. Similarly. two 
regions of high strain can clearly been in the palpograms 
corresponding to patient 2 (Fig. 9 (A-B)) at 4-6 o'clock and 
10-12 o'clock. which is consistent with fatty material. 
Further work is currently planned to validate our system in 
vivo using an atherosclerotic animal-model. and to improve 
our automatic contour detection algorithm. 
Conclusion 
We have demonstrated for the first time that intravascular 
ultrasonic palpation can produce clinicaly useful and reliable 
information in almost real-time. under typical physiological 
conditions in the catherization laboratory. 
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lntracoronary brachyth~rapy has recently 
emerged as a noew therapy to prevent 
restenosis. Initial experimental work was 
achieved in animal models and the results 
were assessed by histomorphornetry. 
Initial clinical trials used angiography to 
guide dosimetry and to assess efficacy. 
Intravascular ultrasound (JVUS) permits 
tomographic examination of the vessel 
wall, elucidating the true morphology of 
the lumen and transmural components, 
which cannot be investigated on the 
lumenogram obtained by angiography. 
the clinical studies of brachytherapy con-
ducted to date. IVUS allows clinicians to 
make a thorough assessment of the 
remodeling of the vessel and appears to 
have a major role to play in facilitating 
understanding of the under1ying mecha-
nisms of action in this emerging field. The 
authors propose that state-of-the-art 
IVUS techniques should be employed to 
further knowledge of the mechanisms of 
action of brachytherapy in atherosclerotic 
human coronary arteries. (lnt J Cardiovasc 
lntervent 2000; 3: 3-12) 
This paper reviews the use of IVUS in 
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Introduction 
On the verge of an exponential increase of the use of 
brachytherapy in interventional cardiology, it is appropri-
ate to keep in mind that this new therapeutic modality is 
still in its infancy. The first case ofbrachytherapy was initi-
ated in Europe as recently as 1992 by Liermann et al, in 
patients who had undergone a femoral percutaneous 
angioplasty. 1 Since radiotherapy has proven to be effective 
in treating the exuberant fibroblastic activity of keloid scar 
formation and o:her nonmalignant benign processes such 
as ocular pterygia/·3 it has been assumed that this adjunc-
tive treatment could inhibit restenosis. Mechanisms 
involved in the restenosis process are elastic recoil of the 
artery, local thrombus formation, vascular remodeling 
with shrinkage of the vessel and an exuberant healing 
process with neointimal cellular proliferation and matrix 
synthesis.H· Stent implantation minimizes elastic recoil 
and remodeling of vessels, but exacerbates the normal pro-
liferative reaction in response to the traumatizing inter-
vention.'·8 Depending on the type of lesions treated, a 
significant restenosis rate of 15-50% remains the major 
hindrance to the success of stent therapy and is mainly 
caused by this exacerbated proliferative reaction. 
Clinical coronary applications of brachytherapy were 
carried out after the experimental work achieved mainly in 
the United States by Wiedermann et a\ in i\.'evv York,') 
Waksman et al in Atlanta 10 and Mazur et al in Houston. 11 
They demonstrated a reduction of intimal hyperplasia in 
swine models of restenosis, initially using -y-radiation 
Cnlr) and thereafter R-sources. 12 In paralleL Verin et al in 
Geneva conducted experimental studies with th>' pur"' ;;. 
emitter 90V in carotid and iliac arteries of rabbits.:: ~~Oil· 
comitantly, Hehrlein et al demonstrated a marked 
reduction of neointima formation in rabbits with low-dose 
radioactive stents, 14 while Carter showed that the dose 
response of a R-partide-emitting radioactive stent in a 
porcine coronary restenosis model was actually complex, 
presenting a bell-shape. 15 These groups provided com-
pelling experimental evidence of efficacy of brachytherapy 
in the prevention of restenosis. In these studies, the short-
and long-term results were evaluated by histomorphometry, 
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measuring the amount of neointima formation after 
balloon overstretch injury. 
The objective of this review is to emphasize the paten~ 
tial of intravascular ultrasound (IVUS) imaging in guiding 
dose prescription, in assessing the results ofbrachytherapy 
in clinical trials as a surrogate ofhistomorphometry and in 
reviewing the different modalities which have been imple-
mented so far. 
Intravascular ultrasound 
An update on its value in predicting restenosis 
Coronary interventions depend mainly on imaging tech-
niques as the source of guidance. Angiography alone pro-
vides a good representation of the complete coronary 
anatomy but a relatively poor image of the diseased vessel 
wall. Angiograms that are difficult to interpret are fre-
quently encountered. These include images of ostial 
lesions, tortuous vessel segments, vessel overlap, interme-
diate lesions, dissections and thrombus. Although the 
value of angiography remains unquestioned, radiographic 
imaging depicts a two-dimensional silhouette of the arter-
ial lumen. This 'lumenogram' is a limited standard on 
which to base therapeutic decisions. 16 Angiography 
demonstrates only lumen narrowing well_ but is inherently 
limited in defining the distribution and extent of wall 
disease. Furthermore, angiography is insensitive to early 
atheromatous thickening of the arterial wall, partly owing 
to vascular remodeling that allows plaque to grow to 
occupy an average of 40% of the vessel cross-section 
before luminal encroachment occurs. 17 Plaque burden in 
reference segments that are considered angiographically 
normal can reach on average 35-40%.18 
In the late Eighties, NUS emerged as a prom1smg 
imaging modality with which to assess vascular disease. 1 ~ 
IVUS provides real-time tomographic images of vessel wall 
cross-sections, elucidating the true morphology of the 
lumen and transmural components of atherosclerotic 
arteries. The field of intravasrular ultrasound imaging has 
led to improvements in the understanding of atheroscle-
rotic disease and its response to various therapeutic inter-
ventions. However, a main thrust of this technique is the 
guidance of therapeutic interventions, and controversial 
data exist in the literature on the value of postintervention 
IVUS parameters to predict the restenosis rate. For percuta-
neous transluminal coronary angioplasty (PTCA), no crite-
ria were -found in the PICIURE study :ncluding 200 
patients/0 whereas Mintz et al found that the residual 
plaque burden measured with IVUS was an independent 
predictor of restenosis. 6 The final report of the GUIDE trial 
that showed the predictive value of IVUS plaque area and 
minimal lumen cross-section is still pending.21 On the 
other hand, it has been demonstrated that, based on IVUS, 
it was safe to increase the nominal balloon-to-artery 
ratio.22 A low rate (14 %) of clinical events at one year has 
been reported in a single-center nonrandomized study of 
252 patients where the balloon sizes were based on the 
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external elastic membrane diameters?3 For stenting, a very 
recent combined analysis from three registries (MUSIC, 
WEST-II, ESSEX) and two randomized stent restenosis 
trials (ERASER and TRAPISf) (n"' 800 patients) has 
demonstrated that the NUS criteria minimum lumen 
cross-sectional area (MLCSA), mean in-stem lumen area, 
stem length and lumen diameter were predictors of six-
month in-stent restenosis, defined as luminal diameter 
stenosis >50% by quantitative angiography (QCA)/4 in 
agreement with other reports which demonstrated also the 
predictive value of an ostial lesion location and the prein-
terventional and residual lesion site plaque burden. 25- 25 
Finally, it remains also controversial whether IVUS guid-
ance may decrease in-stem restenosis and improve event-
free survival after an intervention.2~ In a study matching 
patients between two centers, one performing IVUS guid-
ance, the other using only angiography, there was a signifi-
cant decrease of the restenosis rate (9.2% versus 22.3%) at 
an early stage where the MJS criteria implied aggressive 
dilatation using oversized balloons.30 However, this led to 
a high incidence of vessel ruptures. IVUS criteria were 
modified, the balloon-artery ratio used was decreased to 
achieve a stem cross-sectional area (CSA) equal to or 
greater than the distal lumen CSA, and no further dif-
ference in the outcome of the patients was fouild between 
the angiographic and NUS guidance groups. 
MJS guidance improved the minimal CSA in the stent 
at the end of the intervention in the MUSIC trial, and com-
parison of angiographic data with earlier studies 
demonstrated that the improvement of this minimal 
lumen diameter (MLD) (2.9 mm versus 2.5 mm) was 
associated with a lower restenosis rate (9.7% versus 20% 
respectively for the MUSIC and Benestent 1).31•31 \Vhen the 
IVUS criteria for optimal stent e: .. :pansion are met, the 
restenosis rate is lower.33 However, these criteria cannot be 
met in all patients, and the results of two randomized 
trials (RESIST and OPTICUS) comparing IVUS ,.,;th angie-
graphic guidance today show no difference in clinical and 
angiographic outcome at six-month follow-up.34•3 :; 
On the other hand, it has been demonstrated that the 
rate of target vessel revasrularization in the randomized 
CRUISE trial was reduced from 15.3% to 8.5% (P < 0.05) 
in the arm with IVUS-guided stent implantation. The 
results of AVID, a large multicentre and randomb..ed study 
including 800 patients, were recently revealed by Dr Russo 
at the TIT99 meeting. IVUS was used in one ann to docu-
ment the results of a stent implantation, and in the other 
arm to guide optimal stent implantation using the follow-
ing criteria: (i) full apposition of stent struts; (ii) MLCSA 
>90% of the distal vessel CSA; and (iii) absence of major 
dissection. In the NUS-guided arm, 42% of the patients 
required additional treatment. This led to a mean increase 
of the MLD of 0.3 mm and of the MLCSA of 1.27 mm2 
( +20.3%). At 12-month follow-up, the primary end-point 
(target lesion revascularization, UR) was 12.4% in the 
NUS-documented arm, and 8.4% in the IVUS-guided arm. 
This difference did not reach statistical significance (P"' 
0.08). However, in subgroups, a strong benefit of IVUS 
guidance could be demonstrated, for example when treat-
ing saphenous b)rpass lesions {TLR 20.8 versus 5. 1 %; 
P<O.Ol). 
A major limitation of these studies is that there is no 
comparison between quantitative IVUS and quantitative 
angiographic guidance: only visual assessment of the 
angiographic results was carried out. Recently, the concor-
dance between physiological (fractional myocardial flow 
reserve: FFRmyo ), IVUS and QCA data has been reponed. 
The best agreement was found between IVUS and FFRmyo. 
with a concordance rate of 91%. The concordance rate 
between QCA and IVUS was only 48%.16 
Brachytherapy might be the ideal field in which to 
apply the unique d1aracteristics of IVUS." Indeed, with its 
potential for tomographic imaging of the complete anerial 
wall and quantification of different structures such as the 
volume of plaque or in-stent hyperplasia, IVUS might fill 
the gap between the experimental knowledge acquired 
from histology and the results of ongoing clinical studies. 
IVUS imaging 
IVUS imaging is usually performed before an intervention, 
or after the placement of a stent, and the interpretation is 
based on the successive cross-sections obtained when 
moving the transducer manually. A comprehensive review 
of the clinical use of IVUS has recently been published by 
the study group of intracoronary imaging of tbe European 
Society of Cardiology.38 A natural extension to cross-sec-
tional ultrasound imaging is three-dimensional {3D) 
imaging. To obtain a 3D survey of the vessel. ultrasound 
images are acquired during the 'pull back' of the imaging 
catheter {20-30 frames per second). T)'Pical velocity of the 
pull-back ranges from 0.5 to 1 mmfs. The sequence of 
images contains 30 information that can be presented in 
various ways. A common form of presentation is the longi-
tudinal or sagital view, wh ich shows one of the image 
planes perpendicular to the set of cross-sectional images. 
Since during the pull-back there is motion because of the 
movement of the heart. longitudinal scans may have a 
jagged appearance. Although this ani fact does not impede 
tlle understanding of the vessel structure, the use of EGG-
triggered pull-backs improves the reconstruction.>' 
Recently, the fusion of biplane angiography and IVUS 
images has been described for true 3-D reconstruction of 
coronary segments for computation of parameters such as 
wall shear stress. •• 
Dosimetry evaluation from IVUS 
Assuming that the catheter containing the radioactive 
source is lying in the same position as the IVUS catheter, it 
is possible to measure the d istance from the source to any 
vascular structure in one cross-sectional image, and to con-
struct isodose plots when the activity and physical 
characteristics (dose fall-off with d istance) of the source 
are known.' 1 This is illustrated in Figure I. Isodoses may 
also be superimposed on the sagital view of the pull-back. 
However, the evaluation of the overall dosimetry in the 
anerial wall from successive cross-sectional images is diffi-
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bv the tm:tN The 32 and 16 Gy ISOdoses petllln a quldc evaluation of the 
dose delivered to the target, the advenutlll, limited bv the EEl 
cult. Dose-volume histograms (DVH) have been intro-
duced in radiotherapy to condense the large body of infor-
mation of the complete 3-D dose distribution data into a 
plot summarizing graphically the radiation distribution 
throughout the target volume and the anatomical struc-
tures of interest."·43 The present authors recently described 
the methodology fo r computing DVH for coronary 
brachytherapy from 3-D IVUS data" and the clinical appli-
cations will be illustrated in the review of the clinical trials 
which follows. 
Overview of the use of IVUS in clinical 
brachytherapy trials 
The Venezuelan experience 
Condado and colleagues in Venezuela introduced 
brachytherapy in human coronary a neries using a hand-
delivered 191Ir wire into a non-centered dosed-end lumen 
catheter.' ~ They explo red the feasibil ity and safety of this 
approach in 22 lesions in 21 patients. The doses were pre-
scribed at 1.5 mm from the source (single doses of 18 Gy. 
11 =I; 20 Cy, 11 = ll; 25 Gy, 11 = 9) using angiographic 
assessment. Although reponed as positive, an unexplained 
early reduction of the minimal lumen diameter of 0.45 
mm on average after only 24 hours might have blurred the 
real efficacy of the applied radiotherapy in these patients" 
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who presented no additional loss in MLD between 24 
hours and six-month follow-up. However, doses of up to 
92.5 Gy could have been delivered to the lumen wall 
because of the non-centered device. 37 This may well be 
over the vascular tolerance limits. Such a high dose could 
explain the observation that tv-:o patients experienced early 
total vessel occlusion, and four others developed an 
aneurysm at two-year follow-up. rvus guidance could 
have stressed cases with over-dosage administration. 
The Geneva trial 
In Geneva, Verin et al employed £-irradiation in human 
coronary arteries using a radioactive wire eoy) in a center-
ing balloon device.46 The dose prescribed was 18 Gy at the 
surface of the balloon corresponding to the vessel luminal 
surface. No NUS assessment was performed. The findings 
were disappointing, with a restenosis rate of 40% among 
the 15 studied patients. A retrospective analysis of the dose 
prescribed revealed that at a depth of 2 mm in the vessel 
wall, the dose was only "'2.7 Gy, probably below the 
nominal effective dose against the proliferating cells 
involved in the post-angioplasty restenosis process.47 
The SCRIPPS study 
Shonly after Condado, Teirstein et al started to treat 
restenosis lesions with ')'-therapy in a randomized placebo-
controlled study. They demonstrated a substantial reduc-
tion of the angiographic restenosis rate (17% versus 54%) 
among 55 patients presenting with in-stent restenosis.4;; 
The recently published two-year follow-up data demon-
strate the long-term efficacy of this new therapeutic modal-
ity: the target-lesion revascularization was significantly 
lower in the 1nlr group (15.4% versus 44.8%; P < 0.01). 
Non-target-lesion revascularization was similar in the two 
groups (19.2% versus 20.7%). The composite end-point of 
death, myocardial infarction or target-lesion revasculariza-
tion was significantly lower in 1nlr-treated versus placebo-
treated patients (23.1% versus 51.7%; P = 0.03).49 
A sealed 192lr ')'-source in a non-centered catheter was 
used (Best Medical/Cordis Corp, Warren, NJ, USA). This 
study was the first where the dosimetry was based on MIS 
measurements. A series of tomographic lVUS images were 
obtained with a motorized pull-back apparatus. The dis-
tance between the center of the ultrasound catheter (sup-
posed equivalent to the source position) and the 
adventitial border (the target) was measured every 1 mm 
along the stented segment. As illustrated in Figure 2, the 
aim was to adjust the dwell time to administer 8 Gy to the 
target farthest from the source (A), provided that no more 
than 30 Gy was delivered to the closest target (B). The 
importance of MIS has been clearly demonstrated in a 
retrospective subgroup analysis.50 Late luminal loss and 
loss index were calculated for patients viith diabetes, in-
stem restenosis or minimum dose exposure of the target of 
8.00 Gy. Two-factor analysis of variance was used to test 
for an interaction between patient characteristics and treat-
ment effect. In the treated group Cnlr), late loss was par-
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Figure 2 
In the SCRIPPS study, IVUS was used in order to admin;ste; at :east 8 Gy to 
the target (extemal e:ast:c lamina) farthest from the so~rce (A), provided 
that no more than 30 Gywas delivered to the closest target (B). 
ticularly low in patients with diabetes (0.19 versus 0.46 
mm), in-stent restenosis (0.17 versus 1.02 mm) and also 
in patients who received a minimum radiation dose to the 
entire adventitial border of at least 8.00 Gy (0.06 versus 
0,92). The loss index in this subgroup was 0.03. The two-
factor analysis of variance demonstrated a significant inter-
action between treatment effect (late loss) and the 
subgroup characteristic of receiving a minimum dose of 
8.00 Gy to the adventitial border (P"' 0.009). This illus-
trates the usefulness of IVUS in clarifying results of a 
brachytherapytrial. 
The WRIST trials 
The series of VVRIST' (Washington Radiation for In-Stent 
Restenosis) trials addressed different issues: native or 
saphenous (SVG) bypass in-stent restenosis, long lesions, 
:£- or ')'-sources. They were initiated with a gamma ribbon 
source (192Ir) or placebo ribbon. Qosage prescribed was 
15 Gy at 2 mm from the source in vessels of 2.0-4.0 mm 
in diameter and at 2.4 mm for vessels >4.0 mm in dia-
meter. The data recently presented for 130 patients (100 
native, 30 SVG) have confirmed the efficacy ofbrachyther-
apy: the angiographic restenosis rate was significantly 
lower (19% versus 58%; P < 0.001) as were mortality, 
myocardial infarction and repeat target lesion revascular-
ization combined end-points {29% versus 68%).51 
In this series, IVUS was not used for dosage prescrip-
tion, but was performed systematically after irradiation 
and at six-month follow~up for off-line analysis. From 
IVUS m v~uldr brachytherdpy 
these measurements, it could be demonstrated that the 
volume of intimal hyperplasia increased by 60 mm3 in the 
placebo group, but that in the treated group it was only 
2 mm3, with patients even demonstrating a melting of the 
residual intimal hyperplasia left at the time of the pro: 
cedure. IVUS was also useful for estimating the minimum 
and maximum dose administered to the lumen border 
(7.3 Gy and 45 Gy, respectively). 
Initially performed with a y-source, the expanding 
WRIST series has recently investigated IS-radiation (with 
the 9 f'l\[ source of the Boston Scientific brachytherapy 
system) for in-stent restenosis (beta-WRJSf). With this 
system, which incorporates a balloon to center the source 
in the artecy, 20.6 Gy was prescribed at 1 mm from the 
surface of the balloon. The preliminacy results recently pre-
sented of the first 49 patients with six-month follow-up 
demonstrated a similar efficacy of IS-radiotherapy for in-
stent restenotic lesions, with a 50% reduction in major 
adverse cardiac events, compared with historical controls 
from the y-WRIST.52 
The BERT trial 
The Beta Energy Restenosis Trial (BERT) was initially con-
ducted in the United States. This study was designed to 
evaluate the feasibility and safety of the delivery of 12-16 
Gy with a 90Sr/Y source after balloon angioplasty of de 
novo lesions. A special device (Beta-Cath, Novoste Corp, 
Norcross, GA. USA) consisting of a hand-held hydraulic 
delivery system was used to send 12 encapsulated sources 
in a 5.4 F. catheter lying across the target lesion (total irra-
diated length: 30 mm). The results of the American arm 
in which delivery of IS-radiation was attempted in 23 
patients were obtained with neither IVUS guidance nor 
lVUS documentation. A late loss of 0.05 mm, a late loss 
index of 4% and a restenosis rate of 15% were lower than 
in previous restenosis trials using similar angiographic 
methods.53 In the Canadian arm initiated later, the 30 
patients included were systematically documented by 
IVUS. QCA data were similar, and the IVUS findings after 
six-month follow-up were vecy recently reported54: there 
was no significant change in lumen area (5.7 ± 1.7 mm2 
post-treatment, 6.0 ± 2.6 mm2 at follow-up), nor in exter-
nal elastic lamina (EEL) area (13.7 ± 4.5 mm2 post-treat-
ment to 14.2 ± 4.7 mm2). With these IVUS findings, it was 
suggested that £-radiation inhibit neointima formation 
with no reduction of total vessel area at six-month follow-
up. The authors' findings discussed in the following 
section, and based on 3-D EGG-triggered iVUS assessment 
of the treated area, are more in favor of an adaptative 
remodeling with an increase of the vessel size (EEL) and 
plaque. 
The Thoraxcenter experience 
One of the first IVUS scanners was developed in the 
authors' institution. 55 IVUS is performed routinely and sys-
tematically in studies evaluating new antirestenotic strat-
egies, even when it is not mandatocy for the trial. 
7 
Three-dimensional image reconstruction and analysis 
systems have been introduced that can be used for com-
plete quantitative analysis of IVUS images.56- 59 However, 
image artifacts that result from cyclic changes in coronary 
dimensions and from the movement of the IVUS catheter 
in the arterial lumen limit the acruracy of the 3-D 
boundacy detection systems.(,{) This led to the develop-
ment of a new approach. In order to limit cyclic move-
ment artifacts, an EGG-gated image acqUISitiOn 
workstation is employed which controls a dedicated pull-
back d~ice. The complete 3-D dataset of the coordinates 
of the automatically detected lumen (corresponding to 
the highly echogenic blood-vessel interface) and of the 
echogenic media-adventitia interface {EEL) over the 
complete length of the treated area can be used to study 
the change between baseline and six-month follow-up of 
lumen, plaque and vessel volumes. Dosimetcy evaluation 
at the time of the iradiation is then feasible, when con-
sidering the source in the same position as the IVUS 
catheter.44 
Analyzing 21 patients consecutively included in the 
European ann of BERT in the authors' institution, Sabate 
et al have recently demonstrated that over the 30 mm of 
the irradiated segments with the Beta-Cath delivecy system, 
mean EEL and plaque volumes increased significantly 
(from 451 ± 128 mm3 to 490± 159mm3 and from 
201±59mm3 to 242±74mm3; P=:0.01 and P=O.OOl, 
respectively), whereas luminal volume remained 
unchangedY On the other hand, edges of the treated seg-
ments presented an increase in mean plaque volume with 
no net change in EEL, resulting in a decrease in mean 
luminal volume. This vecy metirulously conducted 3-D 
analysis could assess subtle changes in the remodeling of 
human irradiated coronary arteries. This would otherwise 
have only been possible in an animal study with serial his-
tomorphometric assessment. Analyzing a total of 206 
coronary subsegments of 2 mm lying in the treated area, it 
was possible to demonstrate that the independent predic-
tors of the plaque volume at follow-up were the plaque 
volume post-treatment, the type of plaque and the 
minimal dose absorbed by 90% of the adventitial volume 
(DV90adv).G2 
From the 3-D IVUS dataset, it has been also possible to 
compute DVH to describe the rumulative distribution of 
dose over three specific volumes: at the level of the 
luminal surface, the EEL, and in the volume encompassed 
betvveen the luminal surface and the EEL (plaque + 
media). On average, DVH derived from the authors' BERT 
cases demonstrate that the minimal dose in 90% of the 
adventitial volume (defined with a thickness of 0.5 mm 
from the EEL) was 37 ± 16% of the prescribed dose; the 
minimal dose in 90% of the plaque+ media volume was 
58 ± 24% and of the luminal surface volume was 67 ± 
31%. The minimal dose in the 10% most exposed luminal 
surface volume was 296 ± 42%,63 Simulations of the use of 
a y-emitter andjor a radioactive source train centered in 
the lumen have also been evaluated, with a comparison of 
the homogeneity of the dose distribution. A typical DVH is 
illustrated in Figure 3. 
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10.9% of targets would receive <7 Cy, believed to be sub-
therapeutic. With the angiographic model, the mean 
minimal dose would be 7.51 ± 1.44 Cy, but 38.7% of 
patients would receive a minimal adventitial dose <7 Cy. 
With a fixed-dose strategy of IS Cy delivered at 2 mm 
from the source, the mean minimal dose would be 8.59 ± 
1.64 Cy, with 17.9% of patients receiving <7 Cy at the 
adventitia. However, with this strategy, 41.5% of targets 
would receive >30 Cy. This demonstrates that probably 
only rvus permits the optimal dosimetry, adapted to the 
remodeling of the specific lesion of a patient. 
Limitations of IVUS for dosimetry 
A major assumption made when using lVUS to assess the 
dosimetry is to consider that both the imaging catheter 
and the brachytherapy delivery system are following the 
same course in the treated coronary segment. Compared 
with a 5 F. ("' 1.7 mm) device such as the Beta-Cath, the 
lVUS catheter, which is smaller (2.9 F."' 1 mm), will be in 
a more eccentric position in the coronary lumen. However, 
no easy correction can be applied since the channe.l source 
in the delivery device is not in the center of the catheter. 
When using a centering balloon for the source such as in 
PREVEr-IT or the Schneider Dose Finding Study, it is easy 
to calculate the center of gravity of the lumen of each slice 
from the 3-D !VUS dataset. However, even with the use of 
radiotherapy and !VUS catheters of the same size, or cen· 
tered, it is not certain that when advanced sequentially in 
the arterial lumen, they will occupy the same position. 
Although both catheters should be on the shortest 3-D 
path in the lumen, coronary arteries have a complex 
curved geometry in space, and are partially deformed by 
the catheter lying in their lumen. Thus, catheters with dif-
fering rigidity will occupy different positions. These 
methodological limitations could be partially overcome 
with existing imaging wires which could be introduced in 
the lumen of the irradiation delivery catheter itself.66 
Another very interesting device, illustrated in Figure 5, has 
recently been developed. The unique characteristic of this 
catheter, designed for directional radiation (BRIGADE,.,.', 
EndoSonics Corp, Rancho Cordova, CA, USA) is the com-
bination of a solid-state IVUS imaging array proximal to 
the site in the delivery system where the source lies.67 A 
second unique feature of this device is a gold auenuator 
surrounding the radioactive source asymmetrically, in 
order to direct preferentially radiation in eccentric plaques. 
The incorporation of the imaging possibilities allows for 
rotation of the system towards the most eccentric plaque. 
Clinical trials will soon be laund1ed, after the demonstra-
tion of the feasibi lity of this new approach in an animal 
model. 
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Figure 5 
Illustration of a direc:ttonal radiaLon caltleter, including an asymmetnc goid 
attenuator encompassing only ltle top half olltle area where ltle source is 
pos1tioneo for coronary brachytherapy ( oetween ltle two radiopaque 
mMkers). nts configuration offers an asymmetric dose dtstnbution which 
opumtzes the dosimetry of eccentnc lestons (panel). Optimal orientation of 
such a device can only be performed thanks to the incorporated intravascu-
lar ultrasound transducer attached proximally in this combined device. 
Conclusion 
Radiation therapy bears some resemblance to antibacterial 
therapy, which requires the right dosage to achieve its ther-
apeutic goal. without excessive toxicity related to overdose 
or incorrect targeting (classically called by the radiothera· 
pist a 'geographical miss'). At the present stage, lVUS 
appears to be an indispensable tool for understanding the 
mechanisms of action of radiotherapy in the prevention of 
restenosis and in finding the target volume. The confound-
ing and negative results of the early clinical studies, per-
formed without rvus guidance, support the need to at 
least document by rvus the ongoing clinical trials, even 
when there is no direct guidance of dosage administration. 
To treat coronary arteries effectively, it seems necessary to 
evaluate the dose absorbed in different anerial structures 
since there is still controversy about the target volume to 
be irradiated. This cannot be appreciated with angiogra-
phy, which gives only a lumenogram of the artery. 
Methods based on the determination of specific 
dose-volume histograms might be useful. Only the future 
will tell us whether angiography is a sufficient guideline to 
establish and apply the correct dose. The desire to simplify 
the methodological approach of brachytherapy in this 
early phase might be fatal for this technique in its infancy. 
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Figure 3 
Example of the integral dose- volume histogram a( the adventitia level of the 
patient illustrated in Figure 1, representing the fraction of volume (y-axis: % 
volume) receiving greater than or equal to a spec1fic dose (x-axis: dose 
(Gy)). For th is patient, 90% of the target volume for coronary brachytherapy, 
believed to be the adventitia, receives a case of at least 5.6 Gy. 
Ongoing trials 
There is a series of ongoing trials, recently reviewed by 
Waksman,"' that is soon expeded to shed light on the 
utili ty o f b rachytberapy for prevention of restenosis. 
Modalities of NUS as used in these uials are very different. 
In PREVENT, conducted with a "r ~-source delivered with 
an automatic afterloader (Galileo'~>•, Guidant Corp, 
Houston, TX, USA), the radioaoive wire is centered in the 
target lesion (de novo or in-stent restenosis) in a hel ical 
balloon which preserves distal perfusion (Figure 4 ). The 
size of this balloon is based on the coronary dimensions 
derived from NUS measurements at the m inimal cross-
sectional area in the lesio n. Proximal and distal reference 
segments are measured to est imate the mean vessel d ia-
meter. Th is measurement is used to prescribe a dose of 16, 
20 or 24 Gy at 2 mm in the vessel wall. 
In GAM!v!A-1, a 102lr source o r a placebo was manually 
delivered fo llowing successful treatment for in-stem 
restenosis in 252 patients. A dose greater than 8 Gy but 
less than 30 Gy was administered to the EEL, with a 
similar IVUS guidance to that used in the SCRIPPS trial. 
The angiographic outcome recently reponed was a reduc-
tion at six-month follow-up of the angiographic restenosis 
rate from 52% for the placebo group to 2 1.6% for the irra -
diated group. 
In the ARREST trial investigati ng the restenosis rate after 
riCA and provisional stenting, a mechanical delivery of a 
192ir source in a partially centering balloon (3.2 F.) is used. 
A dose greater than 8 Gy but less than 30 Gy is also pre-
scribed to the adventitia based on NUS measurements. 
There are also studies in wh ich the dose is admin istered 
at a given d istance from the source, without the use of 
NUS. In the BETA-CATI-1 trial(~- 90Sr/Y source), it is 14 Gy 
in vessels >2.7 mm and <3.35 mm, and 18 Gy in vessels 
>3.35 mm and <4.0 mm; in the SMARTS triaL which is 
SG Ci!rlier, VlMA Coen, M Sabate et a! 
Figure 4 
Panel 1 shovvs the lesion in the circumflex artery of a patient included in the 
PREVENT trial in the authors' institution. After stent implantation (panel 2), 
the helical balloon (panel d) used to maintain the "P wire in the center of 
the lumen permits the preservation of distal perfusion (panel 3). Its size was 
chosen using the IVUS stent diameter measured in panel b (3 mm). The 
dwelling time of the source (seen n panel 4) is calculated in order to give 
16, 20 or 24 Gy at 2 mm in the vessel wall. The size of the vessel is calcu-
lated as the average of the d;stal (panel a) and proximal (panel c) intravas-
cular ultrasound vessel size dimensions. 
designed for small vessels ( <2.75 mm ), it is 12 Gy to a dis-
tance of 2 mm from a -y-'"lr source. In the ARTISTIC trial 
investigati ng patients with in-stent restenosis, the same 
mechanical delivery system of a 192 lr source as in ARREST 
is used, but a dose of 12, IS or 18 Gy is prescribed at 2 
mm from the source. In the CURE study conduded with a 
balloon fi lled with '88Re, a dose of 13 Gy at 0.5 mm from 
the surface of the balloon is prescribed. 
Positive results are not obtained only when using IVUS. 
The data of the Schneider/Boston Scientific ~-intracoro­
nary irradiation dose-finding study very recently presented 
by Verin at the European Congress of Cardiology 
(Barcelona, August 1999) demonstrate that with 9-18 Gy 
at 1 m m tissue depth, there was a significant dose-related 
inhibitory effee1 o n restenosis after riCA and a beneficial 
effed on remodeling. The del ivery of 18 Gy at 1 mm tissue 
depth resulted in a low overall restenosis rate of 8.3% and 
an even lower rate of 4.3% in those patients treated with 
balloon angioplasty and radiation alone. Measurements 
were based on QCA. However, Russo et al have compared 
the method of dosage using IVUS during the SCRIPPS uial 
to a method based on an angiographic model and a fixed-
dose strategy."' From 119 NUS pull-backs, the IVUS 
method would give mean minimal and maximal adventi-
tial doses of 7.73 ± 0.69 Gy and 25.81 ± 5.26 Gy, and 
193 
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In 1976, Anderson published the spacing nomo-
graph for 1251, which was a rapid dose planning 
method to facilitate interstitial brachytherapy of 
the prostate [1]. Under this "dimension averaging" 
technique [2], the three orthogonal lengths of the 
prostate were measured operatively and averaged, 
from which the total radioactive strength of the im-
plant was determined by a lookup table. The thera-
peutic dose was characterized by the matched pe-
ripheral dose (MPD) concept-a dose cloud having 
the same volume as that of an ellipsoid constructed 
from the three measured dimensions The lack of 
technological sophistication, of course, reflected 
the overall limitation of that era. However, the sim-
plicity of the method found ready acceptance in this 
largely interventional procedure, even up to today. 
During the course of the past 23 years, our under-
standing of clinical dosimetry for prostate brachy-
therapy has undergone fundamental changes. Sub-
optimal dose distribution due to technical limitations 
was identified as the possible cause of unfavorable 
outcomes from the early series of open surgical im-
plants [3]. Transrectal ultrasound (TRUS) was used 
to provide real-time visualization of the target vol-
ume in three dimensions [4], and was used to de-
velop quantitative dosimetric planning customized 
to each patient [5]. Computed tomography was 
used postoperatively to assess organ-specific dose-
volume histograms (DVH), which revealed that the 
MPD was an unreliable indicator of dosimetric 
quality [6]. Later, it was shovm that the minimum 
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peripheral dose was also an illusive parameter given 
the inaccuracies in radiation source placement, and 
that a dose to 90% of the target volume from the 
DVH, D90, would be a more consistent parameter 
for dose specification [7]. This conclusion was sup-
ported by a recent clinical study, which demon-
strated a clear dose response at 140 Gy for D90 [8]. 
Based on ongoing studies such as these, both the 
American Association of Physicists in Medicine and 
the American Brachytherapy Society recommended 
reporting a handful of parameters obtainable from 
the DVH as potentially significant indicators of 
therapeutic effectiveness [9, 10]. 
As a case study in interventional radiotherapy, 
this body of literature demonstrates the interesting 
interplay between technological advancement and 
clinical needs. It is the nature of brachytherapy to 
accept rapid dose fall-off in the vicinity of the ra-
dioactive source. The actual dose delivered to a ra-
diation target is therefore not a single number, but 
a range of values for different percentages of the 
target volume. A dosimetric parameter based on 
idealized geometries, such as the MPD, may not 
correlate with any therapeutic outcome. On the 
other hand, more complex characterization of the 
dose distribution, such as the DVH, requires serial 
image acquisition, target identification, and com-
puterized dosimetry calculation, all customized to 
each given patient. Wide availability of these tools 
in turn is expected to promote greater understanding 
of dose response and radiation toxicity in a multi·in· 
stitutional setting. In prostate brachytherapy, it may 
be said that we have finally negotiated the learning 
curve and are ready to scale new heights. 
In this context, it is particularly exciting to see 
the paper by Carlier et al. [11] in this second issue 
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of Cardiovascular Radiation Medicine. The authors 
applied an electrocardiogram (ECG)-gated image 
acquisition technique developed previously for in-
travascular ultrasound (NUS) to control cardiac cy-
cle artifacts. Serial cross-sectional images were regis-
tered by means of constant-step pullback of IVUS as 
controlled by the ECG trigger algorithm, which 
also rejected premature beats. Analysis of the irradi-
ated segment was achieved using automated identi-
fication of the lumen-intima and the media-
adventitia boundaries. Based on this target-specific 
information, the DVH was generated for the actual 
radioactive source used in the study, and for simu-
lation of centered vs. noncentered irradiation from 
both ~ and -y sources. This pioneering study dem-
onstrates the feasibility of TVUS-guided target-spe-
cific dosimetry in intravascular brachytherapy at a 
time when reliable, detailed dosimetry information 
is urgently needed to supplement the design and 
analysis of clinical trials. 
The current spectacular revival of prostate brachy-
therapy is due in large part to real-time TRUS guid-
ance. The growing emphasis on target-specific do-
simetry also motivated optimized inverse planning 
of radiation delivery [12]. This technology enables 
the clinician-user to define the dosimetric intent, 
from which an optimized irradiation strategy is 
generated automatically. The feasibility of using 
this technology intraoperatively to perform real-
time planning has been demonstrated [13]. 'Whereas 
Carlier et al. [11] recognized the lack of real-time 
generation of dosimetry based on IVUS due to pro-
cessing speed, the challenge is likely to be met 
soon. This era of accelerated growth of technology 
has helped us shape the field of interventional ra-
diotherapy in many important ways. 
As a case study in interventional radiotherapy, 
intravascular brachytherapy and prostate brachy-
therapy have striking similarities: Both are amena-
ble to real-time ultrasound imaging. Uncertainty 
exists in target movement and irregularity, and in 
radiation source placement. The radiation dosime-
try is modified by the presence of calcification and 
other tissue heterogeneities. There is a lack of con-
sensus understanding regarding the extent of the 
target volume for irradiation. Finally, as in prostate 
brachytherapy, there is some indication that a 
dose-response exists, below which the effect of ra-
diation to prevent restenosis is diminished signifi-
cantly [14, 15]. All these similarities point to the 
importance of quantitative, volumetric dosimetry 
analysis and reporting :in the present context. 
The DVH study reported by Carlier et al. [11] is 
likely to be the first of a body of literature that, as 
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in prostate brachytherapy, deepens our understand-
ing of this therapeutic modality. However, we are 
now :in a position to circumvent the leam:ing curve 
and proceed to new grounds. 
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Purpose. We present in this paper the -comparison, by simulation, of different treat~ 
ment strategies based either on !?>-or )'-sources, both with and without a centering de-
vice. Ionizing radiation to prevent rcstenosis is an emerging modality in interven-
tional cardiology. Numerous clinical studies are presently being performed or planned, 
but there is variability in dose prescription, and both 'Y- and [3-emitters arc used, lead-
ing to a wide range of possible dose distributions over the arterial vessel wall. This 
paper discusses the potential merits of dose-volume histograms (DVH) based on three-
dimensional (3-D) reconstruction of electrocardiogram (ECG)-gated intravascular ultra-
sound (IVUS) to compare brachytherapy treatment strategies. 
Materials and Methods. DVH describe the cumulative distribution of dose over three 
specific volumes: (1) at the level of the luminal surface, a volume was defined with a 
thickness of 0.1 mm from the automatically detected contour of the highly echogenic 
blood-vessel interface; (2) at the level of the IVUS echogenic media-adventitia interface 
(external elastic lamina [EEL]), an adventitial volume was computed considering a 
0.5-mm thickness from EEL; and (3) the volume encompassed between the luminal 
surface and the EEL (plaque + media). The IVUS data used were recorded in 23 of 31 
patients during the Beta Energy Restenosis Trial (BERT) conducted in our institution. 
Results. On average, the minimal dose in 90% of the adventitial volume was 37 =: 16% 
of the prescribed dose; the minimal dose in 90%ofthe plaque+ media volume was 58± 
24o/o and of the luminal surface volume was 67 :: 31%. The minimal dose in the 10% 
most exposed luminal surface volume was 296 ::: 42o/o. Simulations of the use of a 
)'-emitter and/or a radioactive source train centered in the lumen are reported, with a 
comparison of the homogeneity of the dose distribution. 
Conclusions. It is possible to derive DVH from IVUS, to evaluate the dose delivered to 
different parts of the coronary wall. This process should improve our understanding of 
the mechanisms of action ofbrachytherapy. © 1999 Elsevier Science Inc. 
Keywords: Brachythcrapy; Rcstenosis; Vascular; Intravascular ultrasound (IVUS); Dosimetry. 
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Coronary artery diseases remain the major cause of 
death and disabilities in industrialized countries. The 
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only revascularization procedure available up to 1977 
was bypass surgery. Percutaneous transluminal coro-
nary angiop!asty (PTCA) introduced by Andreas 
GrUntzig [1] profoundly modified our therapeutic ar-
senal with a minimally invasive alternative. Presently, 
interventional cardiology consists of several tech-
niques to cut, drill, scrape, bum, and otherwise re-
move atherosclerotic plaque [2]. With more than one 
million interventions undertaken per year worldwide, 
angioplasty is now a cornerstone therapy for coronary 
artery diseases. However, despite a high acute proce-
dural success rate, the long-term benefit is hindered 
by the phenomenon of restenosis. Mechanisms in-
volved in the restenosis process are the elastic recoil of 
the artery, local thrombus formation, vascular remod-
eling with shrinkage of the vessel, and exuberant 
healing process with neointimal cellular proliferation 
and matrix synthesis [3-5]. Stent implantation mini~ 
mizes elastic recoil and remodeling of vessels, and 
carefully controlled and randomized clinical trials 
have demonstrated a significant decrease in the rate 
of restenosis [6--S]. However, stents increase the pro-
liferative response of tissue to the intervention and, 
depending on the type of lesions treated, a significant 
restenosis rate of 15-500/o remains the key limitation 
of transcatheter procedures. Restenosis is the subject 
of numerous investigations to further improve appli-
cability and cost-effectiveness of angioplasty and to 
reduce the need of reinterventions. Virtually all at~ 
tempts to limit restenosis with systemic drugs have 
failed, with the recent exceptions of abdximab, 
probucol, and dlostazol [9-11]. 
Some investigators have considered restenosis as 
an accentuation of the wound healing process asso-
ciated with the trauma of angioplasty, and because 
radiotherapy had proved effective for the treatment 
of keloid formation and other nonmalignant dis-
eases, radiation therapy for intravascular applica~ 
tion was attempted. The therapy was introduced by 
Friedman et al. [12] early in 1964, for the preven-
tion of atherosclerosis, and subsequent animal ex-
periments demonstrated a reduction of intimal hy-
perplasia following endovascular irradiation. 
Waksman [13] has recently reviewed these early 
studies. Three clinical studies have been reported 
that confirmed a significant reduction in the rest-
enosis rate using additional brachytherapy [14-16]. 
Currently, the vascular brachytherapy devices 
available for clinical trials are radioactive stents and 
catheter-based systems using a radioactive wire ad-
vanced with an afterloader, or radioactive seeds 
delivered with a hydraulic delivery system. Other 
systems based on radioactive balloons are in devel-
opment. There is variability in the dose prescrip-
tion, and both 'Y~ and j?.-emitters are used. These 
variations lead to a wide range of dose distributions 
over the arterial vessel wall requiring a careful inter-
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pretation and comparison of the results of the on-
going studies. The typical dose prescription distance 
in the coronary arteries is in the range of 2 mm from 
the source axis. Because of the steep dose fall-off, 
particularly for ~-emitters, accurate dosimetry re-
quires precise knowledge of geometry. 
In this paper, we describe a dosimetry evaluation 
tool for coronary brachytherapy based on three~ 
dimensional (3-D) reconstruction of electrocardio-
gram (ECG)-gated intravascular ultrasound (IVUS) 
images. rvus was developed to overcome the limita-
tions of x-ray angiography. Its methodology and clin-
ical applications have been reviewed extensively [17]. 
rvus, by its tomographic approach, provides a mean 
for the evaluation of both lumen and vessel wall 
morphology. Assuming that the catheter containing 
the radioactive source is lying in the same position 
as the IVUS catheter, it is possible to measure the dis-
tance from the source to any vascular structure in 
one cross-sectional image, and to construct isodose 
plots. IVUS recordings can be performed with a con-
stant speed motorized pull-back device (e.g., 0.5 
mm/s), which permits the evaluation of the length 
of a stenosis. Recently, 3-D image reconstruction 
and analysis systems have been introduced that can 
be used for complete quantitative analysis of IVUS 
images [18-21]. However, image artifacts that result 
from cyclic changes in coronary dimensions and 
from the movement of the IVUS catheter in the arte~ 
rial lumen limit the accuracy of the 3-D boundary 
detection systems [22]. This problem led to the de~ 
velopment of a new approach in our institution. To 
limit cyclic movement artifacts, we use an ECG~ 
gated image acquisition workstation that controls a 
dedicated pull-back device. Feasibility, reprodudbil-
ity, and improvement in the quantitative parameters 
analyzed have been reported recently [23, 24]. The 
complete 3-D data set of the coordinates of the auto~ 
matically detected lumen corresponding to the 
highly echogenic blood-vessel interface, and of the 
echogenic media-adventitia interface can be used 
for dosimetry evaluation. 
Dose-volume histograms (DVH) are used every-
day in radiotherapy to condense the large body of 
information of the complete 3-D dose distribution 
data into a plot graphically summarizing the radia~ 
tion distribution throughout the target volume and 
the anatomical structures of interest [25, 26]. We 
have recently reported preliminary data on the 
methodology to compute DVH for coronary 
brachytherapy from 3-D IVUS data [27]. 
Material and Methods 
Study population 
We used the IVUS data acquired during the Beta 
Energy Restenosis Trial conducted in our institu-
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tion (BERT 1.5 arm). Thirty-one patients were en-
rolled. We report the data of the 23 patients who 
had an ECG-triggered pull-back available before a 
stent implantation (18 men, 5 women, mean age: 
58 :::!::: 9 years). All were in sinus rhythm. The Medical 
Ethics Committee of our institution approved the 
study and all patients signed a written informed 
consent form. Before catheterization, the patients re-
ceived 250 mg aspirin and 10,000 IU heparine 
parenterally. If the duration of the intervention ex-
ceeded 1 h, the activated clotting time was measured 
and intravenous heparin was used to maintain an 
activated clotting time >300 s. The coronary seg-
ments examined were the right (n = 7) and left (n = 
10) anterior descending coronary arteries, and the 
left circumflex coronary artery (n = 6). 
Interventional procedure and BERT 1.5 trial 
The BERT 1.5 trial was the European arm of a feasibil-
ity study of coronary radiation therapy vvith a 90Sr/Y 
source delivered by a hydraulic system (Beta-CathTM 
System, Novoste Corp., Norcross, GA) [16]. All pa-
tients had a single de novo coronary stenotic lesion 
>60% vvith a maximal length of 15 mm and a refer-
ence vessel diameter of 2.5-3.5 mm. After successful 
PTCA, irradiation using a 5 Fr (-1.6 mm) over-the-
wire triple-lumen delivery catheter was performed. 
The catheter has one open lumen and two dosed lu-
mens. The open lumen allows for advancement of 
the device over a 0.014-inch guide wire, and position-
ing at the site of the PTCA (Fig. 1). One of the closed 
lumens permits the hydraulic advancement of the ra-
diation source train (12 independent cylindrical 
sealed 90Sr[Y sources, total length 30 mm) to the le-
sion site. This advancement is performed manually, 
vvith a saline-filled syringe connected to the delivecy 
system. The other closed lumen, in communication 
with the first one at the tip of the delivery catheter, 
permits the opposite fluid flow direction at the end of 
the irradiation time ( ~ 3 min) for the retrieval of the 
sources into the back in the shielded transfer device. 
A randomized dose of either 12, 14, or 16 Gywas pre-
scribed at a distance of 2 mm from the source axis. 
JVUS image acquisition 
IVUS was performed prior to the insertion of the ra-
diation delivery catheter. Intracoronary nitrates were 
administered before the coronary segments were ex-
amined. The ClearViewTM (CardioVascular Imaging 
System [CVIS], Sunnyvale, CA) was used with NUS 
catheter incorporating a 30~MHz single-element ro-
tating transducer in a 2.9 Fr sheath (-1 mm). The 
ECG~gated image digitization system (EchoScan, 
TomTec, Munich, Germany) received the video sig-
nal input from the IVUS console, and the ECG signal 
from the patient. This system steered the ECG-gated 
stepping pull-back device by increments of 0.2 mm. 
Images were acquired at end-diastole for heart cycles 
falling within a predetermined range (0.125 s) around 
the heart rate of the patient. Premature beats and 
RR-intervals outside this range were excluded and 
the IVUS catheter remained at the same site. By ex-
perience, we have noticed that with these settings, 
on average 10-15% of the RR intervals are rejected, 
and that for a heart rate of 60 beats/min, on average, 
the pull-back. speed is 1 em/min. 
Image analysis system 
A contour detection program developed in our labo-
ratory [28] was used for the automated 3-D analysis 
of the IVUS images corresponding to the irradiated 
segment. Two longitudinal sections (corresponding 
to the A and B lines on the IVUS cross-section in 
Fig. 2) were constructed from the data set. The con-
tours of the lumen-intima (internal contour on Fig. 
2, lower left panel) and the media-adventitia (ex-
Figure 1. Angiograms of one patient included in the Beta Energy Restenosis Trial (BERT), (A) The initial lesion in the mid-portion of 
the left anterior descending artery at a bifurcation point with o. diagonal and a septal side-branches is indicated by an arrow. (B) The 
angiogram after successful percutaneous transluminal coronary angiopl.a.sty (PTCA). (C) The triple-lumen delivery catheter advanced to 
the angioplo.sty site, The sealed radioactive cylinders (total length 30 mm) will be between the two gold markers (small arrows). 
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Figure 2. The three-dimensional intravascular ultrasound (IVUS) dota set: the bottom left panel demonstrates an IVUS cross-section 
image, with the catheter in the center, surrounded by blood. The catheter is ;~gainst the lumen wall at Z o'clock. The first detected con-
tour that corresponds to the blood-vessel wall interface is highlighted. The second highlighted contour, more externally, corresponds 
to the mcdi<Hldventitia interface, which encompasses the residual plaque lying between 11 and 4 o'clock. Lines A and B correspond to 
the cutting planes of the corresponding longitudinal views on the right panel. The isodoses of 32 and 16 Gy arc superimposed on the 
longitudinal views and on the IVUS cross-section of the upper left panel. 
temal contour on Fig. 2) boundaries were identified 
using a minimum~cost-based analysis algorithm. 
These longitudinal contours were used to guide au~ 
tomated contour detection in every planar cross~ 
sectional image. Scrolling through the entire data 
set is possible in this Windows™-based program, 
for manual corrections of the contours. From these 
tracings, the total vessel area (encompassing the 
media-adventitia border) and the lumen area were 
determined for each cross~section. The residual 
plaque burden (o/o) on each cross-section was calcu~ 
lated as total vessel area minus lumen area divided 
by the total vessel area. 
DVH 
Selection of the IVUS segment matching the irradi-
ated site was based on anatomical landmarks lying 
next to the treated segment (side branches, bifurca-
tions, etc.). For example, the diagonal artery seen 
on the angiogram of Fig. 1 is marked with an arrow 
on the longitudinal IVUS pull~back of Fig. 2 (right 
panel). The coordinate of the center of the IVUS 
catheter was used as a reference, and was consid-
ered at the same location as the center of the radia~ 
tion train. This assumption is probably violated 
when looking at the differences in size of the IVUS 
and delivery catheters (2.9 vs 5 Fr), but it has to be 
kept in mind that the source does not occupy the 
center of the delivery catheter, and that no easy 
correction might be applied. The radii of the lumen 
and the media-adventitia contours were calculated 
in 24 pie-slices (15°), in all the cross-sections corre~ 
spending to the irradiated site (30~mm length of 
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the train source). The number of required slices was 
a function of their thickness, which was on average 
0.2mm. 
DVH describe the cumulative distribution of dose 
over a specific volume, and summarize the dosime~ 
try that would otherwise have to be interpreted 
from numerous NUS cross-sections with superim~ 
posed isodoses plotted (Fig. 2, upper left panel). 
Three volumes have been studied: the first one at 
the level of the luminal surface is arbitrarily defined 
with a thickness of 0.1 mm from the automatically 
detected lumen contour. The second volume, de-
fining the adventitia volume, is computed consid-
ering a thickness of 0.5 mm from the second con-
tour detected, corresponding to the echogenic 
media-adventitia interface. The third volume, cor~ 
responding to the plaque and media structures, is 
encompassed between the two detected contours. 
The dose distribution over the total vessel wall was 
calculated with 0.1 mm spatial resolution. The 
DVH provided a tool for reporting the actual deliv-
ered dose in different arterial structures, or to detect 
excessive radiation at the luminal level. From the 
complete 3-D IVUS data set, simulations of DVH of 
alternative brachytherapy strategies such as the use 
of a -y-emitter or a centered radioactive source were 
tested. To compute the isodoses and the DVH for 
the Novoste system, we used the dose distribution 
and dose rate around the source train as provided 
by the manufacturer in the user manual. Calibration 
was performed at the National Institute of Stan-
dards Technology, using both an extrapolation 
chamber and GafChromic Dosimetry media. For the 
-y-source, data were derived from Amols et al. [29]. 
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Results 
No complications related to the brachytherapy and 
IVUS procedures were seen. Figure 1 demonstrates a 
typical procedure on a lesion situated in the mid-
portion of the left anterior descending coronary ar-
tery, at the level of the emergence of a septal and a 
diagonal side branch. These anatomical landmarks 
observed on the angiograms were used for position-
ing both the IVUS catheter and the irradiation de-
vice at the site of the lesion. The angiogram after 
PTCA is shovm in Fig. lB. The corresponding ECG-
triggered IVUS pull-back performed at that time is 
illustrated in Fig. 2. The position of the side-branch 
is clearly seen on the mid-portion of the longitudi-
nal view (* and arrow in right panel of Fig. 2). After 
withdrawal of the IVUS catheter, the brachytherapy 
delivery catheter was positioned at the PTCA site, 
using its two radio-opaque gold markers as land-
mark (Fig. 1C). 
Of the 31 patients included in the BERT 1.5, a to-
tal of 7 required stent implantation. In 3 of these 
patients, the IVUS was performed before stenting. 
Absence of an ECG-triggered pull-back or technical 
problems limited the total number of analyzable 
patients without a stent to 23. Quantitative IVUS 
data analysis of these 23 patients demonstrated a 
mean lumen area of 7.7:::!: 3.0 mm2 (-150 cross-sec-
tions per patient). The mean vessel area was 14.8 :::!: 
3.9 mm2 and the residual plaque area was 7.1:::!: 1.6 
mm2, corresponding to a residual plaque burden of 
49 :::!: 8%. For each patient, the minimal, mean and 
maximal distance (-radius r) between the center of 
the IVUS catheter and the lumen or the media-ad-
ventitia interface were computed along the com-
plete pull-back. The minimal r was 0.51 :::!: 0.02 
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rom, the mean r was 1.42 :::!: 0.25 rom, and the max-
imal r was 3.36 :::!: 0.70 rom. For the vessel (media-
adventitia interface) minimal r was 0.88 :::!: 0.17 
mm, mean r was 2.07 :::!: 0.25 rom, and maximal r 
was 3.80 :::!: 0.63 rom. Computer simulation of the 
placement of the IVUS catheter in the center of the 
lumen in each cross-section of the pull-back dem-
onstrated a significant increase of minimal r (p < 
0.0001): 0.67 '= 0.17 mm and 1.23 '= 0.25 mm, re-
spectively, for the lumen and the vessel. In parallel, 
there was a significant decrease of maximal r (p < 
0.0001): 2.46 :::!: 0.42 mm and 3.41 :::!: 0.41 mm, re-
spectively, for the lumen and the vessel. 
On the longitudinal view (right panel) of the 
IVUS pull-back in Fig. 2, and on one cross-section 
(upper left panel), the isodoses corresponding to 8, 
16, and 32 Gy are superimposed. The derived DVH 
for this patient for the luminal surface and adventi-
tial volumes are plotted on Fig. 3. The minimal 
dose in 90% (DV90adv) of the predefined adventi-
tial volume was 47% (this corresponds to the x-axis 
value of the DVH plot with they-axis value = 90%). 
Among the 23 patients, the average DV90adv was 
37 :::!: 16% of the prescribed dose and the minimal 
dose in 90% (DV90lum) of the luminal surface vol-
ume was 67 :::!: 31% of the prescribed dose, and was 
58 :::!: 24% in 90% of the plaque + media volume. 
The average minimal dose in the upper 10% 
(DV10adv) of the adventitial volume exposed to the 
highest dose (the x-axis value of the y-axis value 
10%) was 133 :::!: 19% of the prescribed dose. For the 
luminal surface volume, DV10lum was 296 :::!: 42%. 
Figure 3 summarizes these data with a plot of the 
mean :::!: SD of DV95, DV90, DV75, DVSO, DV25, 
DVlO, and DV05 for the luminal surface and the 
3 4 5 6 
dose/prescribed dose 
Figure 3. Example of integral dose-volume histograms (DVH) at the level of the luminal surface and adventitial volumes of the patient 
illustrated in Figures 1 and 2, representing the fraction of volume (y-axis, %volume) receiving greater than or equal to a sped.fic relative 
dose (x-axis, dose/dose prescribed). For this patient, the mln1mal dose in 90% of the adventitial volume (DV90adv) was 47% of the pre-
scribed dose. The superimposed plots with the error bars correspond to the average among the 23 investigated patients of the DV95, 
DV90, DV75, DVSO, DV25, DVlO, and DVOS of the predefined luminal surface and adventitial volumes. 
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Table 1. Summary of the computer simulations of the use of a ~or a ')'-source (with the same dose prescribed at 2 mm from the center 
of the catheter) or a centering device 
Noncentcred Centered 
DV90 DVlO DV90 DVlO 
~ 
Lum. 0.67 ::t 0.31"t 2.96 = 0.42*t 1.06:::: 0.31 2.03:!: 0.49t 
P+M. 0.58 :!: 0.24*t 2.16 = 0.32"t o.73:::: o.zot 1.66:!: 0.3St 
Adv. 0.37:!: 0.16*t 1.33 :!: 0.19""t 0.49:!: 0.14t 1.05 :!: 0.20 
' L=. 0.79 = 0.21* 2.34 ± 0.31 .. 1.05 ::!: 0.21 1.70::!: 0.32 
P+M. 0.72::!: 0.17* 1.78:!: 0.21"' 0.83 ::!: 0.13 1.45 ± 0.23 
Adv. 0.58 ± 0.12 .. 1.24::!: 0.13* 0.67 :;:':: 0.09 1.05 :!: 0.13 
DV90 "" relative minimal dose (dose/dose prescribed) of 90% of the predefined Iumin.U surface (lum. thickness = 0.1 mm), adventitial 
(adv. thickness= 0.5 mm), and pl<lque +media (P + M =between luminal and external elastic lamina contours) volumes. Means.:!: SD 
for the 23 available electrocardiogram-triggered pull-backs performed during the Beta Energy Rcstenosis Trial (BERT) 1.5. Means were 
compared by paired t-test. 
*p < 0.0001, centered vs. noncentered radiation catheter; tp < 0.00011 ~- vs -y-source. 
adventitial volumes. By randomization, the actual 
doses administered were 12 Gy in 8 patients, 14 Gy 
in 6 patients, and 16 Gy in 9 patients. Plots of rela-
tive dose (dose/dose prescribed) allow the pooling 
of data from patients who received different ran-
domized doses. 
The simulations (assuming that the source was 
centered in the lumen and/or the use of a ')'-Source 
[1 92Ir]), with the same dose prescribed at 2 mm from 
the catheter as in the BERT protocol, are summa-
rized in Table 1. A direct comparison of the homo-
geneity of the absorbed dose or of the high dose ab-
sorbed by the upper 10% of the luminal surface and 
adventitial volumes is possible. Figure 4 illustrates 
the improvement of the homogeneity of the dose 
distribution for the case of Figs. 1-3 when simulat-
ing a source situated in the center of the lumen. 
Figure 5 illustrates similar improvement of the ho-
mogeneity when considering a -y-source. Optimally, 
0 2 
DVH should demonstrate a right step at the dose 
prescribed (x-axis = 1). 
Discussion and Conclusion 
Restenosis rates of 15-50% after percutaneous an-
gioplasty procedures are the major hindrance to the 
success of transcatheter therapies. Supported by en-
couraging results obtained in animal models of cor-
onary restenosis [13}, several clinical trials of vas-
cular brachytherapy have been designed, but with 
different systems and isotopes [30]. The discussion 
below focuses on the catheter-based device like 
the one used in this work. Dosimetry for radio-
active stents has been described recently by Janicki 
et al. [31]. 
In the ongoing clinical trials, there is variability 
in the dose prescribed; the target site for the dose 
prescription, and both 'Y- and [3-ernltters are used. 
3 4 5 6 
doselprescribed dose 
Figure 4. Illustration of the beneficial effect of a centering device on the homogeneity of the dose distribution for the same patient as in 
Figures 1-3. The dose-volume histograms (DVH) were recalculated simulating the irradiation source (!OSr!Y) lying in the center of the lumen. 
The DVH curves for the centered position (Lumen c. and Adventitia c.) are steeper, with a DVlO for the lumen decreasing from 2.9 to 1.8. 
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Figure 5. illustration of the improvement of the dose homogeneity for the same patient as in Figures 1-3, simulating the usc of a 
)'·Source for which the same dose would have been prescribed ilt 2 mm from the center of the catheter (noncentered situation). The 
DVH curves for the ')'-source (Lumen G and Adventitia G) are steeper, with il DVlO for the lumen decreasing from 2.9 to 2.3. 
The consequence is a wide range of possible dose 
distributions over the arterial vessel wall requiring a 
careful interpretation and comparison of the results 
of these studies. The typical dose prescription dis~ 
tance in the coronary arteries is in the range of 2 
mm. As the dose fall-off at this close vidnity is 
steep, particularly for ~-emitters, accurate dosime-
try requires knowledge of the exact geometry, 
which can be only partly assessed by coronary an-
giography. 
Among the four published clinical brachytherapy 
studies today, Condado et al. [14] used a manual af-
terloader, noncentered, in 22lesions, with a 192Ir "/-
source. The doses were prescribed at 1.5 mm (single 
doses of 18 Gy, n = 1; 20 Gy, n = 11; 25 Gy, n = 9) 
and only angiographic assessment was used. Al-
though reported as positive, an unexplained early 
reduction of the minimal lumen diameter of 0.45 
mm on average after only 24 h might have blurred 
the real efficacy of the applied radiotherapy in 
these patients [32] who presented no additional 
loss in minimal lumen diameter at the 6 months 
follow-up. However, doses of up to 92.5 Gy could 
have been delivered to the lumen wall because of 
the noncentered device. This maximum dose may 
well be over the vascular tolerance limits [32). This 
finding could partly explain the observation that 
tvvo patients experienced early total vessel occlu-
sion, and four others developed a pseudoaneurysm 
at 2 years follow-up. In Geneva, Verin et al. [33] de-
veloped a mean for ~-irradiation in human coro-
nary arteries using a radioactive wire (9°Y) in a cen-
tering balloon device. The dose prescribed was 18 
Gy at the surface of the balloon corresponding to 
the vessel luminal surface. No IVUS was performed. 
The findings were disappointing, with a restenosis 
rate of 40% among the 15 patients studied. A retro-
spective analysis of the dose prescribed in the vessel 
wall revealed that at a depth of 2 mm, the dose was 
only -2.7 Gy, probably below the nominal effec-
tive dose against the proliferating cells involved in 
the post-angioplasty restenosis process [34]. The 
only placebo-controlled study of coronary brachy-
therapy published to date demonstrated a substan-
tial reduction of the restenosis rate (17% vs 54%) 
among 55 patients presenting with in-stent rest-
enosis [15]. A sealed 192Ir ')'-source in a noncentered 
catheter was used. The dosimetry was calculated, 
based on IVUS measurements, to be in the range of 
8-30 Gy. Finally, King et al. [16] recently reported a 
restenosis rate of 15% and a late loss index of 4% 
for the American arm of the BERT, using the same 
hydraulic delivery system as the one we used in this 
study. 
IVUS was developed to overcome the limitations 
of x-ray angiography, which portrays only overlap-
ping shadows of the lumen of the coronary arteries 
(luminogram) [35]. In the field of vascular radiation 
therapy it is important to characterize precisely the 
dose prescribed in the vessel wall. IVUS imaging, by 
its angiotomographic nature, can be used to evalu-
ate both lumen and vessel wall morphology. The 
results of our preliminary investigation, using the 
complete 3~0 information available from carefully 
recorded ECG-triggered IVUS pull-back, demon~ 
strate the potential applications for dosimetry and 
the possibilities for the evaluation of doses in spe-
cific target volumes of the vessel wall. DVH appear 
to be a valuable tool and summarize, in a graphic 
form, the large amount of information included in 
the dose distribution of the complete 3-D IVUS data 
sets. DVH cannot be used alone because of the lack 
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of information regarding the spatiality of the dose 
distribution [25]. For the spatiality, two-dimen-
sional isodose displays, such as in Fig. 2, superim-
posed on rvus images will still be required for the 
guidance of a vascular irradiation plan. In our 
study, there was no direct guidance of the brachy-
therapy with IVUS because of the nature of this 
trial, which was a feasibility study in which the pre-
scribed dose was predetermined. However, the data 
set constitutes a preliminary database for the assess-
ment of several radiation strategies, as illustrated in 
Table 1. The homogeneity of the dose distribution 
might be estimated by the difference between the 
DVlO and the DV90. Ideally, a DVH should demon-
strate a steep curve around the desired prescribed 
dose. Flattening reflects that some regions are un~ 
derexposed, whereas others are overexposed. Poten~ 
tial advantages of a centering device for a ~-source, 
as illustrated in Table 1 and Figs. 4 and 5, are that 
the DV90 increases for the luminal (1.06 :!:: 0.31 vs 
0.67:!:: 0.31, p < 0.0001 by paired t- test), the adven-
titial (0.49 ± 0.14 vs 0.37 ± 0.16, p < 0.0001) and 
the plaque + media (0.73 :!: 0.20 vs 0.58 :!: 0.24, p < 
0.0001) volumes. In parallel, DVIO decreases for 
the luminal (2.03 ± 0.49 vs 2.96 :t 0.42, p < 
0.0001), the adventitial (1.05 ± 0.20 vs 1.33 :!: 0.19, 
p < 0.0001) and the plaque + media (1.66 ± 0.35 vs 
2.16 :!: 0.32, p < 0.0001) volumes. As a conse-
quence, the homogeneity, which can be expressed 
as DVlO - DV90, is improved for the lumen (0.97 
vs 2.29), the adventitia (0.56 vs 0.96), and the 
plaque + media (0.93 vs 1.58, respectively, for a 
centered and a noncentered delivery system). How-
ever, only one number, such as DV10- DV90, can-
not summarize a complete DVH curve. The com-
plete shape of the curve, as presented in the figures, 
is important. Several other parameters have been 
proposed [36, 37], but no definitive one has 
emerged as a gold-standard to assess the dose ho-
mogeneity. Looking at the slope of the DVH, for ex-
ample, is a proposed alternative, but the slope will 
vary with the interval chosen to compute it. The 
DVH presented in this study are cumulative plots: 
this integral format shows the fraction of volume 
receiving greater than or equal to a specific dose. 
Another format is the differential DVH constructed 
by dividing the range of dose values into equal in-
tervals and accumulating partial volumes in those 
bins according to their dose values. Plots of dose-
volume distributions have also been proposed [38]. 
Our definition of the thickness of the luminal and 
adventitial volumes is arbitrary. The intima is 
formed only by a superficial layer of endothelial 
cells and a thin subendothelial layer of connective 
tissue. Its thickness increases with age and reaches 
250 1-1-m at 40 years. Diffuse thickening is common 
in older patients, even without atherosclerosis. The 
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adventitia is composed of loose collagen and elastic 
tissue, which merge with the periadventitial tissue. 
The normal thickness of the adventitia is 300-500 
1-1-m [17]. However, we evaluated these DVH for an-
other thickness (0.2 mm) and the results are in 
dose agreement with the data presented in Table 1 
Q.P.A Marijnissen et al., personal communication). 
The differences found with the simulations of the 
use of a )'-emitter or a radioactive source train cen-
tered in the lumen are also present for the plaque + 
media volume for which no arbitrary choice has 
been made. 
On average, in the conditions of our study, 
whereas only 10% of the advential volume were ex~ 
posed to a minimal dose 1.33 times the prescribed 
dose, 1 Oo/o of the luminal surface volume absorbed 
at least 2.96 times the prescribed dose. For a pre-
scribed dose of 16 Gy, this corresponds to an actual 
dose of 47.2 Gy, which may well be above the rec-
ognized vascular tolerance limit. The simulations in 
Table 1 demonstrate that the use of a device to 
maintain the source in the center of the arteriallu~ 
men would decrease this overexposure, which has 
potential deleterious effect such as the develop~ 
ment of an aneurysm. With centering, the upper 
10% of the luminal surface volume is exposed to a 
reduced minimal relative dose of 2. Following our 
results, the best strategy could be the use of a cen-
tered -y-source: the minimal relative dose would 
then be reduced to 1.7 for the upper lOo/o of the lu-
minal surface volume. No clinical data presently 
support these potential advantages, and to our 
knowledge, no trial is planned to address this issue. 
Nevertheless, -y-sources have other drawbacks, at 
the radioprotection level, for example, because 
these more penetrating radiations require stringent 
shielding precautions [39]. These radiation safety 
lssues may be improved if lower energy gamma 
sources can be manufactured. 
There is an interindividual variabilitv related to 
the geometry of the lesion and the moi-phology of 
different coronary arteries, as demonstrated by the 
rather large standard deviations in Table 1. The 
choice of the brachytherapy modality (centering 
device or not,~- vs -y-) cannot be only guided from 
DVH, but must integrate all the information avail-
able from the angiogram and the 3-D IVUS pull~ 
back (such as morphology of the lesion, length, ec~ 
centricity of the plaque). Potentially, catheters 
combining IVUS and asymmetric sources might be 
helpful in the guidance of a radiation treatment for 
eccentric lesions. Such a device with a C-shape 
shielding screen around a radioactive wire has been 
described recently [40]. 
Another limitation of our approach is that we re-
constructed an artificially straight coronary seg-
ment. However, this limitation might be overcome 
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by image fusion of biplane angiography and NUS, 
as developed in our center, to assess the true 3-D 
geometry of coronary vessels [41]. Presently, we 
also do not implement different dose fall-off char-
acteristics in function of the type of plaque seen (fi-
bro-fatty, calcified, etc.). Although there are proba-
bly differences, no data are available. 
One major assumption made in this work was to 
consider that the IVUS and delivery catheters were 
lying in the same position in the treated coronary 
segment. It is important to realize first that because 
the size of the IVUS catheter is smaller (2.9 Fr ~ = 1 
mm in diameter) than the brachytherapy device we 
used (5 Fr- =- 1.6 mm), it lies in a more eccentric 
?OSition in the coronary lumen. However, no easy 
correction can be applied because the channel 
source in the delivery device is not in the center of 
the catheter. The real average DV10lum in our pa-
tients is thus in the range 2.03-2.96 given in Table 
1. Moreover, even with the use of radiotherapy and 
NUS catheters of the same size, it is not certain 
that when advanced sequentially in the arterial lu-
men, they vvill occupy the same position. Although 
they should be on the shortest 3-D path in the lu-
men, coronary arteries have a complex curved ge-
ometry i_n space, and are partially deformed by the 
catheter lying in their lumen. Thus, catheters with 
differir:.6 rigidity will occupy different positions. Fi-
nally, it :s important to understand that the posi-
tion of a catheter inside the arterial lumen is not 
fixed :md varies along the cardiac cycle because of 
ventricular contractions. These methodological 
limitations col_;id be partially overcome with exist-
ing imaging wires, which could be introduced in 
the lumen of the irradiation delivery catheter itself. 
Presently, another limitation we face in our cathe~ 
terizatio:l laboratory is that DVH are not obtained 
on~line. F'..lrther implementations with faster pro-
cessing of the 3-D IVUS data set for optimal auto~ 
matic contour detection are under study. 
In conclusion, we think that the body of addi~ 
tiona! information available from IVUS and derived 
dosimetry parameters such as DVH should improve 
our understanding of the mechanisms of action of 
brachytherapy and be helpful for the comparison 
of trials based on different dosimetry strategies. In 
our center, we systematically assess the lesions 
treated by vascular radiation therapy by IVUS. 
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Residual Plaque Burden, Delivered Dose, and Tissue 
Composition Predict 6-Month Outcome After Balloon 
Angioplasty and /3-R~diation Therapy 
Mane! Sabate, MD; Johannes P.A. Marijnissen, PhD; Stephane G. Carlier, MD; 
I. Patrick Kay, MBChB; Willem J. van der Giessen, MD, PhD; Veronique L.M.A. Coen, MD; 
Jurgen M.R. Ligthart, BSc; Eric Boersma, PhD; Marco A. Costa, MD; 
Peter C. Levendag, MD, PhD; Patrick W. Serruys, MD, PhD 
Background-Inhomogeneity of dose distribution and anatomic aspects of the atherosclerotic plaque may influence the 
outcome of irradiated lesions after balloon angioplasty (BA). We evaluated the influence of delivered dose and 
morphological characteristics of coronary stenoses treated with f3-radiation after BA. 
Methods and Results-Eighteen consecutive patients treated according to the Beta Energy Rcstcnosis Trial 1.5 were 
included in the study. The site of angioplasty was irradiated with the usc of a ,B~cmitting 90SrfOY source. With the side 
branches used as anatomic landmarks, the irradiated area was identified and volumetric assessment was performed by 
3D intracoronary ultrasound imaging after trcanncnt and at 6 months. The type of tissue, the presence of dissection, and 
the vessel volumes were assessed every 2 mm within the irradiated area. The minimal dose absorbed by 90% of the 
adventitial volume (D_.wAdv) was calculated in each 2-mm segment. Diffuse calcified subscgments and those containing 
side branches were excluded. Two hundred six coronary subscgments were studied. Of those, 55 were defined as soft, 
129 as hard, and 22 as normal/intimal thickening. Plaque volume showed less increase in hard segments as compared 
with soft and normaVmtirnal thickening segments (P<O.OOOl). D_.wAdv was associated with plaque volume at follow-up 
after a polynomial equation with linear and nonlinear components (r=0.71; P=O.OOOl). The multivariate regression 
analysis identified the independent predictors of the plaque volume at follow-up: plaque volume after treatment. 
D_.wAdv, and type of plaque. 
Conclusions-Residual plaque burden., delivered dose, and tissue composition play a fundamental role in the volumetric 
outcome at 6-month follow-up after /3-radiation therapy and BA. (CirculatWn. 2000;101:2472-2477.) 
Key Words: balloon • angioplasty • radioisotopes • ultrasonics • rcstcnosis 
E ndovascular radiation therapy is a promising new tech-nique aimed at preventing rcstcnosis after percutaneous. 
coronary intcrvcntion. 1-J Although its effectiveness has been 
proven in the treatment of in-stent restcnosis, 4 the value of 
intracoronary irradiation in de novo coronary lesions remains 
to be established. Radiation delivered to the coronary artery 
by means of catheter-based systems can usc both y- and 
jS-cmitters.5 Long-term results after treatment may be influ-
enced by absolute dose and by the homogeneity in dose 
distribution. /3-Emittcrs demonstrate a more rapid dose fall-
off than y-cmittcrs because of the short range of elcctrons.6 
This feature may lead to a less homogeneous dose distribu-
tion when treating coronary segments with variable degrees 
of curvature, tapering, remodeling, and plaque extent. The 
usc of dose-volume histograms allows one to evaluate the 
cumulative dose received by a certain specified tissue val-
ume7 and has been recently implemented in the field of 
intracoronary brachythcrapy as a tool fordosimetry.8 Aims of 
the study were (1) to dctcnninc, by the usc of dose-volume 
histograms, the dose distribution of the J3-cmittcr 9QSrh 
along the coronary irradiated segment when delivered by a 
nonccntcrcd device, (2) to establish the dose that could 
be predictive of efficacy in intracoronary brachythcrapy, and 
(3) to determine the intravascular ultrasound (NUS) predic-
tors of the plaque volume at 6-month follow-up of coronary 
segments treated with balloon angioplasty (BA) followed by 
J3-radiation therapy. 
Methods 
Patient Selection 
Eighteen consecutive patients with single dc.novo coronary stenosis 
successfully tre31ed with BA followed by intracoronary .S·radiatioo 
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Figure 1. Longitudinal reconstruction and volumetric calculations (charts) of irradiated coronary segments after treatment (A and A') 
and at 6~month follow~up (Band B'). 
therapy were included in the study. Patients receiving a stent were 
excluded from the analysis . .B-Radiation was delivered according to 
the Beta. Energy Rcstenosis Trial 1.5. The isotope selected was the 
pure ,6-emitting wsrfOY, and patients were r.liidomly assigned to 
receive 12, 14, or 16 Gy at2 mm from the source axis. The inclusion 
and exclusion criteria of this trial have been previously reportcd.9 
The delivery of the radiation was performed by the usc of the 
Beta.-Gu:h System (Novoste Corp).10 The radiation source tr.:rin of 
this system consists of a series of 12 independent 2.5-m.m~long 
cylindricill seeds tha.t contain the wsrfOY sources and is bordered by 
2 gold radiopaque =kers at distal and proxim:J.l parts separated by 
30 mm.10 
IVUS Analysis 
The treated coron:II)' segment was evaluated by means of 3D IVUS 
imaging, which allowed volumetric calculations of the irradiated 
area. The selection of the area of interest has been reported 
clsewhere.11 In brief. a few steps were followed: First. an angiogram 
was performed after positioning the delivery catheter and the relation 
between :m:uomic landmarks and the 2 gold markers were docu· 
mented. The :m:.uomic landmark closest to either of the gold m:rrkers 
wa.s used as a reference point. This angiographic reference point was 
identified during a contrast injection with the IVUS imaging element 
at the same position as the gold m:rrker of the source. The :image 
from the IVUS imaging clement was recorded and the reference 
point identified. During the subsequent pullback., this reference point 
was recognized and used for selecting the area subject to the 
analysis: 30 mm for the irradia.ted scgment.12 The system used for 
imaging was a mechanical IVUS system (Clc:rrVicw. CVIS, Boston 
Scientific Corp) with a shcatb~based IVUS catheter incorporating a 
30-MHz, single-element tr:msducerrota.ting at 1800 rpm (Ultracross. 
CVIS). The transducer is placed inside a 2.9F, 15-cm-long sonolu-
ccnt distal sheath that ::Utcrnativcly houses the guide wire (during the 
catheter introduction) or the trnnsduccr (during imaging). The IVUS 
transducer was withdr.J.wn through the stationary i.m.aging sheath by 
an ECG-triggcred pullback device with a stepping motor.l2 The 
ECG-gated image acquisition and digitization was performed by a 
worksta.tion designed for the 3D reconstruction of echocardiographic 
i.mages12 (EchoSc:m. Tomtcc). Description of this system has been 
previously reported in det:lilP--14 In brief, the steering logic of the 
workstation considered the heart ra1e variability and only acquired 
214 
images from cycles meeting a predetermined range :md coinciding 
with the peak of the R wave. If an R~R interval f:rilcd to meet the 
preset range. the IVUS catheter remained at the same site until a 
cardiac cycle met the predetermined R-R r.liigC. The IVUS trnns~ 
duccr then was withdr.J.wn 02 mm to acquire the next im:l.gc.l2-14 
This system ensures the segment-to-segment independence by avoid-
ing taking images during the axial movement of the IVUS catheter 
that occun during the cartfulc cycle. Given the slice thickness of 
02 mm and the length subject to the analysis of 30 mm (distance 
between the 2 gold m:rrkers of the radiation source), 150 cross· 
sectional images per segment were digitized and :maly1.ed. A 
semiautomatic contour detection program wa.s used for the 3D 
analysis.ls This program construct.~ 2longitudinal sections from the 
d:lt:l set and identifies the contours corresponding to the lumen-
intima and mcdia~adventitia boundaries. Corrections could be per· 
formed interactively by "forcing" the contour through visually 
identified points: the entire data set then was updated. 15 Careful 
checking and editing of the contours of the 150 planar images was 
performed with an average of 45 minutes for complete evalu:uion. 
The area encompassed by the lumen-intima and media-adventitia 
bound:Jrics dcfmed the luminal and the total vessel volumes. respcc~ 
tivcly. The diiference between total vessel and luminal volumes 
defmed the plaque volume. Because media thickness cannot be 
measured accurately. we assumed that the plaque volume included 
the atherosclerotic plaque :md the media. 1 ~ Volumetric dat:l. were 
calculated by the formula V"".!",~ 1 A, ·H. where V=volume. A=area 
of total vessel or lumen or plaque in a given cross-sectional 
ultrasound image, H=thickness of the coronary artery slice that is 
reported by this digitized cross-sectional IVUS im:lge. and n=the 
number of digitized cross-sectional images encompassing the vol~ 
umc to be measured.l5 At follow~up. meticulous matching of the 
region of interest wa.s performed by comparing the longitudinal 
reconstruction with tha.t after treatment as previously dcscribcd11 
(Figure 1). The feasibility and intrnobscrver and intcrobserver 
v:ui.ability of this system have been previously reported.ll·13.l7,lM For 
the purposes of the srody. the computed volume of the :iJ:rndiated 
segment was divided into 2-mm~long subscgments. Since the :irradi.~ 
:J.ted segment measured 30 rom, 15 subscgments were defined per 
patient. each of them with 10 IVUS cross sections (02 mm per cross 
sectioD). All individual cross sections were studied by 2 investiga-
tors. blinded to the dosimetry results. Type of plaque and the 
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Figure 2. Dose~volume histogram showing cumulative dose 
received at level of adventitial layer. Minimal dose received by 
90% of adventitial volume (D,.ooAdv) is calculated. 
presence of dissection were qualitatively assessed, Type of plaque 
was dcfmed in every cross section as intirml thickening, soft. 
fibrous. mixed, and diffuse calcified according to the guidelines 
previously reponcd.19 Intimal thickening was defined when the 
thickness of the intima-media complex was <0.3 mm.19 Soft tissue 
was defined when '2::80% of the cross-sectional area was constituted 
by material showing less cchorcllcctivity than the adventitia., with an 
arc of calcium <10°, fibrous plaque when the cchorcfiectivity of 
'2::80% of the matcri:tl was as bright as or brighter than the adventitia 
without acoustic sh:l.dowing. diffuse calcified plaque when it con-
tained material brighter th:m the adventitia showing acoustic sh:ld-
owing in >90°, and mixed when the plaque did not match the 80% 
critcrion.l'.l We categorized the 2-mm-long subsegments as noi'llUll 
intimal thickening, soft, hard (fibrous and mixed), and diffuse 
calcified when ~0% of the cross sections within the subsegment 
were of the same type. In those cross sections contlining up to 90° 
of calcium :II"C, the contour of the external el:l.stic membrane was 
imputed from nonc:J..lcified slices. Dissection of the vessel was 
deflned as a te:lr pamllel to the vessel w:ill.1'.1 Ch:mges in lum.inal. 
plaque, and total vessel volume between immediately after treatment 
:md at follow-up were also computed per subsegment. Those 
subsegments in which the origin of side branches involved >90° of 
the circumferential ::rrc in >SO% of the cross sections or were dcfmed 
as diffuse calcified were excluded from the analysis. 
Dose Calculation 
The actual dose received by the vessel was retrospectively calculated 
by means of dose-volume histogr.uns7 in every 2-mm-long subseg-
ment. This method is based on quantitative NUS UDder the assump-
tion that the radiation source is positioned at the same place as the 
IVUS cathetcr.H The dist:mce between the center of the catheter and 
media-adventitia interface w:!S calculated in 24 pie slices (15°) in :ill 
cross sections corresponding to the irradi::ucd area.? Considering the 
prescribed dose and the accurate geometric data. obt:rined from the 
IVUS, the cumul:J.tivc curve of the dose-volume histogram for a 
prcdefmcd volume (ic, adventiti:.1 :.J.S cal.cubtcd. at 0.5 mm outside the 
extern:J..l el:l.stie membrane) c:m be obtained (Figure 2). From this 
curve, the minimum dose received by 90% of the adventitial volume 
(D~dv) W;1S calculated. The methodology and feasibility of this 
dosimetry approach in vascul:!r brachytherapy Jus been previously 
--· Statistical Analysis 
D.ua :II"C presented as mean:::!:SD or proportions. Differences in 
quantitative IVUS data. between the types of tissue were assessed by 
means of 1-way ANOVA. Differences in quantitative IVUS dab 
between subsegments with and without dissection and with and 
without calcium were evaluated by the use of :m UDp:rired Student's 
t test. To detcr:mlne the rela.tion between the dose received by the 
adventitia. and the phque volume at follow-up, linc:u- regression 
analysis was performed frrst. Then, nonlinear components were 
added to the equation cx-1 and x-2 were added to descnbe the steep 
15 io:n·~r.·s ······p.;:o:oooi" 
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Figure 3. Changes between postprocedure and 6-month mea-
surements in total vessel, plaque, and luminal volumes regard-
ing different types of tissue. TVV indicates total vessel volume: 
PV, plaque volume; and LV, luminal volume. 
increase of plaque volume at low dose). These components were 
included in the model if they described the relation significantly 
better. Fm:illy, the model was corrected for the plaque volume after 
treatment. Multivariable regression analyses were performed to 
identify independent predictors of plaque volume at follow-up 
among IVUS-derivcd (types of tissue, dissection, and plaque volume 
after treatment) :md dosimetric variables (D~dv). All tests were 
2-t:riled, and a v:J..luc of P<0.05 was considered statistically 
significant. 
Results 
Baseline Characteristics 
Two hundred seventy subscgments were defined in 18 pa-
tients successfully treated with BA followed b)r intracoronary 
brachythcrapy. Sixty-four subsegmcnts were excluded from 
the final analysis because of either diffuse calcified plaque 
that precluded the quantification of the total vessel volume 
(n=30) or side branches that involved >90° of the circum-
ferential arc in >50% of the cross sections (n=34). There-
fore, 206 irradiated subscgmcnts were the subject of the 
study. Fifty-five (27%) subsegments were defined as soft. 
129 (62%) as hard, and 22 (11%) as normal!mtimal thicken-
ing. Dissection was observed in 34 (16.5%) subsegmcots. 
Volumetric Changes and Dosimetry 
On average, total vessel volume increased at follow-up 
(325±.9 mm3 after treatment to 35.5±.11 mm3 at follow-up~ 
P<O.OOOl). accommodating a parallel incrCasc in plaque vol-
ume (15.3±.6 to 18.3.±.7 mm3; P<O.OOOI). As a result, mean 
luminal volume remained unchanged (17.1:±::7 to 17.0::=7 mm.3; 
P= NS). Sub segments with hard tissue dcmonstxatcd less in-
crease in plaque, resulting in an increase in luminal volume as 
compared 'n'ith soft and nonnalfmtimal thickening subscgmcnts 
(Figure 3). The behaviOr of those hard subscgmcnts containing 
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Figure 4. Range of dose distribution in irradiated coronary sub-
segments as calculated by dose-volume histograms. 
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" Figure 5. Relation between plaque volume at fo11ow-up and 
D.,Adv. 
mixed calcified tissue (up to 90°; n=104) was compared with 
those containing mixed noncalcificd tissue (n=25). Mean 
changes in plaque and total vessel volumes were comparable 
(.:lplaquc [nun3]: + 1.3::±::4.2 in mixed calcified vs + 1.8::±::5.2 in 
mixed noncalcificd; P=NS; b.total vessel volume [mm3]: 
+26::±::6.2 in mixed calcified vs +4.2::±::5.8 in mixed noncalci-
fi~ P= NS), resulting in a comparable mean increase in luminal 
volume at follow-up (+1.3::±::5.2 mm3 in mixed calcified vs 
~ 1.9::±::5.7 mm3 in mixed noncalcificd; P=NS). Dissected sub-
segments demonstrated a trend toward a smaller increase in 
plaque as compared with nondisscctcd subscgmcnts ( + 1.2::±::3 vs 
+3.3::±::6 mm3; P=O.OS). The mean of a113 prescribed doses at 
2 nun from the source was 14::!:::1.8 Gy. The calculated D~dv 
was 5.5±2.5 Gy (range 0.2 to 124). A wide range of dose 
distribution was observed .in the imldiatcd coronary subscgments 
(Figure 4). The association between D~dv with the plaque 
volume at follow-up is depicted in Figure 5. The model appeared 
" 
mm' 
Parameters Associated Wrth Plaque Volume at Follow-Up 
Parameter Estimate 95% Cl p 
Plaque volume after 0.6 0.810.5 0.0001 
treatment, mml 
o.,A!N. Gy -4.4 -5.6/-2.9 0.0001 
Type of plaque {hard vs other} -1.6 -3.4/0.1 0.06 
to follow a polynomial equation with linear and nonlinear 
components. Nonlinear components described the increase in 
plaque volume at lower doses, wbcrcas the residual plaque 
volume after treatment accounted for the linear relation of the 
curve. Changes in plaque volume appcarc:d to decrease with dose 
(Figure 6). Four Gray was the nrinim.um effective dose to be 
delivered to 90% of the adventitia because subscgments rccciv~ 
ing at least this dose demonstrated a significantly smaller 
increase in plaque volume as compared with those rccciving <4 
Gy (?<0.001). As a result, luminal volume dccrcascd signifi~ 
cantly less in those subscgmcnts rccciving C:4 Gy and even 
increased when the minimal dose to the adventitia was >6 Gy. 
Multi variable regression analyses identified plaque volume after 
treatment as a positive predictor of plaque volume at follow-up, 
whereas D,w\dv and type of plaque (hard) were negative 
predictors (Table). 
Discussion 
This study demonstrates for the first time the relation between 
plaque increase, as assessed by IVUS, and the dose received 
by the adventitia, as calculated by means of dose-volume 
histograms. A plot of dose-volume histogram is a standard 
method used in radiotherapy that condenses the large body of 
information available from conventional 3D distribution data 
ANOVADELTAPLAQUE: p<O.OOOJ 
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Figure 6. Changes in total vessel. plaque, and luminal volumes !'C9atding 5 ranges of closes as calculated by dose-volume histograms. 
TVV indicates total vessel volume. 
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into a plot summarizing graphically the radiation distribution 
throughout the target volume.' 
The assumption of the adventitia as the target tissue is 
supported by experimental studics.20.21 Scott ct al20 localized 
the proliferating cells in the adventitia and their migration 
into the ncointima after angioplasty by using bromodcoxyuri-
dinc immunohistochemistry. Similarly, Waksman ct a121 
demonstrated a greater cell proliferation in contrOl vessels 3 
days after angioplasty in the adventitia at the site of the 
medial teat as compared with the mcclial wall in the same 
region. In this study, the proliferation was significantly 
reduced in irradiated vessels with either a source of90Srt<'Y or 
1onlr that delivered 14 or 28 Gy at 2 mrn into the artery waJJ.21 
The actual dose received by the adventitia appeared to be 
rather_ low as compared with the prescribed dose at 2 mm 
from the source. Furthermore. the dose varied considerably 
between coronary subscgrncnts, as demonstrated by the dose 
distribution depicted in the Figure 4. The usc of }3-radiation 
may account in part for this dose inhomogeneity. As com-
pared with y-radiation, }3-sourecs have more fall-off because 
of the short range of electrons. 6 This feature may become 
crucial when treating vessels with a great degree of vessel 
tapering or, alternatively, lesions showing positive remodel-
ing where the distance from the source to the surrounding 
adventitia may be smaller or greater than expected. In this 
regard, the usc of IVUS as a tool for dosimetry in ,8-radiation 
therapy may become mandatory. 
Dose uniformity also may be influenced by the source 
centering in the lumcn.22 By the usc of dose-volume histo-
grams, Cartier et alg demonstrated in 10 patients treated with 
balloon angioplasty followed by intracoronary ,8-radiation 
that the prescribed dose was administered in only 35% of the 
adventitia. After centering the source in the lumen, up to 60% 
of the adventitia may have received this dose. 
The remnant plaque burden at the site of angioplasty 
becomes a powerful predictor of the outcome. This is in 
accordance with other studies that identified, either in non-
stentcd or stcnted coronary segments, postintcrvcntion cross-
sectional area as a predictor of restenosis.23.24 In this regard. 
the usefulness of a debulking technique before radiation 
therapy should be addressed in further studies. 
D.wA.dv was also identified as an independent predictor of 
the plaque volume at follow-up. The relation between 
D.wA.dv and plaque volume at follow-up appeared to be 
polynomial with linear and nonlinear components. This may 
model the survival curve of mammalian cclls.2S The minimal 
effective dose to be delivered to 90% of the adventitial 
volume appeared to be 4 Gy. Further increase in dose resulted 
in net increase in luminal volume at follow-up. Similarly, in 
a subgroup analysis of the SCRIPPS trial, late loss was 
significantly lower when the entire circumference of the 
adventitial border was exposed to 2:8 Gy.26 Radiation doses 
>20 Gy have been suggested to be able to completely 
eliminate the smooth muscle cell population from the treated 
area. 27 However, because cells from normal tissue have a 
limited capacity to proliferate. 28 lower doses probably would 
be sufficient to permanently prevent restcnosis. 
Fmally, subSegt!lents containing hard tissue (fibrotic and 
calcified material up to 90° of the circumferential arc) 
demonstrated a trend to be a negative predictor of plaque 
volume at follow-up. Hard plaque on rvus consists of a more 
mature tissue with low cellularity and high content of 
extracellular matrix.29.30 These features may induce either a 
physical barrier for migration of smooth muscle cells from 
the surrounding layers or a reduced capacity to proliferate 
when injured as compared with that of the soft tissue with a 
high concentration of smooth muscle eells.29 -31 Further, it is 
hypothesized that tissue composition may potentially exert a 
different degree of shielding effect on radiation and thus 
become less effective. However, the degree of remodeling 
was similar between the different types of tissue, suggesting 
that the effects of attenuation of radiation induced by hard 
material (either containing calcium up to 90° of circumfer-
ential arc or mixed noncalcified tissue) may be negligible as 
compared with that of soft tissue. 
Study Limitations 
We assumed that th~ IVUS and the delivery catheters were 
lying in the same position in the treated coronary segment 
The size of the IVUS catheter is smaller (29F) than the 
brachythcrapy device (SF), which is thus to some extent more 
centered in the lumen. Although the catheters should be on 
the shortest 3D path in the lumen, coronary arteries have a 
complex curved geometry in space and can be partially 
deformed by the catheters. Thus, catheters with different 
rigidity may occupy different positions. The development of 
new systems incorporating the IVUS imaging clement on the 
delivery catheter might resolve this drawback. 
During irradiation, the position of the delivery catheter 
inside the lumen is not fixed and may vary along the cardiac 
cycle because of ventricular contractions. which may lead to 
some degree of inhomogeneity not assumed by data derived 
from the static end-diastolic IVUS images. 
The behavior of diffuse calcified plaques after radiotherapy 
has not been evaluated because the acoustic shadowing would 
have impeded the reliable analysis of total vessel and plaque 
volumcs.l9 
It has not been possible to differentiate those areas that 
have been traumatized and irradiated from those only irradi-
ated. Thus, no conclusions regarding the effect on radiation in 
irradiated but noninjurcd segments can be drawn. ·Further 
studies will address this problem by defining meticulously the 
injured and the irradiated areas either on IVUS or quantitative 
coronary angiography. 
Finally, the dose as presented by the usc of dose-volume 
histograms is not a direct measurement The theoretical value 
obtained at the level of the adventitia is derived from the 
fall-off of the isotope and the geometrical data obtained from 
the IVUS study. The influence of the attenuation of the 
radiation caused by different tissue characteristics bas not 
been taken into consideration. Future investigations should 
address the implementation of a dosimetry program on-line to 
prescribe the radiation dose in a more refined fashion. 
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STRUCTURED ABSTRACT: 
Aim: b-radiation reduces late lumen loss after PTCA. 
However, this benefit is nor observed in all patients. We 
hypothesi::.ed that this may be related to the dose delivered 
to the coronary wall. Therefore we investigated by 3-d NUS 
the actual radiation energy deposited and correlated this to 
6-month angiographic late loss. 
Methods and results: ~radiation was administered using a 
oasr/Y source. Twenty-seven consecutive patients with suc-
ces::.ful PTCA of de novo lesions without stenting undenwnt 
a retrospective analysis of the dose delivered to the treated 
segment using an NUS-based treatment planning system 
Dose suiface histograms were calculated for the lumitwl 
suiface (fum) and the external elastic lamina (eel). The 
minimum dose on 90% of fum (DS9ofwn) and eel (DS90eel) 
were 9.7±6.1 and 5.1±3,0 Gy, respectively. At 6-monrhfol-
low-up. the patients with a DS90eel > 5.2 Gy (n=1 I) had a 
lower angiographic loss (-0.01±0.39 vs. 0.47±0.62 mm, 
p=0.03) and late loss index (-0.4±58 vs. 44±56 %, 
p=0.06). These arteries were smaller (reference diameter: 
2.67±0.52 vs. 3.17±0.59 mm. p<0.001) but had a similar 
relative gain (0.35 vs. 0.36 mm) post-angioplasty. 
Conclusion: Angiographic loss after PTCA followed by 
b-brachytherapy is minimal when 90% of the eel receives a 
minimum dose estimated from our study to be 5.2 Gray. 
Abstract: 
We have evaluated the dose delivered to the coronary wall 
ofnventy-seven patients treated with ~brachytherapy after 
succes::.ful PTCA without stenting. The dose was measured 
with an NUS-based treatment planning system. Dose sur-
face histograms were calculated for the luminal suiface and 
the external elastic lamina (eel). At 6-monthfollow-up, the 
patients with a minimum dose on 90% of the eel > 5.2 Gy 
(n=ll) had a lower angiographic loss (-0.01±0.39 vs. 
0.47±0.62 mm, p=0.03). We conclude from this study that 
the angiographic loss after PTCA followed by {3-brachy-
therapy depends on the minimum dose delivered in the 
coronary wall. 
INTRODUCTION 
Intracoronary radiation therapy is a new therapeutic mod:ility 
to prevent rcstenosis. Positive results observed in animal 
experiments(l-5) have supported the blossoming of nume-
rous clinical trials. The strong reduction of the restenosis 
rate for the treatment of in-stcnt restenosis using y~radia­
tion(6-8) or more recently ~-radiation(9) contrasts with 
more controversial data observed with the usc of ~-radia­
tion as adjunctive therapy after percutaneous angioplasty 
(PTCA) of de novo lesions(l 0). However. three recent 
studies have demonstrated that a reduced late lumen loss 
could be achieved when treating de novo lesions by angio-
plasty followed by ~-radiation.(ll-13) The benefits were. 
however. not observed for all the patients and the reported 
late lumen loss demonstrates large standard deviation. We 
hypothesized that this phenomenon may be related to the 
dose of radiation delivered to the coronary vessel walL 
Tcirstein et al .. for example. have already reported that 
y-thcrapy was only effective when the minimum dose to the 
furthest point of the adventitia was at least 8 gray.(l4) 
The aim of this study is to demonstrate the relationship 
between the angiographic changes and actual dose in the 
setting of catheter-based ~-radiation. To this purpose, we 
have correlated the dose delivered to different coronary 
structures such as the luminal swfacc or the external elastic 
lamina (eel) to the angiographic outcome assessed by quan-
titative coronary angiography (QCA). This dose was 
derived from dose-volume histograms (DVH) computed on 
the three-dimensional (3-d) intravascular ultrasound (IVUS) 
pullbacks using a method recently deseribed.(15. 16) 
METHOD 
Population 
Twenty-seven consecutive patients presenting with de novo 
coronary stenosis, successfully treated with balloon angio-
plasty followed by intracoronary ~-radiation therapy were 
included in this study. Patient characteristics are given in 
table 1. Patients receiving a stent were excluded from the 
analysis. Radiation was delivered within the framework of 
brachythcrapy trials conducted in our institution that were 
Table I: Baseline characteristics 
Patients, n 
Age,y 
Male,% 
Prior MI,% 
Diabetes mellitus 
Hypercholesterolemia 
Smoking history 
Arte ry,% 
left anterior descending 
Circumflex 
Right coronary 
l esion characteristics, % 
A 
B 
27 
58.7 ± 9.6 [39 • 75] 
21 (78 %) 
9 (33 %) 
4 (15 %) 
9 (33 %) 
16 (59 %) 
10 (37 %) 
7(26%) 
10 (37 %) 
4 (1 5 %) 
23 (85 %) 
Dose prescribed at 2 mm off source axis 
12 Gy 9(33 %) 
9 (33 %) 
7 (26 %) 
2 (8%) 
14 Gy 
16 Gy 
18 Gy 
approved by our Investigational Review Board. All patients 
gave wrillen info rmed consent. The isotope used was the 
pure ~-emiuing "'Sr!Y. Pa tients were randomized to receive 
12 to 18 G ray at 2 mm off source axis. Brachytherapy was 
performed with the BetaCath Syste mTM (Novoste Corp., 
Norcross, GA). The radiation source train of this system 
consists of a series of twelve independent 2.5 mm-long 
cylindrical seeds that contain the '"S r!Y source (to ta l length 
is 30 mm).( l l) 
intravascular ultrasound image acquisition 
The treated coronary segment was evaluated by means of 
three-dimensional (3-d) JVUS imaging for volumetric esti-
mation of the irradiated area. The selection of the area of 
interest has been reported e lsewhere.(l7. 18) i n brief. selec-
tion of the IVUS segment matching the irradiated site was 
based on anatomical landmarks such as side branches or 
ostial locations. An angiogram was performed after the 
placement of the delivery catheter to document the relation-
ship between the ana tomical landmarks and the source 
train. This angiographic refe rence point was again identi-
fied during a contrast injection with the IVUS imaging ele-
ment at the same position. The system used for imaging was 
a mechanical IVUS system (ClearView, CVJS. Boston 
Scientific Corporation, Maple Grove, NW) with a sheath-
based IV US catheter incorporating a 30 MHz single-ele-
ment transducer ro tating at 1800 rpm (Uitracross"'. CVJS). 
ECG-gated image acquisition and digitisation was per-
fo rmed by a workstation designed for the 3-d reconstruction 
of echocardiographic images (EchoScan, Tomtec. Munich. 
Germany) as described before.( 19) 
lntravascular ultrasound quantification 
A Microsoft Windowsn•-based contour detection program. 
developed at the Thoraxcenter. was used for off-line volu-
metric quantification following a methodology detailed 
elsewhere.(l7, 18) Brieny, this program identified the con-
tours corresponding to the lumen and eel boundaries in 
Do« (gray) Cnrlier et 31. 
Figure 1: Top panels: typicai iYUS cross-section and sagitnl reconstmction of an IV US pull-back. The 24 points(+) of the luminal surface 
(/11111. in red) and external elastic lamina (eel. in green) where the dose has been calculated. considering that the Sr/Y90 source was lying in 
the same position than the IV US catheter. are superimposed on the cross-section. Bottom panel: the corresponding cumulative dose surface 
histogram for the lumen (in red) and the eel (in green) are shown in the bottom panel. The prescribed dose was 16 Gy at2 mm from the source 
axis. DS901um (8.5 Gy) is the minimum dose (x-axis) received by at least 90'ilc of the voxels (y-axis) corresponding to the luminal surface 
along the complete IYUS pullback illustrated. DS101um (53 Gy) is the highest dose received by at least IO'K of these voxels. Similarly. 
DS90eel (3.5 Gy) is the minimum dose delivered on at least 90% of the eel. 
successive cross~sectional images. Volumetric data of the 
vessel segment of interest were calculated as the sum of all 
cross~section areas multiplied by the slice thickness (on 
average 200 ).llTI). Contours were checked and edited by 
experienced analysts. 
Dose calculation 
The dose delivered in the irradiated coronary segments was 
calculated by means of dose~ volume histograms (DVH) and 
dose-sutface histograms (DSH) derived from the 3~d NUS 
pull~backs. DVH's summarize the dose distribution infor~ 
mation for a region of interest and identify characteristics 
such as dose uniformity and hot or cold spots. To calculate 
a DVH. the dose distribution data must be available for the 
region of interest. The histogram is a plot of the accumulat~ 
ed volume of those clements receiving a dose in a specified 
dose interval versus a set of cqual~spaccd dose intervals (sec 
figure 1). DSH's arc computed for the surface area of vari-
ous target regions. 
The contours of the EchoScan program were processed 
with a software written in MatLab (The Math Works. Inc .. 
Natick. MA) to compute the distances between the centre of 
the source and both the lumen~ intima and media~advcntitia 
(eel) interfaces in 24 pie~slices (15°) in all cross~sections 
corresponding to the fully irradiated segment (25 mm). 
excluding the dose fall~off zone. Because media thickness 
cannot be measured accurately. we assumed that the plaque 
volume included the atherosclerotic plaque and the 
mcdia.(20) The dose distribution over the luminal and eel 
surfaces and in the plaque+mcdia volume was retrospec-
tively computed using an intracoronary treatment planning 
system (iPlann~. Emory University. Atlanta. GA). This sys~ 
tern incorporates a dose calculation engine based on the 
.A..A.PM TG-60 formalism using catheter based delivery sys-
tems with the following radiation sources: 'lOSriY. 3"P. 1 ~I and 
l'r.:rr. The dosimetry is based on the method discussed by 
Soares et al. for calibrating ~-sources and includes 
anisotropy factors to account for the dose fall-off on the end 
of the seeds in the transverse axis.(21) The coordinate of the 
center of the IVUS catheter was used as a reference, and 
was considered at the same location as the center of the 
radiation train. Validation of iPlan TM dosimetry calculation 
has been previously reportcd.(22) The average voxel dose 
(D50) was computed as well as the cumulative curve of 
Table 2: QCA and IVUS results 
the dose from which two measurements. D90 and D10 were 
derived. D90 is the m.inllnum dose received by at least 90% of 
the voxels corresponding to the volume (or surface) of tissue 
considered. D10 is the highest dose received by at least 10% of 
these voxels. DS90eel is thus the minimum dose deposited on 
90% of the eel surface. DV 90p+m is the minimum dose 
deposited in 90% of the plaque plus media volume. 
Quantitative angiography 
Quantitative coronary angiography (QCA) was performed 
pre~. post-procedure and at 6-month follow-up in;:: 2 ortho-
gonal matched projections with the CAAS II analysis 
system (Pic Medical BY. Maastricht. The Netherlands) after 
intracoronary administration of nitrates. This method has 
been extensively v:ilidatcd(23. 24) and applied in numerous 
clinical trials. The following measurements were obtained: 
minimum lumen diameter (MLD). reference diameter. per~ 
cent diameter stenosis (%DS). Acute gain was defined as 
MLD post-procedure minus MLD pre~intervention. Late 
lumen loss was defined as MLD post~procedurc minus 
MLD at 6~month follow-up. The late loss index was com~ 
putcd as the ratio of the late loss over the acute gain.(25) 
Relative gain and loss were computed respectively as the 
gain and the loss divided by the reference diameter. 
Restenosis at 6 months was defined as a %DS>50 %. The 
fully irradiated segment of the vessel was analysed. 
Statistical analysis 
Data arc presented as mean± standard deviation. Sensitivity 
(percentage of patients with restenosis that does exceed a 
given dose threshold) and specificity (percentage of 
restenosis-free patients that docs not exceed a dose thresh-
old) were computed. Angiographic and IVUS variables 
were compared for the groups of patients with a DS90ecl 
lower or equal and a DS90ccl higher than the dose corre-
sponding to the crossing of the sensitivity and specificity 
curves. Receiver operating curves were constructed and the 
area under the curve is rcported.(26) Continuous variables 
were compared with the usc of unpaired Student's t-test. 
Binary variables were compared with the usc of the chi-
square test with normal approximation or Fisher's exact 
test, when appropriate. All tests were two-tailed and a 
p value <0.05 was considered statistically significant. 
preangioplasty postirradiation 6-month follow up 
Reference vessel diameter (mm) 
Minimal lumen diameter {mm) 
Diameter stenosis(%) 
Acute gain (mm) 
Late luminal loss (mm) 
Loss index(%) 
Binary restenosis 
Luminal volume (mm") 
Vessel volume (mm") 
Plaque volume (mm") 
Minimal luminal cross section area (MLCSA, mm') 
Vessel area at MLCSA (mm') 
Plaque at MLCSA (mm') 
Res'1dual obstruction at MLCSA (%) 
2.96±0.54 
0.92>0.39 
69±11 
2.96±0.61 2.78±0.55 
1.98±0.42 1.71±0.62 
32±9 39±18 
1.06±0.42 
0.27±0.58 
26±60 
7 (26%) 
225±97 
423±127 
197±49 
4.5±1.7 
11.4±3.9 
6.9>2.9 
59±11 
Table 3: rvtinimum dose deposited on 90%, 50% and 10% of the lumin:;ll surface, of the cxtem::t.l cl<tStic lamina and in the plaquc+media volume 
REScLTS 
Lumen 
Eel 
Plaque+media 
QCA and NUS measurements 
D 90 (Gy) 
9.7±6.1 
5.1±3.0 
7.0±4.0 
QCA and IYUS results are summarized in table 2. Patients 
were compamble to a Bcncstent-likc population(27) with 
unremarkable risks factors and non-complex lesions. 
Angiographic acute gain and late loss were comparable to 
similar PTCA patients in historic trials. The mean NUS 
lumen diameter, derived from the lumen volume divided by 
the 25 mm of the pullback length (see figure I). was 3.3 mm 
and the mean vessel diameter was 4.6 mm. 
Dosimetry 
The minimum dose delivered on 90, 50 and 10 % of the 
luminal and eel surfaces and in the plaque+media volume 
arc given in table 3. On average. DS90eel was 5.1 Gy and 
DV90p+m was 7.0 Gy, for an average dose of 14.1 Gy pre~ 
scribed 2 mm off source axis. 
Seven patients had a diameter stenosis larger than 50% at 
follow~up within the fully irradiated segment. The area 
under the ROC curves for DS90ecl. DS50eel. DV90p+m and 
DV 50p+m were respectively 0.56, 0.49, 0.54 and 0.51. As 
shown on figure 2. the sensitivity and specificity curves to 
predict a DS>50% at 6~month for DS90eel crossed at 4.5 Gy. 
Sensitivity and specificity were then 0.58. :Ko significant 
threshold could be found for DS9oium and DS5oium. The 
Beta-Cath source has been recently recalibrated by the 
1\lST and the doses prescribed to our patients were actually 
15% higher than believed (e.g. a dose of 16.1 Gy has actu-
ally been given to the patients randomised to 14 Gy). The 
threshold of 4.5 Gy that we have derived for DS90eel cor-
responds to an actual dose of 5.2 Gy. 
Late luminal loss injunction of the dose delivered on the eel 
A significantly lower loss (-0.01±0.39 vs. 0.47±0.62 mm. 
p=0.03), relative loss (-0.007±0.158 vs. 0.15±0.21 mm. 
p=0.04) and loss index (-0.4±58 vs 44±56 %, p=0.06) were 
found in the 11 patients with a DS90eel > 5.2 Gy (see table 4). 
D 50 (Gy) 
23.3±8.6 
11.6±4.5 
16.1±6.0 
D 10 (Gy) 
49.0±7.8 
28.1±6.0 
35.1±6.4 
Similar results were found for the patients with a DV 90p+m 
> 7.1 Gy. There was no difference in the clinical character-
istics of the patients with a DS90eel :::; or > than 5.2 Gy. 
Figure 3 demonstrates that the vessels with a DS90eel 
> 5.2 Gy were smaller. had less plaque accumulation. but 
that the gain (1.15±0.38 vs. 0.93±0.46 mm. p=ns) and the 
relative gain (0.36±0.10 vs. 0.35±0.15 nun. p=ns) were 
similar. None of the observed differences in the angie-
graphic and IVUS parameters could predict a lower 
restenosis rate. loss and loss index at 6 month. Among the 
11 patients with a DS90eel > 5.2 Gy. the binary restenosis 
rate was IS% (2/11) compared to 31 % (5116) when the 
dose delivered on 90 % of the eel was :::; 5.2 Gy. This dif~ 
ferencc did not reach statistical significance. Figure 4 
demonstrates the cumulative plots of the minimum lumen 
diameter (MLD) post-intervention and at 6-month follow-
up. The median loss of the patients with a DS90eel:::; 5.2 Gy 
was 0.55 mm whereas it can be clearly appreciated that at 
6-month follow-up. the majority of the patients with a 
DS90ecl > 5.2 Gy at least preserved their MLD, and that 
40% demonstrated even a positive remodelling (larger 
:MLD at follow-up than post-intervention). 
DISCUSSION 
The objective of this study was to evaluate the relationship 
between the quantitative angiographic changes and actual 
dose in the setting of catheter-based B-radiation. The major 
finding is that the late angiographic outcome of patients 
treated for de novo coronary lesion by angioplasty followed 
by ~-radiation therapy can be partially explained by the 
dose delivered in the vessel wall. This dose can be derived 
from dose volume histograms computed from 3~d IVUS 
pullbacks. A significantly lower loss ( ~0.01±0.39 vs. 
0.47±0.62 mm. p=0.03) and relative loss (0.15±0.21 vs.-
0.007±0.158 mm. p=0.04) were present at 6-month follow·up 
when the radiation energy deposited on the external elastic 
lamina was higher than 5.2 Gy (sec table 4). 
1--~-0 5PQCificltyl 
2 4 • • 
OS90ool 
10 12 14 16 
Curlier et al. 
Figure 2: Sensitivity (filled circles) and specificity (open circles) curves to predict 6-month restcnosis for DS90ccl. The two curves cross at 
4.5 Gy for a specificity and a sensitivity of 58%. 
.(),50 0.50 1.50 2.50 
(IMI) 
3.50 4.50 5.50 
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Figure 3: Comparison of the QCA and IVUS measurements of the 16 patients with a DS90"el < 5.2 Gy (4.5 x 115%. corrected dose. see text) 
and the II patients wilh a DS90eel > 5.2 Gy. The arteries with a dose delivered on 90% of the eel > 5.2 Gy were smaller. had less plaque accu-
mulation. but had a similar gain and relative gain. None of the observed differences in the angiogruphic and IVUS parameters could predict 
the lower loss and los> index observed at 6 months. 
Dose l'Oitlme lristograms to predict rest enos is 
We have investigated whether a given threshold of the mini-
mum dose delivered on 90% of the extemal elastic lamina 
(DS90eel) is a predictor of restenosis at 6-month. The 
threshold of 5.2 Gy for DS9(1eelthat we lind is in agreement 
with a previous lVUS analysis in which we have analysed 
2-mm sub-segments of coronary arteries treated with 
brachytherapy. We could demonstrate that there was an 
increase of the luminal volume, related to an increase of the 
vessel volume larger than the plaque growth. when the 
DS90eel was greater or equal to 6 Gy.( 17) Several 
brachytherapy trials have demonstrated that in a majority of 
patients the luminal diameter at the site of the treated lesion 
may increase during the follow-up.( 13) This phenomenon i s 
induced by the positive remodelling of the vessel wall as 
demonstrated by IVUS.(l7) We do not report the 6-month 
IVUS data since an ECG-triggered pull-back was not sys-
tematically performed in our cohort. 
The major determinant of clinical recurrence of symptoms 
is the minimum luminal diameter (MLD) at 6-month.(25, 
28). We have compared the lumen late loss in the ll 
patients with a DS90eel > 5.2 Gy and the 16 patients with a 
DS90eel ~ 5.2 Gy. The arteries with a DS90eel > 5.2 Gy 
demonstrated a statistically lower loss (table 4). These 
arteries were smaller (figure 3). which can be expected with 
the prescription method used with the Beta-Cath system, 
with a fixed dose prescribed at 2 mm off the source axis. 
However. the relative gain was identical in these arterie; 
with a reference diameter on average 0.5 mm smaller. The 
observed lower loss and loss index could not have been pre-
dicted in these conditions(25, 29. 30) and must directly 
reflect the effect of radiation therapy which mainly leads to 
a remodelling of the vesseL with an enlargement of the eel 
with an adequate dose.( 17) 
The target l'olume of corolla I)' braclrytherapy 
Animal studies showing the efficacy of intracoronary 
brachytherapy were followed immediately by human clinical 
trials. At the time that they were initiated there was little 
information available as to the mechanism of radiation in 
preventing restenosis. This situation continues today. 
Various opinions exist as to the target cell of radiation in 
preventing restenosis. Rubin has postulated the importance 
of the monocyte-macrophage in regulating the development 
Table 4: QCA and tV US data in function of the dose delivered on 90% of the external clastic lumina surface (DS90ee\) 
DS90eel ~ 5.2 Gy (n=16) Preangioplasty Postirradiation 6-month Follow up 
Reference vessel d. (mm) 
Minimal lumen d. (mm) 
Diameter stenosis (%) 
Acute gain (mm) 
Late luminal loss (mm) 
Loss index (%) 
Luminal volume (mm') 
Vessel volume (mm') 
Plaque volume (mm') 
DS90eel > 5.2 Gy (n=11) 
Reference vessel d. (mm) 
Minimal lumen d. (mm) 
Diameter stenosis (%) 
Acute gain (mm) 
Late luminal loss (mm) 
3.12±0.58 
1.05±0.40* 
66±11 
Preangioplasty 
2.72±0.39 
0.74:t0.32 
73:t11 
3.17±0.59* 
2.20±0.38* .. 
30±5 
1.15±0.38 
276±94 .. . 
496±112 .. . 
218±48 .. 
Postirradiation 
2.67±0.52 
1.66±0.25 
36:t12 
0.93±0.46 
2.91±0.63 
1.73±0.73 
41:t21 
0.47±0.62. 
44:t56 
6-month Follow up 
2.59±0.37 
1.68±0.45 
36±14 
-0.01±0.39 
Loss index (%) -0.4±58 
Luminal volume (mm') 150±31 
Vessel volume (mm') 316±44 
Plaque volume (mm') 166±33 
·: p<0.05, .. : p<0.01 ; ···: p<0.001 -unpaired !-test, DS90eel < 5.2 Gy vs. > 5.2 Gy 
0 
'·' '·' 
z 3 
'·' 
Carlier et al. 
MLD(mm) 
Figure 4: Cumulative plots of the minimum lumen diameter (MLD) post~intervention (filled markers) and at &month follow-up (open markers). 
The round markers represents the 16 patients with a DS90ccl < 5.2 Gy. The medi:m loss of these }Xlticnts wa..'> 0.55 mm. The square markers 
represents the 11 patients with a DS90eel > 5.2 Gy. It c:.m be clearly appreciated that at 6-month follow-up, the majority of these patients (open 
squares) at least preserved their )..11.0, nnd that 40% demonstrated even a positive remodelling (larger MLD at follow-up than post-intervention). 
of the proliferative ncointima.(31. 32) Robinson. Wilcox 
and others have stressed the importance of the modified 
smooth muscle cell in the development of the restenotic 
lesion without invoking the monocyte-macrophage in the 
proccss.(33-35) The site of origin of these modified smooth 
muscle cells is however in dispute. Robinson has proposed 
that these cells are most likely to originate in the torn edges 
of the media. Wilcox has shown suggestive evidence that 
the proliferative activity in the vessel wall is seen first in the 
adventitia and only later in the media. suggesting that the 
neointimal cells may have migrated there from the adventi-
tia. Thus there remains debate as to how deep from the 
luminal surface the prescribed dose of radiation needs to be. 
There seems to be consensus that in animal models the pro-
liferative cells forming the cellular neointima does not orig-
inate from the entire circumference of the vessel wall but 
primarily from the site of damaged tunica media. The pro-
liferation following PTCA in human coronary arteries 
seems to occur similarly in a focal manner. Recently Mintz 
and others have shown that shrinkage of the vessel (nega-
tive remodelling) may play the major role in late lumen loss 
following coronary intervention (atherectomy, PTCA).(36) 
Waksman and Wilcox have shown that the adventitial 
myofibroblasts are responsible for this process as a result of 
the contractile nature of these cells and their capacity to par-
ticipate in a form of scar contraction of the arterial wall 
after angioplasty. This may present an additional reason to 
target dose to the tissues beyond the eel.(37) Our data sup-
port that the target for braehytherapy lies at least at the level 
of the external elastic lamina and may be the adventitia 
since the angiographic outcome was best correlated with 
the DS90eel. and not with the DS9oium. 
The minimum dose to prevent restenosis and to induce 
remodelling 
One thing that is clear from the preclinical studies of 
rcstenosis is that a broad range of doses seems to be effec-
tive in preventing restenosis. Work carried out by the 
Emory group with ~- and y- sources has shown that doses 
of 3.5 to 56 Gy were all effective in reducing restenosis in 
comparison to controls.(2. 38) However, the data of the sub-
analysis of the SCRIPPS(14) and of the Dose Finding 
Study(13) cleared demonstrated a dose-effect relationship 
in a narrower range of dose delivered to the vessel wall. In 
SCRIPPS. there was no difference between the placebo 
group and the patients who received less than 8 Gy to the 
most distant part of the eel. In the Dose Finding Study, for 
the patients treated by balloon angioplasty alone. the late 
lumen loss was 0.31 mm in the group in which 9 Gy was 
prescribed 1 mm in the vessel wall. but -0.04 mm in the 18 Gy 
group. These data support our findings of a significant rela-
tionship between the dose deposited in the arterial wall and 
the QCA outcomes. · 
Limitations of the study 
Dose volume histograms (DVH) describe the cumulative 
distribution of dose over a specific volumc(39) and sum-
marize the dosimetry that would otherwise have to be inter-
preted from numerous IVUS cross-sections with superim-
posed isodoses plotted. We have concentrated our analysis 
on the minimum dose delivered to 90 % of the eel (DS90eel) 
but we show that similar results could be derived from the 
DV 90p+m. Several other parameters can be derived from 
DVHs.(40. 41) but no definitive one h::ts emerged as a gold-
standard. 
The reported doses were not directly measured. The theo-
retical value obtained at the level of the adventitia is derived 
from the isotope dose distribution and the geometrical data 
obtained with rvus. The influence of the attenuation of the 
radiation due to different tissue densities has not been taken 
into consideration so far. However. this is likely to be signi~ 
fica.nt and warrants further investigation. It is expected that 
a plaque heavily calcified will decrease the dose reaching 
the eel.(42) 
A recognized limitation of coronary brachytherapy is the 
development of a new stenosis at the edges of the irradiated 
area. This has been likened to the radiation oncology con-
cept of geographic miss. where the radiation field does not 
fully cover the target.(43) We limited our analysis to the 
fully irradiated segment in order to draw unequivocal rcla~ 
tionship between the angiographic loss and the dose. without 
the possibility of geographical miss. The clinical outcome 
depends also on other complications such as late thrombo-
sis.(44) Although it has been suggested that the higher the 
dose in the adventitia is, the higher the thrombosis rate 
is,(45) we did not include any patient presenting a late 
thrombosis, which would have blurred the interpretation of 
the loss and loss index. A larger group of patients would be 
necessary for an analysis of the rate of thrombosis in function 
of the dosimetry. as well as for a study of the influence of 
the clinical characteristics (e.g. diabetes) or the type of 
plaque. The analysis of the receiver operating curves 
demonstrated that the dose is not the only parameter influ-
encing restcnosis since the area under the curves were not 
statistically different from 0.5. 
We assumed that the IVUS and the delivery catheters were 
lying in the same position in the treated coronary segment. 
The brachythcrapy device (5 Fr) is larger than the IVL'"S 
catheter (2.9 Fr) and is to some extent self-centered in the 
lumen. The true dose delivered in different vessel wall 
regions could vary from the data calculated. \Vhen using a 
centering balloon for the source,(12. 13) the center of gravity 
of the lumen of each slice can be calculated fTOm the 3-D 
IVUS to more correctly position the source.(46) For a non-
centered device. even with the use of a brachytherapy and 
an IVUS catheters of the same size. there will always 
remain an uncertainty on the location of the source in the 
lumen. ::v:Ioreovcr. the position of a catheter inside the 
arterial lumen is not fixed and varies during the cardiac 
cycle.(47) These methodological limitations could be par-
tially overcome with imaging wires. which could be intro-
duced into the lumen of the irradiation delivery catheter 
itself.(48) 
CONCLUSION 
Dose volume histogram analysis of 3-d NUS pullback per-
mits the evaluation of the radiation dose delivered to 
different parts of the coronary wall. We have demonstrated 
an inverse relationship between the minimum dose delivered 
to 90 % on the external elastic membrane and the angio-
graphic loss and the restenosis rate. 
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Cardiovascular Echography 
Introduction 
In 1953, Edler and Hertz [1] introduced the M-mode techni-
que in Lund, Sweden allowing the recording of the motion 
pattern of cardiac structures along a single sound beam. 
They described many of the presently known echo patterns. 
Furthermore efforts were carried out to show two-dimen-
sional sequential images of the heart. This was based on a 
mirror system with a yield of 7 frames per second (Asberg et 
at. [2]). The phased array electronic sector scanner was 
first described by Somer in 1968 [3]. This system, originally 
introduced for neurology, has become the "working horse'' of 
clinical cardiology today. The phased array transducer with 
its small "footprint" proved excellent for probe manoeuvrabi-
lity between the ribs. First practical two-dimensional images 
of the moving heart, however, were obtained with an elec-
tronic scanner presented in 1971 in Rotterdam by Born [4] 
and Kloster [5] and was based on the linear array technique. 
A survey on use of echo techniques in cardiology in 1980 in 
the Netherlands resulted in: a) application of M-mode with 
linear array by 32% of the clinicians, b) exclusive M-mode 
by 32 %, c) M-mode with mechanical sector scan by 29% 
and d) M-mode plus electronic sector scan by 7 % of the 
users. Thereafter the phased array technique became 
dominant in cardiology and linear arrays with the larger 
transducer footprint were increasingly used outside cardiolo-
gy in for instance obstetrics, radiology and internal medici-
oe. 
An early invasive, catheter-based system for echo studies of 
the arteries and veins was described by Wells in 1966 [6]. 
This was based on mechanical rotation of the acoustic ele-
ment. An electronic technique with 32 elements was descri-
bed by Bom et at. in 1972 [7]. 
Only with the introduction of interventional card'1ology and 
the balloon dilation methods in the mid-eighties, intravascu-
lar echography became important. A practical, mechanically 
rotated system was described around 1985 by Yock et al. 
and patented in 1989 [8]. 
The evolution of non-invasive echocardiography seems logi-
cal: from information along a single sound beam towards 
cross-sectional imaging. Thereafter, increase of the number 
of cross-sections (in the early years only two perpendicular 
cardiac planes were studied) to today's first applications of 
3-dimensional echocardiography. Also intravascular and 
intracardiac echography started with a single beam in one 
direction only [9] and thereafter the imaging became 20 and 
recently 30 [1 0]. Overall there was improvement of image 
quality by better transducer characteristics and processing 
techniques. 
Probe size, scan depth and resolution 
versus frequency. 
In Figure 1, the frequency range of various cardiovascular 
applications is illustrated. Since attenuation increases with 
19 
CARDIOVASCULAR APPLICATIONS 
Probe size dccreose 
RcsoluMI'l increose ---
Fig. I Range of cardiovascular applications wirfl optimal frequency. 
frequency it becomes clear that for non-invasive echocardio-
graphy in adults (large depth range) low frequencies around 
4 MHz must be used. The mid frequency range around 10 
MHz is indicated for esophageal echo work in children or 
intracardiac imaging. At the high frequency, intravascular 
echography can be used since the distance from echo ele-
ment to vascular wall to be investigated is very limited here. 
As can be observed from the figure, the used transducer 
size decreases with frequency. This is related with the 
acoustic active transducer surface, which for proper beam 
forming must encompass a given number of wavelengths. 
Echo transducers must have a broad frequency spectrum 
around the resonant frequency for proper depth resolution. 
With the introduction of contrast imaging in cardiology and 
based on the fact that in recent years the non linear proper-
ties of contrast as well as from tissue have been discovered, 
second harmonic imaging is becoming to be integrated in 
the echo instruments. This in turn requires very broadband 
transducers. A method described by de Jong et at [11] is 
based on integration of two phased array transducers with 
different resonant frequency into one. Apart from separation 
between contrast and tissue, harmonic imaging also decrea-
ses transducer near field reverberation and side lobe effects 
as illustrated in Figure 2. 
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Lancee, Dr.ing. N. Bruining, Dr.ir. C.L. de Korte and Dr.ir. N. 
de Jong hold functions in the field of technology at the Cardiac 
Department of the Thoraxcentre. Drs. S.G. earlier is a cardio-
logist as well as Prof.dr. J.R.T.C. Roelandt who is the Head of 
this department. Prof. Bom is also a Managing Director of the 
Interuniversity Cardiology Institute of the Netherlands (ICIN). 
AJ::!I' Klinische Fysica. 2000/3 
233 
=rn·· ""'-~ID . 
·• 
~ 
.,. 
~ 
.,. 
' 1:-lO 
' I" ,. 
~· 
F 
o 10 '" ,. •o :w oo 70 110 ., 
A>lola:oj•(llllll} 
->o 0 oo ;o oo 
only "tho fundl!rnontol ill trnnsm;tlod 
2nd h>mtoni<:io aboe~tt 
l.ot<nlu!•(~ 
Fig. 2 Harm<Jnic imaging decreases transducer near field rever-
beration as illustrated to the kft. The harmonic beam pattern !ws 
a lower grating lobe and narrower main Wbe rhus reducing image 
artefacts (figure to the right). 
Standard instruments versus small, battery-powered 
instruments. 
In the cardiology department the standard- or laboratory ins-
trument is rather bulky. It contains all the possible features 
and is mostly permanently located in either the echo- or 
function department, the operating theatre or the inteNen-
tionallaboratory. The following list indicates what type of 
parameters can be obtained or studies can be carried out 
with such machines: 
Measurement of cardiac anatomy, global function and 
regional wall motion. 
Valve pathology, severity and haemodynamic consequen-
ces (Doppler) 
Presence of pericardia! fluid and mass lesions 
• Doppler blood flow and tissue information (Tissue 
Doppler, backscatter analysis) 
• Detect'1on of ischemia or viabinty by stress echocardiography. 
Contrast agents can be injected to enhance the echo image. 
This technique is used to better visualise endocardial bor-
ders, enhance Doppler signals and to study myocardial per-
fusion. Exercise and pharmacological stress is used to 
induce ischaemic and regional motion abnormalities under 
stress conditions. Some applications require a transesopha-
geal approach. On average an echocardiographic study in 
the echo lab would take approximately 25 minutes. 
Handheld portable echo devices have been recently introdu-
ced on a large scale. An early system was the Minivisor. 
Roelandt [12, 13} described first clinical experience in 1978 
and 1980. However, for widespread use it was too early at 
the time. Now these systems are introduced for use in the 
ambulance, outpatient clinic, intensive care, post operative 
ward and at all other locations where in the hospital the car-
diologists' advice is requested. Although the introduction is 
only beginning, it is foreseen that these devices will in parti-
cular be used for screening purposes and quick observa-
tions such as: 
Measurement of chamber/structure size. 
Detection of abnormal wall motion 
Diagnoses of valve pathology 
Observation of presence of pericardia! fluid, mass lesions. 
From two-dimensional (20) to three-dimensional (3D) 
echocardiography. 
Echocardiography is an interactive technique. The cardiolo-
gist or echo technician must aim the transducer at the dia-
gnostic area of interest. For a proper echographic survey 
extensive experience in aiming at cardiac structures is nee-
ded. Since the heart is a complex three- dimensional organ 
there may be variability in the interpretation of difficult patho-
logy amongst investigators. If the echo data were not limited 
to a number of selected cross-sectional imaging planes, but 
the full 3D data were available, then more accurate and 
reproducible data could become available obviating geome-
tric assumptions. In 30, the acquisition could become more 
standardised. In addition, observation may be carried out in 
reconstructed diagnostic cross-sections not available in 
standard 20. Gradually all these advantages are becoming 
clear. So far the vast amount of data, complex transducer 
technology and display post processing time involved (all 3D 
results are not instantly ava'1lable) have limited the advance-
ment of 3D. 
Free hand scanning. 
In order to obtain spatially correct data, one of the appro-
aches is to track the motion of an ultrasound 2D probe in 
space. This so-called 'free~hand scanning" can be carried 
out with an acoustic (spark gap) locator as described by 
Moritz and Sherve in 1976 [14]. Electromagnetic location as 
described by Raab et al [15] and mechanical articulated arm 
reported by Dekker et a! [16] are other methods. 
Sequential triggered scanning. 
With a stepper motor the acquisition plane is sequentially 
rotated by, for instance. steps of 2 degrees. When acquisi~ 
tion is time gated by triggering derived from the electrocar-
diogram and respiration, all data become available to recon-
struct the moving heart in its proper geometry and time 
sequence. Obviously, the transducer should be held steady 
during the acquisition per'lod otherwise motion artefacts are 
introduced. 
Fast acquisition systems. 
Presently two systems have been described where the 
acquisition is so fast that virtually no motion artefacts will 
occur. Firstly this is the electronic real time volumetric ultra-
sound imaging system developed at Duke University by Von 
Ramm and Smith [17]. They use a novel matrix phased 
array transducer in which the elements are arranged in a 
two dimensional grid. With insonification in a wide cone and 
parallel processing in recepf1on fast 3D (or selected 2D) dis~ 
play becomes available. Lancee and Djoa described anot-
her approach [18]. They use a fast rotating phased array 
transducer enabling acquisition of 16 volumetric data sets of 
the beating heart per second. A photograph of this probe is 
shown in Figure 3. 
Fig. 3 Fast rotating plwsed array transducer for 3D acquisition. 
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Display methods. 
The collected two-dimensional images are digitised and 
realigned according to their spatial and temporal sequences. 
Interpolation algorithms are applied and as a following step 
the display principle must be selected. Examples are: 
Mainplane (orthogonal) 
The anyplane method where arbitrarily diagnostic cross~ 
sectional views of the heart which are difficult or physically 
impossible to obtain from conventional acoustic windows 
can be computed. 
Parap!ane views 
A wire~frame display might be selected where 30 images 
of a specific structure are presented. 
A volume rendered display for depth perception with for 
instance gradient shading. 
After surface detection reconstructions can be rotated in 
space to look at them from different perspectives. 
An example of a 3D rendered image of the heart valves is 
illustrated in figure 4 (19}. With the introduction of real time 
acquisition of 30 and faster computers, the use of 3D will 
become much more practical. Today the method is particu~ 
larly indicated for congenital diagnosis of heart disease and 
for correct calculation of volumetric parameters. 
A 
Fig. 4 3D rendered image of the heart valves. Attachment of small 
vegetation to the cusps of the aortic valve (panel A) and the put~ 
monary valve (panel B) are visualised. PV:::: pulmonary valve. Ao 
:::: aortic valve. 
Intravascular ultrasound (IVUS) 
The technique of intravascular ultrasound is based on the 
flex-shaft mechanically rotated single element or the electro-
nically steered phased array method, with or without the use 
of a guide wire (figure 5). They produce cross~sectional vas-
cular real~time images of the lumen, plaque and arterial wall 
[20]. An example of an intravascular image of an artery is 
shown in Figure 6. Mostly the intravascular procedure is 
applied for further decision-making when X-ray angiographic 
data are less conclusive. For obvious reasons there is a 
strong urge to combine "see and do" in interventional proce~ 
dures. This leads to catheters in which, for instance, an 
angioplasty balloon is combined with ultrasonic imaging in 
or close to the balloon. Other combinations may provide gui-
dance during stent implantation. Since intravascular ima-
ging provides accurate geometrical information within the 
cross-section, combination with other interventional proce-
dures is likely to expand in future. ln this category falls the 
assessment of the dose deposited in the arterial wall during 
intracoronary brachytherapy or by radioactive stents as 
described by earlier [21] 
Additional parameters 
Where present, intravascular scanners yield detailed cross-
sectional geometric information of the arterial wall. For the 
evaluation of the arterial function the remaining blood flow 
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Fig, 5 Schematic drawing of present intravascular echo catheters. 
Flex-shaft mechanically rotated element method (A). with guide 
wire (B). electronical beam switching (C) and a combination of 
electronic ~witching with a the therapeutic stent placing technique 
(D). 
through the obstruction is also an important parameter. 
Using a decorrelation technique with the Radio Frequency 
(RF) echo signal, sequentially obtained at the same loca~ 
tion, it seems possible to combine imaging with measure-
ment of instantaneous volume flow through the lumen. An 
example of this technique is illustrated in Figure 7, where 
blood velocity is colour-coded, and instantaneous flow esti-
mated along several cardiac cycles is in agreement with 
flow derived from conventional intracoronary Doppler meas· 
urements [22, 23]. 
First attempts have shown that RF echo data also enable 
the assessment of mechanical properties of the arterial wall. 
In this approach, the echo data are compared in the same 
location, but at different pressures [24]. 
30 imaging and quantitative data 
All organs have a three-dimensional configuration and the-
refore the concept of ultrasonic 30 imaging has become 
Fig. 6 Example of an intravascular image with a lesion between 
10and2o'clock. 
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Fig. 7 Image nnd local colour-coded blood velocity yielding volume flow during various pilaus of the cardiac cycle {a, band c) with corre· 
sponding Doppler recording (bottom). 
Increasingly Important. In non-invasive echo imaging real· 
time volumetric echo data acquisition has been described. It 
is not expected that this will become possible in real·time 
Intravascular methods since it will always require pullback of 
the catheter in order to accumulate all the necessary data. 
Such a device enables data acquisition for the construction 
of arterial 30 images, which are very informative as illustra· 
ted for control of stent deployment in Figure 8. 
Based on 30 echo-data files, it has become possible, with 
interactive semi-automatic contour analyses, to obtain preci· 
se quantitative information on plaque volume and open 
lumen over the entire arterial segment studied. 
Conclusion 
Echocardiography has seen an enormous development 
from the first poor images up to now. It has (with integrated 
Doppler which is dealt with in another chapter in this issue) 
amongst the other imaging techniques such as CT or MRI 
taken the position of primary diagnostic method in cardiolo· 
gy. The 30 use is still in 1ts infancy but undoubtedly it will 
break through in the coming years. We have noted the intro· 
duchon of small rather cheap devices that will further 
expand diagnostic echocardiography. 
The use of echo catheters for intravascular applications is 
much more recent, and it Is limited by the expenditure due 
to single use of these devices. If these catheters become 
cheap, and combined with therapeutic devices, things will 
change. 
Future intravascular scanners will provide improved image 
quality, have interventional therapeutic capabilities incorpo-
rated and possibly be combined with other diagnostic 
methods such as Raman spectroscopy. Furthermore, 30 
display and quantitative data extraction will become more 
and more routine rather than research. 
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Pig. 8 Echo image of stent with struts(*) and corresponding 3D 
image. 
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Abstr:act 
We compare three proposed indices of total arterial 
compliance (Ctot) in normal volunteers (n=9) and 
patients with coronary artery disease (n=l4) using a non· 
invasive approach ( echo·Doppler and carotid 
tonometry): (I) the pulse pressure method (PPM), (2) the 
area method (AM) and (3) the stroke volume·to·pulse 
pressure ratio (SVIPP). 
The best agreement was found between the PPM and 
SVIPP. Compliance estimates were lower in the patient 
group (PPM: 1.2:ffJ.4 vs. J.6:f:0.2; AM: J.6:1fJ.6 vs. 
2.8:1:1.3; SV/PP: J.8i{}.6 vs. 2.4i{}.4), being older (64:1:14 
vs. 35:1;4 y) and with known atherosclerosis. The best 
correlation between compliance and age was found with 
PPM (1=0.52). AM varied with the chosen computation 
interval in diastole. These preliminary data describing the 
very first use of the PPM on rum-invasive human 
recordings suggest that PPM could be a more robust 
estimatqr of Clot tlw.n the widely used AM. and that 
SV/PP could be a reasonable simpler surrogate. 
I. Introduction 
Total arterial compliance (Ctot) is by definition the 
increment of volume of the systemic arterial bed (dV) for 
an increment in distending pressure (dP): Ctot= dV I dP. 
Ctot is an important detenninant of ventricular 
afterload and is directly related to the arterial stiffness of 
the large arteries. It expresses the ability to store blood in 
systole, mainly in the proximal aorta, without excessive 
pressure rise. This biomechanical property also allows 
optimal coronary flow in diastole.{ I] Total peripheral 
resistance, easily measured as the ratio of mean blood 
pressure and cardiac output, reflects the non-pulsatile 
cardiac load. Conversely, Ctot allows estimation of the 
pulsatile load. Although very important to measure 
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because of its changes with ageing[2] or with 
physiopathological conditions such as hypertension(3], 
direct Ctot evaluation can not be exactly performed in-
vivo because of the difficulty to measure dV. Moreover 
the overall pressure-volume relationship of the arterial bed 
is nonlinear and varies with the absolute level of P.[4] 
Consequently, different indirect methods have been 
proposed, but none has been universally accepted.[5] 
Almost all estimations of Ctot rely on the assumption 
that the vascular bed behaves like a windkessel (WK. 
=capacitance chamber), following Hales' original idea.[6] 
Early methods were based on the diastolic decay of the 
blood pressure, approximated by a monoexponential. An 
integral variation of this principle has been described by 
Liu[7] and has been extensively used in various 
physiopathological conditions.[S-10] 
The ratio of stroke volume (SV) and pulse pressure 
(PP=systolic P- diastolic P) is a crude estimate of Oot 
which was introduced by Remington et al.{ll]. Although 
it might violate the fundamental concept of the WK. the 
interest of this readily obtained parameter, has been 
stressed recently.[l2, 13} 
The pulse pressure method (PPM) has been introduced 
by Stergiopulos et al.[14] PPM is based on a recursive 
evaluation of Ctot by comparing the measured PP and the 
one cor:tputed in a 2-element WK with the measured flow 
as input. Comparison with other methods has been 
described in a computerized distributed model of the 
arterial circulation.[S] The purpose of this study was (i) to 
evaluate the feasibility of the PPM on non-invasive human 
recordings, and (ii) to compare the three Ctot estimates. 
2. Materials and methods 
2.1. Patient data 
In 9 normal subjects (34 ± 5 yrs) and 14 patients (62 ± 
12 yrs) with known coronary artery disease, applanation 
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tonometry was perfonned at the carotid level using a 
Millar SPT-301 pen-like transducer. Calibration was 
performed with the mean (calculated as [2x diastolic BP + 
systolic BP]/3) and the diastolic brachial blood pressure 
(BP - sphygmomanometer). Simultaneously, audio 
Doppler signals from an echocardiographic system (AlL 
HOI 3000) were acquired with an NO board 
(Wavebook/512, IOTech Inc.) and a laptop. Customized 
software allowed spectral computation and automatic 
detection of the maximal velocity contour. Aortic (Ao) 
flow was computed as cross-sectional area of the left 
ventricular outflow tract times Ao velocity (Doppler 
echocardiography). The ECG was measured along the 
complete procedure. Post-processing by averaging 
multiple beats allowed reconstructing pressure (P o:a~} and · 
flow data (Q.,) for one representative heart cycle. The 
aortic PP was considered equal to the carotid pp. 
2.2. Total arterial compliance 
In the 2-element windkessel model, the whole arterial 
tree is modeled as an elastic chamber with a constant 
compliance (C) in parallel with the vascular resistance (R) 
calculated as mean pressure/ cardiac output (CO). The 
governing equation in the frequency domain is: 
z, R 
l+jo:i?.C 
where ro=2rtf, f is the frequency, Zm is the input 
impedance, R is mean BPI mean Qao and C compliance. 
In the area method (AM), compliance is calculated as: 
,, 
RC= I Pdt/(~ -P,) 
,, 
where t 1 and t:r time of start and end of the interval for 
Ctot evaluation, P1 is pressure at t~o P2 at t2 
We compared the values of C derived for the intervals 
[tl ;t2] corresponding (i) to the mid-third of diastole 
(CAM213) and (ii) to the last third of the diastole (CAM31J). 
The pulse pressure method (PPM) is based on the 
fact that the modulus of the input impedance of the arterial 
system is represented very well by the 2-element WK 
model for the low frequencies (lst to -5111 harmonics). A 
gross low frequency feature like the pulse pressure (PP) is 
thus similar in the true arterial tree and the 2-element WK. 
The method is based on an iterative scheme based that 
finds the value of C that gives the best fit between the 
measured PP and the PP predicted by the 2-element WK. 
using as input the measured flow ((b.,) and R. 
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3. Results 
3.1. Patient data 
An overview of measured and computed hemodynamic 
data is given in Table 1. As expected, PP _.,. CAMl!J, CPPW. 
CsvJM> were significantly different between the young 
normal controls and the older patients presenting knovm. 
coronary artery disease, but CAM313 was unable to 
differentiate the two groups. 
Controls Patients 
(n=9) (n-14) 
age (yrs) 35±4 64±14. 
SBP(mmHg) 133±11 144±16 
DBP(mmHg) 91±7 87:19 
MBP(mmHg) 105±7 106±10 
llR (/min) 71±8 70±9 
co (Umin) 5.0±Ll 5.2±1.4 
PP~(mmHg) 31±6 45±10" 
CAMW (mllmmHg) 2.8±1.3 1.6±0.6" 
C"""' (mllmmHg) 2.2±05 2.1±0.8 
c.,... (mllmmHg) 1.6±0.2 1.2±0.4" 
c,,. (mllmmHg) 2.4±0.4 1.8±0.6" 
Table 1. Mean value aud standard deviation of 
hemodynamic data (SBP, DBP, MBP: systolic. 
diastolic aud mean sphygmomanometric blood 
pressure; HR: heart rate; CO: cardiac output), PP cw 
carotid tonometric pulse pressure, CAM%13 compliaDc.:e 
with AM computed on last 2 third or diastole, CAMJ/3 Es 
computed on the last third or diastole, ci'PM 
compliance with the PPM aud CsvJPP compliance 
calculated with the stroke volume-to-aortic pulse 
pressure ratio.·: P<O.OOl 
3.2. Relationship between c,PM, c,..., Csv/PP 
Figure Ia demonstrates the best correlation which was 
found between CPPM and CsviPP (CsvJPFl5xCwM - 0.04, 
r'=o.94). C"""' was poorly correlated with C..... (figure 
!b) and c,,. (r"; 0.35 and· 0.32, respectively). The 
correlations between CAM213 and CPPM or Csvm> were even 
worse. There was a rather large difference between CAM213 
and CAM313: the mean difference between individual values 
of CAM213 and CAMm was ~.12±1.1, for an overall mean 
value of C of 2.1 ml/nunHg. 
' ' , , 
f._: (,; i ~·· • 
- ' ... - ' ;..., . ~1~ ... . ~ 
' 0 0 
05 ., 
' ' ' C PPM (mllrrlmHg) C PPM (lnllnomHgi) 
Figure 1: a) left: relationship between total arterial 
compliance estimated non-invas:ively by the pulse 
pn:ssure method (C...,.) and the stroke volume-to-
aortic pulse ratio (Csv/PP); b) right: rclationship 
between CPPM and the Ctot estimation from the area 
method (C...,). (controls: open, patients filled circles) 
3.3. Evolution of Ctot with age 
The best correlation between Ctot and age. showing a 
statistically significant decrease. was found with Cl'fM: 
C,. = O.D!5 x Age + 2.145, r'=052, p=0.0002). As 
illustrated on figure 2. the relationship between age and 
CAM2/J demonstrated more scattering of the data, with a fl 
of only 0.26 (p=O.Ol). The correlation with CsviPP was 
intermediate (il.;:Q.45. p=0.0006). There was no 
correlation between age and CAM313· 
6,-------------------------, 
.~~--~~-------------------1 R~oo0.2621 
"'. t-.:1 ::..:.=::____ ___ _ 
i: ,I o o ~ 3 ~I ~=.::_~---------ooc-----
~:tii~~-~-:~-~--~-=-~~--~-~-~~;-~o~--:-~--~-~~:-~·~q~-~--;-!~~--~0== 
R2.,0.516 • • 6 
0~------------------------,. 50 
" 
70 80 
" Age (y .. ra) 
Figure 2: The correlation between age and Cm.t (filled 
circle) was significantly higher than with CAM (open 
circles). 
4. Discussion and conclusion 
We describe the first non-invasive evaluation of total 
arterial compliance with the pulse pressure method in 
human subjects. We have compared the results with two 
previously reported methods: the area method and the 
stroke volume~to~aortic pulse pressure ratio. 
The area method was calculated over two different 
intervals: the mid·third (CAM213) and the last third (CAMYJ) 
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of the diastole. It is believed that the chosen interval is not 
important.[?] but our results demonstrated that the two 
derived estimations of Ctot are not interchangeable. The 
compliance derived from the area method is a value for 
the mean pressure in the chosen interval of integration. 
The compliance of the large arteries decreases non· 
linearly with an increasing pressure.[4] This was not 
reflected by the average difference between CAMW and 
C~ that we found (·0.12 rnllmmHg). Moreover, there 
was a large interval of agreement between CAMW and 
CAM313: the standard deviation of the differences was 1.1 
ml/nunHg for an overall mean compliance value of 2.1 
ml/mmHg. These discrepancies could be related to an 
inherent additional noise added on the pressure signals 
that we recorded non-invasively with a tonometer at the 
carotid level. We tried to reduce the artefacts by 
maintaining a constant holding pressure of the transducer 
and by using a representative pressure recording that was 
the average of at least 5 to7 good·looking cycles out of a 
continuous recording of minimum 30 seconds. The AM. 
which uses only the mean cardiac output to compute mean 
peripheral resistance, does not take into account the whole 
body of information included in the complete flow profile 
available with simultaneous Doppler echo.-cardiography 
performed at the level of the aortic valve. 
The pulse pressure method and 'the stroke volume-to-
aortic pulse pressure ratio rely only on a gross feature of 
the pressure recording: the systolo-diastolic pulse. In a 
computer model of the arierial tree, Stergiopoulos et al. 
found that the PPM proved to be the most accurate of all 
the methods reported to evaluate total arterial 
compliance.[5] We demonstrated the feasibility to apply 
the PPM on non-invasive human recordings. We found a 
very close correlation between CPPM and CsvJPP cr=0.94) 
which was recently demonstrated as a very good surrogate 
of Ctot (using invasive recordings of aortic pressure and 
thermodilution in 31 catheterized patients).[13] A 
limitation of our method is related to the assumption that 
the carotid tonometric pressure is similar to the aortic 
pressure, but invasive recordings have demonstrated a 
very close similitude between aortic and carotid 
recordings.[l5} Moreover, possible other sources of errors 
are introduced into our measurements via the calibration 
of the tonometer to the mean and diastolic 
sphygmomanometer pressure: diastolic blood pressure 
presents probably a slow decrease along the arterial tree 
and the computation of MBP=(SBP+2.DBP)/3 may vary 
with age or cardiovascular disease. Nevertheless, the same 
limitations are present for the area method. The PPM 
demonstrated the best differentiation between the controls 
and the investigated patients being older, with known 
coronary artery disease and who were expected to present 
a lower compliance. 
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SV /PP estimates of compliance were higher than the 
PPM. This is expected because the SV /PP method 
assumes that the complete stroke volume is buffered in the 
large elastic arteries in systole, without any flow to the 
periphery. However, there is a continuous flow towards 
the capillaries and the volume increase (dV) during the 
ejection is only a fraction of SV. 
With CPPM and CAM• Ctot is estimated at different 
pressures: CPPM corresponds to the mean pressure whereas 
CAM is the compliance at the mean pressure during the 
integration interval. This can explain why CAM was higher 
than CPPM. 
With ageing and the development of atherosclerosis, 
stiffening of lhe arterial tree occurs, lowering Ctot. The 
reported amplitude of the decrease of compliance with 
age[8,12] was in good agreement with our findings. We 
found that the relationship between age and CWM was 
stronger (~=0.52, p=0.0006) than between age and CAM or 
Csv!l'P· 
In conclusion, we have demonstrated the feasibility to 
estimate total arterial compliance non~invasively in human 
subjects with the pulse pressure method. Our observations 
suggest that overall, the pulse pressure method appears to 
be a more robust estimator of Ctot for non-invasive 
applications. The stroke volume-to-pulse pressure could 
be a reasonable simpler surrogate. 
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Segers, P., S. Cartier, A. Pasquet, S. I. Rabben, L. R. 
Hellevik, E. Remme, T. De Backer, J. De Sutter, J. D. 
Thomas, and P. Verdonck. Individualizing the aorto-ra~ 
dial pressure transfer function; feasibility of a model-based 
approach. Am J Physiol Heart Circ Physiol 279: H542-H549, 
2000.-We fitted a three-segment transmission line model 
for the radial-carotid/aorta pressure transfer function (TFF) 
in 31 controls and 30 patients with coronary artery disease 
using noninvasively measured (tonometry) radial and carotid 
artery pressures (P """'"). Except for the distal reflection coef-
ficient (0.85 ± 0.21 inpatients vs. 0.71 ± 0.25 in controls;P < 
0.05), model parameters were not different between patients 
or controls. Puramcters were not related to blood pressure, 
age, or heart rate. We further assessed a point-to-point av-
eraged TFF (TFF .._,u:) as well as upper (TFF =,,.) and lower 
CTFF min) enveloping TFF. Pulse pressure (PP) and augmen-
tation index (Alx) were derived on original and reconstructed 
P co.r CP car)· TFF "">:yielded closest morphological agreement 
between Pc..,. and P """'"-'" (root mean squure "" 4.3 ± 2.3 
mmHg), and TI'F nvu: best predicted PP (41.5 ± 11.8 vs. 41.1 ± 
10.0 mmHg measured) ::md Ab:: ( -0.02 ± 0.19 vs. 0.01 ± 
0.19). PP and Alx, calculated from P cn.J" or P =r n were higher 
in patients than in controls, irrespectively of ihe TFF used. 
We conclude that 1) avenged TFF yield significant discrep-
::mcies between reconstructed and measured pressure wuve~ 
forms and subsequent derived Aix; and 2) different TFFs 
seem to preserve the information in the pressure wave that 
discriminates between controls and patients. 
blood pressure; model; applanation tonometry 
KNO'WLEDGE OF CEJ:\'TRAL AORTA PRESSURE is clinically im-
portant because it permits, together v.rith aortic :flow, 
one to compute arterial input impedance and hemody-
namic parameters characterizing ventricular-arterial 
interaction (wave reflection indexes, hydraulic power) 
of diagnostic value in cardiology (1, 5, 14, 19). Using 
tonometry, one can estimate, noninvasively, the ce-n-
tral aortic pressure wave by measuring the arterial 
pulse 1) at a superficial artery close enough to the 
heart (subclavian, carotid artery) so that the effects of 
Address for reprint requests o.nd other correspondence; P. Sege-rs, 
Hydraulics Laboratory, Institute Biomedical Technology, Univ. of 
Gent, Sint-Pietcrsnieuwstrn.n.t 41, B-9000 Gent, Belgilllll (E-mail; 
patrick.scgers@navier.rug.uc.be). 
wave distortion can be neglected (1, 5, 6, 14, 16), or 2) 
at a peripheral superficial artery (radial or carotid 
artery) v.rith use of a pressure transfer function CTFF) 
to compute the pressure wave at the central aorta (4, 
7-9, 12). 
Averaging transfer functions, measured directly in 
(relatively) large human populations, yielded general-
ized TFF for the radial-aorta (7, 12) and the carotid-
aorta (11) pathway. Such generalized TFF have been 
integrated into commercially available systems, pre-
dicting central aorta pressure and derived indexes, 
such as the augmentation index (Alx), from the carotid 
or radial artery pressure wave (4, 23). However, there 
is large scatter in measured transfer functions, and the 
morphology of reconstructed central pressure, using 
such a generalized TFF, may differ considerably from 
the directly measured pressure. 
The aim of this work was to provide a method to 
individualize TFF, based on a transmission line model 
for the radial-aorticlcarotid pathway (9). If model pa-
rameters characterizing the pressure transfer function 
are related to easily measured patient characteristics 
(age, blOod pressure, etc.), then TFF can be predicted 
on a patient-to-patient basis, enabling a better esti-
mate of the central aorta pressure wave morphology. 
First, we :fitted the model to a published radial-aorta 
pressure transfer function that was derived from inva-
sively recorded pressures (7). This way, we obtained 
reference values for all model parameters. Second, we 
fitted the model to (noninvasively) measured radial-
carotid transfer functions in controls and in patients 
using a selected number of model parameters, and we 
studied the correlation between these model parame-
ters and easily measured hemodynamic indexes. Be-
cause we were unable to assess any relation, we fur-
ther studied the impact of using upper and lower limit 
transfer functions, enveloping measured data, on esti~ 
mated central blood pressure and on derived indexes 
such as pulse pressure (PP) and the Aix. 
The costs of publication of this article were defrayed in p:lrt by the 
payment of page charges. The article m.ust therefore be h~by 
marked ~adr~crtiscmcnt" in nccordo.nce with 18 U.S.C. Section 1734 
solely to indicate this fact. 
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INDIVIDUALIZING PRESSURE TRANSFER FUNCTION H543 
MATERIALS AND METHODS 
Transmission Line Model For Radial-Aortic/Carotid 
Pathway 
The model simulating the aorta-radial pathway is ana-
loguous to the model used by Karamanoglu and Fen ely (9) for 
the finger carotid pathway and consists of a stepwise tapered 
transmission line with three segments (proximal, middle, 
and dista.l) terminated by a lumped parameter model (Fig. 1). 
For each segment, the transmission line equations describing 
the propagation of pressure (P) and ftow (Q) harmonics waves 
apply 
{ 
P(x) =Pre -v + Pbe'~x 
Q{x) = Qre- ~x + Qoe ,x 
with x as the longitudinal coordinate and f and b indicating 
forward and backward waves, respectively. The wave propa-
gation coefficient (-'/), accounting for wave propagation and 
damping, is given as 
with F 10 as the Bessel function as given by Womersley (24) 
and c as the wave propagation velocity given as 
with c0 as the inviscid Moen.s-Korteweg wave velocity, Wall 
viscosity is taken into account by the viscoelastic phase angle 
a as a function of frequency (w) (2, 9, 10) 
a= BoCl- e-2"') 
The relation between pressure and flow harmonics is given 
by the characteristic impedance (Zr) 
z ~ Pr _ Po_ pc/A 
o-~-- Qo- ~1-Flo 
with A as the cross-section of the segments and blood density 
p = 1,050 kg/m3 • Values for vessel dimensions and 80 are 
given in Table 1. The impedance mismatch between the 
terminatingwindkessel model and the distal segment results 
in wave reflection. Instead of explicitly modeling the termi-
nating lumped parameter model, the distal reflection coeffi-
cient (f = PJPr = -QJ~) is modeled as (9) 
r=roe-"'' 
where r 0 and ,. are the modulus and phase of the distal 
reflection coefficient, respectively. 
proximal middle 
distal 
L •• Z,. "-r:;:-z,' -::~:f] 
Fig. 1. Schematic representation of the radinl-aortn/carotid trans-
mission line model. Model consists of3 segments, each ch:ll'llderizcd 
by its length (L) and characteristic impedance (Z0). The tr:lnsmission 
line termination is m.odcled as u reflection site determined by the 
modulus of distul reflection coefficient (f J and phase of the distal 
reflection coefficient ('I'). 
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Table 1. Geometrical and mechanical characteristics 
of the transmission line model segments fitting the 
radial-aorta transfer function of Chen et al. 
Tonninal 
Pro"'=! Middl<t Diatnl Model 
D.~ 12.5 8 4 
.,. 5 7 9 
L.= 24 27 15 
c0 , rn/s 6.88 8.46 6.51 z(!. m.m.Hg- m1- 1. s -1 0.44 1.33 4.08 
ro.- 0.86 
•. ' 0.00 
D, Segment diameter; L, segment length; e0 • viscocklstic phase 
nngle at high frequencies; c0 , inviseid wave velocity; Z0 , segment 
characteristic impedance; f 0 .and,. are modulus and phase of the 
distal reficction coefficient, respectively. The values corresponding to 
D, e0, and L were assum.ed;: the others were the result of the fitting 
procedure. Sec nlso Fig, 2 for more information concerning the 
tr:msfcr function of Chen et al. (7). 
Assessing Reference Model Parameters: Fitting the Model to 
the Transfer Function of Chen et al. 
The modulus and phase angle data for the steady-sta.te 
radial-aorta transfer function of Chen et al. (7) were digi-
tized, and the complex form of the measured transfer func-
tion (TFFcru,,) was calculated. We then derived the transfer 
function for the transmission line model (TFF :moc~o>1), which 
depends on the eight model parameters: length L and wave 
propagation speed c0 for each of the three line segments, and 
two distal model parameters (f0 and ,.). Reference values 
for these parameters were estimated by fitting TFF :modol to 
TFF Chen• hereby minimizing the (complex) sum of squared 
differences between TFF Ch~ and TFF :modo I (}.fatlab, The 
Mathworks, Natic, MA). To reduce the number of parameters 
in the minimization procedure, L was set to fixed values 
between 10 and 30 em for the proximal and between 15 and 
45 em for the middle and distal segments. For each set of 
segment lengths, the remaining five parameters were deter-
mined using a least square fitting algorithm. The goodness of 
fit, expressed as the modulus of the root mean square (RM:S) 
value of the difference between TFF Chen and TFF =<>del• was 
stored for all combinations of segment lengths. The :final set 
of parameters, further considered as a reference, was the one 
yielding the lowest IRMSI. 
After assessing reference model parameters, we studied 
the effect of changes in characteristic impedance (half and 
twice the parameter values following from fitting Chen's 
function) of the pro::cimal segment and of all segments to-
gether, changes in vascular tone, i.e, the distal wave reflec-
tion coefficient cro "" 0 - 1), and the effect of a 20% variation 
in segment length. 
Fitting Measured Radial-Carotid Pressure 
Transfer Functions 
In vivo measurements. Applanation tonometry: was per-
formed successively at the carotid (P =-) and radial (P ,.ao;~) 
artery with a Millar SPT-301 penlike transducer (5) in 31 
controls and 30 patients, in three different centers, and by 
three different operators. Patients were subjects with known 
coronary artery disease confirmed by wall motion abnormal-
ities (rest and/or during dobutamine infusion) on a recent 
e<:hocardiograpbic examination and/or a positive treadmill 
stress test. No patients with uncontrolled hypertension were 
included. The measured sequence of heartbeats was pro-
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Fig. 2. With the usc of the transmis-
sion lio.c model from Fig. 1 und with 
the model po.ro.mctcrs <If Table 1, the 
transfer function {TFF) of Chen ct ul. 
(TFF Chc<>) (7) is well predicted. A: 
transfer function modulus; B: transfer 
function phase angle. 
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cesscd off~line. Using the measured electrocardiogram signal, 
we identified individual heart cycles, and an average pres-
sure wave was calculated from at least five heartbeats. This 
signal was then calibrated by setting its mean and diastolic 
value equal to diastolic and meo.n brachial blood pressure 
measured with a cuff sphygmomanometer. Fourier analysis 
was applied on both pressure waves, and the ratio of corre-
sponding ha.rmonics yielded the measured transfer function 
CTFF rn., .. ...). A maximum of 10 harmonics were taken into 
account, and pressure or flow harmonics with a magnitude 
<1% of the first harmonic were excluded. 
Fitting the model to the measured radial-carotid data. To 
fit the model to the measured radial-carotid pressure trans* 
fer function, we used P =r as an input into the model, and the 
computed distal model pressure CP d,n>.od~1) was fitted to the 
measured radial artery pressure (P r<>e~) by minimization of 
::E(P o:~..>noc~~1 - P .-ac~)2• We first fitted the data by changing four 
p:lr:lmeters: the characteristic impedance of the three seg* 
ments CZo,p• Z0 ..,, Z0 ,d) and the modulus of the distal reflcc* 
tion coefficient (f 0 ). The rem:llning four parameters were 
given their reference value as obtained from fitting TFF Ch.en· 
Second, we further restricted the fitting to one single param* 
eter. the characteristic impedance of the proximal segment 
(Z0,P), with the remaining seven parameters fi."(ed at their 
reference value. For both fitting methods, we studied corre* 
lations between fitted model parameters and (sphygmoma* 
nometer) brachial blood pressure, subject age, heart rate, 
health condition (control subject or patient), and whether 
model parameters were different for controls and patients. 
Average TFF and Maximal and Minimal Enveloping 
Transfer Functions 
We derived an average transfer function (TFF .,_,,) for the 
whole group of31 controls and 30 patients. Measured trans* 
fer functions were resampled at 0.25*HZ intciTals. Averaging 
of all61 tr::msfer functions yielded TFF ....... Furthermore, two 
TFF were selected from all fitted transfu'r functions, repre-
senting an upper and lower enveloping curve. Because the 
low frequency harmonics are most important, we chose the 
transfer function with the highest (TFF ,,.,,) and lowest 
(TFF rn.in) amplitude at 2 Hz. 
TFF m.o.x• TFF min• and TFF """'were used to reconstruct the 
carotid artery pressure (P ear.r) from measured P rad• with data 
from all three centers included. We then calculated pulse 
pressure (PP = systolic - diastolic pressure) and the Aix 
from Pear,.. and Pear Aix is calculated as :t(P8YK- Pin11.)/PP, 
with PaY" being systolic pressure and Pl.ntl as the pressure 
corresponding to the first inflection point on the carotid 
pressure wave. Aix is positive when the inflection pressure 
precedes systolic pressure and indicates an A~type wave (18); 
it is negative when the inflection point occurs after systolic 
pressure CC-type wave). We compm-ed PP and Aix derived 
from P",... and P""".r with TFF=''" TFF,. .... , and TFF,..""' using 
linear regression analysis. We further calculated RMS as 
/2: (P ~'·' P,_l' 
1 N 
with N as the number of sampling points, indicating the 
accuracy with which carotid pressure morphology is recoa~ 
structed. Finally, we also compared average values for PP 
and Aix in the control and patient group. Groups were 
considered statistically different if P < 0,05 (t~test; Sigma~ 
Stat 2.0, Jande! Scientific). 
RESULTS 
Fitting Chen's Radial~.Anrta Pressure 
Transfer Function 
The agreement between the :fitted model TFF model 
and TFF Chen is shown in Fig. 2. Both modulus and 
phase angle were well predicted by the model. The 
derived model parameters for the different segments 
are given in Table 1. The characteristic impedance for 
proximal, middle, and distal segment was 0.44, 1.33, 
and 4.08 mmHg · m.l-1 • s-1 , respectively. The total 
length of the model was 66 em. The distal reflection 
coefficient was practically constant (f 0 = 0.86), inde-
pendent of frequency(,.= 0.00). 
With changing Zo."() (proximal segment properties) 
alone, transfer functwns with very distinct morphol-
ogies were obtained (Fig. 3). A reduction of Zo.P 
increases the peak of the transfer function and shifts 
it to lower frequencies. Because of a lower wave 
velocity, the time delay between the proximal and 
distal location increases, and the phase angle be-
comes more negative. These effects are amplified 
with an overall change of Z 0 • With Z 0 divided by 2, 
the TFF peak is still shifted to lower frequencies, but 
there is hardly any amplification for frequencies <3 
Hz, and the higher frequencies are damped out. 
Vascular tone changes are modeled as changes of the 
reflection coefficient. r, being real, does not change 
the TFF phase angle or the location of the peak. Only 
its magnitude increases with a stronger refiec~ 
tion (vasoconstriction). The overall length of the path 
was changed by ::t:20%. A longer path length damp-
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Fig. 3. Changing the model parameters yields n wide run~;c oftrn.nsfcr function morphologies (top: TFF modulus; 
bottcm: TFF phase angle). From left to right, we show the effect of changing 1) Z0 of the prorimnl segment; 2) Zo 
ofnll segments; and 3) ch.nngcs in vascular tone modeled byvnrying r(l from 0.86 (baseline) to 1, 0, and 0.43; and 
4) an := 20% change in path L. 
ens the peak, shifts it to lower frequencies, and 
increases the phase angle; the inverse is found for a 
shorter path. 
Fitting Measured Radial-Carotid Pressure 
Transfer Functions 
Hemodynamic data for the complete population are 
given in Table 2 as well as average values for Z0 ,P, Zo.m• 
Z0,d, and r 0 , obtained from fitting the model to mea~ 
sured radial~carotid transfer functions. Overall, there 
was good agreement between measured and fitted ra-
dial artery pressure (RMS = 3.3 :±: 2.0 mmHg}, but the 
fitting was slightly better for the control than for the 
patient group (RMS = 2.8 :±: 1.4 vs. 3.9 :±:. 2.5 mmHg; 
P < 0.05}. Zo,p and Zo,m were higher in the patient 
group, whereas Z 0 d was higher in the control group, 
but differences wa.e not significant. r 0 was higher in 
the patient group (0.85 :t 0.21 vs. 0.71 :±: 0.25; P < 
0.05). There was no correlation between any of the 
fitted model parameters and subject age, sphygmoma-
nometer blood pressure (systolic, diastolic, or pulse 
pressure), heart rate, or the subject being classified as 
a patient or control. 
With the model fitted to the measurements using 
only Zo,p• the fitting is again better in controls 
(RMS = 4.6 :t 2.2 vs. 5.4 ::!::: 3.3 mm.Hg). Zo,p is higher 
in patients than in controls, but the difference is not 
statistically significant (1.10 :t 0.64 vs. 1.22 ::!::: 0.60 
mm.Hg • ml-1 • s-1). Again, there was no correlation 
between Zo,p and subject age, sphygmomanometer 
blood pressure (systolic, diastolic, or pulse pressure), 
heart rate, or the subject being classified as a patient 
or control. 
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Average TFF and Maximal and Minimal Enveloping 
Transfer Functions 
The calculated point-to-point TFF nvg is shown in Fig. 
4, together with TFF = and TFF mm· The error bars 
indicate means :t 2 SE. TFF mnx is the transfer function 
with the highest amplitude at 2 Hz (2.0} and is calcu~ 
Table 2. Age, sphygmomanometric blood pressure, 
and heart rate in control groups and patients with 
known coronary artery disease 
n 
Age, yrs 
SBP,mmHg 
DBP.mmHg 
MAP, """""' HR. beats/min 
PP,mmHg 
Controhl 
31 
35:::!::12 
129::::10 
81::::10 
97::::10 
70::::12 
48::::8 
Fitting four parameters 
2.8::::1.4 
0.98::::0.62 
1.5::::0.9 
9.2:::5.5 
0.71:::0.25 
Fitting o~ parameter 
4.6:::2.2 
1.10:::0.64 
Patients 
30 
66.::: 12t 
142.::: 1St 
83.:::10 
103.:::12* 
70.:::10 
59.:::12t 
3.9 .:::2.5* 
1.18.:::0.60 
1.8 = 1.1 
7.3.:::5.2 
0.85.:::0.21* 
5.4::::3.3 
1.21::::0.60 
Vnlucs nrc mcnns :::: SD; n "' number of controls nnd patients. 
SBP, systolic blood pressure; DBP, diastolic blood pressure, PP. 
pulse pressure. Mean arterial pressure (MAP) = DBP + PP/3. HR, 
heart rate. Root mean square (RMS) nnd estimated model pm-am.e-
tcrs are given for the fitting algorithm, fitting 4 parumcters <Zo,p• 
Z0,..,_, Zo,d• and r0) or 1 single parnmctcr <Z0.J. *P < 0.05; tP < 
O.Ql. 
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Fig. 4. The model was fitted to radial and carotid artery 
pressure measured in 31 controls and 30 patients nnd 
changing 4 parameters; Zo,p• Zo.m• Zo,d• and r O· The 
resulting (model) pressure transfer function is charac-
terized by its modulus and phru;e an~;lc for the control 
subjects (A:mdB) andforthc patients (C andD).E and 
F show modulus and plutsc of the uvcra~;c of o.ll 61 
tro.nsfcr functions (TFF ~v.:l and the transfer functions 
vd.th the highest (TFF "''"') and lowest CTFF ,.,j,) umpli-
tudc at 2 Hz, TFF"""' and TFF mu' arc derived using the 
model parameters as t;:ivcn in the text, whereas TFF avg 
is c::tlculutcd o.s a point-to-point average of measured 
datu. The bars represent 2 SE on the mean value. 
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lated using 0.22, 1.15, and 5.34 mmHg · m.l-1 • s-1 for 
Z 0,p, Zo.m• and Zo.d• respectively, and 0.95 for f 0• All 
other parameters have reference values (Table 1). 
TFF min is the transfer function with the lowest ampli-
tude at 2Hz (0.9) and is calculated "With 1.12, 2.39, and 
4.32 mmHg · ml-1 • s-1 for Zo,p• Zo.m• and Zo.d• respec-
tively, and 0.51 for r o· 
We reconstructed carotid pressure from measured 
radial artery pressure using TFF mnx• TFF min• and 
TFF nvF.' respectively. For the whole data set, the aver-
age difference between reconstructed and measured 
carotid pressure, expressed as the RM:S difference, was 
7.8::!: 2.7, 6.9::!::: 3.4, and 4.3::!: 2.3 mmHg, respectively. 
The correlations between PP and the Aix, derived from 
the reconstructed and measured carotid pressure, are 
given in Fig. 5. Best results are found with TFF nvr. 
yielding an average of 41.5 ::!: 11.8 vs. 41.1 ± lO.b 
mm.Hg measured. A paired t-test indicated that both 
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values were not significantly different (P = 0.59). Cor-
relations were less good for Aix. TFF nv;: gave the best 
results, with an average value of -0.02 ± 0.19 vs. 
0.01 ± 0.19 mmHg measured directly on the carotid 
artery pressure wave. However, values were not sig-
nificantly different (P = 0.22; paired t-test). PP and 
Alx, calculated from measured or reconstructed carotid 
artery pressure, were finally grouped for patients and 
controls (Fig. 6). PP and Aix were higher in patients 
than in controlstirrespective the calculation on mea-
sured or reconstructed pressures. 
DISCUSSION 
This study is based on a transmission line model for 
the aorta-radial pathway. The model is similar to the 
finger-carotid model of Karamanoglu and Fenely (9), 
consisting of three tube segments with the same values 
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Fi~;. 5. Comparison of pulse pressure (PP, A) und augm.entution index (Ab:, B) derived from the measured carotid 
artery pressure nnd from the reconstructed carotid urtery pressure usingTFF """'' TFF,.v,, und TFF ,Ln• Solid line 
is the regression line; dash-dot line is the line of perfect agreement. 
for tube diameters and wall viscosity. We :first assessed 
reference model parameters by fitting the model di-
rectly to a recently invasively assessed transfer func-
tion (7, 8). The model parameters (Table 1) are within 
physiological ranges. The total length of the transmis-
sion line is 66 em and is close to the average length of 
the arm (radial to sternum) that we measured in 13 
subjects (66 ::: 6 em). Pulse-wave velocity varies be-
tween 6.5 and 8.5 rnfs and is within reported ranges (9, 
17). A good fit to Chen's data is obtained with a real 
terminal reflection coefficient, in contrast to Kara-
manoglu and Fenely (9). The magnitude (0.86) is 
higher than what Karamanoglu and Fenely (9) found 
A B 
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at the finger level (0.64) but is close to the value of 0.8 
reported for the femoral artery (15). 
It was recently shown that a simple single tube with 
a single distal reflection site can be used to model the 
transfer function for "single tubelike" aortic branches 
such as the carotid artery and to some extent the 
brachial artery (21). However, such a model is too 
simple for the radial~aorta pathway, consisting of mul-
tiple reflection sites, and it was impossible to :fit such a 
model to Chen's data. Using three tubes in series, three 
reflection sites are generated: two sites due to the 
impedance mismatch between the segments and a dis-
tal reflection site at the model termination. V aT)ing 
#. Fig. 6. Comparison of average PP (A) 
I und Alx {B) in the eontl"ol (n = 31) and 
I patient (n = 30) populntion. The bars #. arc means ::t SE. Datu nrc derived from ' + the measured carotid artery pressure I and from the rec::onstructed carotid ar-~ tery pressure using TFF.....,.. TFF _,.. w 0 0 and TFFrn~n (•p < 0.05; +P < 0.01; #P < 0.0011. 
TFF_ TIF.vz TFF.;. 
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the model parameters leads to logical and expected 
changes in the morphology of the transfer function as 
shown in Fig. 3 and as summarized in RESULTS. 
The model was used to fit the measured radial-
carotid transfer function in 61 subjects. The fitting was 
first limited to Zo,p• Zo,m• Zo,d• and f 0. Average model 
parameters in the control and patient group are con-
sistent with reported physiopathological changes in 
arterial mechanical properties. In hypertension, for 
instance, the stiffness of the larger elastic arteries is 
increased, but the effects are far less clear for more 
peripheral, muscular arteries such as the radial or 
femoral artery (13, 20, 22). Nevertheless, individually, 
there was no correlation between model parameters 
and subject characteristics such as age, blood pressure, 
heart rate, or subject classification as a control or as a 
patient. 
A whole family ofTFF curves can be obtained only by 
changing the characteristic impedance of the proximal 
segment (Fig. 3). It is further expected that changes in 
arterial mechanical properties are most pronounced for 
the larger elastic vessels close to the heart (13, 20, 22). 
Therefore, we studied whether the fitting could be 
restricted to Zo,p and whether this improved the corre-
lation between the fitted model parameter and the 
patient data. Fittings were less good than with the four 
parameters but still acceptable (overall mean RMS of 
5.0 ± 2.8 mmHg). The resulting Zo,p were comparable 
to the values that were found when fitting four param-
eters (Table 2), with the same tendency for an in-
creased Zo,p in the patient group, However, again, 
there was no correlation between Zo.p and subject char-
acteristics. 
Z 0 was not different between patients and controls (Tabfe 2). A possible explanation is the limited number 
of subjects included in the study. Also, blood pressure 
is only slightly higher in the patient group, and the 
difference in arterial compliance, most prominent in 
the ascending aorta and aortic arch, may not be high 
enough to yield significant differences in Zo,p· 
The absence of a (simple) relation between model 
parameters and patient data inhibited the computa-
tion of individualized transfer functions. This may be 
due to the simplicity of the model (and the fitting 
procedure), with the model parameters not reflecting 
physiological properties. We also applied a model with 
A 
20 1 
reference parameter values derived for the radial-aorta 
transfer function on measured radial-carotid transfer 
functions. Still our approach is defendable. The radial-
aorta and radial-carotid pathway should at least share 
the properties of the middle and distal segment; the 
differences exist in the small part of the ascending 
aorta and the carotid artery. We assumed the same 
length for these segments, but their mechanical prop-
erties are effectively different: average Zo,p for the 
radial-carotid data (4 parameter fit) is 1.08 mm.Hg · 
ml-1 • s- 1 and is higher than Zo,p that was found for the 
radial-aorta fit (0.44 mmHg · ml-1 • s-1). This agrees 
with the smaller caliber of the carotid artery. One 
might think of introducing arm length as a knovm 
variable into the modeL This will change the values of 
estimated Zo,p• but it is unlikely that the introduction 
of a parameter (radial-carotid path length), which can-
not be measured with great accuracy either, would 
change our observations. One should also consider the 
fact that not only the total path length but also the 
relative length of the three segments determines TFF. 
TFF avr:- yielded the best approximation of PP and 
Aix, whereas TFF max or TFF min gave (very) different 
values for PP and Aix than the values derived from the 
directly measured pressure wave. However, it is re-
markable that when averaged over control subjects 
and patients, PP and Aix were different for both 
groups, irrespective the used transfer function. Thus, 
when (generalized) pressure transfer functions are 
used in clinical studies, comparing control subjects 
with patient groups or comparing different interven-
tions, they may potentially yield reconstructed central 
(aorta) pressures and derived indexes, discriminating 
between groups or interventions. Nevertheless, indi-
vidually, there are considerable differences for PP and 
Ab:: derived from the measured or reconstructed ca-
rotid artery pressure, as indicated by the (modified) 
Bland-Altman plot (3) in Fig. 7 (data shown for TFF av~ 
only). Furthermore, we feel that derived parameters, 
such as the Aix, require reconstructed waves in which 
enough high-frequency information is present to fully 
capture the details of the curve.· Using other algo-
rithms, based on autoregression models (8), may give 
better results than the frequency-domain approach we 
used. 
B 
Fir;. 7. Difference between PP (A) and 
Aix (B) derived from a reCQnstructcd 
curotld artery pressure {using TFF av.,) 
and from the measured curotid artery 
pressure, as a function of PP and Aix 
derived from the measured carotid ar-
tery pressure. Solid line is the mean 
difference; the dashed lines arc the 
means:::: 2SD. 
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This study shows that arterial pressure waves, re-
constructed using (generalized) transfer functions, 
carry analog information as the carotid blood pressure. 
This, however, does not imply that these reconstructed 
pressures are a better approximation of central aortic 
pressure than carotid blood pressure. However, in clin~ 
ical settings, it is easier to monitor central pressure 
from an easily accessible peripheral site such as the 
radial artery, which is more appropriate for applana-
tion tonometry than the carotid artery. Applanation 
tonometry at the carotid artery is more tedious, more 
time consuming, and requires skilled people and aver~ 
aging of the curves. Furthermore, it is better to avoid 
carotid applanation tonometry in people with carotid 
plaque. In our study, we had to exclude about 10% of 
patients because no reliable carotid tonometric signals 
could be recorded. 
We conclude that using averaged, generalized TFF 
leads to significant discrepancies between recon~ 
structed and measured pressure waveforms and sub~ 
sequent derived indexes. Nevertheless, very distinct 
transfer functions (TFF mnx• TFF nvv and TFF m.uJ seem 
to preserve the information in the pressure wave that 
is needed for the computation of indexes as PP and the 
Al."<, discriminating patients from healthy subjects. 
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A simplified index of contructile state 
Abstract 
Background: Cardiac reserve, defined as the change in 
maximal ventricular power output (Pmax) has a prognostic 
value in patients with ventricular dy~function. We wanted to 
investigate whether ( 1) maximal ventricular power output 
and physiological cardiac reserve can be measured non 
invasively with echo-Doppler and tonometry during exer-
cise: (2) a simplified index of power output (sPmax), the 
product of peak aortic flow and mean blood pressure, yields 
similar diagnostic value. 
Methods: A total of 14 patients with known or suspected 
coronary artery disease and 11 normal control subjects 
undern:ent supine bicycle exercise echocardiography to 
measure aerobic exercise capacity (estimated by V02ma:t"). 
At rest and peak exercise, aortic flow was estimated from 
echo-Doppler. and aortic blood pressure from arterial 
tonometry, to calculate Pmax and sPmax. Cardiac reserve 
was defined as the difference bern:een peak exercise and rest 
values. 
Results: Recordings were succes~ful in all subjects. There 
was a strong correlation beN.:een Pmax and sPmax 
(r"=0.97). Cardiac reserve derived from Pmax and sPmax 
were significantly related to V02max (r"=O.SS and 0.82. 
respectively). In a multiple logistic regression, V02max was 
independently predicted by the rate pressure product and 
Pmax or sPmax, but not by steady power output. 
Conclusions: A simplified index of ventricular power out-
put could be validated in a clinical exercise echo setting 
and was found strongly correlated ro a more burdensome 
tonometric evaluation. Both indices add similar diagnostic 
information to conventional hemodynamic and echocardio-
graphic parameters and could be useful for the GFl,!aluation 
of left ventricular contractile state of patients. 
Keywords: cardiac power output, stress echocardiography. 
oxygen consumption 
Condensed abstract 
In 25 subjects, maximal ventricular power output (Pmax) 
was measured non invasively with echo-Doppler and 
tonometry during supine bicycle exercise, and compared to 
a simplified index. defined as the product of peak aortic 
flow and mean blood pressure. Cardiac reserve was esti-
mated by the difference of Pmax at peak exercise and base-
line, Aerobic exercise capacity was estimated by expired 
gas analysis (V02ma:t") and was found statistically correla-
ted to Pmax. There was a strong correlation beMeen Pma:t" 
and its simplified estimation yielding similar diagnostic 
value in a multiple logistic regression of V02ma:t" determi-
nants. This simplified index may be useful and more practi-
cal to evaluate ventricular contractile reserve. 
Ba_ck!rro!J.Jl!l 
Ventricular contractility is best assessed with invasive 
indices of the pressure-volume pump rclationship. 1 -~ 
However. their invasive nature precludes their widespread 
application. Maximal ventricular power (Pma.x, defined as 
the maximum of the instantaneous product of pressure 
chamber and rate of volume change) has been proposed for 
the assessment of ventricular function. ;.Jon-invasive evalu-
ations have been based on cchocardiography and central 
aortic blood pressure estimation with arterial tonometry'. 
pulse transduction4 or automated cuff sphygmomanometry.' 
Contractile reserve (CR) might be defined as the difference 
of Pma.x between peak stress and baseline conditions. In 
patients with heart failure, non-invasive CR has been 
demonstrated to have a better prognostic value than ejection 
fraction," confirming earlier observations by Tan ct alY 
Severe exertion is the most physiological stress for evalua-
tion of the functional reserve of the left ventricle."·10 We have 
recently reported the validation in dogs and preliminary 
clinical experience of a simplified index of Pmax, sPma.x. 
defined as the product of mean blood pressure and peak aor-
tic flow 11 , which is easier to obtain than Pmax 
during exercise echocardiography. We present in this paper 
a validation of sPma.x in a clinical setting where we evalu-
ated "true" peak power via tonometric and cchocardio-
graphic measurements in subjects undergoing supine 
bicycle exercise stress with metabolic testing. 
Material and methods 
Rest and supine bicycle exercise echocardiography were 
performed in 14 patients free of significant valvulopathies 
and atrial fibrillation referred for evaluation of coronary 
heart disease. and in ll normal control subjects. All aspects 
of this investigation conformed to the principles outlined in 
the declaration of Helsinki. Approval to conduct the study 
was granted by the local Investigational Review Board and 
informed consent was obtained from each subject. 
Exercise echocardiography: Echocardiographic examina-
tions were performed using an ATL HDI 3000 machine 
(Advanced Technology Laboratories, Bothell, WA) to 
obtain standard views at rest, maximal exercise and imme-
diately afterwards. Echocardiographic images were recorded 
on 05-inch VHS videotapes and also digitized on-line into 
a quad-screen, cine loop format gated to the R wave of the 
electrocardiogram (Image Vue. Eastman Kodak Health 
Imaging. Allendale, NJ). All digitized images were stored 
on 5.25-inch optical disks. Interpretation of the images was 
performed by two observers using the standard 16-segmcnts 
LV modeJ.l~ 
Measurement of ventilatory respons~ Continuous expired 
go.s analysis was performed with a :\1cdGraphics Cardi02 
system (Minneapolis, MN). Nose clips were used to prevent 
air leak from the nostrils. Breath-by-breath analysis of the 
expired gas was performed. and results were reported as 
30-second averages. Oxygen consumption (VOz) and car-
bon dioxide production (VC02) were measured at rest for 
;?:2 minutes before start of exercise and then continuously 
during exercise. :Maximum oxygen uptake. corrected for 
body weight (V02max) was defined as the oxygen con-
sumption at peak exercise. The respiratory exchange ratio 
(RER) was calculated as the ratio ofVC02 relative to V02. 
Exercise testin<>: All subjects underwent symptom-limited 
exercise testing on a tiltable supine ergometer (American 
Echo. Kansas City. MO) using 2 minute stages. with 
25 Watt workload increments. Hemodynamic response. 
symptom status and 12-lead electrocardiogram were moni-
tored continuously. Brachial artery pressure was measured 
at the end of each stage with a mercury sphygmomano-
meter, based on phase 1 and 4 of the Korotkov sounds. 
Maximal exercise was defined by attainment of> 85% of 
maximum age-predicted heart rate rcsponseu. 
.fu.tj_m:1tion of aortic flow· In the absence of significant 
mitral regurgitation. aortic flow reflects the instantaneous 
rate of volume change of the left ventricle needed to calcu-
late power. To estimate peak aortic flow, aortic annulus 
diameter was me:1sured from the parasternal long axis view 
at rest. and assumed to remain constant with excrcise14 • At 
rest and at peak exercise level. or failing that. immediately 
on cessation of exercise. the aortic root was interrogated 
from the apical five-chamber view using continuous wave 
(CW) Doppler with optimal alignment of the ultrasound 
beam in the left ventricular outflow tract (LVOT). Maximal 
velocity, velocity-time-integral (VTI) and the RR-interval 
were manually measured from the videotape. 
Concomitantly, the audio Doppler signal output of the 
echocardiographic m:1chine was digitized with a cus-
tomized hardware and software interface previously 
dcscribed. 1' Briefly. :1udio Doppler signals were acquired 
with an analog/digital board (Wavebook/512. IOTech Inc .. 
Cleveland, OH) and a laptop computer (Dell LMIP133. 
Austin. TX). Fast Fourier Transform was computed on-line 
to display the spectrogram, :llong with simultaneously 
acquired tonometric and ECG signals. Data were archived 
in binary files and processed off-line. Automatic detection 
of the maximal aortic velocity contour (V Ao:l and computa-
tion of VTI required minimal user interaction with a soft-
ware developed in :MatLab 4.2 (MathWorks Inc .. CK). 
Instantaneous aortic flow (QAJ was computed :1s the cross-
sectional aortic annulus area times V Ao· Manual and auto-
matic measurements of peak V Ao :1nd VTI were compared 
following Bland and Altrnan. 1" 
Estimation of central aortic nressurc· Pma.x should be com-
puted with left ventricular pressure. but aortic root blood 
pressure (BP Ao) is a valid altcmativc. 17·1' We performed non-
invasive tonometric recordings of the carotid and 
radial arteries with a :Millar SPT-301 pen-like transducer 
(Millar Instruments Inc .. Houston, TX). Principles of 
tonometry have been extensively described. 1'' Close agree-
ment at the carotid level with invasive high-fidelity BP Ao 
Table L Rest and exercise paramcten; in patient~ and controb and their univariate correlation with V02 max. 
Patients Controls Correlation with V02max 
n=14 n=11 r (n=25) p 
Rest: 
Ejection fraction (%) 56±13 61±6 0.178 0.440 
Heart rate (min·') 70±10 70±10 -0.103 0.625 
Mean arterial pressure (mmHg) 106±10 104±9 0.124 0.554 
Estimated aortic pulse pressure (mmHg) 45±10 32±5+ ·0.505 0.01 
Rate pressure product (mmHg/min x 1 0") 10.1±1.7 9.2±1.2 -0.221 0.288 
Cardiac output (1/min) 5.3±1.6 5.4±1.2 0.272 0.188 
Maximal power (Watts) 5.9±2.0 6.3±1.7 0.468 0.018 
Simplified maximal power (Watts) 5.0±1.4 5.5±1.5 0.524 0.007 
Steady Power (Watts) 1.2±0.4 1.3±0.3 0.326 0.111 
Peak exercise: 
Ejection fraction (%) 71±13 72±7 0.029 0.902 
Maximal heart rate (min-') 129±21 160±13:j: 0.794 <0.001 
Mean arterial pressure (mmHg) 134±13 137±12 0.175 0.403 
Estimated aortic pulse pressure (mmHg) 68±14 80±34 0.414 0.04 
Rate pressure product (mmHg/min x 10~) 25.1±4.7 32.3±4.9:j: 0.763 <0.001 
Cardiac output (1/min) 9.6±3.4 13.9±3.9t 0.761 <0.001 
Maximal power (Watts) 10.9±3.8 16.8±3.9:j: 0.825 <0.001 
Simplified maximal power (Watts) 9.3±2.8 13.2±2.9t 0.805 <0.001 
Steady power (Watts) 2.9±1.1 4.2±1.3t 0.756 <0.001 
V02max (ml/kg/min) 18±6 35±8:j: 
.. p$0.05 t p$0.01 :t: p$0.001, patients versus controls. 
Table 2. Vcuiation of the hemodynamic parameters (.6. peak exercise -baseline) and their univariate correlation wjth YO~ max, 
Patients Controls Correlation with V02max 
n==14 n==11 r (n"25) p 
t. ejection fraction (%) 16±5 11±4~ -0.333 0.140 
t. mean arterial pressure (mmHg) 28±10 32±7 0.106 0.614 
t. aortic pulse pressure (mmHg) 22±13 48±34" 0.577 0.003 
.6. rate pressure product (mmHg/min x 103) 15.1±4.0 23.0±4.9:j: 0.825 <{).001 
t. cardiac output (1/min) 4.3±2.6 8.5±3.2:j: 0.788 <0.001 
Cardiac reserve (Watts) 5.0±2.3 10.5±2.4:1:: 0.847 <0.001 
Simplified cardiac reserve (Watts) 4.3±1.8 7.7±1.6:j: 0.820 <0.001 
Steady cardiac reserve (Watts) 1.6±0.9 3.0±1.1t 0.782 <0.001 
~ p$0.05 t po;;0.01 + p$0.001 , patients versus controls. 
recordings has been reported."0,:o_1 Consecutive calibrated 
tonometric BP signals (ECG-gated) were displayed for 
visual assessment of the reproducibility and the quality of 
the successive recorded beats. along with the Doppler spec-
trogram. For calibration, diastolic and mean (obtained b-y 
integration over the heart period) tonometric BP were set 
equal to the diastolic and mean cuff pressure measurements 
at the brachial level. Mean sphygmomanometer BP was 
computed as (2 x Diastolic BP + Systolic BP)/3. At peak 
exercise, no reliable tonometric BP recording at the carotid 
level could be performed, due to deep respiratory move-
ment artifacts. Consequently. BP Ao was considered at rest 
equal to the carotid tonometric BP, but at peak exercise. 
BP Ao was derived from the radial recordings on which a 
validated transfer function was applied~. Aortic pulse pres-
sure (PP Ao) was calculated as systolic BP Ao minus diastolic 
BP Ao· We compared carotid and transformed radial 
recordings at rest Analyzed BP waves were the average of 
5-7 beats giving a representative heart cycle. The standard 
deviation of the reconstructed systolic BP (sdSBP) was used 
as an index of the variability of the tonometric recordings. 
Estimation of maximal power and physiolocical cardiac 
reserve: Pma~ was determined as the peak of the instanta-
neous product of realigned ~0 and BP Ao :.'. sPmax wa.s 
computed as peak V Ao x aortic annulus cross sectional area 
x mean BP. Steady (mean) power output (mP) was computed 
as the product of mean BP Ao and cardiac outpuf. CR. sim-
plified CR (sCR) and mean CR (mCR) were computed as 
the difference of peak exercise and rest values of Prnax. 
sPmax and mP. respectively. 
Statistical methods: All values are expressed as mean±stan-
dard deviation. Comparison of hemodynamic variables 
between patients and normal subjects was performed by 
t-test. For multiple comparisons. analysis of variance with 
Bonferroni's correction was applied. Statistical significance 
was defined as a two-tailed p value of 0.05. Pearson's two-
tailed correlation and linear regression were used to com-
pare continuous variable. All parameters found to be signi-
ficantly correlated to V02max by univariate analysis were 
included in a multiple forv~ard stepwise linear regression in 
order to find the independent variables that predicted the 
value of V02max. Analyses were obtained with SPSS 
release 7.5.2. 1997 (SPSS Inc., Chicago.lL). 
Result<; 
Patient characteri~tic>:: Of the fourteen patients (age 64± 
14 years), five were female. one had a resting ejection frac-
tion <45%. two had moderate mitral regurgitation. 
Indications for evaluation were known (5) or suspected (9) 
coronary artery disease. The exercise echocardiograms 
included 6 negative tests and 3 non-diagnostic tests due to 
inadequate heart rate response. Five tests demonstrated rest 
or exercise-induced wall motion abnormalities. All eleven 
control subjects (age 34±5 years) were males. with normal 
TF radial 
/Radial 
Fi~ 1: Upper panel: m=ured radial (dotted line) and carotid (solid line) calibrated tonometric pressure and the estimated aortic pressure 
(broken line) via a transfer function applied to the radial recording (1'Fmww). Calibration i~ based on sphygmomanometric mean and 
diastolic pre~sure measurements. Radial and carotid pressure waves arc the average of 5 to 7 individual beats. Lower panel: simultaneously 
acquired and recomputed Doppler spcctrogro.m with the automatically detected maximal velocity contour (+ ). 
Table 3. Rest and exercise peak aortic velocity (VA<) and velocity-time integr:ll (VTI), at rest and peak exercise, with manual and auto-
matic assessment ofV Ao· 
REST EXERCISE 
Patients Controls Patients Controls 
n:=14 n==l1 n==14 n=11 
Manual tracing 
peak V Ao (m/s) 1.21±0.20t 1.17±0.13t 1.67±0.33* 2.04±0.20 
VTI (m) 0.26±0.04* 0.23±0.03t 0.28±0.06 0.29±0.05 
Automatic assessment 
peak V Ao (m/s) 1.11±0.20t 1.10±0.15t 1.63±0.28* 2.02±0.20 
VTI (m) 0.25±0.04 0.23±0.04t 0.28±0.06 0.29±0.04 
.. p$0.05, patients versus controls ; t p:S0.05. rest versus exercise 
resting and exercise echocardiograms. 
Hemodynamic :md metabolic poramcters at baseline and 
peak exerci!':e: Comparison of baseline and stress parame-
ters is shown in Table 1. With exercise. control subjects 
achieved a higher heart rate, rate pressure product. cardiac 
output. and V02max. Patients achieved a V02max of 
18±6 ml/kg/min (range 11.7-27.5) corresponding to 5.1 
±1.7 metabolic equivalents (METS). with a maximum rate 
pressure product of 25.1±4.7 10' mmHg.beats/min. RER at 
peak exercise was 1.2±0.1. indicating good effort and 
maximum exercise. Three patients and one control failed to 
reach a RER of 1.1. three other patients and one control 
failed to reach 85 % of the maximum age-predicted heart 
rate response. Table 2 summarizes the changes from base-
line to peak exercise. No difference was observed between 
the patients with a negative, non-diagnostic or positive 
exercise test. 
Automated assessment of aortic flow· Comparison of auto-
matic and manual estimation of V Ao is given in table 3. 
Including baseline and peak exercise values. the Bland and 
Altman's analysis revealed a clinically non-significant bias 
of 0.06 m/s for peak V Ao· The agreement interval was 
[-0.20: 0.31) m!s. for an overall mean peak V Ao of 1.5 m!s 
(left panel of figure 2). For VTI, the bias was 0.005 m, and 
the agreement interval [-0.06: 0.07] m. for an overall mean 
VTI of 0.26 m (right panel of figure 1). The scatterplots 
show a random distribution of the differences lying in the 
agreement interval. with the exception of 2 measurements 
obtained at peak exercise. 
Estimation of cenfral aortic blood pressure: The upper part 
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Table 4. Multivariate analysis of V01max (forward step-wise inclusion) of the hemodynamic variables and (i) tonometric indexes of con-
tractility (Pmax and CR), (ii) simplified indexes of contractility (sPrnax and sCR) and (iii) steady power measurements (mP and mCR). 
Model Independent variables 
(;j (with tonometric power measurements) 
Cardiac reserve 
t:. rate pressure product 
Rate pressure product at peak exercise 
Peak power at peak exercise 
Constant 
(ii) (with simplified power measurements) 
t:. rate pressure product 
Simplified cardiac reserve 
Rate pressure product at peak exercise 
Simplified peak power at peak exercise 
Constant 
(iii) (with steady power measurements) 
c. rate pressure product 
b. cardiac output 
Constant 
B: unstandardized coefficients, SE- standard error. 
of figure 2 illustrates, at rest tonometric recordings at the 
carotid and at the radial. levels and the reconstructed aortic 
BP via the transfer function. At the carotid level, at rest. 
systolic BP tended to be higher for the patients (133 
±14 mrnHg) than for the controls (123±10 mrnHg. p=0.06). 
The sdSBP was 3±2 mrnHg. At the radial level. systolic BP 
was 140±16 rnmHg. with no difference between patients 
and controls and sdSBP was 3±2 rnmHg. At peak exercise. 
radial SBP reached 196± 19 mmHg and 222±29 mmHg. 
respectively for the patients and the controls (p<0.05). 
The variability of the tonometric recordings was slightly 
higher at peak exercise, with an average sdSBP of 
5±2 rnmHg. Systolic BP Ao was not different among the 
patients and the controls: 173±15 mmHg. There was a clini-
cally non significant bias of 2±5 rnmHg between the rest 
carotid systolic BP and the reconstructed systolic BP Ao via 
the transfer function. 
Comparison hetween the tonometric and simplified peak 
nowcr index~ Figure 3 shows that there was an excellent 
y = o. 7392x + 0.878-8 
R2 - 0.9737 
0 
~~ 
~u 
B SE p Adjusted r" 
0.833 
0.438 0.145 0.5 
2.6 10"' 1 10-a <0.001 
-2.1 10-:l 1 10"' <0.005 
1.247 0.588 <0.05 
16.9 7.2 0.05 
0.830 
2.9 10-:l 1 1 0-:l <0.001 
0.616 1.12 0.5 
-2.4.10-:l 1 1 0.;. <0.05 
1.792 0.828 <0.05 
15.5 7.1 <0.05 
0.739 
1 10"0 0.1 10"' <0.005 
1.259 0.467 <0.05 
·0.8 3.9 0.8 
correlation between Pmax and sPmax. The correlation 
between CR and sCR was also very good: sCR = 0.64 x 
CR +1.0, r-"=0.94. p<O.OOI. Pmax, sPmax. m.P, CR. sCR 
and mCR were statistically lower for the patients (Table 1 
and2). 
Correlation between hemodynamic parameters and maxi-
mal oxygen uptake: There was no correlation between 
rest hemodynamic parameters and V02max. Pearson's 
univariate correlation coefficients are summarized in Table 1. 
At maximal exercise. V02max was highly correlated to 
peak heart rate, PP Ao· cardiac output, rate pressure product 
and maximal power indexes. With the exceptions of ejec-
tion fraction and mean arterial pressure, all the increases in 
the hemodynamic parameters were correlated with V02max: 
(Table 2). Figure 4 shows the strong correlation found 
between V02max and both Pmax and sPmax. Table 4 sum-
marizes the step-wise forward multivariate regression 
between V02max: and hemodynamic parameters found cor-
related in the univariate regression, and (i) Pmax and CR. 
(ii) sPmax and sCR, (iii) m.P and mCR. With tonometric or 
---" 
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Figure 3: A plot of the simplified index of ventricular peak power output (sPma....-:), defined as peak aortic flow times mean blood pressure. 
against the peak power derived from the tonometric and echo-Doppler measurements (Pmax) during rest (filled circles) and peak exercise (open 
circles). 
simplified derived peak power parameters. the model was 
similar (adjusted t' was 0.833 and 0.830. respectively). No 
steady power parameters were found independently corre-
lated to V02max. 
Discussion 
The major findings of this study are: 
(i) an index reflecting contractile state. Pma.x. and the 
derived physiological cardiac reserve (CR). could be fully 
assessed non-invasively with the combined use ofDoppler-
echocardiography and arterial tonometry: 
(ii) a simplified index. sPma.x defined as mean arterial 
blood pressure times peak aortic flow. more practical to 
obtain in a stress-echo laboratory setting. was highly corre-
lated to the more burdensome tonometric Pma.x: 
(iii) both measurements were strongly correlated to 
V02max. and carried additional independent information 
over peak exercise cardiac output and steady ventricular 
power output. 
~on~invasive evaluation of Pma.x and physiological 
cariliac reserve: 
Mean and pulsatile powers using tonometry and Doppler-
echocardiography have been invasivcly validated in sub-
jects undergoing cardiac catheterization by Kelly et al.-' 
A coefficient of variation of <9% has been reported. During 
stress-echocardiography. variability of Pmax evaluation 
might increase but it was not logistically possible to repeat 
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these measurements perfonncd during the daily activity of 
our stress-lab. Our study is the first to report rest and peak 
stress Pmax determinations with tonometry. Cooke et a1.' 0 
have recently reported a coefficient of variation of 9.1% for 
mP during exercise using the C02 method for evaluation of 
cardiac output. The low standard deviation of the recon-
structed systolic blood pressure (sdSBP) we report. even at 
peak exercise (5±2 mmHg). supports a good reproducibility 
of our measurements. The developed software and hard-
ware for on-line assessment of the simultaneously recorded 
tonometric and Doppler signals facilitated this achievement. 
Pmax has been assessed non-invasivcly using an alternative 
to tonometry for the central BP cvalu::ttion in patient with 
severe heart failure. During dobut:l.mine-induccd inotropic 
stimulation. the preload-adjusted derived con-tractile 
reserve has been demonstrated predictive of the functional 
class/ and for patients in functional class IIVIV following 
the New York Heart Association. the cardiac reserve. and not 
the ejection fraction. was statistically higher in tho&e alive at 
the 3~year follow-up.' Pma."X being preload depchdent 
adjustment dividing it by the square of end-
diastolic volume has been proposed. 17·'" However. 
>Jakayama ct al.'4 have recently demonstrated that the opti-
mal preload adjustment was dependent of the size of the 
ventricle. Since we wanted to determine the overall cardiac 
reserve. including the amount based on preload recruitment 
we did not apply any correction based on ventricular &ize, 
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Figure 4: Plot~ of the linear relationship between: (uppcrpanel) the cardiac reserve derived from tonometric measurements (defined J...'> Pmax 
at peak exercise minus Pmax at rest) and aerobic exercise capacity, YOc.max, for patient.'> (open circles) and controls (filled circles); (lower-
panel) the simplified index of contractile state (defined J...'> sPma....: at peak exercise minus sPmax at rest) and V02max. 
similarly to Tan and colleagues 10·~. 
A simplified index of Pmax: 
We could perform tonometric recordings in all our patients. 
However, this technique requires an additional person and 
extra time. At peak exercise, radial recording could only be 
performed at the cessation of exercise. We demonstrate that 
sPmax. validated in an open-chest dog setting11 and easier 
to obtain. is highly correlated to Pma."X. Determination at 
peak exercise requires only a Doppler recording in the 
LVOT. quickly obtained during the recording of the con-
ventional views for stress echocardiography. Off-line deter-
mination of peak aortic flow can be performed from tape 
recordings. or facilitated with an external setting. as the one 
we describe. There was a very good agreement between 
manual and automatic assessments of V Ao and VTI. The 
discrepancy was slightly higher during exercise. due to the 
more unstable hemodynamic conditions at that time: as 
soon as the exercise is stopped. peak V Ao decreases and 
measurements from the tape did not perhaps always exactly 
match the timing of the computeri7..ed spectrogram analysis. 
Functional capacity assessed by V02max 
The rate of ma.ximal oxygen uptake (V02max) is the best 
test of overall functional reserve. In untrained normal peo-
ple. V02max is determined by the cardiac output at maxi-
mal cxercise1'. For patients with heart failure or pulmonary 
disease. V02max is influenced by changes in peripheral 
oxygen extraction and pulmonary gas exchange. reflecting 
more the functional capacity of the whole organism. It is 
thus the best objective index of aerobic work capacity~7 that 
we considered as our reference physiological cardiac capa-
city measurement. 
Although ejection fraction during exercise echocardio-
graphy has predictive value in some settings such as chronic 
mitral regurgitation~. measurements of resting cardiac 
function do not predict functional reserve. There was no 
correlation between ejection fraction and V02max.~' On the 
other hand. contractility. pressure work and heart rate arc 
the major determinants ofV02maxJ<J and are reflected in the 
evaluation of Pmax. 
Respective correlation between Pmax. sPma."X. mP and 
V02ma."X 
We found a direct linear relationship between V02max and 
Pma.'X, sPma.x and mP. conf1l'ming previous reports1"'"-'. In 
the univariate correlation analysis. the correlation between 
cardiac reserve (CR) and V02max was even higher 
(r=O.S47) than with peak exercise Pmax (r=0.825). 
However, in the multivariate regression. CR was not inde-
pendently correlated with V02max when d(rate pressure 
product). rate pressure product at peak exercise and peak 
exercise Pma.x were included (table 4). With simplified 
power measurements, a similar model with a close adjusted 
r was found. supporting the hypothesis that sPmax might 
yield similar diagnostic value than tonometry. Conversely. it 
appears that mP docs not bring additional independent 
information once the rate pressure product and cardiac out-
put are measured at rest and at peak exercise (table 4). 
Cooke et al.10 reported indeed a correlation between 
V02max and cardiac output at peak exercise higher 
(r=0.922) than mP (r=0.872). The advantage of Pmax 
might be to include the pulsatile load of the ventricle, in 
comparison to only the steady component measured by mP. 
Radial versus aortic blood pressure measurements: 
Elevated blood pressure during submaximal exercise is 
predictive of cardiovascular and myocardial infarction mor-
tality in apparently healthy male populations."1·'" and is 
strongly associated with coronary risk factors. 13 The systolic 
radial arterial pressure can be markedly modified by sum-
mation of peripherally reflected waves. with an overestima-
tion of systolic BP Ao up to 80 rnmHg during exercise.-"'·') On 
the other hand. mean and diastolic radial BP have been 
reported within 3 mmHg of aortic valucs10• supporting the 
validity of our calibration procedure. In our population. at 
rest the radial pulse pressure was statistically higher than 
the carotid one (55±21 rnmHg vs. 39±10 rnmHg. p<O.OOl). 
There was no clinically significant difference between the 
measured carotid pulse pressure and the one derived from 
the radial recordings on which we applied the transfer func-
tion published by Chen et al."~ (41±14 rnmHg). At peak 
exercise. the radial pulse pressure was I 02±26 rnmHg and 
PP Ao was 73±25 rnmHg. The use of peripheral systolic BP 
would lead to an overestimation of Pma.x. 
Limitations: 
A supine bicycle exercise test is less physiological than 
walking on a treadmill and V02max might have been slight-
ly lowcr'7, explairti.ng perhaps that the linear relationship we 
found between V02max and cardiac output at peak exercise 
(COP (L!min) :::: 4.2 + 3.6 V02max (in L!min)) 
differs partly from previous reports: cop :::: 4.0 + 6.0 
V02max for Jones ct al.1" and COP:::: 3.0 + 5.6 V02max for 
Cooke et al. 10 
There were probably too few patients in each group (nega-
tive, non-diagnostic and positive exercise tests) to find a 
difference in their hemodynamic parameters. 
Mandarino et al. have reported on-line computation of 
Pma.-.: based on the evaluation of the rate of change of the 
ventricular volume by echocardiographic automated border 
detection (ABD) 1" while we assess Pmax off-line. Increased 
computational processing capabilities could permit on-line 
Y Ao and Pmax assessment. sPma.-.: might be readily per-
formed on an cchocardiographic system. with mean BP 
entered from the keyboard and a horizontal cursor used to 
visually follow peak V Ao· 
The noise generated during exercise is in the frequency 
range of the Korotkov sounds)'' and sphygmomanometer 
measurements arc more difficult. with potential errors for 
the determination of the diastolic BP very important for the 
calibration of the tonometric measurements. 
This study did not include patients with severe left ventri-
cular dysfunction. The assessment of mean BP as (2 x 
Diastolic BP + Systolic BP)/3 might not be always valid in 
these patients. or in the presence of a modified arterial dis-
tensibility. 
Finally. the transfer function used to estimate BP Ao from the 
tonometric radial recordings has only been validated at 
rest.~ 
Conclusion 
From simultaneously acquired tonometric and Doppler 
echocardiographic recordings. we describe a fully non-
invasive assessment of maximal left ventricular power out-
put during exercise echocardiography. We could validate a 
recently proposed simplified index easier to obtain and 
highly correlated with Pma"X. Both indexes reflect con-
tractile state and demonstrate a strong linear relationship 
with V02max and carry additional independent information 
over more conventional hemodynamic parameters. 
Additional prospective studies in patients with congestive 
heart failure should be performed to further transfer bench-
work pressure-volume studies to the clinical arena. 
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Intracoronary Doppler and pressure measurements (chapters 1-5): 
The last few years have seen rapid advances in coronary Doppler and pressure probe technology 
and the development of new physiological measurements to assess the significance of coronary 
lesions or the results of interventions. In chapter 1, we have reviewed in depth these technologi-
cal improvements and described methods such as the coronary flow reserve (CPR) for the assess-
ment of a coronary lesion. We have stressed the limitations of CPR, which is dependent on an epi-
cardial artery stenosis and on the microvascular bed. This ratio of the maximum hyperemic flow 
over the baseline flow can also vary with changes in the baseline conditions, as observed during 
coronary interventions. Most of the suboptimal CFR measurements after a balloon angioplasty are 
related to increased baseline velocities. 1'2 The advantages of alternative methods such as the fractional 
flow reserve (FFR), based on the pressure gradient across a lesion during hyperemia, have been 
stressed. However, from a fluid mechanics point of view, both pressure and flow are necessary to 
fully characterize the coronary circulation and the influence of a stenosis. Indexes like the instanta-
neous hyperemic diastolic pressure velocity relationship have been introduced. However, they are 
rather cumbersome to use and they present a large coefficient of variation that limit their clinical use. 
In chapter 2, we show that septal hypertrophy is associated with decrements in CFR in patients 
with hypertrophic cardiomyopathy (HCM), and that there is also a decrease in the coronary resist-
ance reserve, CRR, the ratio of coronary resistance during hyperemia over baseline resistance. 
Coronary resistance is defined as (Pao-Ped)N cor, where Pao is aortic pressure, Ped is end diastolic 
pressure and V cor the coronary velocity. Ped corrects the extravascular compression, which cannot 
therefore be implied in the observed decrease of CPR and CRR. We show that capillary density 
tended to decrease and that there was a positive relationship between both CPR and CRR and arte-
riolar lumen: patients with HCM have arterioles with smaller lumen at similar wall thickness that 
can contribute to perfusion abnormalities. In these patients, the ratio of the slopes of the linear 
regression of diastolic pressure and velocity data, which reflect coronary conductance, was more 
sensitive than CFR to detect a decrease in coronary reserve [unpublished data]. Since this index is 
independent of extravascular compression, it has also the advantage to only reflect coronary vas-
cular remodeling. 
In chapter 3, we describe an acquisition system to simultaneously record raw Doppler signals 
along with pressure, ECG and other physiological signals. The off-line post-processing of the 
recomputed power spectrum using a fast Fourier transform permits a better determination of the 
true maximum velocity contour. Averaging multiple cycles increases the signal to noise ratio and 
further improves the detection of the maximum velocity. This system, studied initially in vitro, is 
presently used on a daily basis in our catheterization laboratory. It provides improved archiving and 
viewing possibilities than conventional videotapes. Studies of more complex indices of the coro-
nary circulation such as the coronary conductance reserve are possible. A recent comparison 
between the on-line average peak velocity (APV) and the APV obtained by reprocessing the 
Doppler spectrum showed excellent agreement. The average difference among 66 measurements 
obtained in 11 patients was -0.7±1.2 crnls when there was an optimal on-line detection. However. 
in 12% of the recordings, the on-line tracking failed to recognize the true peak velocity and the 
mean difference between the 2 methods was 3±8 crn!s, with a maximum difference of 15 crn!s. This 
was clinically significant since the average underestimation of the derived CPR was -0.4±0.3 
[unpublished data]. 
In chapter 4, we demonstrate another limitation of the CFR to guide interventions: its lack of cost-
effectiveness. There was no statistical difference in event-free survival at 1 year between primary 
stenting (86.6 %) and provisional angioplasty (85.6%). However, the costs after I year were sig-
nificantly higher (BUR 6573 vs. EUR 5885, p=O.Ol) for the strategy of provisional angioplasty. 
Moreover, the patients with an optimal angioplasty result who received a stent in the second ran-
domization tended to have an improved event-free survival at 1 year (93.5% vs. 84.1 %, p=0.066). 
These data, as well as the results of the other studies discussed in the related editorial of the Debate 
II study, support the ever-increasing use of stents nowadays in interventional cardiology. 
FFR is an alternative physiological method, based on intracoronary pressure measurements, that 
has also been proposed to guide interventions. In chapter 5, we show that FFR fails to discrimi-
nate between optimally and suboptimally implanted stents in an in vitro setup. The FFR variations 
related to the changes of the maximal flow between 50 and !50 m!lmin were 5 to 10 times higher 
than the variations related to the optimal or suboptimal expansion of the stents. The limitations of 
CFR and FFR described in chapters 1-5, as well as others, recently reviewed,3 support the alterna-
tive method of coronary flow measurement using an IVUS catheter that is described in the next part 
of this thesis. 
Intracoronary Flow Measurements with IVUS catheters (chapters 6-9): 
Chapter 6 introduces the principles of the IVUS flow method that was originally developed by 
W. Li et al. in our laboratory:~ Flow velocity is based on decorrelation estimation from sequences 
of radiofrequency (RF) IVUS traces. 
The in vivo va1idation reported in chapter 7 demonstrates a good agreement between the IVUS 
flow method and electromagnetic flowmeter (EM) recordings in a porcine carotid model (IVUS 
f= 1.0 EMf+ 5.72 cc/min). In the early phase of the development of this technique using a single 
rotating IVUS crystal, good agreement was found with intracoronary Doppler measurements in 
5 patients: the mean difference between the IVUS and Doppler derived CFR was -0.01±0.21. for 
a mean CFR of 1.9. 
The study of the disturbances in the velocity profile induced by an IVUS catheter, applying com-
putational fluid dynamics, demonstrated that secondary velocity components were in the order of 
10-15 %. However, the deviation in the flow estimation was less than 1 %when flow calculation 
was based exclusively on the axial velocity. The presence of an IVUS catheter (diameter of ~1 mm) 
in a curved tube of 3 mm in diameter induces a resistance of 10 mmHg.s/m2 for a flow entrance 
with a mean velocity of .4 m/s. The resistance goes up to 38 mmHg.s/m2 in a tube of 2 mm, illus-
trating an important limitation of the IVUS flowmetry: a significant hemodynamic effect on the 
flow in small arteries during hyperemia (chapter 8). This limitation will be improved once new 
smaller IVUS catheters will be available. 
Chapter 9 presents the in vitro evaluation of the IVUS flow method using an IVUS array catheter. 
Excellent linear relationships were found (all r>0.99) with a reference flow ranging from 0 to 
341 cc/min, measured with a Transonics flow-meter, in tubes with a diameter ranging from 3 to 
5 rnm. However, an increasing offset (ranging from 6 to 182 cc/min) and a varying slope were 
observed. These observations are related to the inherent electronic noise picked by the IVUS 
catheter, and to the position of the catheter and the ring-down artifact. Nevertheless, a proposed 
correction, based on the determination of the offset that can be estimated in a zero flow condition. 
permitted the determination of a CFR in excellent agreement with the Transonic catheter. The mean 
difference between the two CFR estimates was 0±0.19. for a mean CFR of2. These results warrant 
further in vivo investigations. 
Chapcterization of Arterial Wall Mechanics by RF Processing (chapters 10-12): 
IVUS elastography is a method for measuring the local elastic properties of coronary atheroscle-
rotic plaques. Mechanical properties of the different tissues within a plaque are measured through 
the strain. We have reviewed in chapter 10 the work of several groups working on vascular and 
non-vascular strain/stress assessment. We describe in detail the elastography method developed in 
our laboratory. and present the preliminary results obtained in tube phantoms, and in human coro-
nary arteries. Chapter 11 focuses on the feasibility of recording elastograms during interventional 
catheterization procedures. In 12 patients we obtained reproducible strain measurements at the end 
of diastole, where the motion of the catheter is minimal. Although these recordings were obtained 
with a low resolution imaging mode (64 angles of the "flow mode"), we partly validated our mea-
surements, demonstrating a significantly lower strain in calcified than in non-calcified regions 
(0.20 vs. 0.51 %. respectively. p<O.OOl). A simplified, more robust and very fast real-time intravas-
cular ultrasonic palpation system is described in chapter 12. Composite palpograms are created 
applying a one-dimensional echo tracking technique in combination with global motion compen-
sation and multi-frame averaging of several pairs of RF echo frames obtained in diastole. The RF 
recording is based on digital beamed-formed RF echo data (512 lines) sampled to 12 bits at 100 
MHz and directly transferred into the PC memory at full frame rate (30 fps). We demonstrated the 
possibility to record consistent palpograms possessing good contrast resolution and elastographic 
signal to noise ratio under physiological conditions. This work warrants further large-scale clinical 
investigations. Comparison of elastography and palpography with histology to demonstrate 
characterization of arterial wall mechanics is one of the ongoing studies that may validate the 
clinical usefulness of this new imaging modality. 
Intravascular ultrasound and intracoronary brachytherapy (chapters 13-16): 
In chapter 13 we review the use of IVUS in the clinical studies of coronary brachytherapy. We 
have been the first to describe the methodology to compute dose volume histograms from 3-dimen-
sional reconstruction ofECG-gated IVUS pullbacks.' Chapter 14 presents the comparison. by sim-
ulation. of different treatment strategies based on either ~- or y-sources with and without a center-
ing device. We show that among 23 patients treated in the Beta Energy Restenosis TriaL the mini-
mum dose on 90% of the adventitial surface was 37±16 % of the prescribed dose, while 67±31% 
of the prescribed dose was delivered to 90% of the luminal surface. In comparison, the use of a cen-
tered device or a g-source would have increased these values, and have decreased the minimum 
dose on the 10% most exposed luminal and adventitial surfaces, thereby improving dose homo-
geneity. Although presently no clinical data support the potential benefits of an improved dose 
homogeneity, our pioneering work demonstrates the feasibility of assessing the dose delivered in 
the arterial wall of arteries treated with brachytherapy. The importance of this work was stressed in 
the accompagnying editorial comments. 
In chapter 15, we analyze a total of 206 coronary 2 mm sub-segments from 18 patients treated for 
de novo lesion with angioplasty followed by ~-brachytherapy. We demonstrate that at 6-month fol-
low-up. the volume of the hard plaques increased less compared to soft plaques and normal/intimal 
thickening regions. We also illustrate that the minimum dose deposited on 90 % of the adventitial 
surface (D90adv) is inversely related to the plaque volume at follow-up. 
In chapter 16 we demonstrate that the 6-month angiographic outcome of 27 patients treated for a 
de novo lesion with angioplasty alone (no stent) followed by ~-brachytherapy could partly be 
explained by the dose delivered in the coronary arterial wall. The minimum dose on 90% of the 
luminal surface (DS9olum). the external elastic lamina (DS9oeel) and in 90% of the plaque+media 
volume (Dv90p+m) were 9.7±6.1 Gy. 5.1±3.0 Gy and 7.0±4.0 Gy. respectively. At 6-month fol-
low-up. the patients with a DS9oeel greater than 5.2 Gy (n=ll) had a lower angiographic loss 
(-0.01±0.39 vs. 0.47±0.62 mm. p=0.03) and late loss index (-0.4±58 vs. 44±56 %. p=0.06). These 
arteries were smaller, however the relative gain was identical and the observed difference in the loss 
could only reflect the remodelling of the coronary segments receiving an adequate dose. 
Transthoracic echocardiography for biomechanical assessment of the left ventricle and the 
aorta (chapter 17-20): 
Chapter 17 is an historical overview of the developments of cardiovascular echocardiography. In 
chapter 18, we show that a recursive evaluation of the total arterial compliance (Ctot) based on a 
2-element windkessel model (the pulse pressure method) is feasible using transthoracic echo-
Doppler and arterial tonometry. The evaluation of Ctot with the pulse pressure method is robust and 
give, among 14 patients with known or suspected coronary artery disease (CAD) and 9 volunteers, 
significantly different arterial stiffness estimation(! .2±0.4 vs. 1.6±0.2 mllmmHg). It is also the best 
method to find the expected inverse relationship of total arterial compliance and age, in compari-
son with the area method and the ratio of the stroke volume over the pulse pressure. 
Chapter 19 describes the quest for an optimized transfer function (TFF) allowing the reconstruc-
tion of aortic pressure from peripheral tonometric recordings at the level of the radial artery. We fit 
a three-segment transmission line model for the radial-carotid pressure TFF derived from 31 nor-
mal volunteers and 30 patients with CAD. We only find a difference. between the patients and the 
controls, of the distal reflection coefficient. We describe the average TFF computed, as well as the 
ones derived from the minimum and maximum enveloping TFF. We show the variability resulting 
from the use of each one on aortic derived pressure characteristics such as the central pulse pres-
sure or the augmentation index. 
Finally. in chapter 20, we describe the assessment of left ventricular (LV) performance and con-
tractile reserve during supine stress echocardiography by the determination of maximum ventricu-
lar power output using simultaneous recordings of aortic flow by Doppler echocardiography and 
aortic pressure by arterial tonometry. We demonstrate a good agreement between the data derived 
from carotid recordings and from transformed radial recordings using a TFF. We also validate a 
simplified index of LV power output that we first described in animal experiments': the product of 
peak aortic flow and mean blood pressure. This surrogate of the true peak power, which is less 
cumbersome to obtain than invasive recordings or even arterial tonometry, showed the same corre-
lations with the V02max recorded in these 25 patients. 
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Miniaturized intracoronary Doppler and pressure wires offer today the possibility to study coronary 
physiology in the cathlab. In clinical practice, the pressure measurements are gaining interest, often 
in order to postpone an intervention. The assessment of the coronary flow reserve remains in a 
research niche. The availability of a combined wire interfaced to a fully digital processing platform 
would offer complete assessment of the coronary circulation. 
A simultaneous morphological and physiological assessment of the coronary arteries with one 
IVUS catheter may be the optimal tool to assess the results of a PTCA. However. further studies of 
the reliability and limitations of the IVUS flow method will be necessary before full clinical imple-
mentation. IVUS flowmetry should be further investigated if we are to demonstrate that IVUS 
guided stent implantation combined with physiological assessment is the most effective approach 
for our patients. 
Elastography will enter the clinical arena once it has been fully validated in vitro. with the deter-
mination of the mean strain values of different types of histology samples. When on-line robust 
hardware processing will be implemented to offer rapid 3-d reconstructions of the mechanical cha-
racteristics of an arterial wall segment this technique will help us detecting rupture-prone plaques. 
Clinical studies will have to determine how many of these plaques are present among our patients. 
If they were ubiquitous, then only a systematic treatment based e.g. on high-dose statins would be 
applicable. If only one or two were found. one could attempt to heal these lesions by stenting. The 
advent of drug-coated stents could permit to do so without a risk of restenosis. If these stents are 
really as good as they seem to be presently. then brachytherapy will have problems competing with 
this easier alternative to prevent restenosis. IVUS dosimetry will then become obsolete. Currently 
IVUS dosimetry is utilized as a post-hoc analysis tool to understand QCA and IVUS results in 
brachytherapy studies. Ideally, on-line treatment planning system should become available in order 
to fully exploit this methodology. 
There is great scope for the further development of the bioengineering technologies described in 
this thesis. For non-invasive pressure and flow recordings, the described acquisition systems are 
presently run in the Netherlands and overseas~ in Brisbane, Australia. The author hopes that with 
further investigations they will be used to improve patient outcome, as well as to prepare other 
PhD's. If a few engineers can also gain some useful information from this thesis to further under-
stand pathophysiological problems in order to develop improved diagnostic and therapeutic 
devices, the author will give back a very small part of what he enjoyed learning, working in close 
collaboration with some of their colleagues. Bioengineering is here to stay, and will hopefully 
remain a multidisciplinary field of expertise and exchanges. 
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lntracoronaire Doppler en drukmetingen (hoofdstukken 1-5): 
Tijdens de laatste jaren is er veel vooruitgang geboekt op bet gebied van coronaire Doppler en druk-
meettechnieken evenals op bet gebied van de ontwikkeling van nieuwe fysiologische metingen om 
de ernst van coronaire lesies of het resultaat van interventies te bepalen. In hoofdstuk 1 hebben we 
nauwkeurig deze technologische verbeteringen nagekeken en hebben bet normale coronaire debiet 
en methodes zoals "coronary flow reserve" (CFR) ter evaluatie van een coronaire lesie beschreven. 
We hebben de beperkingen van CPR welke afhangt van zowel bet epicardiale als bet microvascu-
laire bed benadrukt. Deze ratio van maximaal hyperemisch debiet over basaal debiet varieert ook 
met veranderingen in basale condities zoals geobserveerd gedurende coronaire interventies: de 
meeste van de suboptimale CFR metingen na ballonangioplastie zijn gerelateerd aan verhoogde 
basale bloedsnelheden.1.2 De voordelen van alternatieve methodes zoals de "fractional flow reserve" 
(FFR), gebaseerd op de drukgradient over een lesie gedurende hyperemie worden naar voor 
gebracht. Echter, vanuit hydromechanisch standpunt, zijn zowel druk als debiet noodzakelijk om 
de coronaire circulatie en de invloed van stenose volledig te karakteriseren. Indices zoals de instan-
tane hyperemische diastolische druk-snelheid relatie worden geintroduceerd. Ze zijn echter vrij 
omslachtig in gebruik en ze vertonen een grote variatiecoefficient welke hun klinische bruik-
baarheid beperken. 
In hoofdstuk 2 hebben we aangetoond dat septale hypertrofie geassocieerd is met verminderingen 
in CPR in patienten met hypertrofische cardiomyopathie (HCM), en dater ook een vermindering 
is in "coronaire weerstand (resistance) reserve", CRR, de ratio van coronaire weerstand gedurende 
hyperemie en bas ale weerstand. Coronaire weerstand wordt gedefinieerd als (Pao-Ped)N cor, waar 
Pao de druk in de aorta is, Ped de einddiastolische druk en V cor de coronaire snelheid. Ped cor-
rigeert voor de extravasculaire compressie. Deze factor kon dus niet betrokken zijn in de vast-
gestelde gedaalde CPR en CRR. Er werd aangetoond dat de capillaire densiteit neigde te vermin-
deren en dat er een positief verband bestond tussen zowel CPR als CRR en bet arteriolaire lumen: 
patienten met HCM hebben kleinere arteriolaire lumina bij een zelfde wanddikte wat kan bijdragen 
tot perfusiestoornissen. In deze patienten was de ratio van de hellingen van de lineaire regressie van 
diastolische druk- en snelheidsdata, welke coronaire conductantie weergeeft, gevoeliger dan CFR 
om een daling in coro-naire reserve te detecteren.[ongepubliceerde data] Gezien deze index 
onafhankelijk is van extravasculaire compressie, heeft het ook het voordeel enkel coronaire vascu-
laire "remodeling" weer te geven. 
In hoofdstuk 3 beschrijven we een acquisitiesysteem om simultaan ruwe Doppler signalen, druk-, 
ECG- en andere fysio-logische signalen te registreren. De "off-line" bewerking van bet 
samengestelde power spectrum volgens een "fast" Fourier transformatie laat een betere bepaling 
toe van de maximale snelbeidscontouren. Het middelen van verschillende cycli verhoogt de sig-
naal-tot-ruis ratio en verbetert verder de detectie van de maximale snelheidscontour. Dit systeem. 
initieel bestudeerd in vitro, wordt heden dagelijks gebruikt in ons cathaterisatielab en biedt, naast 
verbeterde archivering en bekijk-mogelijkheden vergeleken met conventionele video. de 
mogelijkheid tot bet bestuderen van meer complexe indices van coronaire circulatie zeals coro-
naire conductantie reserve. Een recente vergelijking tussen de "on-line" gemiddelde pieksnelheid 
("average peak velocity". APV) en deAPV bekomen via herbewerking van bet Doppler spectrum 
toonde een excellente overeenkomst tussen de twee methodes (het gemiddelde verschil tussen 
66 metingen in 11 patienten was -0.7±1.2 cm/s bij een optimale "on-line" detectie). Echter in 12% 
van de registraties faalde de "on-line" contourdetectie de echte pieksnelheid te herkennen waarbij 
het verschil tussen de 2 methodes dan gemiddeld 3±8 crn!s bedroeg, met een maximaal verschil van 
15 cm/s, klinisch significant. gezien de onderschatting van de afgeleide CPR gemiddeld -0.4 
±0.3 was.[ongepubliceerde data] 
In hoofdstuk 4 tonen we een andere beperking aan van CFR om interventies te begeleiden: zijn 
gebrek aan kosten-effectiviteit. De strategie van provisionele angioplastie, geleid door de optimale 
resultaten van kwantitatieve angiografie en intracoronaire flow metingen, leidde in de 75% van de 
patienten die geen "bailout stenting"nodig hadden, tot een vergelijkbare "event-free" overleving na 
1 jaar als de strategie van primaire stenting (85.6 vs 86.6% respectievelijk). Echter. de kosten na 
I jaar waren significant boger (EUR 6573 vs EUR 5885. p=0.01). Bovendien neigden de patienten 
met een optimaal angioplastieresultaat die een stent kregen tijdens de tweede randomizatie, tot een 
betere "'event-free" overleving na I jaar (93.5% vs 84.1 %. p=0.066). Deze data. evenals de resul-
taten van andere studies samengevat in de editoriaal over de Debate II studie, ondersteunen bet 
steeds groeiende gebruik van stems heden ten dage in de interventionele cardiologie. 
In hoofdstuk 5 tonen we in een in vitro setup aan dat de FFR. een alternatieve fysiologische 
methode gebaseerd op intracoronaire drukmetingen ter begeleiding van interventies, faalt om opti-
maal geimplanteerde van suboptimaal geimplanteerde stents te onderscheiden. De variaties van de 
FFR gerelateerd aan veranderingen in maximaal debiet tussen 50 en 150 ml/min waren 5 tot 
10 keren boger dan de variaties van de FFR tussen stents met een residuele diameter stenose (DS) 
van 35% aangetoond met QCA en met duidelijk slecht geappositioneerde struts aangetoond met 
IVUS en volledige ontplooide stents. De beperkingen van CFR en FFR beschreven in hoofdstukken I 
-5, evenals andere beperkingen, recent gereviseerd3 ondersteunen de alternatieve methode van coro-
naire flow metingen met een IVUS catheter zoals beschreven in het volgende deel van deze thesis. 
Intracoronaire debietmetingen met IVUS catheters (hoofdstukken 6-9): 
Hoofdstuk 6 introduceert de principes van de "intravascular ultrasound (IVUS) flow" methode die 
oorspronkelijk ontwikkeld werd in ons laboratorium door W. Li et al 4 • De snelheid van de rode 
bloedcellen is gebaseerd op de schatting van de decorrelatie van opeenvolgende radiofrequentie 
(RF) tracees. 
De in vivo validatie, gerapporteerd in hoofdstuk 7, toont een goede overeenkomst tussen de IVUS 
flow methode en de electromagnetische debietmeter (EM) registraties in een varken carotis model 
(IVUSf= LO EMf+ 5.72 cc/min). In de vroege fase van de ontwikkeling van deze techniek met een 
enkele roterende kristal IVUS catheter , werd ook een goede overeenkomst gevonden met intra-
coronaire Dopplermetingen in 5 patienten: het gemiddelde verschil tussen de IVUS en Doppler 
afgeleide CFR was -0.01 ±0.21. voor een gemiddelde CFR van 1.9. Studie over de storingen in snel-
heidsprofiel geinduceerd door een IVUS catheter, gebruikmakende van de hydrodynamica, toonde 
dat secundaire snelheidcomponenten in de grootte-orde van 10-15% waren, maar dat de afwijking 
in de schatting van bet debiet kleiner was dan 1% wanneer de berekening van de flow enkel 
gebaseerd was op de axiale snelheid. De aanwezigheid van deze catheter van -1 mm in een gebo-
gen tube van 3 mm diameter induceert een weerstand van 10 mmHg.s/m2 voor een debiet die 
binnenkomt met een gemiddelde snelheid van 0.4 m/s. De weerstand loopt op naar 38 mmHg.s/mz 
in een tube van 2 mm, wat een belangrijke beperking van IVUS debietmeting illustreert: een sig-
nificant hemodynamisch effect op de flow in kleine arterien gedurende hyperemie (hoofdstuk 8). 
Deze beperking kan verbeterd worden door het beschikbaar stellen van kleinere IVUS catheters. 
Hoofdstuk 9 stelt de in vitro evaluatie voor van de IVUS flow methode gebruikmak:ende van een 
IVUS array catheter. Er werden excellente lineaire verbanden gevonden (allen r>0.99) met een 
referentie flow gaande van 0 tot 341 cc/min, gemeten met een Transonics debietmeter. in tubes met 
een diameter van 3 tot 5 mm. Echter. een toenemende "offset" (gaande van 6 tot 182 cc/min) en een 
wisselende belling werden geobserveerd. Deze observaties waren gerelateerd aan de inherente elec-
tronische ruis opgenomen door de IVUS catheter, aan de positie van de catheter en aan "ring-down" 
artefact. Het "ring-down" artefact wordt veroorzaakt door bet uitslingeren van de transducer nadat 
er een puis opgezet is. Tijdens bet uitslingeren (± 1 flS) kunnen geen betrouwbare signalen worden 
opgenomen. Niettemin, een voorgestelde correctie. gebaseerd op de bepaling van de "offset" welke 
kan geschat worden bij een "zero flow' conditie. liet de bepaling toe van een CFR welke excellent 
overeenkwam met de gouden standaard gerneten met de Transonic catheter (bet gemiddelde ver-
schil tussen de twee CFR schattingen was 0±0.19 voor een gemiddelde CFR van 0.2). Deze resul-
taten beloven verder in vivo onderzoek. 
Karakterisering van Arteriele Wand Mechanismen door RF Processing (hoofdstukken 10-12): 
IVUS elastografie is een methode voor bet meten van de locale elastische eigenschappen van coro-
naire atherosclerotische plaques. Mechanische eigenschappen van de verschillende weefsels in een 
plaque worden gemeten via rek. In hoofdstuk 10 hebben we het werk gereviseerd van verschillende 
groepen die werken op het domein van vasculaire en non-vasculaire rek/spanning. We beschrijven 
in detail de methode ontwikkeld in ons laboratoriurn. en de voorlopige resultaten bekomen in tube 
fantomen, en later in humane coronairen. 
Hoofdstuk 11 handelt over preliminaire registraties in patienten, waarbij we bet nut van elas-
togrammen tijdens catheterisatieprocedures konden aantonen. In 12 patienten konden we repro-
duceerbare rekmetingen bekomen in einddiastole, wanneer de beweging van de catheter minimaal 
is. Ofscboon deze opnames bekomen werden via beeldvorming met een lage resolutie (64 hoeken 
van de "tlow mode"). konden we gedeeltelijk onze metingen valideren door een significant lagere 
rek aan te ton en in gecalcifieerde dan in non-gecalcifieerde regios (0.20 vs 0.51% respectievelijk, 
p<O.OOl). Ben gesimplifieerd, meer robust en bijna "real-time" intravasculair palpatiesysteem 
wordt beschreven in hoofdstuk 12. Samengestelde palpogrammen worden gemaakt met een 
1-dimensionele echo "tracking" techniek in combinatie met globale bewegingscompenstie en bet 
"multi-frame" middelen van verscbillende paren RF echo "frames" in diastole. RF registratie is nu 
gebaseerd op digitale "beam-formed" RF echo data (512lijnen) verzameld tot 12 bits bij 100 MHz 
en direct getransfereerd naar het PC geheugen met volledige frame rate (30 fps). We konden regis-
traties maken van consistente palpogrammen met goede contrast resolutie en elastografische sig-
naal tot ruis ratio onder fysiologische omstandigheden, die vragen voor verder 
klinische investigaties op grote schaal. Vergelijking van elastografie en palpografie met histolo-
gis~h materiaal bekomen met directionele atherectomie is een van de aan de gang zijnde va1idati-
estudies welke het klinische nut moet bewijzen van deze nieuwe beeldvormingsmoda1iteit die 
karakterisering van de arteriele wand mechaniek toelaat. 
Intravasculaire Ultrason en Intracoronaire Brachytherapie (hoofdstukken 13-16): 
We hebben het gebruik van IVUS in de tot nu toe uitgevoerde klinische studies van brachytherapie 
gereviseerd in hoofdstuk 13 waarin deze nieuwe therapeutische optie oak geintroduceerd wordt 
voor de preventie van restenose. Hoofdstuk 14 stelt de vergelijking voor, door simulatie. van ver-
schi1lende behandelingsstrategieen gebaseerd op ofwel f)- of y-bronnen met en zonder een cen-
treringsmiddeL Het introduceert de bepaling van dosis volume histogrammen vanuit 3-dimen-
sionele reconstructie van "ECG-gated IVUS pullbacks" welke onze groep als eerste rapporteerde. 5 
We toonden in 23 patienten behandeld in the Beta Energy Restenosis Trial in ons instituut aan dat 
de minimale dosis op 90% van het oppervlak van de adventitia enkel 37±16 % was van de 
voorgeschreven dosis. terwijl het 67±31% bedroeg op 90% van het luminale oppervlak. Door si-
mulatie zou het gebruik van een centreringsmiddel of y-bron deze waarden verhoogd hebben eve-
nals de mi-nimale dosis op de 10% meest blootgestelde luminale en adventitia oppervlakken ver-
minderd hebben, daarbij de homoge-niteit van de dosis verbeterend. Ofschoon op heden geen 
enkele klinische data deze rnogelijke voordelen ondersteunen. was het belang van ons pionierwerk 
dat het nut aantoont van de evaluatie van de dosis neergezet in de arteriele wand behandeld met 
brachytherapie, benadrukt in de editoriale commentaren van dit manuscript. 
In hoofdstuk 15 toonden we aan door bet bestuderen van 206 coronaire subsegmenten van 2 mm 
in 18 patienten behandeld voor een de novo lesie met enkel angioplastie gevolgd door 
~-brachytherapie, dat na 6 maanden follow-up het volume van de plaque minder toegenomen was 
in harde segmenten vergeleken met zachte segmenten en segmenten met normale/intimale 
verdikking. We toonden eveneens aan dat de minimale dosis neergezet op 90% van het adventitia 
oppervlak (D90adv) omgekeerd evenredig was met het volume van de plaque bij follow-up. We 
toonden ook aan in hoofdstuk 16 dat de 6-rnaand angiografische uitkomst in 27 patienten behan-
deld voor de novo Iesie met angioplastie al1een gevolgd door f)-brachytherapie gedeeltelijk kon 
verklaard worden aan de hand van de dosis gedeponeerd in de coronaire wand. Minimale doses op 
90% van het luminale oppervlak (DS90lum), de lamina elastica externa (DS9oeel) en op 90% van 
plaque+media volume (DV90p+m) waren 9.7±6.1 Gy, 5.1±3.0 Gy en 7.0±4.0 Gy respectievelijk. 
Na 6 maanden follow-up hadden de patienten met een DS90eel groter dan 5 Gy (n=ll) een lager 
angiografisch verlies (-0.01±0.39 vs. 0.47±0.62 mm. p=0.03) en "late loss index" (-0.4±58 vs. 
44±56 %, p=0.06). Deze arterien waren kleiner, maar de relatieve winst was identisch en het geob-
serveerde verschil in het verlies kon enkel de weergave zijn van de "remodelling" van de coronaire 
segmenten die een adekwate dosis ontvingen. 
Transthoracale echocardiografie voor de biomechanische evaluatie van bet linker ventrik:el 
en de aorta (hoofdstukken 17-20): 
Hoofdstuk 17 is een historisch overzicht van de ontwikkelingen van de cardiovasculaire echocar-
diografie waarbij studies geintroduceerd worden die gebaseerd zijn op de combinatie van simultane 
registratie van non-invasieve druk en flow (via transthoracale Doppler echocardiografie). 
In hoofdstuk 18 tonen we aan dat evaluatie van de totale arteriele compliantie (Ctot) gebaseerd op 
een 2-element Windkessel model (de "pulse pressure method") mogelijk is gebruikmakende van 
transthoracale echo-Doppler en arteriele tonometrie. In een studie uitgevoerd in 14 patienten met 
gekend of verdacht voor coronair lijden en in 9 vrijwilligers, was de evaluatie van Ctot met de 
"pulse pressure method" robust en toonde een significant verschil in arteriele stijfheid (1.2±0.4 vs 
1.6±0.2 ml/mmHg). Het was ook de beste methode om het verwachte omgekeerde verband te vin-
den tussen totale arteriele compliantie en leeftijd, in vergelijking met de "area method" en de ratio 
van slagvolume over polsdruk. 
Hoofdstuk 19 beschrijft de zoektocht naar een geoptimaliseerde transfer functie (TFF) welke de 
reconstructie toelaat van aortadruk vanuit een perifeer tonometriesignaal ter hoogte van de arteria 
radialis. We pasten een drie-segmenten transmissielijnmodel toe voor de radialis-carotis druk TFF 
afgeleid uit 31 gezonde vrijwilligers en 30 patienten met coronair lijden. 
Jammergenoeg konden we geen verschil aantonen in de parameters van dit model tussen patienten 
en controles, behalve wat betreft de distale reflectie coefficient. We beschrijven de gemiddelde 
berekende TFE evenals deze afgeleid van de minimale en maximale omgevende TFE en de vari-
abiliteit van de afgeleide aortadruk karakteristieken zoals centrale polsdruk of augrnentatie-index. 
resulterend uit het gebruik van elk. 
Tenslotte, in hoofdstuk 20 beschrijven we de evaluatie van de linker ventrikel (LV) functie en de 
contractiele reserve gedurende liggende stressechocardiografie via de bepaling van maximale ven-
triculaire "power output" gebruikmakende van simultane registratie van aortaflow met Doppler 
echocardiografie en aortadruk met arteriele tonometrie. We tonen een goede overeenkomst aan 
tussen de data afgeleid van carotisregistraties en van getransformeerde radialisregistraties gebruik-
makende van een TFF zoals beschreven in hoofdstuk 19. We valideerden eveneens een gesirnpli-
' fieerde index van linker ventrikel "power output" die we voor het eerst beschreven hadden in dier-
experimenten: bet product van peak aorta flow en gemiddelde bloeddruk. Dit surrogaat van de 
echte "peak power", minder omslachtig om te bekomen dan invasieve registraties of zelfs arteriele 
tonometrie, toonde dezelfde correlatie met de V02 gemeten in deze 25 patienten. 
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